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DBU 1,8  -diazabicy clo [5.4.0] undec-7 -ene
DEAD diethyl azodicarboxylate
DIBAL-H diisobutylaluminum hydride
DMAP 4 -(dimethy lamino)py ridine
DMF N  .N-dimethylformamide
DMPU 1,3-dimethyl-3,4,5,6-tetrahydro-2(l ƒ/)- 
pyrimidinone
El electron impact (in mass spectrometry)
Et ethyl
FMOC fluorenyl methoxycarbony 1
Gly glycine
HMPA hexamethylphosphoric triamide




mp melting point (range)
MS mass spectrometry
mjz mass to charge ratio (in mass 
spectroscopy)
NBS N-bromosuccinimide





pTS A pora-toluenesulfonic acid monohydrate
R ƒ retention factor (in chromatography)
THF tetrahydrofuran




APPLICATIONS OF ORGANIC HYDRAZINE DERIVATIVES
1.1 INTRODUCTION
Hydrazine (N2H4) is an inorganic compound which is conveniently handled in its 
hydrated form ( ^ H ^ ^ O ) . Hydrazine (p^ Ta 7.95) is a weaker base than ammonia (pATa 9.24), 
but unlike amines, its basicity is lowered when alkyl substituents are introduced (Table l . l ).1 
The basicity is further decreased if the steric bulk on the nitrogen atoms is increased, e.g. tri- and 
tetraalkylhydrazines with groups larger than butyl are nearly non-basic. Introduction of electron- 
withdrawing or electron-delocalizing substituents at nitrogen will also cause a substantial 
lowering of the pK R.
Table 1.1
Hydrazine pATa of the protonated hydrazine
n 2h 4 7.95
CH3NHNH2 7.85
c h 3n h n h c h 3 7.49
(Ch3)2n n h 2 7.12
(CH3)2NNHCH3 6.58
(CH3)2NN(CH3)2 6.10
Despite their relatively low basicity, hydrazine and its derivatives display a strong 
nucleophilic character and react more vigorously with alkylating agents and carbonyl compounds 
than amines. This phenomenon, known as the a-effect,2 is more generally observed in 
compounds that possess two adjacent heteroatoms with unshared electron pairs. One of the 
possible explanations for this effect is based on the repulsion between the adjacent lone pairs, 
causing a raised ground state energy. In the transition state, this repulsion between the two lone 
pair orbitals is decreased, as one of the lone pairs becomes involved in bond formation with the 
electrophilic reagent. The a-effect is substantial for substitution at a carbonyl or at unsaturated 
carbon atoms, but is generally smaller or absent for substitution at saturated carbon atoms.
n N/ ' x N 'N
> 1  II I
Ny1 2 ' 3 4




This thesis will mainly deal with synthesis and reactions of linear and cyclic tetrasubstituted 
hydrazine derivatives 4.
1.2 CONFORMATIONS OF HYDRAZINES
Compounds with adjacent heteroatoms are likely to adopt a conformation in which the 
lone pair orbitals on the heteroatoms are nearly perpendicular to each other (the dihedral angle 6 
~ 90°, Scheme 1.1). This ‘gauche-effect’ ,3 as it is called, is rationalized by two principal factors: 
repulsion between the lone pair orbitals4 and attractive lone pair-adjacent bonding pair 
interactions.5
Because of the relatively short N-N bond of cyclic hydrazines and the resultant large 
overlap between the lone pair orbitals, large torsional effects are observed. These effects cause 
that hydrazines form an attractive object for studies on conformational equilibria and the 
influence of the dihedral angle on the conformation of the hydrazines.6
Scheme 1.1
See
The conformation of a cyclic hydrazine is a result of both steric and electronic 
interactions. As an example, 1,2-dimethylhexahydropyridazine exists only in the 5ee and 5ae 
conformation, while the 5aa conformation is not found (Scheme 1.1). The See conformation is 
electronically destabilized (0 ~ 180°), but has the methyl groups in a favorable equatorial 
position. The 5ae conformation is electronically more favored (0 ~ 60“), but has unfavorable
1,3-diaxial Me,H interactions. If these diaxial interactions are reduced by introduction of a 
double bond, the ee conformation is no longer observed so that tetrahydropyridazine 6 exists 
only in the 6ae conformation.
Conformational changes at the nitrogens (inversion at nitrogen and rotation around the 
N-N bond) are also influenced by steric and electronic factors. Carbonyl substituents on the 
nitrogen atoms cause them to flatten completely if the lone pair orbitals can be perpendicular to 
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If this is not possible, substantial deformation of the nitrogens from planarity can occur. For 
example, the average bond angle at nitrogen (a(av)) in 8 = 119.5% whereas in the strained 
system 9 a(av) = 115.80.7
Like tetraalkylhydrazines, tetrasubstituted N,N' -diacylhydrazines also show a high 
rotational barrier around the N-N bond.7»8 The origin of this barrier is partly steric, as rotation 
around the N-CO bond is necessary to force the acyl groups past the alkyl groups. But it also 
has been shown that compared to the tetraalkylhydrazines the electronic component of this 
barrier is increased which is explained by a rehybridization of the nitrogen lone pair orbitals to 
essentially pure p character, causing a larger overlap between these orbitals.
In order to study inversion at the nitrogen atoms,6 rotation around the N-N bond,7*8 
conformations,9»10 and pATa values11 of hydrazines as well as other physical aspects of 
molecules containing an N-N moiety, numerous cyclic hydrazines have been synthesized and 
studied with various techniques like NMR,12 crystallography, cyclic voltammetry,1^  and 
photoelectron spectroscopy.14
1.3 AZAANALOGS OF PHYSIOLOGICALLY ACTIVE COMPOUNDS
In the past, many attempts have been undertaken to influence the potency of biologically 
active substances by synthesizing analogs of these compounds. Main targets in increasing the 
potency of these compounds are the manipulation of receptor and enzyme interactions and also 
the extension of duration of action of these compounds by inhibiting the generally fast enzymatic 
degradation. Some examples will be given to illustrate the potency of hydrazines in the synthesis 
of analogs of physiologically active compounds.
1 .3 .1  AZAPEPTTDES
Peptide analogs have been synthesized by either modification of the side chain or of the 
backbone structure of the amino acids, in such a way that the original structure and conformation 
of the peptide are largely preserved.
One compound class which looks promising as peptide analogs consists of the so-called 
azapeptidesll.14
10 11
Compared with ordinary peptides 10, the a-CH group in one or more amino acid residues is 




accessibility which enables any amino acid to be exchanged, irrespective of its position in the 
original peptide. Analogs of various amino acids have been reported, which include more 
complex amino acids such as tyrosine,15 tryptophan,15 asparagine,16 ornithine,17 proline,18 
glutamic acid,19 and pyroglutamic acid.15
Several decades ago, the first stepwise synthesis of such chain m olecules was 
described,20 while Hess et a l  reported the first natural product analog of this type namely 
[Azaval3]-angiotensin II (12 ).21 Through these studies, an impetus was given to further 
research directed at the synthesis of natural product analogs of biological interest.
1 2 3 4 5 6 7 8
Asp-Arg-Azaval-Tyr-Val-His-Pro-Phe
12
From a purely structural point of view, the CH/N exchange does not cause a major 
change in the conformation of a peptide as atomic distances, bond angles, and side chains remain 
the same. On the other hand, the chirality at the a-center is lost and the area of planarity is 
extended.16 This causes a change of conformational freedom, allowing the side chains to take up 
a conformation somewhere between the D- and L-conformation of the original amino acid.
Measurements have confirmed that the acidity of the NH function attached to the a-N  
atom is higher than in normal amino acids.22 This higher acidity favors hydrogen bonding, but 
prevents protonation at physiological pH 23 Thus, the modified ‘local’ configuration and the 
higher NH acidity will affect absorption, transport, enzyme/receptor binding and metabolic 
stability of the analog of a biologically active substance in the organism.
The physiological effects of local changes also strongly depend on other interactions in 
the peptide. Formation of H-bonds and the presence of Van der Waals and charge-transfer 
interactions in other parts of the molecule can largely ‘restore’ the shape of the original 
molecule 24 Of course, this will be more likely for larger than for smaller peptides.
The biological importance of the azapeptides will be demonstrated with only a few 
examples; many azaanalogs have been reported in various fields of action with promising 
inhibiting or stimulating effects.14d Some noteworthy results were found with azaanalogs of the 
decapeptide hormone luliberin (LHRH) (13).
1 2 3 4 5  6 7  8 9  10 
Glu-His-Trp-Scr-Tyr-Gly-Leu-Arg-Pro-Gly-NH2
13
It proved to be possible to prepare strong agonists with an ovulation-inducing effect, as 
well as antagonists causing total ovulation inhibition. The agonistic analogs with [Azagly6], 
[Azagly10] and [Azaala6] residues were many times more active than luliberin itself.14(1 If the 
[Azagly10] analog was substituted in the 6-position with the lipophilic amino acid 3-(2-
14
Applications o f organic hydrazine derivatives
naphthyl)-D-alanine, it was shown to be 100-230 times more active than luliberin.25 
Furthermore, [D-Ser(r-Bu)6, Azagly10]-LHRH was introduced into the pharma market as a drug 
for treating carcinoma of the prostate.2^
1 .3 .2  a-HYDRAZINOACIDS
In addition to N ~alkylated a-amino acids27 and N-hydroxy-a-amino acids,28 another 
class of analogs of a-amino acids 14 consists of the so-called a-hydrazino acids 15, in which 
the amino function is replaced by a hydrazino function. As a result of their strong resemblance to 
the corresponding a-amino acids, a-hydrazino acids are potential inhibitors of certain amino 
acid metabolizing enzymes, especially ammonia lyases29 and pyridoxal phosphate dependent 












Syntheses of these compounds have been achieved by reduction of a-diazo esters,32 
nitrosation and reduction of amino acids,^ Hofmann rearrangement of a-ureido acids34 and 
treatment of a-halocarboxylic acids with hydrazine.35 However, these methods often suffer 
from low yields and loss of optical purity. Some new methods have been introduced, which are 
based on amination of silyl enol ethers and lithium enolates with azodicarboxylates.31»36 More 
recently, a-hydrazino acids were prepared by reaction o f r-butyl carbazate with 2-{[(4- 
nitrobenzene)sulfonyl]oxy }(2-nosyloxy) esters and 2-triflyloxy esters in high yields.37
\  Me, PH
L~ 156,602 (16)
a-Hydrazino acids also occur in nature, although infrequently. Examples are hexa- or
15
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tetrahydropyridazine-3-carboxylic acids (piperazic acids), which are incorporated in larger 
molecules. One of them is the cyclic hexadepsipepdde antibiotic L-156,602 (16),38 which was 
isolated from cultures of Streptomyces ssp. MA6348.39 In this molecule two of such piperazic 
acid moieties are present in the large ring. These piperazic acid residues have also been used as a 
building block in analogs of A.C.E. inhibitors.40
OH NH2  O Me
h2n n ,  N ^ c o 2h
H
(+)-negamycin ( 2  2 )
A linear naturally occurring a-hydrazino acid is (+)-negamycin (22),41 an antibiotic that 
was isolated from cultures of the Streptomyces purpeofuscus. Several total syntheses of this 
molecule have been published.42
1.3.3 p'LACTAM TYPE ANTIBACTERIALS
p-Lactam antibiotics act by binding to and inhibiting the action o f various 
transpeptidase/carboxypeptidase enzymes (the penicillin-binding proteins (PBPs)) which are 
involved in the synthesis of bacterial cell wall peptidoglycan. A ‘fit’ at the active site of the 
enzyme and a reactive P-lactam ring are both necessary for acylation and inhibition of these 
enzymes. While searching for new classes of antibiotics 43 many compounds were tested in 
which the p-lactam ring system was replaced by a chemically activated 7-lactam ring system. 
Among these substances were the bicyclic pyrazolidinone LY 186826 (23 )44 and the 





These bicyclic pyrazolidinones were the first non-p-lactam containing compounds that 
were reported to bind to the PBPs. Especially, LY 186826 (23) showed a very strong activity in 
inhibiting bacterial cell wall synthesis, which is even larger than that of several penicillins and 
cephalosporins.44 The homologous bicyclic tetrahydropyridazinone 24 was also expected to be 
sufficiently reactive to exhibit antibacterial activity. However, no activity was found in the tests, 
which was explained, after various modeling experiments, by the presence of too much steric 
bulk of the tetrahydropyridazinone ring, which hinders good binding to the PBPs.
16
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1 .3 .4  (3-TURNMIMICS
Several conformation ally restricted nonpeptide mimetics were designed by Kahn et al. in 
order to investigate the relationship between peptide structure and function. Among these 
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Stimulated by molecular modeling experiments of the interactions between inhibitors and 
the enzyme HIV-1 protease, both systems 26 and 2748 were connected to a peptide chain and 
tested for their activity in inhibiting HIV-1 protease49 This enzyme is essential for viral 
replication and thus represents an ideal target for antiviral therapy. The P-tum mimetics 26 and 
27 proved to exhibit moderate to good activity against HIV-1 protease and might therefore serve 
as lead compounds for the development of more potent HIV-1 inhibitors.
1.4 N-N-BONDS AS A TOOL IN ORGANIC CHEMISTRY
Hydrazines possess, compared with C-C bonds, relatively weak N-N bonds which are 
easily oxidized to N-N double bonds, cleaved or which rearrange to the corresponding amides or 
medium-si zed lactams. Therefore, a hydrazine moiety in a molecule can serve as a versatile tool 
for further transformations. Some applications of these possibilities will be illustrated.
1 .4 .1  CLEAVAGE OF N-N BONDS
Reductive cleavage of N-N bonds in hydrazines has been achieved by various methods 
such as hydrogenation,50 reduction with diborane,51 electroreduction52 and reduction with 
Raney nickel53 and dissolving metals.54 This approach is not often used, but can be a suitable 
method for the synthesis of cyclic amines and lactams that are less easily accessible via other 
sequences.
In general, it appears that the ease of the reduction is strongly related to the structure of 
the hydrazine that is involved. The ease of the reduction can be enhanced by relief of strain in the 






This concept has been applied in the synthesis of some natural products like saxitoxin,56 
celacinnine57 and glidobacdn antibiotics.58 An example of the reduction with a dissolving metal 
is the reaction of the bicyclic hydrazine 28 with Na in NH3 to give the nine-membered azalactam 
29 (eq 1.1), which is a key intermediate in the synthesis of the alkaloid celacinnine.57
1 .4 .2  THE 3,4-DIAZA-[3,3]-SIGMATROPIC REARRANGEMENT
The 3,4-diaza-[3,3]-sigmatropic rearrangement has often been applied in synthetic 
organic chemistry 59 Both aromatic and aliphatic versions of this reaction are known. An 
important example of the aromatic rearrangement is found in the Fisher indole synthesis (eq 
1.2), in which the first step, the conversion of an enylhydrazine 30 to a diimine 31, is believed









After the sigmatropic shift, the diimide reacts further with loss of methylamine to the indole 32. 
Aliphatic versions of the rearrangement are also possible, starting from substituted bis(enyl)- 
hydrazines and leading to the corresponding substituted pyrroles.61
















An interesting example of this anionic sigmatropic shift is shown in eq 1.3. The diacylated 
pyrazolidine 33 is converted into the dienolate 34 by deprotonation with LDA, which 
immediately rearranges to the medium-sized ring system 35. Protonation affords the medium-
18
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sized lactam 3 6 as a mixture of diastereomers.62
1 .4 .3  PHOTOCHEMICAL REARRANGEMENT TO N -AMINO P-LACTAMS
A novel approach for the synthesis of p-lactams from 3-pyrazolidinones was presented 
by Johnson et al,63 and further elaborated by White and co-workers.64 Irradiation of the 
(substituted) 3-pyrazolidinones 37 afforded in moderate to good yields the //-amino substituted 
azetidinones 4 0.
The proposed mechanism for this photochemical rearrangement is shown in eq 1,4.
R’
r / - v











OA NxR (eq L4)
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Irradiation of the pyrazolidones 37 with light (k < 300 nm) will give the biradical 38, that reacts 
via the bicyclic diaziridinium ion 39 to the W-amino-p-lactams 40, The cleavage of the 
diaziridinium C-N bond is assisted by the presence o f the electron-withdrawing acetyl 
substituent at the nitrogen atom, ensuring that the reverse reaction is not taking place.
1.5 THE REACTIVITY OF (SUBSTITUTED) IMINIUM IONS
Iminium ions 4 land 42 are well-known to react in inter- and intramolecular processes as 
electrophilic species with various nucleophiles like alkenes, alkynes, arenes, silyl enol ethers, 
allylsilanes and vinylsilanes.65 They are, therefore, useful intermediates in the synthesis of 
numerous azacycles 43 and natural products.
The conjugate base of an iminium ion, i.e. an imine or enamine, is a relatively strong 
base, which facilitates the formation of the iminium ion. Thus, the iminium ion can be generated 
under almost neutral conditions.
A
41 42 43
Introduction of electron-withdrawing substituents onto nitrogen renders the imine less 
basic and thus makes the formation of the iminium ion more difficult. N -Acyliminium ions, as an 
example, can be generated only under acidic conditions. Recently, Seebach and co-workers
19
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showed that after introduction of a formyl or nitro function on nitrogen the resulting iminium 
ions were strongly destabilized.66 By using oh initio calculations, they compared the reactivity of 
an N-formyliminium (45) and an N-nitroiminium ion (46) with an oxycarbenium ion, present in 
the same molecule (eq 1.5). The formyl group destabilizes the iminium ion, but leaves it still 
more stable than the oxycarbenium ion, so that product 44 will be formed. The nitro group 
appears such a strongly electron-withdrawing group that reaction will take place with the 










44 4 5 X = CHO 
46 X -  N 02
47
The above reasoning leads to the expectation that introduction of an amino function 
should have a similar effect, as the inductive electron-withdrawing effect of the nitrogen atom 
will be more important than the mesomeric electron-donating influence. The latter can be 
visualized by considering the unlikely resonance structure 49 that will be formed by resonance 
stabilization of the positive charge of the hydrazonium ion 48 (eq 1.6).
Y 1-  A Y^ A
V N ' + S '1 1 (eq 1.6)
Although an enhancement of the reactivity is expected, this type of intermediate has, in 
contrast with iV-oxygen substituted iminium ions,67 never been used in electrophilic addition 
reactions. In the literature, some examples are known in which hydrazonium ions are generated. 
They are obtained as the stable salts 51 and 5 3 from the corresponding hydrazones 5 0 and 5 2 
upon alkylation (eq 1.7) or protonation with a strong acid (eq 1.8).68
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X (eq 1 .8 )
Other derivatives of these hydrazonium structures are the ylide-like intermediates 54 
which consist of a hydrazonium part which is both positively and negatively charged.69 These 
ylides are stable structures, which serve as useful dipolarophiles in both inter-70 and 
intramolecular71 cycloaddition reactions (eq 1.9) with olefins and acetylenes to give various 
bicyclic hydrazines. Hydrolysis of these ylides leads to the deprotected hydrazines.72 It has been 
shown that nucleophilic addition reactions can be carried out with the anionic part73 whereas the 
iminium part has been used as an electrophile in Grignard addition reactions.74
R






C 02Me (eq 1.9)
55
The more reactive equivalents of iminium ions, the N-acyliminium ions, have proven to 
be extremely useful intermediates in cyclization reactions as they react readily with a variety of 
nucleophiles 75 In addition to hydrazonium ions and iV-acyliminium ions, /V-acylhydrazonium 
ions such as 56 are expected to be even more destabilized as a result of the combined effect of 
the two electron-withdrawing substituents. These species might therefore display a high 
reactivity in intramolecular addition reactions (eq 1.10).
Y
55 56
*  ( e q U 0 )
I  I
57
Such a reactivity would make them useful intermediates in the synthesis of cyclic hydrazine 
derivatives 57 . The reactivity o f N -acylhydrazonium ions has not been described in the 
literature.
1 .6 NUCLEOPHILES IN INTRAMOLECULAR ADDITION REACTIONS
As stated earlier, numerous nucleophiles have been used in intramolecular additions. 
Overman et at. compared the reactivity of several rc-nucleophiles in intramolecular reactions of
21
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iminium ions in acetonitrile 65 For example, in the case of amine 58 (eq 1.11), the unsubstituted 
(Z)-vinylsilane reacts faster than the substituted (Z)-vinylsilane moiety as is concluded from the 
ratio of the six-membered tetrahydropyridines 5 9 and 6 0.
Me3Si
Me3Si
ch2o, r s o 3h




5 9 70% 6 0 20%
In this type of reaction, it was found that allylsilanes 61 show the highest reactivity, 
followed by the substituted olefin 62, which in turn is more reactive than both vinylsilanes 63 
and 64 . The unsubstituted olefin 68 showed a reactivity which is equal to that o f the 














The high nucleophilicity of allylsilanes76 propargylsilanes and vinylsilanes76 in this type 
of cyclization reactions can be explained by invoking the p-effect77 The double or triple bond of 
the silane is more nucleophilic as. the positive charge of the intermediate 70 can be stabilized by 
the silicon atom. This is only possible if the positive charge develops at the P-position with 
respect to the silicon atom, so that a strong directive effect is observed as well (eq 1,13). Attack 
of a nucleophile on silicon then leads to the formation of the olefin 71.
SiMea E+
69
Si Me* Nuc + NucSiMe3 (eq 1.13)
There is evidence that the conversion shown in eq 1.13 is not a concerted reaction, in 
which nucleophilic attack at the silicon atom and attack of the olefin are taking place
22
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simultaneously, but that the whole process occurs in two steps, with the carbocation 73 as an 
intermediate.77 The stabilization of the positive charge may occur either via the three-membered 
ring siliconium ion 72 in which pentavalency of silicon is permitted by its d-orbitals, or by 
hyperconjugation (74) as shown in eq 1.14.
Me3




In both cases, the positive charge is stabilized by the less electronegative silicon atom. In 
addition to these mesomeric effects, there is also the inductive effect of the more electropositive 
silicon which assists in stabilizing the positive charge.
Throughout this thesis, several of the above nucleophiles will be subjected to reaction 
with N -acylhydrazonium ions in order to prepare new cyclic hydrazine derivatives.
1.7 PURPOSE OF THE INVESTIGATION
In this thesis, the reactivity and the usefulness of several types of N -acylhydrazonium 
ions in the synthesis of cyclic hydrazine derivatives will be discussed.
In Chapter 2, the synthesis o f simple hydrazines via cyclizations with N \N  
diacylhydrazonium ions as intermediates will be detailed.
In Chapter 3, attention will be focused on the deprotection of cyclic hydrazines, in which 
both nitrogens are protected with allyloxycarbonyl functions.
In Chapter 4, endocyclic N -acylhydrazonium ions will be utilized in the synthesis of 
bridged bicyclic hydrazines.
In Chapter 5, the synthesis of an azaderivative of cocaine will be described as well as 
some studies towards a synthetic route to chiral bridged azabicyclics.
In Chapter 6, exocydic //-acylhydrazonium ions are applied in the synthesis of bicyclic 
[3.3.0] and [4.3.0] pyrazolidinones. In this way, both simple bicyclic hydrazines and bicyclic a -
hydrazino esters were prepared.
In Chapter 7, ot-methoxycarbonyl substituted //-acylhydrazonium ions are applied in the 
synthesis of cyclic a-hydrazino acids.
Parts of this thesis have already been published.78
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SYNTHESIS OF CYCLIC HYDRAZINE DERIVATIVES VIA 
N ,N ’ -DIACYLHYDRAZONIUM INTERMEDIATES1
2 .1  INTRODUCTION
Substituted cyclic hydrazine derivatives of type 1 are known compounds which have 
been synthesized via several methods.2 Among these methods, one of the most important 
reactions for the synthesis of six-membered rings is the hetero Diels-Alder reaction of azo 
diesters with 1,3-dienes.3 Methods for the synthesis of other rings include: dialkylation of 
hydrazo 1,2-diesters with a , G> dihalides 4 a,co-dimesylates5 or a,co-ditosylates,6 and reductive 
condensation of hydrazines with a , û>-dialdehydes7. In this Chapter, attention will be focused on 
a novel approach for the synthesis of this type of compound, which will lead to a larger choice of 
cyclic hydrazines 1 of different ring sizes and with various substitution patterns. The outline of 
the method is given in eq 2.1 in retrosynthetic form.
R 0 2C .
r o 2c
R 0 2 Cn ^
I
R 0 2C * " + ^
1 2




The cyclic hydrazines 1 are formed by an intramolecular attack of the internal nucleophile 
at the electrophilic 1,2-diacylhydrazonium ion 2. The hydrazonium ions 2 are generated from the 
precursors 3 under the influence of a Lewis or a Br0nsted acid. These precursors, in turn, are 







X n . n y o
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Compared with the well-investigated iV-acyliminium ions 5 , 8 the N ,N ’-diacyl- 
hydrazonium ions 6 bear an extra electron-withdrawing substituent i.e. an amide function. This 
substituent will have an extra destabilizing effect on the positive charge, thus resulting in 
relatively difficult formation and a more electrophilic character of the hydrazonium ions relative 
to the corresponding iminium ions.9
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It might be somewhat naive to expect that this increased electrophilicity will lead to a 
higher reactivity. It is important to take into account that in this type of intermediate, there is an 
sp2-center at the a-position relative to the iminium part, which might influence the transition 
state of the cyclization reaction. Furthermore, the amide function is a reasonably good leaving 
group, which might cause cleavage of the relatively weak N-N bond prior to formation of the 
hydrazonium ion. Another problem could be that the more severe conditions which are required 
for formation of the intermediates, will give rise to side reactions or decomposition*
2 .2  SYNTHESIS OF THE AZO ESTERS
An example of the synthesis of azo esters is presented in eq 2.2, Generally, hydrazine 
hydrate is easily 1,2-diacylated with a chloroform ate10 to give the corresponding hydrazo 1,2- 
diester 7, which can be further oxidized to the azoester 8 . Several methods11 are known for this 
oxidation, but in the case of the diallylhydrazo ester 7, only treatment with Pb(OAc)4 in cold 
CH2CI2 gave a satisfying result.12 Other azodicarboxylates (dimethyl, diethyl, diisopropyl or 
di-terf-butyl) are all commercially available.
X X X I
Y (2 equiv) Alloc,, Pb(OAc)4 (1 equiv) Alloc
H2 NNH2 H20  ------------------ -- I -------------------- -- ff (eq 2.2)
i q c q ,  ( 1  equiv) Alloc'' C H j C l j , 0 o C  A | | 0 C ^ N
Et0H/H20, 0 °C 7 gg%
8 86%
2 .3  SYNTHESIS OF THE HYDRAZIDES
Monoalkylated hydrazo esters 9 can be synthesized via different methods, such as ene 
reactions of olefins with azodicarboxylates13 and 1,4-additions to azodicarboxylates. By using 
the latter route, alkyl- and aryllithium compounds,14 lithium enolates (eq 2.3)15 and silyl enol 
ethers16 have been aminated via a 1,4-addition. However, only one example of an addition of a 
Grignard reagent to azo esters is known.17
n„C0 2R  ^-78 °C—» it RS - C 0 2R
( e q  1 3 )




slurry of the azo ester 4 in ether or THF
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Table 2.1. Addition reactions to azodicarboxylates.
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2 1 R = Me (64%)
22 R = Et (63%)













The results of these addition reactions are summarized in Table 2.1. The choice of 
alkenyl halides and azodicarboxylates was primarily aimed at determining the scope of this 
method. The iodides 1 8 18 and 2 4 19 were prepared from the corresponding alcohols2® via the 
mesylates, whereas bromide 20 was prepared from the alcohol21 via the tosylate.22
The addition reaction usually proceeded in moderate to good yields, although in some
f
cases (entries 6 and 9) rather low yields were obtained. These latter unsatisfactory results could 
be partly explained by incomplete conversion of the halides into the corresponding Grignard 
reagents, which was concluded from the amount of unreacted magnesium that was recovered 
after the reaction. The results in the Table also show that variation of the protective groups does 
not lead to significant changes in the yield of the addition reaction.
It appeared that hydrazide 25 could not be prepared via a Grignard addition. This is 
probably due to a rearrangement of the Grignard reagent. The compound was eventually 
synthesized by a simple alkylation of the hydrazo ester 7 (NaH (1.1 equiv), DMF, 0 °C —» rt) 
with the suitable iodide 24.
MeC^C,*
„  ^ , 1  ------------------------------------ ,
Me02(T H ^ S iM e 3 A Me02 C"NH ^SiMe;
2 7  (£)/(Z) 1:1.5 (82%)
(eq 2.4)
In order to obtain the vinylsilane 2 7 , another route was chosen .23 If dimethyl 
azodicarboxylate was heated in allyltrimethylsilane (1 equiv), an ene reaction occurred (eq 2.4) 
to produce a 1:1.5 mixture of (E)- and (Z)-isomers in almost quantitative yield (according to 
NMR data of the crude product). After distillation, the pure (£)/(Z)-mixture was obtained in 82% 
yield.
2 ,4  LEWIS ACID-MEDIATED CYCLIZATION REACTIONS
The cyclization precursors 28-38 could be obtained in a straightforward manner upon 
deprotonation with NaH and subsequent alkylation with chloromethyl methyl ether in DMF. In 
this way, a unit with a good leaving group was introduced. These alkylations proceeded in 
fair yields, as summarized in Table 2.2. Under these conditions hydrazide 21 was found to give 
a considerable amount of the desilylated product. After treatment of the crude mixture with 
CsF/n-Bu4NF in THF, 3 6 was obtained in 49% yield.
From the same Table, it is evident that the yields of the cyclization reactions vary. At 
first, some attempts were made to cyclize the di-terf-butoxycarbonyl precursor 29. This would 
lead to cyclic hydrazines protected with teri-butoxycarbonyl functions, which can be removed 
under relatively mild acidic conditions. This acid-1 ability, however, seriously thwarted the 
cyclization reactions.
32
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Table 2.2. Lewis acid-m ediated cyclizations.













n = 1: 28 R 
n = 2: 29 R 
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n = 1:39 R = Me (32%)
n = 2: 40 R = Me (80%) 





































Under the influence of Lewis acid (TÍCI4 or SnCl4 (2 equiv), -78 °C —> rt) no cyclization 
occurred, and loss of the /err-butyl groups was observed. Reaction at lower temperature (TÍCI4 
(2 equiv), -78 °C) or with a milder Lewis acid (BF3’OEt2 (2 equiv), 0 *C rt) only afforded 
starting material.
Treatment of methallyl precursor 32 with SnCl4 (2 equiv, -78 °C —» rt) led to a small
»
amount of cyclization product 42 , together with unreacted 32 , whereas TÍCI4 (2 equiv, -78 “C 
—> rt) led to complete formation of 42. Therefore, all cyclizations were carried out with TÍCI4 
(except for entries 8,10  and 11).
It is remarkable that there is a large yield difference in the formation of the six- and 
seven-membered rings 39 and 40, respectively (entries 1 and 3). As this type of cyclization 
reaction is comparable to the corresponding iminium24 and iV-acyliminium ion8 cyclizations, the 
reaction is likely to occur via the chair-like transition state 51, similar to its iminium analog 50. 
The observed difference in yield is probably due to the two adjacent carbamate functions. 
Conformational studies indicate that 1,2-diacylated hydrazines prefer a conformation in which 
both nitrogen lone pair orbitals are perpendicular to each other (0 = 90°).25 Such an electronic 
effect implies that the transition state 51 is relatively strained as a result of the smaller dihedral 
angle (0 ~ 60°) between the carbamates. In addition to this effect, the transition state 51 will be 
even more strained by the presence of an additional angle of ca. 120* in the molecule compared 
with 50. These effects will be smaller in the conformationally less strained transition state 52 of 
the seven-membered ring. Another (steric) reason for favoring the latter transition state might be 




On the other hand, despite the longer chain, the eight-membered ring 41 was formed in 
low yield. This result is in agreement with the usually observed more difficult formation of 
medium-sized rings. The (Z)-hexenyl precursor 33 led to an inseparable mixture of 
diastereomers of six- and seven-membered rings 43 and 44 (entry 6) which could not be further 
characterized because of the complex NMR spectra (for spectral data and proof, see: Section
2.9). Consistent with the proposed transition state, formation of the seven-membered ring is 
more likely to occur, but NMR data show that the six-membered ring is formed as well.
Slightly higher yields were obtained in the synthesis of six-membered rings, if more 
activated nucleophiles were used such as thé methallyl precursor 32 and the allylsilane 35. 
Upon treatment of 35 with TiCl4 (2 equiv, 20 min at -78 °C) only protodesilylation was 
observed, resulting in formation of precursor 31. The protodesilylation is probably a result of 
the presence of traces of HC1 in the T1CI4-solution. Therefore, BF3*OEt2 was used to cyclize the
34
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allylsilane 35, the propargylsilane 37 and the vinylsilane 38. CycHzation of the propargylsilane 






The differences in yields of the various six-membered ring products are also remarkable. 
Both the phthalazide 45 and the tetrahydropyridazine 49 are obtained in significant higher yields 
than the other six-membered rings. This behavior might be explained by the conformation of the 
final products. They will adopt a half-chair conformation27 (eq 2.5) in which the strain between 
the carbamates is decreased compared with a normal chair conformation. This more stable 
conformation of the final products might already be felt in the transition state 53, thus giving rise 
to higher yields.
2 .5  CHLORIDE AS A LEAVING GROUP
In order to improve the yield of the cyclization products in entries 1 ,4  and 6 (Table 2.2), 
the precursors 2 8 ,3 1  and 3 3 were activated by substitution of the methoxy group by a better 
leaving group in the form of a chlorine atom.28 Variation of the leaving group will affect the 
equilibrium between the precursor and the corresponding hydrazonium ion.
Table 2.3. Chloride as a leaving group.
entry chloride (yield) a cyclization product(s) (yield)
M e0 2C^
1 N
M e0 2C ' N's^ CI
56 (61 %)





M e0 2CX 
3 y













2 —  41 (8%)
+




43 and 44 (20%)
59 (39%)
Me02Cs 
Cl +  
Me02C"
60 (29%)
a) PC15 (1.5 equiv), CCI4 , 0 °C (yield after filtration and concentration in vacuo)
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A better leaving group will lead to an increased concentration of the hydrazonium ion and 
hence will result in a higher cyclization rate. Treatment of the methoxy compounds 28, 31 and
33 with PCI5 afforded the corresponding chlorides 56-58 in good yields (Table 2.3). These 
chlorides were reacted with TiCl^ (2 equiv, -78 °C —> rt) thereby providing the cyclization 
products as summarized in Table 2.3.
Formation of the 6-membered ring 3 9 was indeed improved, but in the other cases side 
products were also obtained. Formation of the eight-membered ring 41 was accompanied by 
formation of the pyrrolopyrazole 59 , which is formed in a transannular reaction of one of the 
nitrogen atoms with the electrophilic carbon ring atom (eq 2,6).4b*22 This bicyclic product was 





Cyclization of the (Z)-hexenyl precursor 33 led to the formation of a mixture of six- and 
seven-membered rings 4 3 and 4 4 in addition to the elimination product 6 0. The latter product 
has the (¿^-configuration as concluded from the *H NMR spectrum (^CH=CH = ^ .2  Hz).
2.6 C YCLIZATIONS WITH FORMIC ACID
Table 2.4. HCOOH cyclizations.









2 36 R=rMe,Ri = H,R2 = Me
3 63 R = Et, Ri = H:SiMe3 1:1.
Rj = CH2CH2OMe
4 65 R = allyl, Rj a H:SiMe3 1:1,
R2 = CH2CH20Me
40 °C, 18 h







62 R = Me (83%) 
64 R = Et (64%)a
66 R = allyl (53%)a
a) yield after introduction of the 2 -(ethoxymethoxy)methyl function and cyclization.
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Several precursors were also subjected to Br0nsted acid conditions in order to be 
cyclized. They were dissolved in neat formic acid and as stirring at room temperature did not 
lead to any cyclization product, reactions were performed at 40 °C (Table 2.4). The hydrazide 30 
afforded in high yield the seven-membered formate 61 after 18 h, while for the acetylenes 36, 
63 and 65 (entries 2-4) even longer reaction times were required (42 h). The use of the 2- 
(ethoxymethoxy)methyl group gave slightly lower yields than the methoxymethyl group. The 
crude mixtures 63 and 65 of silylated and desilylated acetylenes afforded the corresponding 
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Literature examples show that precursors for the cyclization reactions can also be 
generated in situ starting from the monoalkylated hydrazides by treating these with 
formaldehyde30 or 1,3,5-trioxane31 under acidic conditions. Results of the application of these 
methods are summarized in Table 2,5. Surprisingly, the allyl precursor 10 did not give 
cyclization under these conditions, despite the formation of the cyclization precursor 7 0. On the 
other hand, the more easily formed seven-membered ring 61 was obtained in a reasonable yield.
Table 2.5. HCOOH cyclizations.










n = 1 : 1 0  
n = 2 : 1 2
R O a c
„ .N H
r o 2c
= Me16 R 
16
17 R = /-Pr 
17
1.3.5-trioxane (1.3 equiv), 70 °C
1.3.5-trioxane (1.3 equiv), 40 °C
1.3.5-trioxane (1.3 equiv), 70 °C 
(CH20 )n (1.5 equiv), 70 °C
1.3.5-trioxane (1.3 equiv), 90 ÔC 

















The less nucleophilic acetylenes did not cyclize under these conditions. The benzyl 
precursors 16 and 17 easily gave cyclization under several conditions. Slightly lower yields
37
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were obtained for the more hindered di(isopropoxycarbonyl) substituted hydrazines.
These results are in agreement with those that were found starting from the 
methoxymethylated precursors. Apparently, formic acid is a less suitable acid for the generation 
of this type of hydrazonium ions, so that cyclization is less likely to occur. Under these 
circumstances only the favored seven-membered rings and phthalazides are obtained in 
reasonable yields.
2 .7  ATTEMPTS TO INTRODUCE A GLYOXYLATE MOIETY
Introduction of a methoxymethyl function in hydrazides like 16 leads, after cyclization, 
to cyclic hydrazine systems, which bear no substituents at the a-position. Introduction of a 
methoxycarbonyl group at this a-position would lead to a-amino acid type compounds, in 
which an amino function is attached to the nitrogen atom. Considering the biological importance 
of amino acids in general and the extensive interest in analogs, it would be interesting to study 
the synthesis of this compound class.
Several attempts were made to synthesize precursors, which bear both a 
methoxycarbonyl function and a leaving group at the a-position. Possible routes to obtain these 
products from 16 include condensation reactions with methyl glyoxylate,32 and alkylations with 
methyl chloromethoxyacetate33 or methyl chloro(phenylthio)acetate34 under Lewis acidic and 
basic conditions. Unfortunately, neither of these methods were successful (for positive results 
with methyl glyoxylate, see: Sections 6.3 and 7.3). Attempts to introduce a bromine atom in 
hydrazide 58  at the a-position via a radical mechanism (NBS, CCI4)35 only led to 
debenzylation, probably via hydrolysis of the intermediate hydrazonium ion after bromination at 
the benzylic position.
Precursor 7 2 was prepared in order to investigate whether a thiophenyl function could be 
introduced with a strong base (LDA, 2 equiv) and PhSSPh (1 equiv).36 In this case, 2 equiv of 
base were used as the enolate anion of the desired product is more stable than that of the starting
9
material and therefore could give dialkylation. Surprisingly, sulphenylation did not take place, 
but instead the rearranged product 73 was obtained (eq 2,8). Variation of temperature or base 
could not prevent the formation of this rearranged product as is shown in Table 2.6,
1) NaH (1.1 equiv),
Me02 Cs DMF, rt Me02 CN J  base, ^  ,
1 ------------------------ 1 ---------- ► Me02 C ' Y  'C O zMe (eq 2.8)
Me02C 2)ClCH2C02Et Me02C' ^  PhSSPh ¿ 0 Et
(1.2 equiv), C0,Et
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Table 2.6.
entry base (equiv) PhSSPh (equiv) T (°C) solvent produces) (yield)
1 LDA (2) 1.1 -78 —^ rt THF 73 (41%)
2 NaH (2) 1.1 -78 rt THF 7 3 (20%)
3 LDA (2) 1.1 -115 THF/hexane 7 3 (8%) + 7 2 (58%)
4 LDA (1) 0 -78 —^ rt THF 73 (59%)
Similar rearrangements of hydrazides have been reported in literature.37 The enolate 
anion 74 attacks the p-nitrogen atom, while the other nitrogen serves as a leaving group (eq
2.9). The nucleophilicity of the enolate anion and the stabilization of the negative charge in the 
rearranged product are believed to be important factors which are involved in this reaction. If the 
reaction was carried out without PhSSPh and only one equiv of LDA (entry 4), the rearranged 
product 7 3 was obtained in a reasonable yield.
58
Ph









2 N ^ C 0 2Et
75
-  73 (eq 2.9)
2 .8 CLEAVAGE OP THE N-N-BONDS
Various examples are known in which cleavage o f the N-N-bond is useful for the 
preparation of linear or cyclic diamines.38 Reductive methods are most often used such as 
lithium or sodium in NH3 or LiAlH^ Cyclic products 45 and 77 (the keto function was 
protected as a dioxolane) were subjected to these conditions (Li (4 equiv), NH3, -78 6C —> rt) to 
give the ring opened diamides 76 and 78. Remarkably, debenzylation is not encountered under 
these conditions.
Table 2.7. Cleavage of the N-N-bond.
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Cleavage of the carbamates will lead to primary diamines. The diamide 7 6 might also be 
prepared by reduction of 1,2-dicyanobenzene, but the diamide 78 is less accessible via other 
routes. Cleavage of these types of cyclic hydrazides might therefore be useful in order to obtain 
functionalized primary diamines.
2 .9  NMR DATA AND STRUCTURAL PROOF
The presence of two carbamate functions in almost all of the molecules described in this 
chapter often caused significant line-broadening and appearance of rotamers in both and ^ C  
NMR spectra. In particular, the spectra of the methoxymethylated hydrazides and the cyclization 
products were often difficult to interpret. These rotamers are in the case of the first group a result 
of hindered rotation around both the N-N and amide bonds and in the latter group only a result 
of hindered rotation around the amide bonds.25,27
Spectra of a typical example are shown in Figure 2.1. In the NMR spectrum in 
CDCI3 and DMSO-d6 all ring protons of pyridazine 46 appear as broad multiplets. On heating 
the solution to 70 °C in DMSO-^6 the signals of the spectrum considerably shaipened (Fig 2.3). 
£15^ appears as a double quartet (3/ ^  =4.5 Hz, 3Jm  -  2/  ~ 12.8 Hz), while H5gq appears as a 
broad doublet (V  = 12.0 Hz). Both H3ax and H6ax show a triplet ( =  V  = 12.4 and 13.1, 
respectively), whereas H6ax also shows another small coupling (3/ ae »1 .5  Hz). The other ring 
protons (H4, H3eq and H6eq) only appear as multiplets. Unfortunately, higher temperatures did 
not allow complete assignment of the NMR spectra in all cases.
2.10 DISCUSSION
From the results of the cyclizations via the intermediate N ,N’ -diacylhydrazonium ions 
compared with those of iV-acyliminium ions,8 a few conclusions can be drawn. Several 
observations point to the fact that formation of this type of intermediate is indeed more difficult 
than that of the N-acylirninium ions. For instance, a strong Lewis acid (TiCl^) has to be used 
with most nucleophiles. Another indication is that at -78 °C the hydrazonium ion is not formed, 
but that cation formation and cyclization take place at higher temperatures. A similar observation 
is made with the formic acid cyclizations. The reaction mixture has to be warmed up in order to 
get a reaction. However, formic acid is less suitable than TiCl4 to induce cyclization. Only if 
cyclizations with TiCl  ^proceed well, formic acid also affords a good result. If the barrier for 
cyclization is increased (low yields with T1CI4), cyclization with formic acid does not occur, 
even at higher temperatures.
In contrast with ordinary iminium ion cyclizations, formation of six-membered rings via  
N,N’ -diacylhydrazonium ions is not particularly favorable, unless the final products possess 
some special features like the phthalazides and the tetrahydropyridazines.
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The remarkably facile formation of seven-membered rings might be a result of a less 
strained transition state compared with six-membered rings, caused by a more favorable 
conformation of the adjacent carbamate functions.
In conclusion, it is evident that a variety of cyclic substituted hydrazides can be prepared 
via this method. The efficient formation of the seven-membered rings is particularly interesting 
because such products are not readily accessible via other methods.
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2.11 EXPERIMENTAL SECTION
G eneral in fo rm ation . All reactions were carried out under an inert atmosphere of dry nitrogen, unless 
otherwise described. Standard syringe techniques were applied for transfer of Lewis acids and dry solvents. Infrared 
(IR) spectra were obtained from CHCI3  solutions, unless indicated otherwise, using a Perkin-Elmer 298 or 
Perkin-Elmer 1310 spectrophotometer and wavelenghts (v) are reported in cm-*. Proton nuclear magnetic 
resonance (*H NMR) spectra were determined in CDCI3  (unless indicated otherwise) using a JEOL PMX 60 (60 
MHz), a Bruker AC 200 (200 MHz), a Bruker WM 250 (250 MHz) or a Broker AMX 300 (300 MHz) 
spectrometer. The latter three machines were also used for *3C NMR (APT) spectra (50, 63 and 75 MHz resp.) in 
CDCI3  (unless indicated otherwise). Chemical shifts (8 ) are given in ppm downfield from tetramethylsilane. Mass 
spectra and accurate mass measurements were carried out using a Varian MAT 711 or a VG Micromass ZAB-2HF 
instrument. Elemental analyses were performed by Domis u. Kolbe Mikroanalytisches Laboratorium, Miilheim
a.d. Ruhr, Germany. R j  values were obtained by using thin-layer chromatography (TLC) on silica gel-coated 
plastic sheets (Merck silica gel 60 F2 5 4 ) with the indicated solvent(mixture). Chromatographic purification refers 
to flash chromatography3 9  using the same solvent as for TLC and Merck silica gel 60 (230-400 mesh) or Janssen 
Chimica silica gel (0.030-0.075 mm). Melting and boiling points are uncorrected. CH2 CI2  was distilled from 
P2 O5  and stored over MS 4A under an atmosphere of dry nitrogen. T1CI4  and SnCl4  were distilled and stored 
under a dry nitrogen atmosphere as a solution in CH2 Cl2 . BF3 *OEt2  was distilled and stored under a dry nitrogen 
atmosphere. Dry THF and Et2 0  were distilled from sodium benzophenone ketyl prior to use. Dry DMF was 
distilled from CaH2  and stored over MS 4 A under a dry nitrogen atmosphere.
1,2-Hydrazinedicarboxylic acid diallyl ester (7). Allyl chloroformate (63.5 mL, 0.60 mol) was added 
dropwise to a solution of hydrazine hydrate (14.6 mL, 0,30 mmol) in MeOH (250 mL), while the temperature 
inside the flask was kept below 5 *C. After one half of the chloroformate had been added, a solution of K2 CO3  
(41.5 g, 0.30 mol) in water (125 mL) was added dropwise simultaneously. After the addition was complete, the 
precipitate was washed from the flask with water (125 mL) and the mixture was stirred for another 30 min. 
Filtration, washing with water (3 x) and drying in vacuo yielded 7 (53.0 g, 265 mmol, 8 8 %) as a white solid, mp 
85-86 ‘C (methanol/water). IR v 3410,1730; !H NMR (200 MHz) 8  4,65 (d, / =  5.6 Hz, 4  H, 2  x CH2), 5.30- 
5.45 (m, 4 H, 2 x CH2), 5.91-6.09 (m, 2 H, 2 x =CH), 6.57 (br s, 2 H, 2 x NH).
I
42
D iallyl azod icarboxy la te  (8 ). To a well-stirred suspension of hydrazoester 7 (2.00 g, 10.0 mmol) in 
CH2 CI2  (20 mL) was added Pb(OAc) 4  (4.43 g, 10.0 mmol) in portions at 0 *C over a period of 30 min. The 
resulting mixture was filtered over Celite and the residue was washed with pentane. After concentration of the 
filtrate in vacuo, the residue was taken up in pentane, filtered over Celite and washed with aq satd K2 CO3 . The 
organic layer was dried (MgSC^), filtered and concentrated in vacuo to afford 8  as an orange oil (11.99 g, 61.0 
mmol, 8 6 %). IR v 3090, 1770; !H NMR (200 MHz) 8  4.90 (d, / =  5.9 Hz, 4 H, 2  x CH2), 5.34-5.49 (m, 4 H,
2 x =CH2), 5.90-6.09 (m, 2 H, 2  x =CH).
Genera! procedure A for the synthesis of hydrazides 10-23. Synthesis of the Grignard reagent (unless 
indicated otherwise): to magnesium chips (excess) and one iodine crystal was added one fifth of a solution of the 
halide in ether or THF. When the brown color dissappeared, the remaining solution was added slowly in such a 
way that a gentle reflux was maintained. After the addition was complete, the solution was refluxed for another 2 
h and allowed to cool to rt. The Grignard reagent was added slowly by syringe to a slurry of the azo ester in THF 
or ether (0.15 M) at -78 *C. After the addition was complete, the mixture was stirred at -78 *C for 1 h and 3-4 h at 
rt. It was poured into aq satd NH4 CI and the aq layer was extracted with ether (3 x). The combined organic layers 
were dried (MgSC>4 ), filtered and concentrated in vacuo. The pure hydrazide was obtained after flash 
chromatography or distillation.
l-(2 -P ro p en y l)-l,2 -h y d raz in ed ica rb o x y lic  acid d im ethyl ester (10). According to the general 
procedure A, allylmagnesium chloride (15.1 mL of a 2.0 M solution in THF, 30.1 mmol) was added at -78 *C to 
a well-stirred solution of dimethyl azodicarboxylate (4.01 g, 27.5 mmol) in THF. After work-up and purification 
by flash chromatography (ethyl acetate/hexane 1:1.5), 10 (1.86 g, 9.88 mmol, 36%) was obtained as a yellowish 
oil, R f  0.30. IR v 3400,1755,1710; JH NMR (200 MHz) 5 3.70 (s, 6  H, 2 x C02 CH3), 4.06 (d, J  = 5.9 Hz, 2
H, CH2), 5.11-5.20 (m, 2 H, =CH2), 5.69-5.88 (m, 1 H, CH), 6.87 (br s, 1 H, NH).
l-(3-B utenyl)-l,2-hydrazinedicarboxylic acid di-terf-butyl este r (11) 3-Butenylmagnesium bromide 
was prepared from magnesium chips (0.150 g, 6.17 mmol) and a solution of 4-bromo-l-butene (702 mg, 5.19 
mmol) in ether (4 mL). After cooling to rt, the solution was added to a solution of di-ter/-butyl azodicarboxylate 
(1.04 g, 4.52 mmol) in ether (30 mL) according to the general procedure A. The residue was purified by flash 
chromatography (ethyl acetate/hexane 1:4) to yield 11 as a white solid (1.04 g, 3.64 mmol, 81%), mp 77-78 'C 
(ethyl acetate/hexane 1:8), R t  0.35. IR v 3400, 1745, 1700; !H NMR (200 MHz) 8  1.47 (s, 18 H, 2 x tert- 
butyl), 2.32 (q, J  = 7 Hz, 2 H, CH2 C//2 CH), 3.52 (t, J  = 5 Hz, 2 H, NCH2), 4.96-5.12 (m, 2 H, CH=Ctf2), 
5.68-5.89 (m, J  = 7 Hz, 1 H, =CH), 6.28 (br s, 1 H, NH); Anal. Calcd for C1 4 H2 6 N2 0 4 : C, 58.72; H, 9.15; N, 
9.78. Found: C, 58.76; H, 9.17; N, 9.72.
l-(3 -B u teny l)-l,2 -hydraz ined icarboxy lic  acid dim ethyl ester ( 1 2 ). 3-Butenylmagnesium bromide 
was prepared from magnesium chips (439 g, 18.1 mmol) and 4-bromo-l-butene (2.03 g, 15.1 mmol) in ether (25 
mL). The addition reaction was carried out following the general procedure A with dimethyl azodicarboxylate (2.00 
g, 13.7 mmol) in THF (100 mL). After work-up and purification by flash chromatography (ethyl acetate/hexane
I.1:1), 12 (1.41 g, 7.00 mmol, 51 %) was obtained as a light-yellow oil, R j  0.32. IR v 3400,1748,1705; *H 
NMR (200 MHz) 6  2.29 (q, J  = 7.0 Hz, 2  H, NCH2 C#2)> 3.53 (br s, 2  H, NCH2), 3.70 (s, 6  H, 2  x C02 CH3), 
4.96-5.08 (m, 2 H, =CH2), 5.72 (m, 1 H, =CH), 6.90 (br s, 1 H, NH).
Synthesis o f cyclic hydrazine derivatives
l-(4-Pentenyl)-l,2-hydrazinedicarboxylic acid dimethyl ester (13). 4-Pentenylmagnesium bromide
43
Chapter 2
was prepared from magnesium chips (590 mg, 24.3 mmol) and a solution of 4-bromo- 1 -pentene (3.05 g, 20.5 
mmol) in ether (35 mL). Following the general procedure A, the Grignard reagent was added at -78 'C to a 
solution of dimethyl azodicarboxylate (2.67 g, 18.3 mmol) in ether. After work-up and purification by flash 
chromatography (ethyl acetate/hexane 1,2:1), 13 (2.11 g, 9.79 mmol, 53%) was obtained as a colorless oil, Rj- 
0.35. IR V 3395,1750,1705; *H NMR (200 MHz) 5 1.59-1.77 (m, 2 H, NCH2 C//2), 2.03 (q, 2 H, J  = 7.0 Hz, 
NCH2 CH2 C//2), 3.50 (t, J  = 7.0 Hz, 2 H, NCH2), 3.74 (s, 6  H, 2 x C 0 2 CH3), 4.94-5.06 (m, 2 H, =CH2), 
5.79 (m, 1 H, =CH), 6.73 (br s, 1 H, NH).
l - ( 2 -M ethy!-2 -p ro p e n y I)- l,2 -hydrazined icarboxy lic  acid d im ethy leste r (14). Preparation of
methallylmagnesium chloride:4 0  to magnesium chips (801 mg, 33.0 mmol) and one iodine crystal was added 4 
mL of a solution of 3-chloro-2-methyl-l-propene (2.73 g, 30.1 mmol) in THF (20 mL) at 0 *C. When the brown 
color disappeared, the remaining chloride was added slowly in 30 min. After addition, the mixture was refluxed for 
1 h, allowed to cool to rt and added to a solution of dimethyl azodicarboxylate (3,99 g, 27,3 mmol) in THF 
according to the general procedure A. After work-up and purification by flash chromatography (ethyl 
acetate/hexane 1.5:1), 14 (3.85 g, 19.1 mmol, 70%) was obtained as a white solid, mp 59-62 *C, /?ƒ 0.31. IR v
3400, 1750, 1715; *H NMR (200 MHz) 8  1.72 (s, 3 H, CH3), 3.75 (s, 3 H, C 0 2 CH3), 3.76 (s, 3 H, 
C02 CH3), 4.05 (br s, 2 H, NCH2), 4.82 (br s, 1 H, =CH2), 4.90 (br s, 1 H, =CH2), 6.65 (br s, 1 H, NH).
l-[(Z )-3-hexenyl]-l,2-hydrazinedicarboxylic acid dim ethyl ester (15). The Grignard feagent of 6 - 
bromo-(Z)-3 ~hexene was prepared from magnesium chips (633 mg, 25.9 mmol) and a solution of 6~bromo-(Z)-3- 
hexene (3.47 g, 21.3 mmol) in ether (35 mL). It was added to a solution of dimethyl azodicarboxylate (2.83 g,
19.4 mmol) in ether according to the general procedure A. After work-up and purification by flash chromatography 
(ethyl acetate/hexane 1 :1), IS (1.71 g, 7.45 mmol, 38%) was obtained as a light yellow oil, /?ƒ 0.35. IR v 3400, 
1745, 1705; JH NMR (200 MHz) 8  0.94 (t, /  = 7.5 Hz, 3 H, CH3), 2.03 (quintet, J  = 7.2 Hz, 2 H, C//2 CH3),
2.31 (q, 7 = 7.1 Hz, 2  H, NCH2 Ctf2), 3.51 (t, J=  7.0 Hz, 2  H, NCHj), 3.74 (s, 6  H, 2  X C0 2 CH3), 5.26 (td, 
ƒ= 7.2,10.7 Hz, 1 H, CH3 CH2 Cfl), 5.46 (td, J  = 7.1,10.7 Hz, 1 H, NCH2 CH2 C//), 6.73 (br s. 1 H, NH).
l-B e n z y ]- l,2 -hyd raz ined icarboxy lic  acid d im ethyl es te r (16). Benzylmagnesium chloride was 
prepared from magnesium chips (2.00 g, 82.0 mmol) and a solution of benzyl chloride (9.44 g, 75.0 mmol) in 
ether (50 mL). The mixture was added to a solution of dimethyl azodicarboxylate (9.95 g, 68.0 mmol) in ether 
following the general procedure A. After woiic-up and purification by flash chromatography (ethyl acetate/hexane 
1:1), 16 (12.8 g, 53,7 mmol, 79%) was obtained as a white solid, mp 88-93 *C, Ry 0.35. IR v 3410, 1750, 
1710; *H NMR (200 MHz) 8  (some signals appear as rotamers) 3.73,3.78 (s, 6  H, 2 x CO2 CH3 ), 4.69 (br s, 2 
H, NCfljPh), 6.57 (br s, 1 H, NH), 7.31 (s, 5 H, ArH).
l-B e n zy l-l,2 -hydrazinedicarboxylic acid d iisopropyl ester (17). Benzylmagnesium chloride was 
prepared from magnesium chips (1.46 g, 60.0 mmol) and a solution of benzyl chloride (6.13 g, 54.5 mmol) in 
ether (50 mL). The mixture was added to a solution of dimethyl azodicarboxylate (10.0 g, 49,5 mmol) in ether 
following the general procedure A. After work-up and flash chromatography (ethyl acetate/hexane 1:1), 17 (9.46 
g, 32.2 mmol, 65%) was obtained as a white crystalline solid, mp 79-81 *C (ethyl acetate/hexane 1:5), /?ƒ 0.40. 
IR v 3405, 1720, 1700; ’ri NMR (200 MHz) 8  1.20-1.27 (m, 12 H, 2 x (C/Z^CH), 4.66 (br s, 2 H, NCH2), 
4.88-4.99 (m, 2 H, 2 x (CH3 )2 Ctf), 6.25 (br s, 1 H, NH). 7.24-7.29 (m, 5 H, ArH).
l-[5-(Trimethyl$ilyl)-3-(Z)-pentenyl]-l,2-hydr&zinedicarboxylic acid dimethyl ester (19). The
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Grignard reagent of 5-iodo-1 -(trimethylsilyl)-(Z)-2-pentene^ 8  was prepared from magnesium chips (370 mg, 15.0 
mmol) and a solution of iodide 18 (1.70 g, 6.31 mmol) in ether (15 mL). The resulting mixture was added slowly 
to a solution of dimethyl azodicarboxylate (850 mg, 5.80 mmol) in ether following the general procedure A. After 
work-up and purification by flash chromatography (ethyl acetate:hexane 1 :1), 19 (499 mg, 1.75 mmol, 28%) was 
obtained as a light yellow oil, R t  0.40. IR v 3410, 1750, 1710, 1245, 855; %  NMR (200 MHz) 8  0 (s, 9 H, 
(CH3 )3 Si), 1.47 (d, J  = 8 . 6  Hz, 2 H, CH2 Si), 2.28 (q, J  = 7.1 Hz, 2 H, CH2 Ci/2 CH), 3.52 (t, J  = 6.7 Hz, 2  H, 
NCH2), 3.76 (s, 6  H, 2  x C 0 2 CH3), 5.20 (q, J  = 7.2 Hz, 1 H, =C«CH2 CH2), 5.50 (q, J  = 8 . 6  Hz, 1 H, 
=CWCH2 Si), 6.61 (br s, 1 H, NH).
4 -B ro m o -l-(trim e th y ls ily l)-l-b u ty n e  (2 0 ) ,^  To a solution of 4-(trimethylsilyl)-3-butyn-l-oi'^ (49.0 g, 
0.34 mol) in pyridine (175 mL) was added at 0 *C p-toluenesulfonyl chloride (78.0 g, 0.41 mmol) in portions. 
The suspension was stirred for 30 min at 0 *C and 2 h at r t  It was poured into an ice water mixture (500 mL) and 
extracted with ether (5 x 200 mL). The combined ether extracts were washed with 6  N HCl (2 X 200 mL) and aq 
NaHCC>3 (200 mL), dried (MgSO^, filtered and concentrated in vacuo to afford the crude tosylate (87.0 g, 0.29 
mmol) as a light yellow solid. The crude tosylate was dissolved in DMF (350 mL), potassium bromide (55.0 g, 
0.46 mol) was added and the mixture was stirred at 60 *C for 25 h. After cooling to rt, the mixture was poured 
into water (2 L) and extracted with pentane (5 x 500 mL). The combined organic layers were dried (MgSO^), 
filtered and concentrated in vacuo. Distillation of the residue yielded 20 (49,0 g, 0.24 mol, 70%) as a colorless 
oil, bp 81-82 ‘C (27 mm). IR v 2170,1250, 840; *H NMR (200 MHz) 8  0.16 (s, 9 H, (CH3 >jSi), 2.77 (t, J  =
7.5 Hz, 2 H, CH2 C=C), 3.42 (t,7 =  7.5 Hz, 2 H, CH2 Br).
l-[4 -(T rim e th y Is ily l)-3 -b u ty n y l]-l,2 -h y d raz in ed ica rb o x y lic  acid  d im ethyl es te r (21). The 
Grignard reagent2 2  of 4-bromo-l-(trimethylsilyl)-l-butyne was prepared from magnesium chips (711 mg, 21.9 
mmol) and a solution of bromide 20 (4.01 g, 19.5 mmol) in THF (20 mL). The mixture was added to a solution 
of dimethyl azodicarboxylate (2.59 g, 17.7 mmol) in THF following the general procedure A. After work-up and
*
purification by bulb-to-bulb distillation, 21 (3.08 g, 11.3 mmol, 64%) was obtained as a viscous yellow oil, bp 
143-148 'C (0.03 mm), R f  0.35 (ethyl acetate/hexane 1:1). IR v 3410, 2170, 1750, 1715, 1250, 840; ^  NMR 
(200 MHz) 5 0.14 (s, 9 H, (CH3 )3 Si), 2.52 (t, J  = 6.9 Hz, 2 H, CH2 C=C), 3.68 (t, J  = 6 . 8  Hz, 2 H, NCH2),
3.76 (s, 6  H, 2 x C02 CH3), 6.76 (br s, 1 H, NH).
l- [4 -(T r im e th y ls ily l) -3 -b u ty n y l]- l ,2 -h y d ra z in e d ic a rb o x y lic  acid d ie th y l e s te r (22). The 
Grignard reagent2 2  of 4-bromo-l-(trimethylsilyl)-l-butyne was prepared from magnesium chips (3.59 g, 0.14 
mol) and a solution of bromide 20 (24.2 g, 0.12 mol) in THF (120 mL). The mixture was added to a solution of 
diethyl azodicarboxylate (18.8 g, 0.11 mol) in THF following the general procedure A. After work-up and 
distillation, 2 2  (20.4 g, 69.3 mmol, 63%) was obtained as a viscous yellow oil, bp 145-150 *C (0.03 mm), R j  
0.35 (ethyl acetate/hexane 2:3). IR v 3405, 2170, 1745,1710,1250, 840; XH NMR (200 MHz) 8  0.12 (s, 9 H, 
(CH3 )3 Si), 1.25 (t, 7 = 7.1 Hz, 6  H, 2  x CH2 Ctf3), 2.50 (t, J  -  7.0 Hz. 2 H, C=CCH2), 3.65 (t. J  = 6 . 8  Hz, 2 
H, NCH2), 4.17 (q, J  = 7.1 Hz, 4 H, 2 x C//2 CH3), 6.76 (br s, 1 H, NH).
l- [4 -(T rim e th y ls ily l) -3 -b u ty n y l]- l ,2 -h y d ra z in e d ic a rb o x y Iic  acid  d ia lly l e s te r (23). The 
Grignard reagent2 2  of 4-bromo-l-(trimethylsilyl)-l-butyne was prepared from magnesium chips (1.13 g, 46.5 
mmol) and a solution of bromide 20 (9.55 g, 46.5 mmol) in THF (40 mL). The mixture was added to a solution 
of diallyl azodicarboxylate (8 ) (8.38 g, 42.3 mmol) in THF following the general procedure A. After work-up and 
flash chromatography (ethyl acetate/hexane 1:4), 23 (7.63 g, 23.4 mmol, 55%) was obtained as a colorless oil,
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Rf0.35. IR V 3400,3080,1740,1715,1245, 840; !H NMR (200 MHz) 8  0.14 (s, 9 H, (CH3 )3 Si), 2.53 (t, J -
6.9 Hz, 2  H, CH2 C=C), 3.70 (t, J  = 6.9 Hz, 2 H, NCH2), 4.63 (d, J  = 5.5 Hz, 4 H, 2  x  OCH2), 5.21-5.36 (in, 
4  H, 2 x =CH2), 5.84-5.97 (m, 2  H, 2  x =CH), 6.80 (br s, 1 H, NH).
l-[4 -(T rim e th y ls¡Iy I)-2 -b u ty n y l} -l,2 -h y d raz iiied ica rb o x y l¡c  acid  d ia lly l e s te r  (25). To a 
suspension of NaH (66.3 mg, 2,75 mmol, the oil was washed from the NaH with pentane) in DMF (5 mL) was 
added dropwise a solution of 7 (500 mg, 2.50 mmol) in DMF (2 mL). After being stirred at rt for 15 min, the 
resulting clear solution was added via syringe to a solution of 4-iodo-1 -(trimethylsilyl)-2-butyne (2 4 )^  in DMF 
(5 mL). After being stirred for 30 min at rt, the mixture was poured into aq satd NaCl (25 mL) and extracted with 
CH2 CI2  (3 x 1 5  mL). The combined organic layers were dried (MgS04), filtered and concentrated in vacuo. The 
residue was chromatographed (ethyl acetate/hexane 1:4) to afford 25 as a colorless oil (302 mg, 0.93 mmol, 
37%), Rf 0.37. IR v 3400, 3080, 2210, 1745, 1720, 1250, 850; *H NMR (200 MHz) 8  0.09 (s, 9 H, 
(CH3 )3 Si), 1.46 (t, J=  2.5 Hz, 2 H, CH2 Si), 4.32 (br s, 2 H, NCH2), 4.60 (m, 4 H, 2 x CH2 0), 5.19-5.36 (m,
4 H, 2 x =CH2), 5.81-6.00 (m, 2  H, 2 x =CH), 6.73 (br s, 1 H, NH).
l-[3 -(T rim eth y Is ily l)-2 -p ro p en y l]-l,2 -h y d raz in ed ica rb o x y Iic  acid d im ethy l e s te r (27). A 
solution of dimethyl azodicarboxylate (3.00 g, 20.5 mmol) in allyltrimethylsilane 26 (2.40 g, 21.0 mmol) was 
heated at reflux temperature until the orange color disappeared (2.5 h). The resulting solution was distilled to yield 
27 (4.35 g, 16.7 mmol, 81%) as a colorless oil, (E)/(Z)-ratio 1.5:1, bp 124-126 *C (0 . 0 1  mm). IR v 3410, 
1750,1710,1450,1260,1245, 855, 840; (£)-isomer: *H NMR (200 MHz) 8  0.06 (s, 9 H, (CH3 )3 Si), 3.74 (s, 
6  H, 2 x C02 CH3), 4.17-4.21 (m, 2 H, NCH2), 5.78 (d, J  = 18.7 Hz, 1 H, CHSi), 6.05 (dt, J  = 18.7, 5 Hz, 1 
H, C//CH2), 6.67 (br s, 1 H, NH); 13C NMR (63 MHz) 8  -1.5 ((C H ^Si), 51.7 (NCH2), 52.8 (C02 CH3),
133.8, 139.5 (C=C), 156.5 (C(0)); (Z)-isomer: XH NMR (200 MHz) 8  0.11 (s, 9 H, (CH3 )3 Si), 3.74 (s, 6  H, 2 
x C02 CH3), 4.17-4.21 (m, 2 H, NCH2), 5.75 (d, J  = 14.2 Hz, 1 H, CHSi), 6.26 (dt, J  = 14.2, 7.1 Hz, 1 H, 
CHCH2), 6.67 (br s, 1 H, NH); 13C NMR (63 MHz) 8  -0.1 ((CH3 )3 Si), 53.4 (C02 CH3), 55.0 (NCH2), 133.8,
141.4 (C=C), 156.5 (C(O)); MS (El, 70 eV) m h  (relative intensity) 260 (M+, 2), 254 (14), 213 (30), 186 (87), 
170 (52), 89 (100), 73 (58), 59 (76); HRMS calcd for C 1 0 H2 0 N2 O4Si 260.1192, found 260.1206.
General procedure B for the reactions with chlorom ethyl methyl ether. Sodium hydride (purchased 
as a 55% dispersion in oil) was washed prior to use with pentane, removing the pentane by syringe after the 
sodium hydride had settled The dry solid was then mixed with DMF and the hydrazide, dissolved in DMF was 
added dropwise to the suspension at r t  After being stirred for 15 min at rt, the resulting clear solution was cooled 
to 0 *C and a solution of chloromethyl methyl ether in DMF was added. After being stirred for 15 min at 0 *C and
3 h at rt, the mixture was poured into aq satd NaCl, extracted with 1,1,1-trichloroethane ( 6  x), dried (MgSC^), 
filtered and concentrated in vacuo. The residue was subjected to flash chromatography to afford the pure hydrazides,
l-(M eth o x y m eth y l)-2 -(2 -p ro p en y I)-l,2 ~ h y d raz in ed ica rb o x y lic  acid d im e th y l e s te r  (28).
According to the general procedure B, 10 (508 mg, 2.70 mmol) was deprotonated with NaH (128 mg, 2.93 
mmol) and alkylated with chloromethyl methyl ether (300 |iL, 4,00 mmol), while all compounds were dissolved 
in DMF (5 mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 28 (567 mg, 2.44 mmol, 
90%) was obtained as a light yellow oil, R f  0.30. IR v 1710; JH NMR (200 MHz) 8  3.35 (s, 3 H, OCH3), 3.72 
(s, 6  H, 2 x C02 CH3), 3.94-4.25 (m, 2 H, NC//2 CH=), 4.64-4.69 ( d , /=  11.0 Hz, 1 H, NCWHO), 4.86-5.05 
(m, 1 H, NCHHO), 5.12-5.23 (m, 2 H, =CH2), 5.80-6.00 (m, 1 H, =CH),
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l-(3"B u teny l)-2 -(m ethoxym ethyI)-l,2 -hydraz ined icarboxy lic  acid d i- /e r/-b u ty l e s te r  (29). 
According to the general procedure B, 11 (149 mg, 0.521 mmol) was treated with NaH (13.9 mg, 0.577 mmol) 
and chloromethyl methyl ether (60 jiL, 0.79 mmol), all compounds were dissolved in DMF (2 mL). After work­
up and flash chromatography (ethyl acetate/hexane 1:4), 29 (163 mg, 0.495 mmol, 95%) was obtained as a 
yellowish oil, Rf 0.40. IR v 1700; JH NMR (60 MHz, CDC13) 8  1.47 (s, 18 H, 2  x  <ert-butyl), 2.38 (q, J = 7 
Hz, 2 H, NCH2 C//2), 3.37 (s, 3 H, OCH3 ), 3.27-3.70 (m, 2 H, NC//2 CH2), 4.37-5.17 (m, 4 H, CH20  and 
=CH2), 5.43-6.13 (m, 1 H, =CH).
l- (3 -B u te n y I)-2 -(m e th o x y m e th y l)- l ,2 -h y d ra z in e d ic a rb o x y lic  ac id  d im e th y l e s te r  (30). 
According to the general procedure B, 12 (502 mg, 2.49 mmol) was deprotonated with NaH (65.1 mg, 2.70 
mmol) and alkylated with chloromethyl methyl ether (280 pJL, 3.70 mmol), all compounds dissolved in DMF (5 
mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 30 (493 mg, 2.01 mmol, 81%) was 
obtained as a colorless oil, Rf  0.32. IR v 1720, 1700; *H NMR (200 MHz) 8  2.39 (q, J = 6.9 Hz, 2 H, 
NCH2 C//2), 3.30-3.40 (m, 1 H, NC//HCH2), 3.37 (s, 3 H, OCH3), 3.60-3.80 (m, 1 H, NCH//CH2), 3.73 (s, 6  
H, 2 x C 0 2 CH3), 4.58 (d, J = 11.0 Hz, 1 H, NCWHO), 4.92-5.11 (m, 3 H, =CH2  and NCH/ZO), 5.70-5.81 (m,
1 H, =CH).
l-(M e th o x y m e th y l)-2 -(4 -p e n te n y l)- l,2 -h y d ra z in e d ic a rb o x y lic  acid  d im ethy l e s te r  (31). 
Following the general procedure B, 13 (501 mg, 2.32 mmol) was treated with NaH (61 mg, 2.55 mmol) and 
chloromethyl methyl ether (260 pL, 3.47 mmol), all compounds dissolved in DMF (5 mL). After work-up and 
flash chromatography (ethyl acetate/hexane 1:1), 31 (534 mg, 2.05 mmol, 89%) was obtained as a light yellow 
oil, R f  0.45. IR v 1715, 1690; *HNMR (200MHz) 5 1,72 (m, 2 H,NCH2 C//2 CH2), 2.06 (q, J  = 7,0 Hz, 2 H, 
NCH2 CH2 C//2), 3.37 (s, 3 H, OCH3), 3.73 (s, 6  H, 2 x C02 CH3), 3.27-3.79 (m, 2 H, NCtf2 CH2), 4.574.67 
(m, 1 H, NC//HO), 4.93-5.12 (m, 3 H, =CH2  andNCHtfO), 5.97 (m, 1 H, =CH).
l-(M ethoxym ethy l)-2-(2-m ethyI-2«propenyl)-l,2 -hydrazined icarboxylic  acid dim ethyl ester 
(32). According to the general procedure B, 14 (1.48 g, 7.34 mmol) was deprotonated with NaH (198 mg, 8.23 
mmol) and alkylated with chloromethyl methyl ether (850 jiL, 11.0 mmol), while all compounds were dissolved 
in DMF (20 mL). Work-up and purification by flash chromatography (ethyl acetate/hexane 1:1.5) afforded 32 
(1 .57 mg, 6.39 mmol, 87%) as a yellowish oil, R f  0.35. IR v 1700,1735; *H NMR (200 MHz) 8  1.76 (s, 3 H, 
CCH3), 3.34 (s, 3 H, OCH3), 3.71-3.77 (m, 6  H, 2 x C02 CH3), 3.81-3.88 (m, 1 H, NCflHC), 4.08-4.37 (m, 1
H, NCH//C), 4.86 (br s, 2 H, =CH2), 4.66-4.99 (m, 2 H, OCH2).
l-[(Z )-3 -h exeny l]-2 -(m eth oxy m eth y I)-l,2 -h yd raz ined icarbox y lic  acid d im ethyl este r (33). 
According to the general procedure B, 15 (509 mg, 2,21 mmol) was deprotonated with NaH (58 mg, 2.39 mmol) 
and alkylated with chloromethyl methyl ether (250 pL, 3.20 mmol), while all compounds were dissolved in DMF 
(3 mL). Work-up and purification by flash chromatography (ethyl acetate/hexane 1 :1 ) yielded 33 (551 mg, 2.01 
mmol, 91%) as a colorless oil, Rf  0.45. IR v 1715,1690; XH NMR (200 MHz) 8  0.95 (t, J = 7.5 Hz, 3 H, 
CH2 0 / 3), 2.05 (quintet, J = 7.3 Hz, 2 H, Ctf2 CH3), 2.39 (q, J = 7.1 Hz, 2 H, NCH2 C//2), 3.38 (s, 3 H, 
OCH3), 3.74 (s, 6  H, 2 x C 0 2 CH3), 3.20-3.80 (m, 2 H, NC//2 CH2), 4.51 (d, J = 11.0 Hz, 1 H. NCHHO), 
4.93-5.13 (m, 1 H, NCHHO), 5.26-5.52 (m, 2 H, CH=CH).
l-B enzyl-2~(m ethoxym ethy!)-l,2-hydrazinedicarboxylic acid dim ethyl ester (34). Following the 
general procedure B, 16 (1.50 g, 6.31 mmol) was deprotonated with NaH (167 mg, 6.93 mmol) and alkylated
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with chloromethyl methyl ether (570 pL, 7.56 mmol), while all compounds were dissolved in DMF (12 mL), 
After work-up and flash chromatography (ethyl acetate/hexane 1:1), 34 (1.74 g, 6.17 mmol, 98%) was obtained 
as a light yellow oil, R f  0.45. IR v 1720; *H NMR (200 MHz) 5 (some signals appear as rotamers) 3,15, 3.30 
(s, 3 H, OCH3), 3,55, 3.75, 3.80 (s, 6  H, 2 x C02 CH3), 4.20-5.20 (m, 4 H, N O /2Ph andNCH2 0), 7.32 (sf 5 
H, ArH).
l-(M eth o x y m eth y l)-2 -[5 -(trim e th y ls ily l)-3 -(Z )-p en ten y I]-l,2 -h y d raz in ed ica rb o x y H c  acid 
dim ethyl ester (35). Following the general procedure B, 19 (285 mg, 1.00 mmol) was treated with NaH 
(26.5 mg, 1.10 mmol) and chloromethyl methyl ether (91 |iL, 1.20 mmol), while all compounds were dissolved 
in DMF (2 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) afforded 35 (245 mg, 0.74 mmol, 
74%) as a light yellow oil, R j  0.45. IR v 1710,1240, 855; lU NMR (200 MHz) 6  0.0 (s, 9 H, (C H ^S i), 1.48 
(d, J a  8 . 6  Hz, 2 H, CH2 Si), 2,37 (br s, 2 H, NCH2 C//2), 3.39 (s, 3 H, OCH3 ), 3,25-3.39 (m, 1 H, 
NC//HCH2), 3.74 (s, 6  H ,2  x C 0 2 CH3)f 3.71-3.80 (m, 1 H, NCHffCH2), 4.60 (d, J  = 10.9 Hz, 1 H, 
NO/HO), 4.90-5.60 (m, 3 H, NCHtfO and HC=CH).
l-(3 -B u ty n y l)-2 ~ (m e th o x y m e th y I)-l,2 -h y d raz in ed ica rb o x y Iic  acid  d im e th y l e s te r  (36).
According to the general procedure B, 21 (500 mg, 1.84 mmol) was deprotonated with NaH (49 mg, 2.02 mmol) 
and alkylated with chloromethyl methyl ether (168 |iL, 2.21 mmol), while all compounds were dissolved in DMF 
(2 mL). After work-up and flash chromatography, an inseparable 1:1 mixture was obtained of silylated- and 
desilylated hydrazide 3 6 . The mixture (303 mg) was dissolved in THF (10 mL) and treated with CsF (304 mg, 2.0 
mmol) and /1-BU4 NF (0.2 mL of a 1.0 M solution in THF, 0.2 mmol). After being stirred at rt for 15 min, the 
mixture was poured into aq satd NaCl (25 mL) and extracted with CH2 C12  (3 x 25 mL), The combined organic 
layers were dried (MgSO^), filtered and concentrated in vacuo. Purification of the crude residue by flash 
chromatography (ethyl acetate/hexane 1:1) afforded 36 (130 mg, 0.53 mmol, 49%) as a colorless oil, /?ƒ 0.35. IR 
v 3305,2110,1720; %  NMR (200 MHz) 5 1.98 (br s, 1 H, C=CH), 2.56 (br s, 2 H, CH2 CsC), 3.40 (s, 3 H, 
OCH3), 3.53 (m, 1 H, NCWHCHj), 3.75 (s, 6  H, 2 x C02 CH3), 3.72-3.80 (m, 1 H, NCHWCHj), 4.61 (m, 1
H, NC//HO), 5.08 (m, 1 H, NCHtfO).
l-(M ethoxym ethy l)-2 -[4 -(trim ethy lsU yl)-2 -bu tyny l]-l,2 -hydrazined icarboxylic  acid  d ially l 
ester (37). According to the general procedure B, 25 (280 mg, 0.86 mmol) was deprotonated with NaH (26 mg,
I.08 mmol) and alkylated with chloromethyl methyl ether (95 |jlL, 1.26 mmol), while all compounds were 
dissolved in DMF (2 mL). Work-up and purification by flash chromatography (ethyl acetate/hexane 1:3) afforded 
37 (157 mg, 0.42 mmol, 43%) as a colorless oil, R t  0.32. IR v 3080,2210,1745,1720,1250, 850; *H NMR 
(200 MHz) 5 0.06 (s, 9 H, (CH3 )3 Si), 1.43 (t, J  = 2.5 Hz, 2 H. CH2 Si), 3.40 (s, 3 H, OCH3), 4.10-4.70 (m, 6
H, NCH2C and 2 x =CHCf/2), 4.87-5.07 (m, 2  H, NCH2 0), 5.10-5.30 (m, 4 H. 2  x =CH2), 5.75-5.95 (m, 2
H, 2 x =CH).
l-(M e th o x y m e th y I)~ 2 -[3 -( tr im e th y Is iIy I)-2 -p ro p e n y I]-I ,2 -h y d ra z in e d ic a rb o x y Iic  ac id  
dim ethyl ester (38). According to the general procedure B, 27 (2.00 g, 7.69 mmol) was alkylated with NaH 
(204 mg, 8.46 mmol) and chloromethyl methyl ether (700 pL, 9.23 mmol), while all compounds were dissolved 
in DMF (10 mL). Work-up and purification by flash chromatography (ethyl acetate/hexane 1:4) afforded 38 (1.91 
g, 6.28 mmol, 82%) as a colorless oil, (E)/(Z)-ratio 1:1.8, R t  0.35. IR v 1705,1440,1280,1235, 850, 830; JH 
NMR (200 MHz) 8  ((E)/(Z)-mixture) 0.02, 0.09 (s, 9 H, ( O ^ S i ) .  3.32 (br s, 3 H, OCH3), 3.70, 3.73, 3.74
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NC//HO), 4.81-4.97 (m, 1 H, NCHtfO), 5.61-5.75 (m, 1 H, CHSi), 6.0-6.15, 6.30-6.41 (m, 1 H, CtfCH2).
G eneral p rocedure C for the cyclization reactions with T iC ^ . To a 0.1 M solution of the hydrazide 
in CH2 CI2  was added T1CI4  (2 equiv, as a solution of T1CI4  in CH2 CI2 ) at -78 #C by a syringe. The mixture was 
stirred at -78 *C for 15 min and for 3-5 h at rt. The reaction mixture was poured into cold aq satd NaHCOg and the 
resulting suspension was filtered over Celite and extracted with CH2 C12  (3 x). The combined organic layers were 
dried (MgSC>4 ), filtered and concentrated in vacuo. Purification of the residue by flash chromatography afforded the 
pure cyclization product(s).
4 -C h lo ro te trahydro -l,2 -py ridazined icarboxy lic  acid dim ethyl ester (39). Following the general 
procedure C, 28 (205 mg, 0.884 mmol) was cyclized by using TiC^ (1.44 mL of a 1.2 M solution, 1.72 
mmol). After work-up and purification by flash chromatography (ethyl acetate/hexane 1:1), 39 (67.5 mg, 0.29 
mmol, 32%) was obtained as a colorless oil, R t 0.30. IR v 1715; *H NMR (200 MHz) 8  1.70-2.20 (m, 2 H, 2 x 
H5), 2.94-3.00 (m, 1 H, HS^), 3.25-3.47 (m, 1 H, 3.72 (s, 6  H, 2 x C 0 2 CH3), 3.70-4.43 (m, 3 H,
and H4); !H NMR (250 MHz, CgDg, 70 'C) 8  1.25-1.50 (m, 2 H, 2 x H5), 2.54 (dt, 7 = 2,12.1 Hz, 
H e^), 2.81 (t, J  = 12.0 Hz, 1 H, M ^ ) ,  3.40 (s, 6  H, C02 CH3), 3.8-4.0 (m, 2 H, and 4.3-4.4 (m,
1 H, H4); 13C NMR (63 MHz) 8  34.3 (C5), 50.2, 52.0 (C3 and C6 ), 51.3 (C4), 53.3, 54.1 (2 x C02 CH3); MS 
(El, 70 eV) m/z (relative intensity) 236 (90, M+), 205 (6 ), 201 (15), 177 (90), 59 (100); HRMS calcd for 
C8H13N2°4CI 236.0564, found 236.0567.
5 -C h lo ro te trahyd ro -l//-l,2 -d iazep ine-l,2 (3 //)-d icarboxy lic  acid dim ethyl ester (40). According 
to the general procedure C, 30 (210 mg, 0.854 mmol) was cyclized by using TiC^ (0.81 mL of a 2.1 M 
solution, 1.71 mmol). Work-up and purification by flash chromatography (ethyl acetate/hexane 1:1) afforded 40 
(175 mg, 0.700 mmol, 82%) as a yellowish oil, R t  0.32. IR v 1720, 1695; JH NMR (250 MHz) 8  1.94-2.15 
(m, 4 H, 2 x H4 and 2 x H6 ), 3.25-3.40 (m, 2 H, H3 and H7), 3.68 (s, 6  H, 2 x C 0 2 CH3), 3.90-4.10 (m, 2 H, 
H3 and H7), 4.28-4.35 (m, 1 H, H5); %  NMR (250 MHz, DMSO-^j, 70 *C) 8  1.86-2.00 (m, 1 H, H4), 2.07 
(m, 2 H, H4 and H6 ), 2.04-2.27 (m, 1 H, H6 ), 3.20-3.35 (m, 2 H, H3 and H7), 3.69 (s, 6  H, 2 x C 0 2 CH3), 
3.86-4.02 (m, 2 H, H3 and H7), 4.50-4.58 (m, 1 H, H5); 13C NMR (50 MHz) 8  (some signals appear as 
rotamers) 34.5, 34.7, 36.2, 36.7 (C4 and C6 ), 45.3, 45.5, 45.7 (C3 and C7), 53.2 (2 x C02 CH3), 58.0 (C5),
155.4.155.8 (C(O)); MS (El, 70 eV) m/z (relative intensity) 250 (65, M+), 215 (100), 191 (65), 59 (76); HRMS 
calcd forC9 H1 5 N2 0 4Cl 250.0721, found 250.0721.
5-C hlorohexahydro-l,2 -d iazocine-l,2 -d icarboxylic  acid dim ethyl ester (41). Hydrazide 31 (200 
mg, 0.770 mmol) was cyclized by using TiC^ (1.28 mL of a 1.2 M solution, 1.54 mmol) according to the 
general procedure C. After work-up and purification by flash chromatography (ethyl acetate/hexane 1:1), 41 (31 
mg, 0.12 mmol, 15%) was obtained as a colorless oil, /?ƒ 0.30, IR v 1700, 1725; *H NMR (200 MHz) 8 (some 
signals appear as rotamers) 1.48-1.80 (m, 2 H, 2 x H7), 2.07-2.21 (m, 4 H, 2 x H4 and 2 x H6 ), 3.07-3.43 (m,
2 H, H3 and H8 ), 3.72, 3.75, 3.78 (s, 6  H, CO2 CH3 ), 3.84-4.18 (m, 2 H, H3 and H8 ), 4.25-4.30 (m, 1 H, H5); 
13C NMR (63 MHz) 8  (all signals appear as rotamers) 22.4, 22.8 (CH2), 32.4, 32.7 (CH2), 35.8, 36.2 (CH2),
43.5.43.8 (CH2), 47.8,48.5 (CH2), 53.3, 53.5 (2 x C02 CH3), 59.7, 60.0 (CH); MS (El, 70 eV) m/z (relative 
intensity) 264 (2 0 , M+), 229 (78), 205 (43), 59 (100); HRMS calcd for C 1 0 H1 7 N2 O4CI 264.0877, found 
264.0894.
4-Chlorotetrahydro-4-methyl-l,2-pyridazinedicarboxylic acid dimethyl ester (42). According to
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the general procedure C, 32 (205 mg, 0.833 mmol) was cyclized by using TiCl4  (0.77 mL of a 2,1 M solution,
1.6 mmol). Work-up and purification by flash chromatography (ethyl acetate/hexane 2:1) yielded 42 (112 mg, 
0.45 mmol, 54%) as a colorless oil, R f  0,30. IR v 1744,1705; *H NMR (250 MHz) 6  (some signals appear as 
rotamers) 1.56 (s, 3 H, CH3), 1.67-1.99 (m, 2 H, 2 x H4), 2.91, 3,06 (d, J  = 14 Hz, 1 H, H e^), 3.40-3,44 (m,
1 H, m ^ ) ,  3.73, 3.74 (s, 6  H, 2 x C02 CH3), 4.0-4.2 (m, 1 H, 4.13,4.32 (dd, J  * 14,4,1.9 Hz,
NMR (50 MHz) 8  (some signals appear as rotamers) 29.7, 29.8 (CH3), 38.9 (C5), 53.2, 53.6 (2 x 
C02 CH3), 55.6* 57.3 (C3 and C6 ), 66,1, 66.4 (C4), 155.3, 155.7 (2 X C(O)); MS (El, 70 eV) m/z (relative 
intensity) 250 (100, M+), 191 (76), 59 (83); HRMS calcd for C9H15N20 4C1250.0720, found 250,0716.
Cyclization of hydrazide 33. According to the general procedure C, 33 (200 mg, 0,730 mmol) was cyclized 
by using T1CI4  (1.22 mL of a 1.2 M solution, 1,46 mmol). Work-up and purification by flash chromatography 
(ethyl acetate/hexane 1 :1 ) afforded an inseparable mixture of 4 - ( l- c h lo ro p ro p y I ) te tr a h y d ro - l ,2 -  
p y rid az in ed ica rb o x y lic  acid d im ethyl es te r (43) and 5 -c h Io ro -4 -e th y lte tra h y d ro - l//- l ,2 -  
diazepine-l,2(3J7)-dicarboxylic acid dim ethyl ester (44) (80 mg, 0.285 mmol, 39%) as a colorless 
oil, R j  0.30. IR v 1710,1700; %  NMR (250 MHz) 8  1.0-1.20 (m, CH3), 1.25-1.90 (m, CH3 Ctf2, NCH2 Ctf2  
and CH), 2.40-3.10 (m, NCH), 3.75 (s, C02 CH3), 4.0-4.4 (m, NCH and CHC1); 13C NMR (50 MHz) 8  10.9, 
25.6, 27.8, 28.4, 28.5, 29.3, 32.2,40.1,43.6,44.2,44.0, 50.0, 53.4, 54.9, 66.3, 66.7,155.6; MS (El, 70 eV) 
m/z (relative intensity) 278 (100, M+), 243 (8 ), 219 (64), 59 (36); HRMS calcd for Cn H1 9 N2 0 4 Cl 278.1033, 
found 278.1027.
l,4-Dihydro-2,3-phthalazinedicarboxylic acid dimethyl ester (45). Following the general
procedure C, 34 (640 mg, 2.27 mmol) was cyclized by using TiC^ (3,78 mL of a 1 , 2  M solution, 4.54 mmol). 
After work-up and purification by flash chromatography (ethyl acetate/hexane 1:1), 45 (558 mg, 2.23 mmol, 
98%) was obtained as a yellow oil, R f  0.40. IR v 1720, 1705; *H NMR (200 MHz) 8  3.77 (s, 6  H, 2  x 
C02 CH3), 4.49, 5.04 (br AB system, 4 H, 2 x NCH2), 7.09-7.34 (m, 4 H, ArH); 13C NMR (50 MHz) 8  45.0 
(2 x NCH2), 53.5 (2 x C 0 2 CH3), 126.3,128.5 (4 x ArH), 131.1 ( 2  x ArC), 155.8 (2 x C(0)); MS (El, 70 eV) 
m/z (relative intensity) 250 (38, M+), 219 (7), 191 (58), 59 (42); HRMS calcd for Cl 2 H1 4 N2 0 4  250.0953, 
found 250.0956,
4-E thenyItetrahydro-l,2-pyridazinedicarboxytic acid dim ethyl ester (46). To a solution of 35 
(153 mg, 0,47 mmol) in CH2 C12  (5 mL) was added at 0 *C BF3 *OEt2  (116 jiL, 0.93 mmol). After being stirred 
at 0 ‘C for 15 min and at rt for 16 h, the reaction mixture was poured into aq satd NaCl (50 mL) and extracted 
with CH2 C12  (3 x 50 mL). The combined organic layers were dried (MgSC>4 ), filtered and concentrated in vacuo. 
Hash chromatography (ethyl acetate/hexane 1:1,7) yielded 35 (15 mg) and 46 (57 mg, 0.25 mmol, 54% (after 
correction)) as a colorless oil, R< 0.32. IR v 1700, 1710; *H NMR (200 MHz) 8  1.38-1.60 (m, 1 H, HS^),
1.71-1.87 (m, 1 H, HSgq), 2.20-2.40 (m, 1 H, H4), 2.60-2.70 (m, 1 H, r a ^ ) ,  2.80-3.00 (m, 1 H, H e^), 3.73 
(s, 6  H, 2 x C 0 2 CH3), 4.10-4.20 (m, 2 H, and H6 „ ), 5.07 (d, J  = 10.8 Hz, 1 H, =CHH), 5.09 (d, J  = 17.0 
Hz, 1 H, =CHH), 5.62 (ddd, J  = 6.4,10. 8,17.0 Hz, 1 H, =CH); *H NMR (200 MHz, DMSO-^, 70 *C) 8  1.44 
(dq,y = 4.5, 12.8 Hz, 1.76 (d, J=  12.0 Hz, 1 H, 115^, 2.37 (m, 1 H, H4), 2.73 (t, J  = 12.4 Hz, 1 H, 
m ^ ) ,  3.00 (dt, J  = 1.5, 13.1 Hz, 1 H, TO^), 3.69 (s, 6  H, 2 X C02 CH3), 4.044.30 (m, 2 H, and H6 „ ) ,
5.07 (d, J  = 10.0 Hz, 1 H, =CHH), 5.13 (d, J  = 16.0 Hz, 1 H, =CHH), 5.74 (ddd, J  = 6.4, 10.0, 17.0 Hz, 1 H, 
=CH); 13C NMR (50 MHz) 5 29.5 (C5), 38.3 (C4), 44.0,48.0 (C3 and C6 ), 53.4 (2 x C02 CH3), 115.7 (=CH),
138.1 (=CH2), 155.6 (2 x C(O)); MS (El, 70 eV) m/z (relative intensity) 228 (100, M+), 197 (6 ), 169 (85), 59 
(37); HRMS calcd forC 1 0 H1 6 N2 O4  228.1110, found 228.1108.
I
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5 -C h lo ro -4 ,7 -d ih y d ro - lJ /- l ,2 -d ia z e p in e - l,2 (3 H )-d ic a rb o x y lic  acid  d im ethy l e s te r  (47)* 
Following the general procedure C, 36 (111 mg, 0.455 mmol) was cyclized by using TÍCI4  (0.76 mL of a 1.2 M 
solution, 0.91 mmol). Work-up and purification by flash chromatography yielded 47 (90 mg, 0.40 mmol, 80%) 
as a colorless oil, R j  0.33. IR v 1725,1705; *H NMR (200 MHz) 5 (some signals appear as rotamers) 1.75-1.95 
(m, 1 H, H6 ), 2.40-2.60 (m, 1 H, H6 ), 2.8-3.0 (m, 1 H, H7), 3.30-4.20 (m, 2 H, H7 and H3), 3.75 (s, 6  H, 2 x 
C02 CH3), 4.5-4.8 (m, 1 H, H3), 5.72 (t, J  = 3 Hz, 1 H, H5); 13C NMR (50 MHz) 8  (some signals appear as 
rotamers) 33.9 (C6 ), 44.248.0 (C3 and C7), 53.3 (2 x CO2 CH3 ), 123.3 (C5), 155.4 (2 x C(0)); MS (El, 70 
eV) mlz (relative intensity) 248 (14, M+), 213 (26), 189 (28), 59 (100).
4 -E th en y lid en e-l,2 -p y razo lid in ed ica rb o x y lic  acid d ia lly l es te r (48). BF3 *OEt2  (60 jaL, 0.48 
mmol) was added at 0 *C to a solution of 37 ( 8 8  mg, 0.24 mmol) in CH2 CI2  (3 mL). After being stirred at 0 *C 
for 15 min and 70 h at rt, the solution was poured into aq satd NaCl (5 mL) and extracted with CH2 CI2  ( 4 x 5  
mL). The combined organic layers were dried (MgSC>4 ), filtered and concentrated in vacuo. The residue was 
chromatographed (ethyl acetate/hexane 1:6) to yield 48 (38 mg, 0.14 mmol, 60%) as a light yellow oil, Rj> 0.33. 
IR v 3080, 1965, 1720; ]H NMR (200 MHz) 5 3.91-4.04 (br m, 2 H, 2 X NC/ffl), 4.58-4.67 (m, 6  H, 2 x 
NCHtf and 2 x OCH2), 4.99 (quintet, J  = 4.2 Hz, 2 H, C=C=CH2), 5.19-5.36 (m, 4 H, 2 x C H =0/2), 5.81-
6.01 (m, 2  H, 2  x =CH); 13C NMR (50 MHz) 5 49.3 (2 x NCH2), 67.1 (2 x OCH2), 80.9 (CM^CHj), 97.0 
(C=C=CH2), 118.1 (2 x CH=CH2), 131.9 (2 x =CH), 156.4 (2 x C(0)), 198.3 (C=C=CH2).
3,6-Dihydro-l,2-pyridazinedicarboxylic acid dimethyl ester (49)/*^ BFj-OEtj (205 nL, 1.64
mmol) was added to a solution of 38 (250 mg, 0.822 mmol) in CH2 CI2  ( 8  mL) at 0 *C. After being stirred at 0 
°C for 15 min and 18 h at rt, the solution was poured into aq satd NaCl (50 mL) and extracted with CH2 CI2  (3 x 
50 mL). The combined organic layers were dried (MgSC>4 ), filtered and concentrated in vacuo. Flash 
chromatography (ethyl acetate/hexane 1:1) afforded 49 (127 mg, 0.635 mmol, 77%) as a colorless oil, Rj? 0.35. 
IR v 1700,1440; !H NMR (200 MHz) 8  3.73 (s, 6  H, 2 x C02 CH3), 3.81 (br s, 2 H, 2 x NCHfl), 4.35 (br s,
2 H, 2 x NCHff), 5.75 (br s, 2 H, HC=CH); 13C NMR (63 MHz) S 44.1 (2 x NCH2), 53.2 (2 x C02 CH3),
123.5 ( 2  x CH), 155.7 (2 x C(0)). MS (El, 70 eV) ml2 (relative intensity) 200 (M+, 10), 141 (25), 59 (100).
l-(C hIo rom ethy l)-2 -(2 -p ropeny l)-l,2 -hyd raz ined icarboxy Iic  acid dim ethyl ester (56). To a 
solution of 28 (317 mg, 1.36 mmol) in CCI4  (5 mL) was added PCI5  (460 mg, 2.18 mmol) and the mixture was
residue was taken up in hexane (5 mL). After separation of the sticky residue and concentration in vacuo of the 
organic layer, 56 (198 mg, 0.84 mmol, 62%) was obtained as a light yellow oil, R j  0.40 (ethyl acetate/hexane
1 :1). %  NMR (60 MHz, CDC13) 8  3.72 (s, 6  H, 2  x C02 CH3), 4.08 (t, J  = 7 Hz, 2 H, NCtf2 CH), 5.0-6.3 (m,
5 H, NCH2 C1 and CH=CH2).
l-(C h lo rom ethy l)-2 -(4 -pen te iiy l)-l,2 -hydraz ined icarboxyH c acid d im ethyl ester (57). To a 
solution of 31 (311 mg, 1.20 mmol) in CCI4  ( 6  mL) was added PCI5  (370 mg, 1.80 mmol). After being stirred 
at rt for 42 h, the mixture was concentrated in vacuo, dissolved in hexane and the residue was separated. After 
concentration in vacuo of the organic layer, 57 (293 mg, 1.11 mmol, 94%) was obtained as a light yellow oil. IR 
v 1720;1H NMR (250 MHz) 8  1.79 (m, 2 H, CH2 Ctf2 CH2), 2.06 (q,/ =  7.2 Hz, 2 H, C//2 CH=), 3 .31(dt,/ = 
7.2, 12.0 Hz, 1 H, NCHH), 3.75 (s, 6  H, 2 x C02 CH3), 3.76 ( d , /=  12 Hz, 1 H, NC/ffl), 4.92-5.05 (m, 3 H, 
NC//HCI and =CH2), 5.69-5.85 (m, 2 H, NCH//C1 and =CH); 13C NMR (63 MHz) 8  (some signals appear as 
rotamers) 27.2 (CH2 CH2 CH2), 30.8 (CH2 CH=), 50.8 (t, NCH2 CH2), 53.5, 54.1 (C02 CH3), 61.4, 61.5
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(NCH2 C1), 115*1 (=CH2), 137.5 0=CH).
l-(ChloromethyI)-2-[(Z)-3-hexenyll-l,2-hydrazinedicarboxylic acid dimethyl ester (58). Toa
solution of 33 (200 mg, 0370 mmol) in CCI4  ( 6  mL) was added PCI5  (230 mg, 1.10 mmol) and the mixture 
was stirred at rt for 64 h. After concentration in vacuo, taking up the residue in hexane and separation of the 
remaining residue, the organic layer was concentrated in vacuo to afford 58 (184 mg, 0.66 mmol, 91%) as a light 
yellow oil. IR v 1730,1700; *H NMR (200 MHz) 8  0.95 ( t , /  = 7.5 Hz, 3 H, CH2 Ctf3), 2.06 (quintet, J = 7.3 
Hz, 2 H, CH2 CH3), 2.30-2.50 (ra, 2 H, NCH2 C//2), 3.26-3.31 (in, 1 H, NCWHCH2), 3.77 (s, 6  H, 2  x 
C02 CH3), 3.71-3.85 (m, 1 H, NCHtfCH2), 4.77-5.80 (m, 4 H, NCH2 C1 and HC=CH).
C yclization of chloride 56. According to the general procedure C, 56 (198 mg, 0.837 mmol) was cyclized 
by using TÍCI4  (1.39 mL of a 1.2 M solution, 1.67 mmol). After work-up and purification by flash 
chromatography (ethyl acetate/hexane 1:1), 39 (138 mg, 0.58 mmol, 6 8 %) was obtained as a colorless oil,R j  
0.30.
C yclization of chloride 57. Following the general procedure C, 57 (213 mg, 0.805 mmol) was cyclized by 
using TÍCI4  (1.34 mL of a 1.2 M solution, 1.61 mmol). Work-up and purification by flash chromatography 
(ethyl acetate/hexane 1:1) afforded 41 (17 mg, 0.06 mmol, 8 %) as a colorless oil, R f  0.35 and 2 ,3 ,3a,4,5,6-  
h exahydro -l//-py rro lo [l,2 "£]pyrazolecarboxylic acid methyl ester (59) (53 mg, 0.31 mmol, 39%) 
as a colorless oil, Rf 0.10. 59: IR v 1685; !H NMR (250 MHz) 8  1.42-1.84 (m, 3 H), 1.92-2.14 (m, 2 H), 2.52 
(m, 1 H), 3.21-3.43 (m, 2 H), 3.54-3.72 (m, 3 H), 3.67 (s, 3 H, C 0 2 CH3); I3C NMR (50 MHz) 8  23.5, 29.2,
32.0, 44.9 (CH2), 52.8 (C02 CH3), 55.3 (CH2), 63.8 (CH), 156.0 (C(0)); MS (El, 70 eV) m h  (relative 
intensity) 170 (27, M+), 111 (100), 59 (4); HRMS calcd for CgH1 4 N2 0 2  170.1057, found 170.1042.
Cyclization of chloride 58. According to the general procedure C, 58 (137 mg, 0.492 mmol) was cyclized 
by using TÍCI4  (0.81 mL of a 1.2 M solution, 0.98 mmol). After work-up and purification by flash 
chromatography (ethyl acetate/hexane 1:2) two fractions were obtained containing a mixture of 43 and 44 (27
mg, 0.097 mmol, 20%) as a colorless oil, /?ƒ 0.35, and 4 - [ l - ( £ ) - p r o p e n y l ] te t r a h y d r o - l ,2 -  
pyridazinedicarboxylic acid dimethyl ester (60) (35 mg, 0.145 mmol, 29%) as a colorless oil, Rj-0.17. 
60: IR v 1720, 1705; !H NMR (200 MHz) 8  0.78-1.09 (m, 1 H, HS^), 1.40-1.55 (m, 1 H, H S ^ , 1.63-1.66 
(d, J  = 6.4 Hz, 3 H, CH3), 2.20-2.40 (m, 1 H, H4), 2.60-2.75 (m, 1 H, TO^), 2.85-3.05 (m, 1 H, H ó^), 3.74 
(s, 6  H, 2 x C02 CH3), 3.90-4.30 (m, 2 H, H 3„ and H6 „ ) , 5.20 (dd, J  = 8.5,15.2 Hz, 1 H, CHCW=CH), 5.49 
(dt, J  = 15.2, 6.3 Hz, 1 H, CHCH3); 13C NMR (50 MHz) 8  18.0 (CH3), 30.2 (C5), 37.6 (C4), 44.0, 49.5 (C3 
and C6 ), 53.4 (2 x C02 CH3), 126.5,131.0 (HC=CH), 155.7 (2 x C(0)); MS (El, 70 eV) mh (relative intensity) 
248 (100, M+), 211 (5), 183 (52), 59 (40).
5“(Formyloxy)tetrahydro-líM,2-diazepine-l,2(3//)-dicarboxylic acid dimethyl ester (61). A
solution of 30 (223 mg, 0.91 mmol) in HCOOH (5 mL) was stirred at 40 *C for 18 h, the mixture was 
concentrated in vacuo. Purification by flash chromatography (ethyl acetate/hexane 2:1) yielded 61 (179 mg, 0.69 
mmol, 76%) as a colorless oil, Rf 0.20. IR v 1710,1695; *H NMR (200 MHz) 8  1.75-2.10 (m, 4 H, 2 x H4 
and 2  x H6 ), 3.10-3.30 (m, 2 H, H3 and H7), 3.67 (s, 6  H, 2  x C02 CH3), 3.70-4.00 (m, 2 H, H3 and H7), 5.11 
(t, J  = 8.0 Hz, 1 H, H5), 7.98 (s, 1 H, CHO); *3C NMR (50 MHz) 8  (some signals appear as rotamers) 30.9,
31.8, 32.3 (C4 and C6 ), 44.4, 45.0 (C3 and Cl), 53.3 ( 2  x C02 CH3), 71.2 (C5), 155.5,159.9 (3 x C(O)); MS 
(El, 70 eV) m h  (relative intensity) 260 (26, M+), 229 (4), 215 (36), 201, (6 ), 155 (100), 59 (87); HRMS calcd
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for C1 0 Hl 6 N2 O4  260.1008, found 260.1009.
T etrahydro-5-oxo-lH -l,2 -d iazep ine-l,2 (3#)-d icarboxy lic  acid dim ethyl ester (62). A solution 
of 3 6  (80 mg, 0.33 mmol) in HCOOH (2 mL) was stirred at 40 *C for 42 h. After addition of water (1 mL) and 
being stirred at rt for 2 h, the reaction mixture was poured into water (30 mL) and extracted with CH2 C12  (3 x 25 
mL). The combined organic layers were washed with aq satd NaHCO^ (25 mL), dried (MgS04), filtered and 
concentrated in vacuo. Purification of the residue by flash chromatography (ethyl acetate/hexane 1.7:1) afforded 62 
(63 mg, 0.27 mmol, 83%) as a colorless oil, R t  0.20. IR v 1710,1695; *H NMR (200 MHz) 8  2.51-2.83 (m, 4 
H, 2  x H4 and 2 x H6 ), 3.21-3.38 (m, 2 H, H3 and H7), 3.74 (s, 6  H, 2 x C02 CH3), 4.04-4.27 (m, 2 H, H3 
and H7); 13C NMR (50 MHz) 8  42.7 (C4 and C6 ), 42.9 (C3 and C7), 53.6 (2 x C02 CH3), 208.2 (C5); MS (El, 
70 eV) m /2 (relative intensity) 230 (93, M+), 199 (12), 171 (47), 101 (100), 59 (98); HRMS calcd for
C9H14N2°5 230.0903, found 230.0906.
T etrahydro-5-oxo-l//-l,2 -d iazep ine-l,2 (3 /y)-d icarboxylic  acid diethyl ester (64). Following the 
general procedure B, 22 (14.0 g, 47.0 mmol) was deprotonated with NaH (1.23 g, 51 mmol) and alkylated with 2- 
(ethoxymethoxy)methyl chloride (6.96 mL, 56 mmol), while all compounds were dissolved in DMF (80 mL). 
After work-up and concentration in vacuo, 63 (17.5 g) was obtained as a mixture of silylated and desilylated 
product (2:1). The viscous brown oil was dissolved in HCOOH (500 mL) and stirred at 60 *C for 6 6  h. After 
addition of water (250 mL) and being stirred at rt for 5 h, the dark brown solution was extracted with CH2 C12  (4 
x 400 mL). The combined organic layers were washed with aq satd NaHC0 3  until the washings had a basic pH, 
dried (MgS04), filtered and concentrated in vacuo. Flash chromatography (ethyl acetate/hexane 1:1) afforded 64 
(7.76 g, 30.1 mmol, 64%) as a viscous light yellow oil, R f  0.35. IR v 1725,1705; XH NMR (200 MHz) 8  1.22 
(t, J  m 7.0 Hz, 6  H, 2  x CH2 CH3), 2.51-2.76 (m, 4 H, 2 x  H4 and 2 x H6 ), 3.21-3.38 (m, 2 H, H3 and H7), 
4.13-4.19 (m, 2 H, H3 and H7), 4.16 (q ,/=  7.0 Hz, 4 H, 2 x Cff2 CH3).
T etrahydro -5 -oxo -l/M ,2 -d iazep ine-l,2 (3 /J)-d icarboxyIic  acid d ially l ester (6 6 ). According to 
the general procedure B, 20 (7.59 g, 23.3 mmol) was treated with NaH (675 mg, 28.0 mmol) and 2- 
(ethoxymethoxy)methyl chloride (3.77 g, 30.3 mmol), while all compounds were dissolved in DMF (40 mL). 
After work-up and concentration in vacuo, the alkylated product 65 was obtained as a 2:1 mixture of silylated and 
desilylated product This viscous dark oil was dissolved in HCOOH (300 mL) and stined at 60 *C for 60 h. The 
dark brown solution was diluted with water (150 mL) and stirred at rt for 5 h before it was extracted with CH2 C12  
(5 x 150 mL). The combined organic layers were washed with aq satd NaHCOg until the washings had a basic 
pH, dried (MgS04), filtered and concentrated in vacuo. The residue was subjected to flash chromatography (ethyl 
acetate/hexane 1:1.1) to give 6 6  (3.45 g, 12.2 mmol, 53%) as a colorless oil, /?ƒ 0.35. IR v 3080,1720,1705; 
!H NMR (200 MHz) 8  254-2.86 (m, 4 H, 2 x H4 and 2 x H6 ), 3.19-3.40 (m, 2 H, H3 and H7), 4.054.19 (m, 2
H, H3 and H7), 4.62 (br s, 4 H, 2 x OCH2), 5.17-5.31 (m, 4 H, 2 X =CH2), 5.79-5.98 (m, 2 H, 2 x =CH); 13C 
NMR (50 MHz) 8  42.6 (C4 and C6 ), 44.1 (C3 and C7), 67.0 (OCH2), 118.3 (=CH2), 131.9 (=CH), 208.1 
(C(0)); MS (El, 70 eV) mlz (relative intensity) 282 (M+, 35), 197 (37), 153 (67), 41 (100), 17 (100); HRMS 
calcdforC1 3 H1 8 N2 0 5  282.1216, found 282.1222.
l-[(Form yloxy)m ethyl]-2-(2-propenyl)-l,2-hydrazinedicarboxyIic acid dim ethyl ester (70). To 
a solution of 10 (314 mg, 1.67 mmol) in HCOOH (10 mL) was added 1,3,5-trioxane (201 mg, 2.22 mmol) and 
the mixture was stirred at 70 *C for 18 h. Concentration in vacuo and purification by flash chromatography (ethyl 
acetate/hexane 1:1) afforded 70 (189 mg, 0.77 mmol, 46%) as a colorless oil, /?ƒ 0.50. IR v 1740, 1710; *H
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NMR (200 MHz) 6  3.71-3.81 (m, 6 H ,2 x  C 0 2 CH3), 3.86-3,97 (dd, J  = 7.0,15.2 Hz, 1 H, NC//HCH),4.15- 
4.40 (m, 1 H, NCHtfCH), 5.15-5.46 (m, 3 H, =CH2  and NC//H0), 5.69-5.96 (m, 2 H, =CH and NCHtfO),
8.04-8.09 (m, 1 H, OC(O)H).
C yclization of 12 with 1,3,5-trioxane/H C O O H  to 61. To a solution of 12 (313 mg, 1.55 mmol) in 
HCOOH (5 mL) was added 1,3,5-trioxane (181 mg, 2.0 mmol) and the mixture was stirred at 40 *C for 16 h. 
Concentration in vacuo and purification by flash chromatography (ethyl acetate/hexane 1:1) yielded 12 (92 mg, 
0.45) and 61 (112 mg, 0.431 mmol, 40% (after correction)) as a colorless oil.
C yclization of 16 w ith 1,3,5-trioxane/H C O O H  to 45. To a solution of 16 (519 mg, 2.18 mmol) in 
HCOOH (10 mL) was added 1,3,5-trioxane (260 mg, 2.88 mmol) and the mixture was stirred at 80 *C for 20 h. 
Concentration in vacuo and purification by flash chromatography (ethyl acetate/hexane 1:1) yielded 45 (506 mg,
2.02 mmol, 93%) as a colorless oil.
C yclization  of 16 w ith (C H 2 0 )n/H C 0 0 H to 45. To a solution of 16 (810 mg, 3,40 mmol) in 
HCOOH (10 mL) was added (CH2 0)n (189 mg, 6.3 mmol) and the mixture was stirred at 70 *C for 18 h. 
Concentration in vacuo and purification by flash chromatography (ethyl acetate/hexane 1:1) afforded 45 (629 mg, 
2.52 mmol, 74%) as a light yellow oil.
1.4-D ihydro-2,3-phthaIazinedicarboxylic acid diisopropyl ester (71)/*1 To a solution of 17 (297 
mg, 1.01 mmol) in HCOOH ( 8  mL) was added 1,3,5-trioxane (118 mg, 1.31 mmol) and the mixture was stirred 
at 90 °C for 20 h. Concentration in vacuo and purification by flash chromatography (ethyl acetate/hexane 1:1) 
yielded 71 (198 mg, 0.647 mmol, 64%) as white crystals, mp 97-99 'C, Rr  0.45. IR v 1700; ^  NMR (200 
MHz) 8  1.25 (d, J = 6.2 Hz, 12 H, 2 x (C//3 )2 CH), 4.37 (d, J  = 15.7 Hz, 2 H, 2 x NC//H), 4.97 (septet, J  = 6.2 
Hz, 2  H, 2  x (CH3 )2 C//), 5.09 (d, J  = 15.7 Hz, 2 H, 2 x NCHH), 7.20 (m, 4 H, ArH); 13C NMR (50 MHz) 8
22.0, 22.1 ((CHj^CH), 45.3 (NCH2), 70.1 ((CH3 )2 CH), 126.3, 126.8 (ArH), 132.0 (ArC); Anal. Calcd. for 
C16H22N2°4: c ’ 6 2 / 7 3  ^ H’ 7-24; N- 9.14. Found: C, 62.64; H, 7.21; N, 9.04.
C yclization of 17 w ith H C 0 0 H /(C H 2 0 )n to  71. To a solution of 17 (297 mg, 1,01 mmol) in 
HCOOH (10 mL) was added (CH2 0)n (45.5 mg, 1.52 mmol) and the mixture was stirred at 60 ’C for 20 h. 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 71 (197 mg, 0.64 mmol,
64%) as a white solid, R f  0.45.
l-B enzy l-l,2 -di(m ethoxycarbonyl)hydrazineacetic acid ethyl ester (72). According to the general 
procedure B, 16 (5.01 g, 21.1 mmol) was deprotonated with NaH (557 mg, 23.1 mmol) and alkylated with ethyl 
chloroacetate (2.66 mL, 25.3 mmol), while all compounds were dissolved in DMF (30 mL). After work-up and 
flash chromatography (ethyl acetate/hexane 1.6 :1) 72 (6.19 g, 19.1 mmol, 91%) was obtained as a light yellow 
oil, R f  0.32. IR v 1745, 1720, 1705, 695; !H NMR (200 MHz) 8  1.18 (t, J  = 7.2 Hz, 3 H, CH2 CH3), 3.56,
3.76 (s, 6  H, C02 CH3), 4.06 (q, J = 7.1 Hz, 2 H, CH2CH3), 4.25-4.50 (m, 1 H, NCflHC(O)), 4.54 (d ,/=  15.1 
Hz, 1 H, NC//HPh), 4.88 (d, J=  15.1 Hz, 1 H, NCHtfPh), 5.0-5.25 (m, 1 H, NCHWC(O)), 7.24-7.39 (m, 5 H, 
ArH).
Ethyl [jV-benzyl-iV-(methoxycarbonyl)amino]IW -(niethoxycarbonyI)ainino]acetate (73). LDA 
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hexane, 1.94 mmol) in THF (5 mL) at 0 *C. PhSSPh (203 mg, 0.93 mmol) was added to this solution and the 
mixture was added dropwise via syringe to a solution of 72 (300 mg, 0.93 mmol) in THF (10 mL) at -78 *C. 
After being stirred at -78 *C for 30 min and 1 h at rt, the mixture was poured into aq satd NH4CI (20 mL) and 
extracted with CH2C12 (3 x 20 mL). The combined organic layers were dried (MgSC>4), filtered and concentrated 
in vacuo. After flash chromatography (ethyl acetate/hexane 1:4), 73 (122 mg, 0.377, 41%) was obtained as a 
colorless oil, Rjr 0.35. IR v 3410, 1740, 1710, 1690, 690; *H NMR (200 MHz) 8 (some signals appear as 
rotamers) 1.17 (t, J  = 6.7 Hz, 2 H, CH2Ctf3), 3.67, 3.73 (s, 3 H, C 02CH3), 4.10 (q, J  = 6.7 Hz, 2 H, 
C//2CH3), 4.50 (d, J  = 15.9 Hz, 1 H, NC//H), 4.80 (d, J  = 15.9 Hz, 1 H, NCHH), 5.36-5.49 (m, 1 H, CH), 6.0,
6.31 (br s, 1 H, NH), 7.30-7.36 (m, 5 H, ArH); 13C NMR (200 MHz) 8 13.6 (CH2CH3), 51.3 (NCH2), 52.9 
(CH3), 62.1 (CH2CH3), 64.2, 65.4 (CH), 127.3, 127.9 (ArH), 136.6 (ArC), 156.3, 167.4 (C(O)); MS (El, 70 
eV)m/z (relative intensity) 251 ((M+- C02Ht), 100), 164 (40), 91 (100).
a ja '-D iam in o -o -x y len e-^A ^-d icarb o x y lic  acid dim ethyl ester (76). A solution of 45 (140 mg, 
0.551 mmol) in THF (5 mL) was added to a solution of Li (15.3 mg, 2,20 mmol) in anhydrous NH3 at -78 *C. 
The resulting dark blue solution was stirred at -78 *C for 30 min and at -33 *C for 1 h. Then, the reaction was 
quenched by addition of solid NH4CI (294 mg, 5.50 mmol) and the ammonia was allowed to evaporate. The 
residue was dissolved in water (20 mL) and extracted with CH2CI2 (3 x 20 mL). The combined organic layers 
were dried (MgSC^), Filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to yield 76 
(67 mg, 0.262,48%) as a white solid, mp 143-145.5 *C (ethyl acetate/hexane 1:10), £ƒ  0.50. IR v 3440, 3320, 
1710, 1510, 1230: *H NMR (200 MHz) 8 3.67 (s, 6 H, 2 x C 02CH3), 4.39 (d, J  = 5.9 Hz, 4 H, 2 x CH2),
5.48 (br s, 2 H, 2 x NH), 7.23-7.37 (m, 4 H, ArH); 13C NMR (50 MHz) 8 42.4 (2 x CH2), 52.3 (2 x 
C02CH3), 128.1, 129.3 (ArH), 136.3 (AiC), 157.1 (2 x C(O)); MS (El, 70 eV) m/r (relative intensity) 252 
(M+, 2), 177 (100), 118 (50), 59 (20); HRMS calcd for C12H16N20 4 252.1110, found 252.1149.
5 ,5 -E thy lened ioxy te trahydro-l/f-l,2 -d iazep ine-l,2 (3£0-d icarboxyH c acid diethyl ester (77).
To a solution of 64 (5.65 g, 21.9 mmol) in benzene (150 mL) was added ethylene glycol (2.72 g, 43.8 mmol) 
and a catalytic amount of pTSA. The mixture was heated at reflux for 18 h with use of a Dean Stark trap. After 
cooling to rt, the mixture was poured into water (100 mL) and extracted with CH2C12 (3 x 100 mL). The 
combined organic layers were dried (MgSC^), filtered and concentrated in vacuo. Purification by flash 
chromatography (ethyl acetate/hexane 1:1) afforded 77 (5.28 g, 19.7 mmol, 90%) as a yellowish oil, Rjr 0.35. IR 
v 1710,1695; !H NMR (200 MHz) 8 1.22 (q, J  = 7.0 Hz, 6 H, 2 x CH2CH3), 1.70-1.99 (m, 4 H, 2 X H4 and 2 
x H6), 3.16-3.41 (m, 2 H, H3 and H7), 3.93 (s, 4 H, 2 x OCH2), 3.75-4.03 (m, 2 H, H3 and H7), 4.11-4.20 (m,
4 H, 2 x CH2CH3).
l^-D iam inopentane-JV jiV '-dicarboxylic acid diethyl ester (78). A solution of 77 (500 mg, 1.66 
mmol) in THF (3 mL) was added dropwise to a solution of Li (46 mg, 6.64 mmol) in anhydrous NH3 (15 mL) at 
-78 °C. The dark blue solution was stirred at -78 *C for 30 min and at -33 *C for 2 h. The reaction was quenched 
by addition of solid NH4CI (888 mg, 16.6 mmol) and the NH3 was allowed to evaporate. The residue was 
dissolved in water (20 mL) and extracted with CH2C12 (3 x 20 mL). The combined organic layers were dried 
(MgSC>4), filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to give 78 (260 mg, 
0.855 mmol, 70%) as a white solid, mp 84-85 *C (ethyl acetate/hexane 1:5), R f  0.45. IR v 3440, 1710, 1510; 
*H NMR (200 MHz) 8 1.20 (t, J  = 7.1 Hz, 6 H, 2 x CH2CW3), 1.82 (t, 7 = 6.6 Hz, 4 H, 2 x CCñ¿), 3.25 (q, 
J  = 6.2 Hz, 2 x NCH^), 3.95 (s, 4 H, 2 x OCH2), 4.06 (q, J  = 7.1 Hz, 4 H, 2 x Ctf2CH3), 5.18 (br s, 2 H, 2 x 
NH); 13C NMR (50 MHz) 8 14.4 (2 x CH2CH3), 36.0 (2 x CH2C), 42.5 (2 x NCHj), 60.4 (2 x Cff2CH3),
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64.6 (2 x OCH2), 110.3 (C), 155.5 (2 x C(0)); Anal. Calcd. for C, 51.31; H, 7.95; N, 9.20.
Found: C, 51.24; H, 7.86; N, 9.28.
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In the previous Chapter, the synthesis of various protected cyclic hydrazine compounds 
1 via an intramolecular N ,N 1 -diacylhydrazonium ion cyclization has been described. In this 
Chapter, a method to obtain the free hydrazines 2 will be discussed, as well as some further 
reactions with these hydrazines to form the bicyclic products 3 (eq 3.1),
(eq 3.1)
3
Various procedures are known to cleave methyl and ethyl carbamates, which include 
basic hydrolysis (e.g. KOH, MeOH)2 and cleavage with M ^SiL3 These methods have also 
been applied to deprotect hydrazines with good results,4 but often suffer from formation of side 
products. This is particularly true for the seven-membered rings, which are easily oxidized (even 
by air) to the corresponding hydrazones.5 Several attempts to deprotect some hydrazines of type 
1 did not lead to reproducible results upon use of either of these methods.
3.2 THE ALLYLOXYCARBONYL (ALLOC) FUNCTION AS A PROTECTIVE GROUP
V
The use of allyl and allyloxycarbonyl functions as protective groups is based on the well- 
known palladium-catalyzed allylic alkylation method.6 Allyl esters, allyl carbonates and allyl 
carbamates have been used in various fields of chemistry like (i-lactam chemistry7 and peptide,8 
glycopeptide9 and oligonucleotide10 synthesis. Although other methods are known for removal 
of this protective group,11 the deprotection is most frequently carried out under relatively mild 
conditions using a palladium(O) catalyst in the presence of a nucleophile (eq 3.2).
9  »pd0’
R'NA 0 ^  ------- N + N u c ^ ^  + C02 (eq 3.2)
R' Nuc R’
4 5
In this reaction, the palladium catalyst will react with the allyloxycarbonyl moiety of the 
carbamate 4 to form a - ally lp all adium complex, which is attacked by the nucleophile to give the
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free amine 5 , the allylated nucleophile and carbon dioxide. Several compounds have been 
studied as the nucleophile in this process, including potassium 2-ethylhexanoate,7 morpholine,8 
dimedone,9 formic acid,10»12 and n-butylamine.10’12
3.3 DEPROTECTION OF ALLOC PROTECTED HYDRAZINES
As model systems for these deprotection reactions both the ketone 6 and its protected 
analog 7 were chosen. Deprotection of both compounds upon use of standard conditions (10% 
Pd(PPh3)4, 0.6 equiv PPI13, excess of the nucleophile, THF, rt)10*12 led to rather disappointing 
results which are summarized in Table 3.1.
Table 3.1. Deprotection under 'standard' conditions.
entry Alloccompound
nucleophile
(equiv) solvent products (yield)
Alloc^Ns~—
HCOOH (10) THF 1 W o
6 8 (49%)
a"oc' n '~ v s
2 A l l o c ^ v J V
n-BuNH2 (10)
\ / S
^  H Ù ^ o J  + 0 0
7 9 (55%) 10 (12%)
3 7 n-BuNH2 n-BuNH2 10 (49%)
Depending on the nucleophile that was used, either diallylhydrazine 8 was formed (entry 
1), or a mixture of allylhydrazine 9 and azo compound 10 (entry 2). Formation of the NN 
double bond was indicated by an absorbance in the UV spectrum at 380 nm.5 If the reaction, 
work-up and purification were not carefully carried out under an inert nitrogen atmosphere, 
oxidation of allylhydrazine 9 to the corresponding allylhydrazone 11 took place rapidly (eq 3.3). 
Upon using n-BuNH2 as the solvent, N-allylation was not observed and azocompound 10 was 




These results can be explained by the reaction sequence shown in Scheme 3.1. 
Pd(PPh3)4 dissociates to react with the allyl carbamate under the formation of the tc- 
allylpalladium complex 13. This intermediate can react with any nucleophile present in the 
reaction mixture. Either formic acid or n-butylamine can act as a nucleophile, but also a (partly)
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deprotected hydrazine which will lead to the formation of N-allylated products. Considering the 
relatively large amounts of N-allylated products, it can be concluded that these cyclic hydrazines 
give a very fast reaction with the 7C-allylpaUadium complex. The high reaction rate might be a 
result of the a-effect,13 but on the other hand, it could also point to some intramolecular 
















RHN---- ----  + COz + 'PdL2'
12
Only if a large excess of a different nucleophile was used (/1-BUNH2 as solvent), 
formation of allylated products could be avoided, but under these conditions the initially formed 
free hydrazine is further oxidized to the azo compound 10 .
N-Allylation as a side reaction has also been reported in the literature14 and has even 
been used intentionally.12 In order to prevent N-allylation, Guib6 and co-workers used n- 
Bu3SnH,8»15 which acts as a very fast hydride-donor. Rapid reaction with the rc-allylpalladium 
complex 13 affords the relatively stable tri-n-butyltin carbamate 14 as an intermediate and 
propene, which immediately evolves from the reaction mixture (see Scheme 3.1). The tin 
carbamate 14 is cleaved in situ with a proton donor (water or acetic acid) that is already present
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in the reaction mixture to give the free amine 15, carbon dioxide and a tributyltin salt.
Surprisingly, application of the exact Guibé conditions in the deprotection of hydrazine 7 
led to allylhydrazine 9 in a quantitative yield (eq 3.4). The formation of this product can only be 
explained by assuming a very fast reaction between deprotected hydrazine and the iz- 
allylpalladium complex that is still present in the reaction mixture.
7
Pd(PPh3)4 (0.04 equiv), 
Bu3SnH (2.2 equiv),




This result made clear that, again, the hydrazine reacts faster with the rc-allylpalladium 
complex than the external nucleophile (the tin hydride) present in the reaction mixture. Therefore 
a modification of the Guibé method was used in which the intermediate ditin carbamate 17 was 
generated in the absence of a proton donor. Only a/ter complete reduction of the 7t-ally ¡palladium 
complex with n-B^SnH and concomitant conversion of the diallyl carbamate into the ditin 
carbamate, a proton donor was introduced in order to cleave the ditin carbamate.
6
Pd(PPh3)4 (0.04 equiv)
■ ■■■ I I ......« —
Bu3SnH (2.2 equiv) 
CH2C12, rt, 10 min
HCl(g) %




An example of this modification is shown in eq 3.5 in which dry HCl(g) was used to 
cleave the ditin carbamate 17 and to protonate the resulting free hydrazine. In this way, the 
oxidation-sensitive hydrazine was precipitated from the reaction mixture to afford the more stable 
HCl-salt 18 in a quantitative yield.16 This salt could be alkylated17 with activated dihalides (1.5 
equiv, K2CO3 (5 equiv), Nal (cat), 2-butanone, rt) to afford the bicyclic hydrazines 19 and 20 







Remarkably, the ditin carbamate 17 proved to be an interesting intermediate because it 
could not only be cleaved by a simple proton donor, but also by other electrophilic species such 
as activated carbonyl groups, to give the corresponding amides or carbamates. Thus, treatment
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of the intermediate ditin carbamate 17 with an excess of acetic anhydride gave a quantitative 
yieldofdiacetylhydrazine21 (eq 3.7).
Pd(PPh3)4 (0.04 equiv), 
Bi^SnH (2.2 equiv),
7  ------------------------------------------------------------------------ ---
AQ2O (5 equiv),
CH2C12, rt, 10 min
(eq 3.7)
In contrast with the deprotection reactions, the electrophile was added together with the 
palladium catalyst and the n-Bu3 SnH, without formation o f any W-allylated products. 
Apparently, the ditin carbamate shows a high selectivity towards the activated carbonyl 
compound and does not give any reaction with the palladium complex present in the reaction 
mixture. This reaction proved to be more generally applicable and some examples of this 
acylation with activated carbonyl compounds are shown in Table 3.2.
Table 3.2. Pd-Catalyzed formation of amide bonds

































[a] +6.0 (c 0.5, CHC13)
“After treatment of the crude mixture with HCl/MeOH.
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Different from the reaction with acetic anhydride and although in some cases an excess of the 
electrophile was used (entries 1 and 2), only the monosubstituted products 24 and 25 were 
formed* This is probably due to steric hindrance of the first introduced substituent, which 
hinders the introduction of the second substituent
In entry 1, the Alloc group is replaced by a Boc group in a one-pot procedure. Thus, one 
protective group is replaced by another protective group, so that this reaction might also be 
called a ‘transprotection’. In this way, the stable compound 24 is obtained, which can also be 
easily deprotected to give the salt of the the free hydrazine upon treatment with acid (HCl/MeOH 
or HCOOH). The Boc-protected hydrazine is, in contrast with its HCl-salt, a stable compound 
as the presence of the carbamate function in the molecule suppresses the oxidation to the 
corresponding hydrazone.
Coupling with succinic anhydride afforded, after concentration of the reaction mixture, 
the corresponding tributyltin ester. The methyl ester 25 was obtained upon stirring of the crude 
reaction mixture in a HCl/MeOH solution. The use of the N-pro tec ted a-amino acids glycine and 
alanine,18 that are activated by a pentafluorophenoxy group (22 and 23, entries 3 and 4) led to 
the hydrazides 26 and 27 in reasonable yields.
3.4 DISCUSSION
The rapid reaction of tin carbamates with activated carbonyl compounds might be 
explained by assuming a cyclic transition state 28 (eq 3.8) in which the nucleophilicity of the 
nitrogen atom is strongly enhanced by cleavage of the Sn-0 bond and concomitant formation of 
carbon dioxide.
0
R ' S v .  -SnB u3 ------------------ / N V R' + C C h  +  B u ^ n 0 R  ( C q 3 ,8 )
0  O' II
1 o  
R 28
It is not very likely that the a-effect is responsible for the increased nucleophilicity of the 
nitrogen atom in this transprotection reaction. This can be concluded from reactions that were 
earned out with Alloc-protected a-amino acids 29 and a-amino acids 30 of which the carbonyl 
groups were activated (eq 3.9). In these cases, the corresponding dipeptides 31 were obtained 
in high yields.19 Thus, it has been shown that with this method it is also possible to couple two 
amino acids under neutral conditions with high efficiency. An interesting aspect of this coupling 
is that the protected starting material is reacted without an extra deprotection step. Comparison 






AIIoc' N - V OR' + Z' N ^ V X — — ^  ^  ^ O R . (eq 3.9)
H ^  n-BujSnH
29 30 31
In conclusion, the deprotection method described herein provides a useful route to 
deprotected hydrazines. Reaction of an Alloc-protected hydrazine with n-BugSnH and 
Pd(PPh3)4 affords a versatile intermediate, which can be transformed in several ways: (i) it can 
be directly cleaved with a proton donor to yield the salt of the free hydrazine; (ii) it can be 
‘transprotected’ with a different protective group, leading to a stable protected product, that can 
be deprotected under other conditions; (iii) it can be directly coupled with other activated 
carbonyl compounds so that in a one-pot procedure the Alloc group is replaced by another 
substituent under formation of an amide bond. An application of the transprotection method will 
be detailed in Section 7.5.
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3.5 EXPERIMENTAL SECTION
*
General inform ation. n-BujSnH was purchased from Aldrich and Merck and used without further purification. 
As the quality of the n-Bu^SnH proved to be crucial in the deprotection reactions, a test reaction was run to 
determine whether further purification was necessary. Distillation of the residue provided K-Bu3SnH of sufficient 
quality.20 Pd(PPh3)4 was purchased from Aldrich and stored in the absence of light under a dry nitrogen 
atmosphere. The rotation was measured with a Perkin Elmer 241 polarimeter. For further experimental details, 
see: Section 2.11.
5 ,5 -E thyIened ioxy te trahydro-lir-l,2“diazepine-l,2(3jff)-dicarboxylic acid diallyl ester (7). To 
a solution of 6 (5.65 g, 21.9 mmol) in toluene (100 mL) were added ethylene glycol (419 mg, 3.89 mmol) and a 
catalytic amount of pTSA, The mixture was heated at reflux for 18 h with the use of a Dean Stark trap. After 
cooling to rt, the solution was concentrated in vacuo. The residue was dissolved in CH2CI2 (50 mL), washed with 
water (20 mL), dried (MgSC>4), filtered and concentrated in vacuo. Purification by flash chromatography (ethyl 
acetate/hexane 1:1) afforded 7 (1.16 g, 3.39 mmol, 88%) as a yellowish oil, /?ƒ 0.35. IR v 2990, 2950, 2880, 
1720, 1700, 1445, 1405, 1335, 1115, 1040, 990; l H NMR (200 MHz) 8 173-2.04 (m, 6 H, 2 x NCflH and 
CH2C(0 )CH2), 3.19-3.48 (m, 2 H, 2 x NCHtf), 3.63 (s, 4 H, 0CH2CH20), 4.65 (m, 4 H, 2 x CH20), 5.15-
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5.35 (m, 4 H, 2 x =CH2), 5.79-5.91 (m, 2 H, 2 x =CH).
1.2-D i-(2-propenyl)-5-oxohexahydro-l,2-diazepine (8). To a solution of 6 (23 mg, 0.084 mmol) in 
THF (1 mL) was added PPti3 (22 mg, 0.084 mmol), HCOOH (38 mg, 0.84 mmol) and Pd(PPh3)4 (18 mg, 
0.014 mmol). The mixture was stirred at it for 45 min and concentated in vacuo. The residue was subjected to 
flash chromatography (ethyl acetate/hexane 1:4) yielding 8 (15 mg, 0.041 mmol, 49%) as a colorless oil, Rj- 
0.30. IR v 2940, 1710, 1410, 1255, 990, 860, 820, 720; %  NMR (200 MHz) 8 2.63 (t, /  = 4.8 Hz, 4 H, 
CH2C(0 )CH2), 3.05 (t, J  = 5.8 Hz, 4 H, 2 x NCH2), 3.34 (dt,/ =  1.2,6.2 Hz, 4 H, 2 x NCH2), 5.06-5.23 (m,
4 H, 2 x =<:%), 5.73-5.93 (m, 2 H, 2 x =CH).
D eprotection of 7 w ith n-BuNH2 (10 equiv). To a solution of 7 (67 mg, 0.20 mmol) in THF (2 mL)
was added PPh3 (28 mg, 0.12 mmol), n-BuNH2 (264 mg, 3.6 mmol) and Pd(PPh3)4 (24 mg, 0.020 mmol). The 
solution was stirred at rt for 2 h, concentrated in vacuo and subjected to flash chromatography (ethyl 
acetate/hexane 3:1) to afford a mixture of 5,5-ethylenedioxy-l>(2-propenyl)hexahydro-l,2-diazepine 
(9) (22 mg, 0.11 mmol, 55%) as a colorless oil, Rj? 0.20 and 4,5,6,7-tetrahydro-3//-5,5«ethyIenedioxy-
1.2-diazepine  (10) (10 mg, 0.06 mmol, 12%) as a light yellow oil, R f  0.50. 9: IR v 3350, 3070, 2960, 
1430, 1170, 1115; *H NMR (200 MHz) 5 1.89 (t, J = 6.0 Hz, 2 H, NCH2Ctf2), 2,00 (t, J  = 6.5 Hz, 
HNCH2CH2), 2.64 (t, J  = 6.0 Hz, 2 H, NCH2), 2.92 (t, J  » 6.5 Hz, NCH2), 3.24 (d, ƒ = 6.2 Hz, 2 H, 
CH2CH=0, 3,92 (s, 4 H, OCH2CH2), 5.09-5.21 (m, 2 H, =CH2), 5.83-6.02 (m, 1 H, =CH); 10: IR v 2990, 
1480,1440,1115,1070,1040,940,900; *H NMR (200 MHz) 8 1.63 (t, 4 H, J  = 5.4 Hz, CH2CCH2), 3.96 (s,
4 H, 2 x O O y ,  4.25 (br s, 4 H, 2 x NCH2).
Upon standing, hydrazine 9 was oxidized to 4,5,6,7-tetrahydr0-lff-5,5-ethylenedioxy-l-(2-propenyl)-
1.2-diazepine (11): IR v 2970, 1480,1430,1180,1120,1090,1070,1020, 990, 920; XH NMR (200 MHz) 
8 1.91 -1.97 (m, 2 H, NCH2Ctf2), 2.62 (d, J  = 4.9 Hz, N ^H C tfj) , 2.73-2.79 (m, 2 H, NCH2), 3.67 (d, J  = 6.2 
Hz, 2 H, C//2CH=), 3.87-4.03 (br s, 4 H, 2 x OCH2), 5.14-5.28 (m, 2 H, =CH2), 5.91-5.99 (m, 1 H, =CH),
7.02 (t, J  = 4.9 Hz, 1 H, N=CH); 13C NMR (50 MHz) 8 39.6,40.1 (CH2CCH2), 50.1 (NCH2), 64.3 (NCH2),
64.5 (0CH2CH20), 105.5 (Q , 117.3 (=CH2), 135.4 (=CH), 146.9 (N=CH); MS (El, 70 eV) mtz (relative 
intensity) 196 (M+, 28), 155 (15), 109 (10), 99 (100), 83 (27), 55 (24); HRMS calcd for C10H16N2O2 
196.1212, found 196.1204.
R eaction of 7 in rt-BuNH2. To a solution of 7 (58 mg, 0.18 mmol) in n-BuNH2 (2mL) were added PPh3 
(28 mg, 0.11 mmol) and Pd(PPh3)4 (22 mg, 0.018 mmol). The mixture was stirred at rt for 2 h, concentrated i n 
vacuo and purified by flash chromatography (ethyl acetate/hexane 3:1) to yield 10 (14 mg, 0.090 mmol, 49%) as 
a yellowish oil, /?ƒ 0.50.
General procedure A for the deprotection reactions. To a well-stirred solution of the Alloc-protected 
compound in CH2C12 was added Pd(PPh3)4 (0.04 equiv), immediately followed by the addition of the whole 
amount of n-Bu3SnH (2.2 equiv). Evolution of gas was observed and after being stirred for 15 min, the 
electrophile was added to the yellow solution. After being stirred for an additional 15 min, the mixture was 
concentrated in vacuo and the remaining residue was purified by flash chromatography.
General procedure B for the deprotection reactions. To a well-stirred solution of the Alloc-protected 
hydrazine in the presence of the electrophile in CH2C12 was added Pd(PPh3)4 (0.04 equiv), immediately followed




Deprotection o fl 2 -di(ally loxy carbonyl)hydrazines
stirred at rt for 30 min, the yellow solution was concentrated in vacuo and the remaining residue was subjected to 
flash chromatography.
D eprotection  of 7 via procedure A. According to the general procedure A, 7 (50 mg, 0.15 mmol) was 
treated with water (15 mg, 0.83 mmol), Pd(PPh3)4 (7.5 mg, 0.006 mmol) and n-BujSnH (87 jiL, 0.33 mmol) in 
CH2CI2 (2 mL). After flash chromatography (ethyl acetate/hexane 1:1, under a nitrogen atmosphere), 9 (30 mg, 
0.15 mmol) was obtained as a yellow oil, which upon standing, was oxidized to hydrazone 1 1 .
5-O xo-hexahydro-l,2-d iazep ineH C l (18). According to the general procedure B, 6 (41 mg, 0.15 mmol) 
was converted into the ditin carbamate 17 by using Pd(PPh3)4 (7.5 mg, 0.006 mmol) and n-BugSnH (87 pL, 
0.33 mmol) in CH2CI2 (2 mL). After 30 min, dry HCl(g) was bubbled through the yellow soludon, so that a 
solid precipitated from the reaction mixture. Removal of the solvent by syringe and washing with dry ether (5 x 3  
mL) afforded 18 (24 mg, 0.15 mmol, 100%) as a light yellow solid. IR (KBr) v 3400,2900, 1700,1430, 1390, 
1230,1180, 1090, 740; !H NMR (200 MHz, D20 ) 8 2.92 (t, J  = 5.4 Hz. 4 H, CH2C(0 )CH2), 3.49 (t, J  = 5.4 
Hz, 4 H, 2 x NCH2); 13C NMR (50 MHz. D20) 8 43.9 (CH2C(0)CH2), 45.7 (2 x NCH2), 215.2 (0(0)).
l,5 -D iaza-3 -m ethy lene-8 -oxob icyclo [5 .3 .0 ]dodecane  (19). To a suspension of 18 (85 mg, 0.70 
mmol) in 2-butanone (2 mL) were added K2CO3 (483 mg, 3.5 mmol), 3-chloro-2-chloromethyl-l-propene (131 
mg, 1.05 mmol) and a catalytic amount of Nal. The reaction mixture was stirred at rt for 17 h, concentrated in 
vacuo, taken up in CH2CI2 (10 mL), washed with water (10 mL), dried (MgS04), filtered and concentrated in  
vacuo again. Purification by flash chromatography (CH2Cl2/acetonc/Et3N 2:1:0.1) afforded the bicyclic hydrazine
19 (18 mg, 0.11 mmol, 16%) as a light yellow oil, Rjr 0.40. IR v 2950, 2920, 1700, 1440, 1370, 1305, 1250, 
1120, 1005, 890; !H NMR (200 MHz) 8 2.67-2.73 (m, 4 H, CH2C(0)CH2), 2.90-2.96 (m, 4 H, 2 x 
NCH2CH2), 3.53 (t, J  = 2.1 Hz, 4 H, 2 x NCH2C=), 4.91 (t, J  = 2.2 Hz, 2 H, =CH2); 13C NMR (50 MHz) 8
44.2 (2 x CH2C(0)), 52.4 (NCH2CH2), 61.7 (NCH2C=), 104.1 (=CH2), 212 (C(0)).
Bicyclic hydrazine 20. To a suspension of 18 (52 mg, 0.34 mmol) in 2-butanone (5 mL) were added K2CO3 
(143 mg, 1.05 mmol), a,a*-dibromo-o-xylol (133 mg, 0.51 mmol) and a catalytic amount of Nal. After being 
stirred at rt for 18 h, the reaction mixture was concentrated in vacuo, taken up in CH2CI2 (15 mL), washed with 
water (10 mL), dried (MgS04), filtered and concentrated in vacuo again. After purification by flash 
chromatography (CH2Cl2/acetone/Et3N 6:1:0.1), the bicyclic hydrazine 20 (12 mg, 0.055 mmol, 16%) was 
obtained as a yellowish oil, R f  0.25. IR v 2980,1700,1430,1350,1170,1120,900, 690; XH NMR (200 MHz) 
8 2.73 (t, J = 5.9 Hz, 4 H, 2 x NCH2CW2), 3.16 (t. J  = 5.9 Hz, 4 H, 2 x NCH2CH2), 4.02 (s, 4 H, 2 x 
CH2Ar), 7.06, 7.18 (2 x d d ,/=  5.5, 3.5 Hz, 4 H, CH); 13CNMR (50 MHz) 8 42.6 (CH2C(0)CH2), 46.9 (2 x 
NCH2CH2), 51.0 (NCH2Ar), 126.5,126.6 ( 2 x ArH), 132.2 (2 X AiC), 210.0 (C(0)).
l»2-D iacetyl-5 ,5-ethylenedioxyhexahydro-l,2-diazepine (21). Following the general procedure A, 7 
(355 mg, 1.10 mmol) was transprotected by using acetic anhydride (561 mg, 5.5 mmol), Pd(PPh3)4 (54 mg, 
0.043 mmol) and n-BugSnH (705 mg, 2.42 mmol) in CH2CI2 (5 mL). After flash chromatography (ethyl 
acetate), 21 (294 mg, 1.10 mmol, 100%) was obtained as a white solid, mp 56-57 #C (ethyl acetate/hexane 1:1), 
R f  0.35. IR v 3000,2950,2880,1660,1440,1395, 1380,1345,1240,1080,940; *H NMR (200 MHz) 8 1.68-
1.79 (m, 2 H, 2 x NCH2CA/H), 1.81-2.05 (m, 2 H, NCH2CHW), 2.02 (s, 6 H, 2 x CH3), 3.03-3.16 (m, 2 H, 2
x NCtfH), 3.93 (s, 4 H, 2 x OCH2), 4.15-4.31 (m, 2 H, NCHW); 13C NMR (50 MHz) 8 20.0 (2 x CH3), 34.4 
(2 x CCH2), 43.1 (2 x NCH2), 64.2 (2 x CH20), 108.5 (C), 171.8 (2 x C(0)); MS (El, 70 eV) m/z (relative
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intensity) 242 (M+, 10), 200 (100), 157 (42), 99 (43), 43 (43); HRMS caled for Cn H18N20 4 242.1267, 
242.1272; Anal. Caled. C, 54.53; H, 7.49; N, 11.56. Found: C, 54.66; H, 7.53; N, 11.51.
5-O xo-hexahydro-l,2-diazepine-l-carboxyIic acid tert-butyl este r (24). According to the general 
procedure A, 6 (129 mg, 0.457 mmol) was transprotected by using di-terf-butyl dicarbonate (490 mg, 2.25 
mmol), Pd(PPh3)4 (23 mg, 0.018 mmol) and n-BugSnH (290 mg, 1.00 mmol) in CH2CI2 (5 mL). After 
purification by flash chromatography (ethyl acetate/hexane 2:1), 24 (85 mg, 0.40 mmol, 87%) was obtained as a 
colorless oil, R f  0.30. IR v 2970,2870,1670,1470,1390,1240,1160,1010,1080, 940; JH NMR 5 1.46 (s, 9
H, (CH3)3C), 2.68 (m, 4 H, CH2C(0)CH2), 3.04 (m, 2 H, NCHj), 3.67 (m, 2 H, NCH2); 13C NMR (50 
MHz) 8 28.2 (CH3), 43.5 (NCH2CH2), 44.0 (NCH2CH2), 45.1 (NCH2), 46.5 (NCH2), 81.1 (C), 154.5, 210.4 
(C(O)). MS (El, 70 eV) mlz (relative intensity) 213 (M+-1, 12), 158 (M+-56,100), (M+-100, 28), 86 (28), 57 
(100), 41 (100).
T ransprotection  with succinic anhydride (25). According to the general procedure B, 6 (38 mg, 0.13 
mmol) was coupled with succinic anhydride (26 mg, 0.26 mmol) by using Pd(PPh3)4 (7 mg, 0.005 mmol) and 
n-B^SnH (83 mg, 0.28 mmol) in THF (2 mL). After concentration in vacuo, the residue was taken up in 4 mL 
of a 1.5 N solution of HCL in methanol and stirred at rt for 2 h. After this period, ether (3 mL) was added and a 
precipitate appeared. After removal of the solvent by syringe and washing with ether ( 5 x 2  mL), the remaining 
solid was taken up in aq satd NaHCC>3 (10 mL) and extracted with CH2CI2 ( 3 x 5  mL). The combined organic 
layers were dried (MgSC^), filtered, and concentrated in vacuo. Purification of the residue by flash 
chromatoghraphy (ethyl acetate) afforded 25 (18 mg, 0.079 mmol, 62%) as a colorless oil, R j  0.20. IR v 3300, 
1745,1700, 1645; NMR (250 MHz) S (some signals appear as rotamers) 2.40-2.70 (m, 8 H, 4 x CH2C(0 )),
3.03-3.20 (m, 2 H, 2 x NC/ffl), 3.66,3.68 (s, 3 H, C02CH3), 3.80-3.90 (m, 2 H, 2 x NCHW); 13C NMR (50 
MHz) 27.6, 29.0 (2 X CH2C(0)), 42.9, 44,3, 47.3, 47.5 (4 x CKy), 51.7 (C02CH3); MS (El, 70 eV) m lz  
(relative intensity) 228 (M+, 23), 201 (12), 197 (15), 115 (28).
l-FM O C -G Iy-l,2-diaza-5-cycloheptanone (26). According to the general procedure B, 6 (34 mg, 0.12 
mmol) was coupled with FMOC-Gly-O-pentafluorophenol (22) (67 mg, 0.14 mmol) by using Pd(PPh3)4 (6 mg, 
0.005 mmol) and /i-Bu3SnH (77 mg, 0.26 mmol) in CH2C12 (2 mL). Flash chromatography (ethyl 
acetate/hexane 2:1) afforded 26 (35 mg, 0.09 mmol, 74%) as a light yellow oil, R j  0.20. IR v 3420, 1700,
1660,1500,1440, 1260, 800; NMR (200 MHz) 8 2.62-2.82 (m, 4 H, CH2C(0 )CH2), 3.09-3.12 (m, 2 H, 
NCtf2CH2), 3.83-3.92 (m, 2 H, NCH2), 4.20-4.26 (m, 3 H, NCH2C(0) and CH), 4.37 (d, J  = 7.0 Hz, 2 H, 
CH20), 5.65 (br s, 1 H, NHC(O)), 7.30-7.77 (m, 8 H, ArH); 13C NMR 8 42.6,42.9, 44.2,47.1,47.3 (CH2),
47.2 (CH), 67.0 (CH20), 119.9, 125.1, 127.0, 127.6 (ArH), 141.2, 143.8 (ArC), 156.4, 170.0, 209.1 (C(0)); 
MS (El, 70 eV) mlz (relative intensity) 366 (14), 277 (100), 199 (20), 172 (40), 152 (12), 77 (14).
l-FM O C -L-A la-l,2-diaza-5-cycloheptanone (27). Following the general procedure B, 6 (26 mg, 0.09 
mmol) was coupled with FMOC-L-Ala-0-pentafluorophenol (23) (44 mg, 0.09 mmol) by using (Pd(PPti3)4 (5 
mg, 0.004 mmol) and n-Bu^SnH (59 mgt 0.20 mmol) in CH2CI2 (2 mL). Flash chromatography (ethyl 
acetate/hexane 2:1) yielded 27 (12 mg, 0.03 mmol, 33%) as a viscous colorless oil, /?ƒ 0.20, [<x]27p  6.0 (c 0.5, 
CHCI3). IR v 3420,2980,1700,1650,1500,1445,1435,1400; *H NMR (200 MHz) 8 1.32 (d, J  = 6.8 Hz, 3
H, CH3), 2.65-2.82 (m, 4 H, CH2C(0)CH2), 3.17 (m, 2 H, NCH2), 3.70-4.24 (m, 3 H, NCH2 and CHAr),
5.08 (q, J  = 7.5 Hz, 1 H, CHCH3), 5.68 (br s, 1 H, NHC(0)), 7.29-7.77 (m, 8 H, ArH); 13C NMR (50 MHz) 8
19.0 (CH3), 42.6, 44.3, 47.2, 47.4 (CH2), 46.9, 47.1 (CH), 66.8 (CH20), 119.8, 125.1, 127.0, 127.6 (ArH),
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141.1, 143.9 (ArC), 156.6, 174.5 (C(O)); MS (El. 70 eV) m/z (relative intensity) 407 (2), 277 (100), 201 (12), 
180 (37), 152 (14), 114 (8), 77 (7); HRMS ealed for C23H25N3O4 407.1845, found 407.1853.
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SYNTHESIS OF BRIDGED BICYCLIC HYDRAZINES VIA ENDOCYCLIC
A'-ACYLHYDRAZONIUM INTERMEDIATES1
4.1 INTRODUCTION
The synthesis and applications of bridged bicyclic hydrazines with a 1,7-diazabicyclo 
[2.2.1]heptane or a l,8-diazabicyclo[3.2.1]octane skeleton such as 5 and 7 respectively, have 
received scant attention in the literature. The structures with a heptane skeleton are particularly 
interesting compounds as both the N-chloro and N-methyl substituted molecules have been 
reported to exhibit very high nitrogen inversion barriers for the bridge nitrogen atom.2*3»4 One 
method for the preparation of these types of compounds was developed by Oppolzer,5 who 
obtained the 1,7-diazabicyclo[2.2.1 ]heptane 5 via an intramolecular 1,3-dipolar cycloaddition 
reaction of the intermediate ylide 3 (m = 1, Scheme 4.1). However, the regiochemistry of this 
cycloaddition reaction proved to be strongly dependent on the length of the olefin side chain as 





















The regiochemistry could also be influenced by using substituted aldehydes or 
functionalized alkenyl substituents. If benzaldehyde was used in the condensation reaction, 
mixtures of stereoisomers were obtained. On the other hand, if the pentenyl group was 
functionalized with a phenyl moiety (i.e. 6 , eq 4.1), the regioselectivity changed completely and 







Another method that provides l,8-diaza[3.2.1]bicyclooctanes is shown in eq 4.2.6,7 
Again, a 1,3-dipolar cycloaddition reaction is the key step in the synthesis of the products. 
Deprotonation of the tosylate salt 8 affords the stable betaine 9 which reacts intermolecularly 










From these examples it can be concluded that the existing methods for the preparation of 
bridged 1,7-diazabicycloheptanes and 1,8-diazabicyclooctanes are rather limited as far as 
substitution pattern and ring size are concerned. In this Chapter, a novel pathway for the 
preparation of these compounds will be detailed, which offers the possibility of synthesizing 









A short outline of the method is given in eq 4.3. The key intermediate is the endocyclic 
iV-acylhydrazonium ion 12, which is converted via an intramolecular attack of the internal 
nucleophile into the bicyclic product 11. Compared to the N ,N ’-diacylhydrazines that are 
described in Chapter 2, the second nitrogen atom in these types of hydrazines will be less 
electron-withdrawing, probably resulting in a somewhat more easy formation of the intermediate 
N -acylhydrazonium ion. The precursor of the iV-acylhydrazonium ion 12 is readily obtained in a 
few steps starting from the alkylated 3-pyrazolidinone 13.
4.2 SYNTHESIS OF THE PRECURSORS
The starting material, 3-pyrazolidinone 15 could be efficiently obtained by the 
condensation of hydrazine hydrate with ethyl 3,3-dimethylacrylate (14) in refluxing ethanol (eq 
4.4).8 Distillation of the crude residue afforded the pure 3-pyrazolidinone 15 as a colorless oil 
which solidified upon standing.
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E^NNH2*H20 (1.05 equiv)
C 02Et EtOH, reflux, 18 h
14 15 (95%)
Alkylation of the pyrazolidinone 159,10 with various activated alkenyl halides was 
expected to give the hydrazines 16, that after alkoxycarbonylation and subsequent reduction of 
the ring oxo function should yield the precursors 17 for the cyclization reactions (eq 4.5). These 




In the alkylation reactions, the different nature of the two nitrogen atoms was very 
important. The N-l nitrogen is an amine type nitrogen atom, whereas the N-2 nitrogen is an 
amide type nitrogen atom. If the pyrazolidinone 15 is treated with alkenyl halides, only the more 
nucleophilic N -l atom will give an Sfsj2 reaction. The results of the alkylation of 15 with 
methallyl chloride (1.05 equiv) under various circumstances are shown in Table 4.1.
Table 4.1. Alkylations with m ethallyl chloride.
entry solvent3 base yield*3
1 MeCN Et3N 12%
2 THF Et3N 13%
3 EtOH Et3N 19%
4 2-butanone Et3N 19%
5 THF DBU 37%
6 THF DBMP 38%
7 THF k 2c o 3 57%
8 2-butanone k 2c o 3 88%
a) reflux temperature, 18 h. b) The alkylations were performed in the presence of Lil (cat).
From this Table, it is evident that the choice of the base played an important role in this 
reaction. The results with Et3N were poor (entries 1-4), while DBU and the very hindered 
DBMP (di-i^ri-butyl-4-methylpyridine) gave better yields (entries 5 and 6). This is probably due 
to the fact that the N-l nitrogen atom is sterically hindered (by the gem-dimethyl substituent) so 
that a competition occurs between alkylation of the pyrazolidinone and the base. If the base
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becomes too hindered, alkylation of the pyrazolidinone is favored. In some cases, the 
quartemary ammonium salts could be isolated. Introduction of an inorganic non-nucleophilic 
base (i.e. K2CO3, entries 7 and 8) led.to a significant increase of the yield.
Generally, the latter reaction conditions (K2CO3, Lil (cat), 2-butanone, reflux) were 
found to give fair yields with different alkylating agents as summarized in Table 4.2. The low 
yield in the case of propargyl bromide (entry 8) was explained by the formation of a considerable 
amount of the dialkylated pyrazolidinone 28 (30%). It was also shown that use of an excess of 
the alkylating agent led to the formation of the dialkylated product. For example, if 1.5 
equivalent of allyl bromide was added (eq 4.6), 27 was formed in 42% yield.
allyl bromide (1.5 equiv),
LH (cat), K2C03 (1.5 equiv) V-NH + ^  (eQ 4'6)
2-butanone, reflux
19 47% ~ 27 42%
The pyrazolidinone 26 was obtained upon alkylation with 4-iodo-1 -(trimethylsilyl)-2-butyne,11 
which was prepared via the corresponding mesylate.12
The alkoxycarbonylation of the hydrazines 19-26 was performed using four different 
methods:
A: deprotonation with a strong base (NaH (LOS equiv), rt) and alkylation with methyl 
chloroformate (1.2 equiv, 0 ttC - » rt) in THF;
B: the same procedure as A with ethyl chloroformate instead of methyl chloroformate;
C: treatment with diethyl dicarbonate (2.0 equiv, rt) in the presence of Et3N (1 equiv) and 
DMAP (1 equiv) in CH2C12;13 
D: deprotonation with LDA (1.1 equiv, -78 °C), followed by methoxycarbonylation with methyl 
cyanoformate (2 equiv, -78 °C rt) in THF.14 
The results of the different methods are given in Table 4.2. A disadvantage of the first two 
methods is that mixtures of N- and O  alkylated products (entries 7 and 10) or only the 0-  
alkylated products were obtained (entries 1 and 5).15,16 The selectivity of this reaction could not 
be influenced by changing the temperature of the reaction. The formation of the O-alkylated 
products was indicated by a strong absorbance in the IR spectra at 1630 cm' 1 as a result of the 
presence of the O N  bond.15 In the case of entry 7, an unexpected rearrangement occurred, in 
which presumably 39 was formed. The assignment of this structure is in full accord with the 
NMR data, showing a vinyl substituent without further couplings, and an absorbance at 1680 
cm"1 in the IR spectrum indicating the presence of a 3-pyrazolidinone ring, which is not bearing 
a methoxycarbonyl group at the N-2 nitrogen atom. The formation of this product can be 
explained via the intermediacy of the ylide-type structure 30 (eq 4.7). An SN2’-reaction of the 
negatively charged nitrogen atom with the prenyl substituent will lead to the rearranged hydrazine 
39.
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Table 4.2. Alkylation and alkoxycarbonylatlon.

















21 (61%) £/Z 3.3:1
22 (82%)




















3 2 R = Et (82%)




R = Me (33%)
COzEt
36 R = Et (64%)
3 5 R = Me (47%)
,,C02Me
3 7 (24%) 
37 (93%)






















The lack of regioselectivity could be overcome by using the more selective reagent 
methyl cyanoformate, instead of methyl or ethyl chloroformate (entries 3,8  and 14).17
The alternative method C, in which the use of a strong base is avoided, afforded also 
satisfactory results (entries 2 ,6,11 and 12). Although in this reaction, in principle, a base is not 
required, it proved that the best results were obtained by using stoichiometric amounts of Et^N 
and DMAP.
The reduction of the pyrazolidinone ring was performed under conditions that were also 
used for the corresponding pyrrolidinones.14 Treatment of the hydrazines at -20 *C in ethanol 
with a large excess of sodium borohydride (6 equiv) and a catalytic amount of H2SO4 afforded 
the hydroxypyrazolidines, which were directly converted into the corresponding ethoxy- 
pyrazolidines 45-50 by stirring in ethanol which was acidified with H2SO4. This last step 
already indicates the intermediacy of the endocyclic N-acylhydrazonium ion. The reduction steps 
proceeded in fair yields as can be seen from Table 4.3.
The hydroxypyrazolidines 51 and 52 (entries 13 and 15) were isolated only in the case 
of the allyl- and propargylsilanes 43 and 44. This was done in order to prevent protodesilylation 
under the acidic conditions that are required for the hydioxy/ethoxy exchange.
4.3 CYCLIZA7TON REACTIONS WITH LEWIS AND BR0NSTED ACID
The cyclization reactions were performed under standard conditions with the Lewis acid 
TiCl4 (2 equiv, C ^ C ^  -78 °C -4 rt) and in the case of the silanes 51 and 52 with BF3*OEt2 
(2 equiv, CH2CI2, 0 °C —> rt). For the cyclization reactions in entries 1, 3, 5 and 7 SnCl4 was 
also tried as the Lewis acid but gave lower yields. In the cyclizations with Br0nsted acid, the 
best results were obtained by stirring in HCOOH for 18 h at 50 °C. The results are summarized 
in Table 4.3. ’
Treatment of 45 with TiCl4 afforded the bridged hydrazine 53 in a good yield (entry 1). 
Its stereochemistry was established by using NOE-difference *H NMR techniques on the 
corresponding free hydrazine 72 (see Section 4.4). Irradiation of the endo-Me signal of 72 gave 
a strong enhancement of the signal of the proton adjacent to the chlorine atom. This is only 
possible if the six-membered ring is in a chair conformation with the chlorine atom in the 
equatorial position. This assignment was confirmed by the NMR spectrum of 72, in which 
the signal of the hydrogen atom adjacent to the chlorine atom (4.20 ppm, tt) showed two axial- 
axial @Jm =11.1 Hz) and two axial-equatorial couplings = 6.3 Hz).
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Table 4.3. Reduction and cyclization products,




























































54 X = Cl (56%)































Such a conformation is in agreement with the expected cyclization mechanism for a 
cationic olefin cyclization,18 in which the ring closure takes place via a chair-like transition state 




This transition state also explains the stereochemical outcome of the cyclization of the 
crotyl precursor 47 to 57 (entry 5), in which both substituents occupy the equatorial position. 
In the transition state of the (£)-precursor, the methyl group is in the equatorial position (68 , R = 
Me), while chloride attacks from the equatorial side, thus giving rise to the formation of the 
trans-product 57 as the only product. The (Z)-isomer would lead to a transition state with the 
methyl group in the axial position, so that cyclization to the ds-product would take place. 
However, this product was not observed in the reaction mixture. The relative configuration of 
57 was inferred from the splitting pattern of the *H NMR signal of the proton adjacent to the 
chlorine atom (3.76 ppm, dt) showing one eq-ax (?Jae = 6.3 Hz) and two ax-ax couplings (?Jaa 
= 10.8 Hz).
Cyclization of the methallyl precursor 46 (entry 2) afforded an inseparable mixture of 54 
and the elimination product 55. The stereochemistry of the product 54 could not be fully 
ascertained, but it is most likely that the methyl substituent is equatorial in view of the severe 
steric interaction between the two endo-methyl groups in the alternative stereoisomer.






At first glance, the formation of these products might look anomalous as attack of 
chloride occurs from the most hindered bottom side (see 7 0, eq 4.9). This could be explained by 
assuming the initial formation of the dioxycarbenium ion 71, in which the positive charge is 
stabilized by the carbamate function, and a subsequent SN2-type attack of a nucleophile leading 
to the product 54 with the assigned conformation. The crowded nature of the product is also 
reflected in the formation of a relatively large amount of the elimination product 55. As the 
double bond causes the six-membered ring to flatten, a favorable conformation is obtained in
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which the interaction of the substituents with the carbamate function and the endo-methyl group 
is decreased.
Upon cyclization of precursor 48 with TiCl^ the 1,7-diazabicyclo[2,2.1]heptane 58 
was formed as a single product in high yield (entry 7). The bulky substituent is in the exo­
orientation, which was concluded from the splitting pattern of the signal of the bridgehead 
hydrogen atom (4.43 ppm, d, 3/  = 4.9 Hz),3 The coupling constants of the bridgehead proton 
with both adjacent ewfo-protons are zero as a result of dihedral angles of approximately 90*.
The less nucleophilic acetylene 49 cyclized in a rather low yield (entry 9). This can be 
either a result of the poor nucleophilicity of the acetylene or of the instability of the product 60. 
The benzyl precursor 50 (entry 11) afforded the corresponding hydrazine 62 in 62% yield. Both 
silanes 51 and 52 cyclized in reasonable yields to give the elimination products 63 and 64.
In contrast with the Lewis acid cyclizations, the outcome of the HCOOH cyclizations 
was variable as is evident from the Table. In some cases (entries 2, 6 and 12), the corresponding 
hydroxypyrazolidines 65-67 were recovered as single products after the reaction. This is 
somewhat surprising, as during work-up the use of water is avoided. Presumably, the 
formyloxy group was exchanged during flash chromatography to give the more stable 
hydroxypyrazolidines. From the formation of the hydroxypyrazolidines it is evident that the N- 
acylhydrazonium ion was formed, but that cyclization did not take place. For precursor 45, 
other acidic circumstances were also tried e.g. CF3CO2H in GH2Q 2* HCOOH at 100 °C or in a 
sealed tube, HC1 in MeOH, and Me3SiOTf, but none of these conditions proved to be 
successful.
The cyclization products were obtained in reasonable to good yields only in the cases 
where cyclization leads to a stabilized carbocation. The stereochemical outcome is similar 
compared to the Lewis acid cases. These results emphasize that formic acid is less suitable for 
the cyclization reactions than Lewis acids, which was also observed in the diacylhydrazonium 
series.
4.4 DEPROTECTION AND FURTHER REACTIONS
The cyclization products 5 3 ,6 2  and 63 were deprotected to give the free hydrazines 72, 
74, and 75, respectively (eqs 4.10 to 4.12). Two methods were applied i.e. hydrolysis under 
basic conditions (KOH in MeOH)19 and cleavage with Me3SiI.20
Me3SiI (1.2 equiv), \  j  V  37% aq (CH20)
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Conversion of the carbamate 63 into the corresponding methylated hydrazine 76 took 
place in a rather poor yield. An alternative route that provided the N-methyl compound is the 
reductive methylation of the free hydrazine 72, in which the intermediate iminium ion is reduced 
with N aB ^C N  leading to the desired compound 73 in a fair yield,21
4.5 NMR DATA AND STRUCTURAL PROOF
The ^H NMR spectra of the cyclizadon products show some characteristic signals which 
immediately point towards the formation of a bridged bicyclic compound. The endo-proton 
adjacent to the gem-dimethyl function shows a doublet (V  ~ 12 Hz for the bicyclooctanes and 
2ƒ ~ 11 Hz for the bicycloheptanes, 3 ƒ ~ 0, 6 -  90°), whereas the exo-proton shows a double 
doublet (2/  -  12, V  ~ 8 Hz for the bicyclooctanes, 2/  ~ 11, 3ƒ -  5 Hz for the bicycloheptanes). 
Furthermore, the bridgehead proton shows in the case of the bicyclooctanes a multiplet (even at 
90 °C) near 5 ppm and in the case of the bicycloheptanes a doublet (3/  ® 5 Hz) around the same
position.
Another phenomenon which is observed in most of the and ^ C  NMR spectra is the 
appearance of rotamers, which is a result of a hindered rotation around the amide bond of the 
carbamate. In some cases, by recording the spectrum at a high temperature the rotation became 
fast on the NMR timescale so that only one rotamer was observed. This is clearly shown in the 
spectra of the cyclic hydrazine 53 (Fig 4.1 and 4.2). The spectrum at room temperature (Fig
4.1) shows the characteristic multiplet around 4.5 ppm and rotamers of all signals. Raising the 
temperature to 90 °C in CyDg led to signals of a single rotamer (Fig 4.2), thereby excluding the 
possibility that the signals belong to a different stereoisomer. Conversion of the carbamate 53 
into the free hydrazine 70 led to the same conclusion. Sharp signals of only one isomer were 
observed (Fig 4.3).
80
Synthesis of bridged bicyclic hydrazines
H66X0
Fig 4 .3 .
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4 .6 CONCLUDING REMARKS
The method described in this Chapter offers an efficient novel route to functionalized 
bridged bicyclic hydrazines. Compared with the N ,N ’ -diacylhydrazonium ions described in 
Chapter 2, it is expected that the formation of the endocyclic Ar-acylhydrazonium intermediates 
will be somewhat easier as a result of the less electron-withdrawing amino function. However, 
no striking differences were observed in the conditions that were required to form the reactive 
intermediates. As a Lewis acid, TiC^ afforded better results than the milder SnCl^ except for 
the silanes where BF3*OEt2 was preferred. Cyclization with the Br0nsted acid formic acid took 
only place upon heating at 50 °C. Again, a remarkable difference was observed between the 
Lewis acid and the formic acid promoted reactions* In the cases of less activated nucleophiles, 
cyclization did not take place under the protic acid conditions, whereas it did under Lewis acid 
conditions. Furthermore, it can be concluded that both five- and six-membered rings can be 
obtained in similar yields.
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4.7 EXPERIMENTAL SECTION
G eneral in form ation . The cyclization products described in this Chapter are numbered according to the 
structures 53 and 58. For more experimental details, see: Section 2.11.
Et02C * \
5,5-dim ethyl-3-pyrazolidinone (15).** To a solution of ethyl 3,3-dimethylacrylate (14) (80 mL, 0.58 mol) 
in ethanol (300 mL) was added (37 mL of an 80% solution in 0.61 mol). The mixture was
refiuxed for 18 h, concentrated in vacuo and the residue was distilled to give 15 (63.2 g, 0.55 mol, 96%) as a 
viscous colorless oil, which solidified upon standing, bp 100-105 *C (0.1 mbar). IR v 3430, 3220, 1690; 
NMR (200 MHz) 5 1.27 (s. 6 H, (C I^ C ) ,  2.29 (s, 2 H, CH2), 4.10 (br s, 1 H, NH), 7.99 (br s, 1 H, NH).
i
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G eneral p rocedure for the a lky lation  reactions. The halide (1.1 equiv), K2CO3 (1,5 equiv) and a 
catalytic amount of Lil were added to a solution of 3-pyrazolidinone 15 in 2-butanone. The solution was heated at 
reflux temperature for 18 h, concentrated in vacuo, taken up in water and extracted with CH2CI2 (3 x). The 
combined organic layers were dried (MgSO ,^ filtered and concentrated in vacuo. The residue was chromatographed 
to afford the pure alkylation product,
5 .5 -D im e th y l- l- (2 -p ro p e n y l) -3 -p y ra z o lid in o n e  (19), According to the general procedure, 3- 
pyrazolidone 15 (2.0 g, 17.5 mmol) was alkylated with allyl bromide (1,51 mL, 17,5 mmol), K2CO3 (2,67 g,
19.3 mmol) and Lil in 2-butanone (80 mL). Work-up and flash chromatography (ethyl acetate) afforded 19 (1.71 
g, 11.5 mmol, 66%) as a white solid, mp 40-42 *C, R f  0.19. IR V 3340, 3400, 3080, 1675; XH NMR (200 
MHz) 5 1.22 (s, 6 H, (CH3)2C), 2.28 (s, 2 H, CCH2), 3.22 (d, J  = 6.4 Hz, 2 H, NCH2), 5.15 (dd, J  = 1.8, 8.1 
Hz, 1 H, =CWH), 5.23 (d, /  = 2.8 Hz, 1 H, =CHH), 5.65-5.90 (m, 1 H, =CH), 8.27 (br s, 1 H, NH). Upon use of
1.5 equiv of allyl bromide, 5 ,5-dim ethyl-l,2-di(2-propenyl)«3-pyrazoIidinone (27) was also formed, 
IR v 3080, 1670; NMR (200 MHz) 5 1.14 (s, 6 H, (CHjJjC), 2.23 (s, 2 H, CH2), 3.37 (d, / =  6.6 Hz, 2 H, 
CH2), 3.92 (d, J  = 6.6 Hz, 2 H, CH2), 5.00-5.20 (m, 4 H, 2 X C H j) , 5.60-5.95 (m, J  = 1.9,6.6,10.1 Hz, 2 H,
2 x =CH).
5 .5 -D im ethy l-l-(2 -m ethyI-2-propenyl)-3-pyrazo lid inone (20). 3-Pyrazolidinone 15 (1,00 g, 8,80 
mmol) was alkylated (according to the general procedure) with 3-chloro-2-methyl-l~propene (0.91 mL, 9.21 
mmol), K2CO3 (1,27 g, 9.20 mmol) and Lil in 2-butanone (50 mL), After work-up and flash chromatography 
(ethyl acetate), 20 (1.29 g, 7.69 mmol, 88%) was obtained as a white solid, mp 97.5-98.5 *C (ether), R f  0.45. IR 
v 3430, 3400, 3080, 1680; JH NMR (200 MHz) 8 1.25 (s, 6 H, (C H ^C ), 1.75 (s, 3 H, CH3), 2.34 (s, 2 H, 
CCH2), 3.12 (s, 2 H, NCH2), 4.92 (m, 2 H, =CH2), 7.24 (br s, 1 H, NH); Anal. Calcd. for C9H16N20: C, 
64.25; H, 9.59; N, 16.65. Found: C, 64.27; H, 9.57; N, 16.56.
l-(2-B utenyl)-5 ,5-d im ethyl-3-pyrazolid inone (21). Following the general procedure, 3-pyrazolidinone 
15 (3.02 g, 26.3 mmol) was alkylated by using 4-bromo-2-butene ((£)/(Z) 3.3:1) (2.8 mL, 27.6 mmol), K2CO3 
(3.82 g, 27.6 mmol) and Lil in 2-butanone (100 mL). After work-up and flash chromatography (ethyl acetate), 21 
(2.71 g, 16.0 mmol, 62%) was obtained as white crystals, mp 66.5-68 'C, R f  0.20, (E)/(Z) 3.3:1, IR V 3430, 
3190,1689; (£)-isomer: %  NMR (200 MHz) 8 1.29 (s, 6 H, ( O ^ C ) ,  1.69 (dt, J  = 6.3,1.0 Hz, 3 H, CH3),
2.35 (s, 2 H, CC’ftj), 3.21 (d, J  = 6.5 Hz, 2 H, NCH2), 5.35-5.55 (m, 1 H, CH2Cff=), 5.60-5.80 (dq, J  = 15,
6.3 Hz, CH3CH). 7.60 (br s, 1 H, NH). (Z)-isomer: XH NMR (200 MHz) 8 1.32 (s, 6 H, (C H ^C ), 1.69 (dt, J  
= 1.0, 6.3 Hz, 3-H, CH3), 2.38 (s, 2 H, CCH2), 3.33 (d, J  = 6.9 Hz, 2 H, NCH2), 5.35-5.55 (m, 1 H, 
CH2CH=), 5.60-5.80 (m, 1 H, CtfCH3), 7.60 (br s, 1 H, NH).
5 .5 -D im ethy l-l-(3 -m ethy l-2 -bu tenyI)-3»pyrazoIid inone (22), Following the general procedure, 3- 
pyrazolidinone 15 (7.61 g, 67.0 mmol) was alkylated by using 4-bromo-2-methyl-2-butene (10.5 g, 70.5 mmol), 
K2CC>3 (13.9 g, 0.10 mol) and Lil in 2-butanone (400 mL). After work-up and flash chromatography (ethyl 
acetate), 22 (9.75 g, 53.6 mmol, 80%) was obtained as white needles, mp 96.5-97 *C (CH2Cl2/ether 1:10), R f  
0.30. IR v 3430, 1685; %  NMR (200 MHz), 8 1.30 (s, 6 H, (CH3)2C), 1.74 (s, 3 H, CH3), 2.36 (s, 2 H, 
CCH2), 3.30 (d, J=  7.1 Hz, 2 H, NCH2), 5.20 (tt, J  = 1.3, 7.1 Hz, =CH), 6.90 (br s, 1 H, NH).
5 .5 -D im e th y l- l - (2 -p ro p y n y l) -3 " p y ra z o l id in o n e  (2 3 ). Following the general procedure, 3- 
pyrazolidinone 15 (4.02 g, 35.1 mmol) was alkylated by using 3-bromo-l-propyne (4.11 mL, 36.9 mmol),
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K2CO3 (5.11 g, 36.9 mmol) and Lil in 2-butanone (150 mL). Work-up and flash chromatography (ethyl 
acetate/acetone 1:1) afforded 23 (2.11 g, 13.9 mmol, 40%) as yellow crystals, mp 100-105 *(?,/?ƒ 0.54 and 5,5- 
dim ethyl-1,2-di(2-propynyI)-3-pyrazolidinone (28) (2.01 g, 10.5 mmol, 30%) as a dark oil, R j  0.89. 
23: IR v 3430, 3300, 2250, 1690; *H NMR (200 MHz) 8 1.32 (s, 6 H, (CHj^C), 2.27 (t, J  = 2.4 Hz, 1 H, 
CsCH), 2.44 (s, 2 H, CCH2), 3.52 (d, J  = 2.4 Hz, 2 H, NCH2), 8.07 (br s, 1 H, NH). 28: IR v 3300,2250, 
1690; *H NMR (200 MHz) 8 1.29 (s, 6 H, (CHj^C), 2.11 (s, 2 H, CCH2), 2.25 (t, J  = 2.3 Hz, 2 H, 2 x 
CsCH), 3.45-3.75 (m, 4 H, 2 x NCH2).
l-B enzyI-5,5-dim ethyl-3-pyrazolidinone (24). According to the general procedure, 3-pyrazolidinone 15 
(3.02 g, 26.3 mmol) was alkylated by using benzyl chloride (3.03 mL, 26.3 mmol), K2CO3 (4.00 g, 29.3 
mmol) and Lil in 2-butanone (130 mL). Work-up and flash chromatography (ethyl acetate) afforded 24 (4.30 g,
22,1 mmol, 80%) as white needles, mp 107.5-108.5 'C (hexane), R j  0.42. IR v 3430, 3400, 1685; *H NMR 
(200 MHz) 8 1.35 (s, 6 H, ( O ^ C ) ,  2.39 (s, 2 H, CCH2), 3,77 (s, 2 H, NCH2), 6.77 (br s, 1 H, NH), 7.31 (s,
5 H, ArH); Anal. Calcd. for C12H16N20: C, 70.56; H, 7.90; N, 13.71. Found: C, 70,52; H, 7.92; N, 13.68.
5 ,5-D im ethyI-l-{2>[(trim ethylsU yI)m ethyl]-2-propenyl}-3-pyrazolid inoiie (25). According to 
the general procedure, 3-pyrazolidinone 15 (2.50 g, 21.5 mmol) was alkylated upon use of 2-chloromethyl-3- 
(trimethylsilyl)-l-propene (2.90 g, 22.8 mmol), K2CO3 (2.73 g, 19.7 mmol) and Lil in 2-butanone (70 mL). 
Work-up and flash chromatography (ethyl acetate) afforded 25 (3,61 g, 14,8 mmol, 83%) as white crystals, mp 
59-61 *C (ether), R* 0.60. IR v 3440, 3400, 3080, 1690, 1250, 850; %  NMR (200 MHz) 8 0.0 (s, 9 H, 
(CH3)3Si), 1.26 (s, 6 H, (C H ^C ), 1.61 (d, J  = 0.7 Hz, 2 H, CH2Si), 2.34 (s, 2 H, CCH2), 3.08 (s, 2 H, 
NCH2), 4.72 (d, J  = 0.6 Hz, 1 H, =CWH), 4,85 (d, J  = 1.9 Hz, 1 H, =CHH), 6.83 (br s, 1 H, NH).
5 ,5 -D im e th y l-l-[4 -(tr im e th y ls iiy l)-2 -b u ty n y ]]-3 -p y razo lid in o n e  (26). Following the general 
procedure, 3-pyrazolidinone 15 (2 ,6 0  g, 22.8  mmol) was alkylated with 4 - io d o - l - ( t r im e th y ls i ly l ) - 2 - b u ty n e ^
(6.00 g, 23.9 mmol) and K2CO3 (3,30 g, 23.9 mmol) in 2-butanone (130 mL), After work-up and flash 
chromatography (ethyl acetate), 26 (3.70 g, 15.4 mmol, 68 %) was obtained as yellowish crystals, mp 81.5-83,5 
•c (ether), R ,  0.45. IR v 3420, 3200, 2220,1690,1250, 850; *H NMR (200 MHz) 8 0.09 (s, 9 H, (CH3)3Si),
1.33 (s, 6 H, (CHj^C), 1.46 (t, J  = 2.4 Hz, 2 H, CH2Si), 2.42 (s, 2 H, CCH^, 3.52 (l, J  = 2.4 Hz, 2 H, 
NCH2), 7.70 (br s, 1 H, NH).
General procedure A for the m ethoxycarbonylation. To a suspension of NaH (obtained from a 55% 
dispersion in oil by washing with dry pentane) in THF was added dropwise a solution of the hydrazide in THF. 
After being stirred at rt for 30 min, the resulting clear solution was cooled to 0 *C and a solution of Me02CCl in 
THF was added. Stirring was maintained at 0 *C for 30 min and for 2 h at rt. The reaction mixture was 
concentrated in vacuo and the residue was taken up in water and extracted with CH2CI2 (3 x). The combined 
organic layers were dried (MgSC^), filtered, concentrated in vacuo and purified by flash chromatography to afford 
the pure product.
G eneral p rocedu re  B for the e th o x y carb o n y la tio n . See procedure A with E t02CCl instead of 
Me02CCl.
General procedure C for the ethoxycarbonylation. To a solution of the hydrazide in CH2CI2 were 
added Ht3N (1.1 equiv), diethyl dicarbonate (2.1 equiv) and a solution of DMAP (1.1 equiv) in CH2C12. The light
1
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yellow solution was stirred at rt for 18 h, concentrated in vacuo and purified by flash chromatography.
G en era l p ro c e d u re  D for the  m e th o x y ca rb o n y la tio n . To a solution of LDA (prepared from 
diisopropylamine (1.1 equiv) and rt-butyllithium (1.1 equiv) at 0 *C) in THF was added at -78 *C a solution of the 
hydrazide (1 equiv) in THF. After being stirred at -78 *C for 1 h, MeO^CCN dissolved in THF, was added and the 
mixture was allowed to warm to rt. After being stirred for 30 min, the mixture was poured into an ice/water 
mixture and extracted with ether (3 x). The combined organic layers were dried (MgSC>4), filtered and concentrated 
in vacuo. The pure product was obtained after flash chromatography.
5 .5-D im ethyl-3-[(ethoxycarbonyl)oxy-l-(2-propenyl)-2-pyrazoline (31). According to the general 
procedure A, 19 (2.00 g, 13.0 mmol) was treated with NaH (680 mg, 15.6 mmol) and Me02CCl (3.0 mL, 39 
mmol), all compounds dissolved in THF (20 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) 
afforded 31 (920 mg, 4.3 mmol, 33%) as a yellow oil, /?ƒ 0.74. IR v 3080,1760,1630; l H NMR (200 MHz) 5 
1.26 (s, 6 H, (CH3)C), 2.73 (s, 2 H, CCH2), 3.40 (dd, J  * 1.2, 6.1 Hz, 2 H, NCH2), 3.81 (s, 3 H, C 02CH3),
5.11 (dd,/ = 1.2,10.7 Hz, 1 H, =C//H), 5.22 (dd, J  = 1.2,17.2 Hz, 1 H, =CH//), 5.85-6.05 (m, 1 H, r=CH),
5 .5-D im ethyl-l-(2-propenyl)-3-pyrazolid inone-2-carboxylic acid ethyl ester (32). According to 
the general procedure C, a solution of 19 (12.6 g, 82.0 mmol) in CH2C12 (300 mL) was treated with Et3N (11.6 
mL, 86 mmol), diethyl dicarbonate (24.1 mL, 164 mmol) and a solution of DMAP (10.0 g, 82.0 mmol) in 
CH2C12 (30 mL). After concentration in vacuo and purification by flash chromatography (ethyl acetate), 32 (11.5
g, 50.9 mmol, 82% (after correction)) was obtained as a colorless oil, /?ƒ 0.64. IR V 3080,1780,1730; *H NMR 
(200 MHz) 6 1.23 (s, 6 H, (CH3)2C), 1.24 (t, J  = 7.1 Hz, 3 H, CH2Cff3), 2.43 (s, 2 H, CCH2), 3.46 (d, J  « 6.9 
Hz, 2 H, NCH2), 4.22 (q, J  = 7.1 Hz, 2 H, Ctf2CH3), 5.05-5.13 (m, 2 H, =CH2), 5.75-5.90 (m, 1 H, =CH).
5 .5-D im ethyl-l-(2-propenyI)-3-pyrazolidinone-2-carboxyH c acid m ethyl ester (33). Following 
the general procedure D, 19 (300 mg, 1.95 mmol) was deprotonated with LDA (prepared from diisopropylamine 
(0.33 mL, 2.33 mmol) and /i-butyllithium (1.4 mL, 2.33 mmol)) and alkylated with Me02CCN (350 mg, 4.0 
mmol). Work-up and flash chromatography (ethyl acetate) afforded 33 (235 mg, 1.11 mmol, 57%) as a yellow oil, 
«y0.59. IR v 3080,1785,1735; %  NMR (200 MHz) 5 1.31 (s, 6 H, (CH3)2C), 2.52 (s, 2 H, CCH2), 3.53 (d, 
J = 6.9 Hz, 2 H, NCH2), 3.84 (s, 3 H, C 02CH3), 5.13-5.22 (m, 2 H, =CH), 5.82-6.03 (m, 1 H, =CH).
5.5-D im ethyl-l-(2-m ethyl-2-propenyl)-3-pyrazoIidinone-2-carboxyU c acid m ethyl ester (34). 
According to the general procedure A, 20 (500 mg, 2.98 mmol) was reacted with NaH (79 mg, 3.28 mmol) and 
Me02CCl (0.69 mL, 8.94 mmol) in THF (5 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) 
afforded 34 (497 mg, 2.20 mmol, 74%) as a colorless oil, R ,  0.45. IR v 3090,1810,1760; XH NMR (200 MHz)
8 1.27 (s, 6 H, (CH3)2C), 1.84 (s, 3 H, CH3), 2.53 (s, 2 H, CCH2), 3.34 (s, 2 H, NCH2), 3.78 (s, 3 H, 
C02CH3), 4.84,4.86 (s, 2 H, =CH2).
l-(2 -B u teny l)-5>5-dim ethyl-3-[(m ethoxycarbonyl)oxy]-2-pyrazoline (35). Following the general 
procedure A, 21 (2.20 g, 13.1 mmol) was treated with NaH (630 mg, 14.4 mmol) and Me02CCl (3.04 mL, 39.3 
mmol), all compounds were dissolved in THF (30 mL). Work-up and flash chromatography (ethyl acetate/hexane 
1:2) afforded 35 (1.40 g, 6.21 mmol, 47%) as a colorless oil, (¿s)/(Z)-ratio 3.3:1, /?ƒ 0.75. IR v 1760,1630; (£)- 
isomer; %  NMR (200 MHz) 8 1.26 (s, 6 H, (C H ^C ), 1.67 (d, J  = 4.6 Hz, 3 H, CH3), 2.74 (s, 2 H, CCHo),
3.33 (dd, J  = 1.1, 3.9 Hz, 2 H, NCH2), 3.82 (s, 3 H, C 02CH3), 5.55-5.70 (m, 2 H, HC=CH); (Z)-isomer: *H
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NMR (200 MHz) 5 1.28 (s, 6 H, (CH3)2C)t 1.65 (d, /  = 6.1 Hz, 3 H, CH3), 2.75 (s, 2 H, CCH2), 3.45 (dd, ƒ =
1.1, 3.9 Hz, 2 H, NCH2), 3.82 (s, 3 H, C02CH3), 5.55-5.70 (m, 2 H, HC=CH).
l-(2-B utenyl)-5,5-dim ethyl-3-pyrazolidinone-2-carboxylic acid ethyl ester (36). Following the 
general procedure C, a solution of 21 (1.13 g, 6.70 mmol) in CH2C12 (25 mL) was treated with Et3N (0.9 mL,
6.7 mmol), diethyl dicarbonate (1.97 mL, 13.4 mmol) and a solution of DMAP (0.82 g, 6.7 mmol) in CH2C12 
(5 mL). Concentration in vacuo and flash chromatography (ethyl acetate) afforded 36 (1.03 g, 4.3 mmol, 64%) as 
a yellowish oil, R j 0.76, (E)/(Z)-ratio 3.3:1. IR v 1780,1730; (£)-isomer: lH NMR (200 MHz) 8 1,26 (s, 6 H, 
(CH3)2C), 1.30 (t, 7 = 7.1 Hz, 3 H, CH2Ctf3), 1.60 (d, 7 = 4.8 Hz, 3 H, CH3), 2.50 (s, 2 H, CCH2), 3.57 (d,
7 = 5.4 Hz, 2 H, NCH^, 4.28 (q, 7 = 7.1 Hz, C//2CH3), 5.40-5.70 (m, 2 H, CH=CH); (Z)-isomer: JH NMR 
(200 MHz) 8 1.27 (s, 6 H, (CHj^C), 1.30 (t, 7=7.1  Hz, 3 H, CH2Ctf3), 1.56 (d, 7 = 9.2 Hz, 3 H, CH3), 2.46 
(s, 2 H, CCH2), 3.43 (d, 7 = 7.1 Hz, 2 H, NCH2), 4.28 (q, 7 = 7.1 Hz, C//2CH3), 5.40-5.70 (m, 2 H, CH=CH).
5 .5-D im ethyl-l-(3-m ethyl-2-butenyl)-3-pyrazolid inone-2-carboxylic acid m ethyl ester (37) 
via the general procedure A. 22 (2.02 g, 11.0 mmol) was treated with NaH (380 mg, 15.8 mmol) and 
Me02CCl (2.56 mL, 33.0 mmol) in THF (20 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) 
afforded 37 (635 mg, 2.65 mmol, 24%) as a light yellow oil, /?ƒ 0.27, 5 ,5 -d im e th y I [ (3 -  
m ethoxycarbonyl)oxy]-l-(3-m ethyI-2-butenyI)-2-pyrazoline (38) (486 mg, 2.0 mmol, 18%), as a 
yellowish oil, Rjr 0.75 and 5 ,5 -d im e th y l-2 - ( l , l -d im e th y l-2 -p ro p e n y l) -3 -p y ra z o lid in o n e - l-  
carboxylic acid m ethyl ester (39) (338 mg, 1,4 mmol, 13%) as an orange oil, R j 0.45. 37: IR v 3030, 
1780, 1730; !H NMR (250 MHz) 8 1.32 (s, 6 H, (CH3)2C), 1.58 (s, 3 H, CH3), 1.70 (s, 3 H, CH3), 2.51 (s, 2
H, CCH2), 3.55 (d, 7 = 7.6 Hz, 2 H, NCH2), 3.85 (s, 3 H, C 02CH3), 5.20-5.35 (m, 1 H, =CH). 38: IR v 
3030, 1760, 1630; ’ h  NMR (200 MHz) 8 1.28 (s, 6 H, (CH3)2C), 1.65 (s, 3 H, CH3), 2.27 (d, 7 = 0.9 Hz, 3
H, CH3), 2.74 (s, 2 H, CCH2), 3.37 (d, 7 = 6.5 Hz, 2 H, NCH2), 3.83 (s, 3 H, C 02CH3), 5.30-5.45 (t, 7 = 6.5 
Hz, 1 H, =CH). 39: IR v 3080, 1720, 1680; !H NMR (250 MHz) 8 1.38 (s, 6 H, (C H ^C ), 1.49 (s, 6 H, 
=C(CH3)2), 2.33 (s, 2 H, CCH2), 3.71 (s, 3 H, C 02CH3), 5.03 (d, 7 = 10.8 Hz, 1 H, =C«H), 5.12 (d, 7 = 17.4 
Hz, 1 H, =CHH), 6.12 (dd, 7 = 10.8, 17.4 Hz, 1 H, =CH); 13C NMR (50 MHz) 8 24.3 (2 x CH3), 26.5 (2 x 
CH3), 47.5 (CH2), 52.9 (C02CH3), 61.6 (NC), 65.1 (NC), 112.5 (=CH2), 141.5 (=CH), 159.8,172.5 (C(O)).
5 .5-D im ethyl-l-(3-m ethyl-2-bupenyI)-3-pyrazolid inone-2-carboxylic acid m ethyl es te r (37) 
via the general p rocedure  D. 22 (25 mg, 0,14 mmol) was alkylated by using LDA (prepared from 
diisopropylamine (24 mL, 0.17 mmol) and n-butyllithium (105 mL, 0.17 mmol)) and Me02CCN (24 mg, 0.28 
mmol), all compounds dissolved in THF (1 mL). After work-up and flash chromatography (ethyl acetate/hexane 
1:1), 37 (31 mg, 0.13 mmol, 93%) was obtained as a colorless oil, A ƒ  0.30.
5 .5-D im ethyl-l-(2-propynyl)-3-pyrazolid inone-2-carboxylic acid ethyl ester (40). Following 
the general procedure B, 23 (1.06 g, 7.00 mmol) was treated with NaH (201 mg, 8.36 mmol) and Et02CCl (2.0 
mL, 21 mmol) in THF (50 mL), Work-up and purification by flash chromatography (ethyl acetate/hexane 1:1) 
afforded 40 (1.05 g, 4.70 mmol, 67%) as a light yellow oil, R * 0.41. IR v 3300, 2105, 1780, 1725; !H NMR 
(200 MHz) 8 1.34 (t, 7 = 7.1 Hz, 3 H, CH2C#3), 1.34 (s, 6 H, (C H ^C ), 2.30 (t, J  = 2.4 Hz, 1 H, C=CH),
2.74 (br s, 2 H, CCH2), 3.81 (d, J=  1.7 Hz, 2 H, NCH2), 4.32 (q, 7= 7.1 Hz, 2 H, C//2CH3).
l-B enzyl-5,5-dim ethyl-3-pyrazolidinone-2-carboxylic acid ethyl ester (41) via the general 
procedure B. 24 (2.03 g, 10.0 mmol) was treated with NaH (550 mg, 12.7 mmol) and E t02CCl (2.86 mL, 30
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mmol), while all compounds were dissolved in THF (30 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 2:1) afforded 41 (1.64 g, 5.94 mmol, 59%) as white crystals, mp 89-92 *C, Rjr 0.54 and 1- 
benzyl-5,5-dimethyI-2-[(ethoxycarbonyl)oxy]-2-pyrazoline (42) (1.07 g, 3.40 mmol, 39%) as a 
colorless oil, R f  0.92. 41: IR v 1780,1740; *H NMR (200 MHz) 8 1.17 (t, J=  7.1 Hz, 3 H, CH2Ctf3), 1.28 
(s, 6 H, (CH3)2C), 2.57 (s, 2 H, CCH,), 4.03 (s, 2 H, NCH2), 4.08 (q, J  = 7.1 Hz, 2 H, CH2CH3), 7.25-7.45 
(m, 5 H, ArH). 42: IR v 1760,1635; %  NMR (200 MHz) 8 1.33 (t, J  = 7.1 Hz, 3 H, CH2C//3), 1.34 (s, 6 H, 
(CH3)2C), 2.81 (s, 2 H, CCH2), 3.96 (s, 2 H, NCH2), 4.25 (q, 2 H, 0 / 2CH3), 7.15-7.45 (m, 5 H, ArH).
l-Benzyl-5,5-dimethyI-3-pyrazoIidinone-2-carboxylic acid ethyl ester (41) via the general 
procedure C. A solution of 24 (2.00 g, 9.80 mmol) in CH2CI2 (40 mL) was treated with EtgN (1.47 mL,
10.9 mmol), diethyl dicarbonate (2.9 mL, 19.6 mmol) and a solution of DMAP (1.20 g, 9,80 mmol) in CH2CI2 
(4 mL). After being stirred for 66 h, the solution was concentrated in vacuo and purified by flash chromatography 
(ethyl acetate/hexane 2:1) to yield 41 (1,36 g, 4.90 mmol, 81% (after correction)) as white crystals.
5>5-Dimethyl-l-{2-[(trimethylsilyi)methyl]-2-propenyl}-3-pyrazoIidinone-2-carboxylic acid 
ethyl ester (43). Following the general procedure C, a solution of 25 (3,50 g, 14.6 mmol) in CH2CI2 (60 
mL) was treated with Et^N (2.06 mL, 15.3 mmol), diethyl dicarbonate (8.6 mL, 58 mmol) and a solution of 
DMAP (1.78 g, 14.6 mmol) in CH2CI2 (10 mL). Concentration in vacuo and purification by flash 
chromatography (ethyl acetate/hexane 1:2) afforded 25 (900 mg, 3.75 mmol) and 43 (2.11 g, 6.76 mmol, 62% 
(after conection)) as a colorless oil, R f  0.38. IR v 3080, 1780, 1740,1250, 850; %  NMR (200 MHz) 8 0.0 (s,
9 H, (CH3)3Si), 1.27 (s, 6 H, (C H ^ C ), 1.29 (t, J  = 7.1 Hz, 3 H, CH2Cff3), 1.70 (d ,/  = 0.5 Hz, 2 H, CH2Si), 
2.52 (s, 2 H, CCH2), 3.23 (s, 2 H, NCH2), 4.23 (q, J  = 7.1 Hz, 2 H, Cff2CH3), 4.66 (s, 1 H, =CWH), 4.83 (t, 
J = 0.7 Hz, 1 H, =CHH).
5.5-Dim ethyl-l-[4-(trimethylsi!yI)-2-buty nyl]-3-pyrazolidinone-2-carboxylic acid methyl 
ester (44) via the general procedure A. 26 (412 mg, 1.73 mmol) was treated with NaH (51 mg, 2.1 
mmol) and MeC^CCl (0.40 mL, 5.2 mmol) in THF (15 mL). Work-up and purification by flash chromatography 
(ethyl acetate/hexane 1:1) afforded 44 (317 mg, 1.07 mmol, 62%) as a colorless oil, /?ƒ 0.60. IR v 2250, 1780, 
1730, 1250, 850; !H NMR (200 MHz) 8 0.03 (s, 9 H, (CH3)3Si), 1.33 (s, 6 H, (C H ^C ), 1.39 (t, J  = 2.3 Hz,
2 H, CH2Si), 2.73 (br s, 2 H, CCH^), 3.79 (br s, 2 H, NCH2), 3.87 (s, 3 H, C02CH3).
5.5-Dimethyl-l-[4-(trimethylsilyl)-2-butyny]]-3~pyrazoIidinone-2-carboxylic acid methyl 
ester (44) via the'general procedure D. 26 (130 mg, 0.55 mmol) was alkylated upon use of LDA 
(prepared from diisopropylamine (84 |iL, 0.60 mmol and n-butyllithium (380 |±L, 0.61 mmol)) and MeC^CCN 
(94 mg, 1.10 mmol). Work-up and flash chromatography (ethyl acetate/ hexane 1:1) afforded 44 (87 mg, 0.29 
mmol, 53%) as a colorless oil, Rjr0.60.
General procedure E for the reduction reactions with NaBH^. A solution of the functionalized 
pyrazolidinone in ethanol was cooled to -20 ‘C and NaBH4 (6 equiv) was added in one portion. The solution was 
stirred at -20 'C while each 10 min 1 drop of a 2 M solution of sulfuric acid in ethanol was added to the mixture. 
The reaction was monitored by TLC. After complete reducdon (2-3 h), the solution was cooled to -78 *C and 
acidified to pH « 3 with a 2 M ^ S O ^ tO H  solution. After being stirred at rt for 4-5 h, the reaction mixture was 
poured into aq satd NaHCOg and extracted with CH2CI2 (3 x). The combined organic layers were washed with 




5 .5 -D im e th y I-3 -e th o x y -l-(2 -p ro p e n y I)-2 -p y ra z o lid in e c a rb o x y Iic  ac id  e th y l e s te r  (45). 
According to the general procedure E, 32 (10.0 g, 44.2 mmol) was reduced with NaBify (10.0 g, 0.27 mol) in 
EtOH (500 mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 45 (9,36 g, 26.6 mmol, 
83%) was obtained as a light yellow oil, R ,  0.50. IR v 3080,1720,1680; NMR (200 MHz) 8 0.95 (s, 3 H, 
CH3), 1.08 (t, / =  7.1 Hz, 3 H, OCH2Ctf3), 1.19 (t, / =  7.0 Hz, 3 H, C 02CH2C//3), 1.26 (s, 3 H, CH3), 2.02 
(dd, J = 4.7,13.5 Hz, 1 H, CHC/ffl), 2.22 (dd, J  = 6.0,13.5 Hz, 1 H, CHCHH), 3.30-3.70 (m, 4 H, OC//2CH3 
and NCH2), 4.15 (q, J  = 7.0 Hz, 2 H, C 02Ctf2CH3), 5.01 (s, 1 H, =CHH), 5.07 (d, J  = 10.0 Hz, 1 H, =CHH),
5.49 (dd, / =  5.0, 6.0 Hz, 1 H, OCH), 5.85-6.10 (m, 1 H, =CH).
5.5-Dim ethyI-3-ethoxy“l-(2-m ethyl-2-propenyl)-2-pyrazoIid inecarboxylic acid m ethyl ester 
(46). Following the general procedure E, 34 (465 mg, 2,06 mmol) was reduced with NaBH^ (467 mg, 12.3 
mmol) in EtOH (25 mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 46 (397 mg, 1.55 
mmol, 75%) was obtained as a colorless oil, R ,  0.78. IR v 3070, 1680; XH NMR (200 MHz) 8 0.99 (s. 3 H, 
CH3), 1.16 (t, J  = 7.0 Hz, 3 H, CH2C//3), 1.28 (s, 3 H, CH3), 1.85 (s, 3 H, CH3), 2.07 (dd, J  = 4.9,13.5 Hz,
1 H, CHC/ZH), 2.27 (dd, J  = 7.3, 13.4 Hz, 1 H, CHCHH), 3.38 (s, 2 H, NCH2), 3.59 (q, J  = 7.0 Hz, 2 H, 
C/72CH3), 3.69 (s, 3 H, C02CH3), 4.82 (s, 2 H, =CH2), 5.55 (dd, J  = 5.0, 7.2 Hz, 1 H. OCH).
l-(2-B utenyl)-5,5-dim ethyl-3-ethoxy-2-pyrazolidinecarboxylic acid ethyl este r (47). Following 
the general procedure E, 36 (502 mg, 2.1 mmol) was reduced with NaBH^ (473 mg, 12.6 mmol) in EtOH (25 
mL). Work-up and flash chromatography (ethyl acetate) afforded 47 (404 mg, 1.5 mmol, 71%) as a colorless oil, 
(E)/(Z)-ratio 3.3:1, R f  0.70. IR V 1690; l E  NMR (200 MHz) 8 (mixture) 0.98 (s, 3 H, CH3), 1.14 (t, J  = 7.0 
Hz, 3 H, OCH2C//3), 1.24 (t, J  * 7.0 Hz, 3 H, C 02CH2C//3), 1.29 (s, 3 H, CH3), 1.55 (m, 3 H, CHCtf3),
2.07 (dd, J = 4.7, 13.5 Hz, 1 H, CHCHH),  2.24 (dd, J  = 7.3, 13.4 Hz, 1 H, CHCHtf), 3.30-3.45 (m, 2 H, 
NCH2), 3.45-3.75 (m, 2 H, OC//2CH3), 4.05-4.40 (m, 2 H, C 02C//2CH3), 5.45-5.65 (m, 3 H, C ttC H  and 
OCH).
5 .5-D im ethyI-3-ethoxy-l-(3-m ethyI-2-butenyl)-2-pyrazoIid inecarboxylic acid  m ethyl este r 
(48). Following the general procedure E, 37 (634 mg, 2,35 mmol) was reduced with NaBH^ (620 mg, 16.5 
mmol) in EtOH (60 mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 48 (318 mg, 1.18 
mmol, 44%) was obtained as a colorless oil, R j  0.55. IR v 3030, 1685; *H NMR (250 MHz) 8 0.96 (s, 3 H, 
CH3), 1.09 (t, / =  7.0 Hz, 3 H, CH2Ctf3), 1.28 (s, 3 H, CH3), 1.56 (s, 3 H, CH3), 1.64 (s, 3 H, CH3), 2,06 
(dd, .7=5.0, 13.4 Hz, 1 H, CHC//H), 2.23 (dd, ƒ = 7.3, 13.4 Hz, 1 H, CHCHtf), 3.35-3.40 (m, 1 H, NC//H), 
3.45-3.65 (m, 3 H, NCHH and C//2CH3), 3.70 (s, 3 H, C 02CH3), 5.27 (br s, 1 H, =CH), 5.51 (dd, J  = 5.4, 6.8 
Hz, 1 H, OCH).
5 .5 -D im e th y I-3 -e th o x y -l-(2 -p ro p y n y l)-2 -p y razo lid in eca rb o x y lic  acid  e thy l e s te r  (49).
According to the general procedure E, 40 (1.00 g, 4.50 mmol) was reduced with NaBH^ (1.02 g, 27.0 mmol) in 
EtOH (50 mL). After work-up and flash chromatography (ethyl acetate/hexane 1:1), 49 (741 mg, 2,92 mmol, 
65%) was obtained as a colorless oil, R f  0.56. IR v 3310, 1690; l H NMR (200 MHz) 8 0.93 (s, 3 H, CH3),
1.07 (t, J  = 7.1 Hz, 3 H, OCH2C//3), 1.18 (t, J  « 7.1 Hz, 3 H, C 02CH2C//3), 1.22 (s, 3 H, CH3), 1.95 (dd, ƒ = 
4.4, 14.2 Hz, 1 H, CHCtfH), 2.07 (t, 7=  2.4 Hz, 1 H, C-CH), 2.20 (dd, ƒ = 7.2,13.6 Hz, 1 H, CHCHtf), 3.50-
3.70 (m, 2 H, OCtf2CH3), 3.61 (dd, /  = 2.4,9.3 Hz, 2 H, NCH2), 4.05-4.25 (m, 2 H, C 02Ctf2CH3), 5.50 (dd, 
/  = 4.5, 7.0 Hz, 1 H, OCH).
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l-B enzyl-5 ,5-dim ethyl-3-ethoxy-2-pyrazolidinecarboxylic acid ethyl ester (50). Following the 
general procedure E, 41 (2.00 g, 7.24 mmol) was reduced with NaBH^ (1.64 g, 43.4 mmol) in EtOH (100 mL). 
Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded 50 (2.02 g, 6.53 mmol, 90%) as a colorless 
oil, fly 0.43. IR v 1680; !H NMR (200 MHz) 8 0.97 (t, J  = 7.0 Hz, 3 H, OCH2Ctf3), 1.01 (s, 3 H, CH3), 1.19 
( l , / =7.1 Hz, 3H , C 02CH2CW3), 1.36 (s, 3 H, CH3), 2.21 (dd, J  = 5.2, 13.4 Hz, 1 H, CHCHH), 2.32 (dd, J  =
7.1, 13.4 Hz, 1 H, CHCHH), 3.59 (q,J =  7.1 Hz, 2 H, OCtf2CH3), 3.89 (d, 7=  11.7 Hz, NCHH), 3.92 (q, ƒ =
7.0 Hz, 2 H, C0 2C//2CH3), 4.08 (d, /  = 11.7 Hz, 1 H, NCHH), 5.56 (dd, J  = 5.3,7.0 Hz, OCH), 7.15-7.45 (m,
5 H, ArH).
5.5-D im ethyI-3-hydroxy-l-{2-[(trim ethyIsilyI)m ethyI]-2-propenyI}-2-pyrazoH dinecarboxyIic 
acid ethyl ester (51). Following the general procedure E, 43 (678 mg, 2.17 mmol) was reduced with NaBH^ 
(493 mg, 13.0 mmol) in EtOH (25 mL). After being stirred for 2 h at -20 *C, the reaction was quenched with cold 
aq satd NaHC03 (30 mL). After work-up according to the general procedure and flash chromatography (ethyl 
acetate/hexane 2.2:1), SI (653 mg, 2.08 mmol, 96%) was obtained as a white solid, mp 66-68 *C (hexane), ƒ?ƒ 
0.68. IR v 3450, 3080, 1725, 1660, 1240, 850; JH NMR (200 MHz) 8 0.0 (s, 9 H, (C H ^S i), 1.05 (s, 3 H, 
CH3), 1-25 (t, J  = 7.0 Hz, 3 H, CH2Ctf3), 1.26 (s, 3 H, CH3), 1.63 (d, J  = 13.6 Hz, 1 H, CflHSi), 1.84 (d, 1
H, 7 = 13.6 Hz, CHHSi), 2.07 (dd, J  = 5.4,13.3 Hz, 1 H, CHCHH), 2.22 (dd, J  = 7.2,13.2 Hz, 1 H, CHCHH),
3.25 (s, 2 H, NCH2), 4.05-4.20 (m, 2 H, CH2CH3), 4.62 (s, 1 H, =CHH), 4.80 (s, 1 H, =CHH), 5.71 (t, ƒ =
5.4 Hz, 1 H, OCH).
5 .5 -D im ethy l-3“h y d ro x y -l-[4 -(tr im e th y ls iIy l)-2 -b u ty n y l]-2 -p y razo U d in eca rb o x y lic  acid 
m ethyl este r (52). Following the general procedure E, 44 (315 mg, 1.06 mmol) was reduced with NaBH^ 
(241 mg, 6.39 mmol) in EtOH (10 mL). After being stirred at -20 'C for 2 h, the reaction was quenched with cold 
aq satd NaHC03 (50 mL) and worked up following the general procedure. Flash chromatography (ethyl 
acetate/hexane 3:2) afforded 52 (185 mg, 0.62 mmol, 59%) as a colorless oil, R j  0.52. IR v 3500, 2200, 1679, 
1250, 850; *H NMR (200 MHz) 8 0.07 (s, 9 H, (CH3)3Si), 1.15 (s, 3 H, CH3), 1.35 (s, 3 H, CH3), 1.45 (t, J =
2.3 Hz, 2 H, CH2Si), 2.18 (br s, 1 H, CHCHH), 2.41 (dd, J  = 7.3, 13.2 Hz, 1 H, CHCHH), 3.45 (br s, 1 H, 
OH), 3.66 (br s, 2 H, NCH2), 3.79 (s, 3 H, C 0 2CH3), 5.71 (br s, 1 H, OCH).
G eneral procedure F for the cyclization reactions with TÍCI4. To a 0.1 M solution of the hydrazide 
in CH2CI2 was added TÍCI4 (2 equiv, as a solution of T1CI4 in CH2CI2) at -78 *C by a syringe. The mixture was 
stirred at -78 *C for 15 min and for 5-18 h at r t  The reaction mixture was poured into cold aq satd NaHCO^ and 
the resulting suspension was filtered over Celite and extracted with CH2CI2 (3 x). The combined organic layers 
were dried (MgSO^), filtered and concentrated in vacuo. Purification of the residue by flash chromatography 
afforded the pure cyclization product(s).
re /-(3 5 ,5 5 )-3 -C h lo ro -l,8 -d iaza -7 ,7 -d im e th y Ib icy c lo [3 .2 .1 ]o c tan e -8 -ca rb o x y lic  acid  ethyl 
ester (53). According to the general procedure F, 45 (3.00 g, 11.7 mmol) dissolved in CH2CI2 (120 mL) was 
cyclized with TÍCI4 (19.5 mL of a 1.2 M solution, 23.4 mmol). The mixture was worked-up after being stirred at 
rt for 18 h and the residue was purified by flash chromatography (ethyl acetate) to afford 53 (2.72 g, 11.1 mmol, 
95%) as a yellow oil, /?ƒ 0.76. IR v 1670; *H NMR (200 MHz) 8 (some signals appear as rotamers) 1.11,1.16 
(s, 3 H, CH3), 1.28 (t, J  = 7.0 Hz, 3 H, O ^ C ^ ) ,  1.41 (s, 3 H, CH3), 1.65 (br d, 12.9 Hz, 1 H, H e ^ ,  
2.00-2.25 (m, 3 H, H6exo and 2 x H4), 3.05-3.25 (m, 1 H, H2), 3.40-3.50 (m, 1 H, H2), 4.10-4.35 (m, 2 H, 
CW2CH3), 4.40-4.45, 4.59-4.62 (m, 1 H, H5); ]H NMR (250 MHz, C7Dg, 90 fC) 8 0.94 (s, 3 H, CH3), 0.96
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(s, 3 H, CH3), 1.06 (t, J  = 7.1 Hz, 3 H, CH2Ctf3), 1.17 (d, J  = 12.8 Hz, 1 H, H ó g ^ ,  1.65 (dd, J  = 8.0,12.7 
Hz, 1 H, H6exo), 1.79 (ddd,/ = 2.8,6.5,12.7 Hz, 1 H, H4), 2.03 (dt, 7=3.0,10.7 Hz, 1 H, H4), 3.10-3.20 (m,
2 H, NCH2), 3.90-4.10 (m, 3 H, C02Ctf2CH3 and H3), 4.08-4.38 (m, 1 H, H5); 13C NMR (50 MHz) 8 (all 
signals appear as rotamers) 14.5,14.7 (CH2CH3), 22.5, 22.6 (CHj), 31.1, 31.3 (CHj), 4Ó.2, 40.4 (C4), 43.9,
44.5 (C6), 49.5 (C3), 54.7, 55.4 (C5), 56.7, 57.5 (C2), 61.2, 61.6 (CH2CH3), 64.7, 65.7 (C7), 153.0, 153.7 
(C(0)); 13C NMR (50 MHz, C6D6, 65 -C) 8 15.5 (CH2CH3), 22.4 (CH3), 32.4 (CH3), 41.5 (C4), 45.1 (C6),
51.0 (C3), 56.3 (C5), 58.5 (C2), 61.9 (CH2CH3), 65.5 (C7), 153.0 (C(0)); MS (El, 70 eV) m/z (relative 
intensity) 246 (M+, 40), 211 (100), 142 (32), 128 (36), 70 (18); HRMS calcd for Cn H19N202Cl 246.1135, 
found 246.1129.
re /- (3 f l ,5 S )-3 -C h lo ro - l ,8 -d ia z a -3 ,7 ,7 -tr im e th y lb ic y c lo [3 .2 .1 ]  o c ta n e -8-c a r  boxy lie  ac id  
methyl es te r (54), According to the general procedure F,46 (228 mg, 0.89 mmol) dissolved in CH2CI2 (9 
mL) was cyclized by using TiCl4 (1.48 mL of a 1.2 M solution, 1,78 mmol). After being stirred at rt for 18 h, 
the reaction was worked-up and the residue was chromatographed (ethyl acetate/hexane 1:1) to give an inseparable 
mixture (153 mg) of 54 (56%) and l,8-d iaza-3 ,7 ,7-trim ethylbicyclo[3 ,2 .1]oct-2-ene-8-carboxylic 
acid methyl ester (55) (16%) as a colorless oil, /?ƒ 0.37, 54 (mixture): IR v 1690; ^HNMR (200 MHz) 8 
(some signals appear as rotamers) 1.08-1,62 (m, 9 H, 3 x CH3), 1.90-2.12 (m, 2 H, 2 x H6), 2.33-2,36 (m, 1 H, 
H4), 2.64 (d, J  = 12.8 Hz, 1 H, H4), 3.36 (d, J = 16.3 Hz, 1 H, H2), 3.72 (s, 3 H, C02CH3), 3.76 (d, ƒ = 16 Hz, 
1 H, H2), 4.35-4.55 (m, 1 H, H5); 13C NMR (50 MHz) 8 25.7 (CH3), 31.8 (CH3), 37.0 (CH3), 40.7 (C6),
41.5 (C4), 52.6 (C02CH3), 52.8 (C5), 63.1 (C2), 65.9 (C7), 66.9 (C3), 155.0 (C(0)). 55; IR v 1680; l H 
NMR (200 MHz) 8 1.15 (s, 3 H, CH3), 1.33 (s, 3 H, CH3), 1.58 (s, 3 H, CH3), 1.50-1.70 (m, 2 H, H4 and 
H6endo) '2 08 (dd- J = n -8- 8 0 Hz- 1 H. H6ex0), 2.60 (m, 1 H, H4), 3.73 (s, 3 H, C 02CH3), 4.40-4.50 (m, 1
H, H5), 6.10-6.14 (s, 1 H, H2); %  NMR (250 MHz. CgDg, 65 *C) 8 1.09 (s, 3 H, CH3), 1.14 (s, 3 H, CH3),
I.20 (dd, J = 12.3, 5.4 Hz, 1 H, H e g ^  1.15-1.25 (m, 1 H, H4), 1.28 (s, 3 H, CH3), 1.79 (dd, J  = 12.2, 7.9 
Hz, 1 H, H6ex0), 2.56 (d, J  = 15.7 Hz, 1 H, H4), 3.54 (s, 3 H, C 02CH3), 4.46 (br s, 1 H, H5), 6.04 (s, 1 H, 
H2); 13C NMR (50 MHz) 8 (some signals appear as rotamers) 19.6 (CH3), 24.2 (CH3), 29.3 (CH3), 37.3, 37.6 
(C4), 45.5, 46.2 (C6), 52.6 (C02CH3), 53.6 (C5), 73.2 (C7), 124.7 (C3), 134,8 (C2), 154.6 (C(O)); MS (El, 
70 eV) m/z (relative intensity) 210 (M+, 11), 154 (67), 153 (70), 109 (56), 95 (100); HRMS calcd for
C11H18N2°2 210.1368, found 210.1322.
rW -(3/?,5S)-l,8-D iaza-3-(form yloxy)-3,7 ,7-trim ethylbicycIo[3.2.13octane-8-carboxyIic acid 
m ethyl ester (56). A solution of 32 (232 mg, 0.91 mmol) in HCOOH (9 mL) was stirred at 50 ‘C for 18 h. 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 56 (85 mg, 0,33 mmol, 
37%) as a colorless oil, R j  0.20 and 55 (65 mg, 0.31 mmol, 34%) as a colorless oil, /?ƒ 0,34. 56: IR v 1720, 
1680; JH NMR (200 MHz) 8 (some signals appear as rotamers) 1.07 (s, 3 H, CH3), 1.43 (s, 3 H, CH3), 1.47 (s,
3 H, CH3), 1.91-2.13 (m, 3 H, 2 x H6 and H4), 2.51 (d, J  = 15.2 Hz, 1 H, H4), 3.16 (d, J  = 16.2 Hz, 1 H, H2),
3.74 (s, 3 H, C02CH3), 3.79 (d, J  = 16.2 Hz, 1 H, H2), 4.35,4.46 (br s, 1 H, H5); !H NMR (250 MHz, C6D6, 
65 ”C) 8 1.05 (s, 3 H, CH3), 1.11 (s, 3 H, CH3), 1.23 (s, 3 H, CH3), 1.65 (dd, J  = 7.9, 12.3 Hz, 1 H, H6ex0), 
1.82 (d, J = 11.1 Hz, 1 H, Hógndo), 1.87 (d, J  = 16.7 Hz, 1 H, H4), 2.23 (d, J  = 15.0 Hz, 1 H, H4), 3.12 (d, J  -
16.3,1 H, H2), 3.55 (s, 3 H, C 02CH3), 3.59 (d, J  = 16.3 Hz, 1 H, H2), 4.20^.40 (m, 1 H, H5), 7.50 (s, 1 H, 
CHO); 13C NMR (63 MHz) 8 (some signals appear as rotamers) 23.2 (CH3), 27.4 (CH3), 31.7 (CH3), 40.9 
(C6), 41.8, 42.5 (C4), 52.1, 52.4 (C02CH3), 52.8, 52.9 (C5), 58.7, 59.4 (C2), 65.3, 65.7 (C7), 78.7 (C3),
155.0, 159.8 (C(0)); MS (El, 70 eV) m/z (relative intensity) 256 (M+, 25), 227 (59), 154 (31), 143 (29), 129 
(60), 128 (100), 95 (43), 70 (64); HRMS calcd for C i2H20N204 256.1423, found 256.1407.
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re /-(35 ,4 /? ,5S )-3 -C hlo ro -l,8 -'d iaza-4 ,7 ,7 -trim ethyIb icycIo [3 .2 .13octane«8-carboxy lic  acid 
ethyl e s te r (57). Following the general procedure F, 47 (145 mg, 0.54 mmol) was cyclized with TÍCI4 (0.92 
mL of a 1.2 M solution, 1.11 mmol) in CH2CI2 (5 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 2:1) afforded 57 (67 mg, 0.26 mmol, 53% (after correction)) as á colorless oil, R j  0.50. IR v 
1690; *H NMR (200 MHz) 8 1.03 (d, J  = 6.7 Hz, 3 H, CHC//3), 1.18 (s, 3 H, CH3), 1.30 (t, J  = 7.0 Hz, 3 H, 
CH2Ctf3), 1.36 (s, 3 H, CH3), 1.63 (d, J  = 12.7 Hz, 1 H, H ó , ^ ,  1.88 (dd, J  = 12.7, 8.0 Hz, 1 H, H6ex0),
2.12 (m, 1 H, H4), 3.10 (dd, ƒ = 14.4,11.2 Hz, 1 H, H2ax), 3.42 (dd, J  = 5.9, 11.1 Hz, 1 H, H 2-), 3.76 (d t,/=
6.3, 10.8 Hz, 1 H, H3), 4.26 (m, 2 H, Ctf2CH3), 4.35 (m, 1 H, H5); 13C NMR (50 MHz) 8 (all signals appear 
as rotamers) 14.6, 14.8 (CH2CH3), 14.9, 15.4 (CHCH3), 22.5, 22.6 (NCCH3), 31.2, 31.3 (NCCH3), 39.8,
40.4 (C6), 42.8, 43.1 (C4), 56.7, 57.5 (C2), 57.6, 57.7 (C5), 59.4, 60.1 (C3), 61.2, 61.8 (CH2CH3), 64.6,
65.6 (C7), 152.8, 153.2 (C(0)); MS (El, 70 eV) mlz (relative intensity) 260 (M+, 37), 225 (100), 215 (7), 187 
(6), 171 (13), 142 (27), 128 (33), 70 (19); HRMS calcd for C j ^ j N ^ C l  260.1292, found 260.1284.
rel-(3R  ,4 S )-3 -(l-C h lo ro -l-m e th y le th y 1 )-l,7 -d iaza -6 ,6 -d im e th y l-b icy c lo [2 .2 .1 ]h ep tan e -7 - 
carboxylic acid methyl ester (58). To a solution of 48 (141 mg, 0.52 mmol) in CH2CI2 (5 mL) was 
added TÍCI4 (0.87 mL of a 1.2 M solution, 1,04 mmol) according to the general procedure F. After being stirred at 
rt for 18 h, the reaction mixture was worked-up and purified by flash chromatography (ethyl acetate) to afford 58 
(84 mg, 0.32 mmol, 84% (after correction)) as a light yellow oil, Rjr 0.35. IR v 1690; *H NMR (200 MHz) 5
1.23 (s, 3 H, CH3), 1.24 (s, 3 H, CH3), 1.43 (s, 3 H, CH3), 1.54 (s, 3 H, CH3), 1,69 (d, J  = 9.3 Hz, 1 H, 
H5endo), (dd*J  = 4*9* n *5 Hz* 1 H* H5exo>’ 2*02-2*20 (m, 1 H, H3), 2.65-2.80 (m, 1 H, H2), 3.25-3.40 
(m, 1 H, H2), 3.70 (s, 3 H, C0 2CH3), 4.53 (d, J  = 5.1 Hz, 1 H, H4); 13C NMR (50 MHz) 8 (all signals appear 
as rolamers) 25.1, 25.2 (CH3), 28.6, 29.0 (CH3), 30.1, 30.2 (CH3), 30.4, 30.5 (CH3), 46.3, 47.1 (C5), 52.6,
53.0 (C02CH3), 53.1, 53.8 (C2), 57.4, 57.9 (C4), 61.3, 61.8 (C3), 66.5, 66.7 (C6), 70.5, 70.6 (CC1), 153.4 
(C(0)); MS (El, 70 cV) mlz (relative intensity) 260 (M+, 19), 225 (25), 212 (18), 204 (46), 169 (30), 141 (21), 
127 (100), 83 (42); HRMS calcd for C12H210 2N2C1 260.1292, found 260.1292.
re/-(3fl,4 ,S )-l,7-D iaza-6 ,6-dim ethyl-3-[d im ethyl(form yloxy)m ethyl]b icyclo[2 .2 .1]heptane-7- 
carboxylic acid methyl ester (59). A solution of 48 (142 mg, 0.52 mmol) in HCOOH (5 mL) was stirred 
at 50 °C for 18 h. Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 59 (118 
mg, 0.44 mmol, 84%) as a yellow oil, /?ƒ 0.14. IR v 1715; *H NMR (200 MHz) 6 (all signals appear as 
rotamers) 1.09-1.20 (m, 7 H, 2 x CH3 a n d H S ^ ^ , 1.39 (s, 3 H, CH3), 1.42 (s, 3 H, CH3), 1.72,1.70 (dd, J  =
4.9.11.5 Hz, 1 H, H5exo), 2.05, 2.14 (t, J  = 7.4 Hz, 1 H, H3), 2.70, 2.73 (dd, J  = 6.5,13.0 Hz, 1 H, H2), 3.22,
3.24 (dd, J  = 8.0, 12.6 Hz, 1 H, H2), 3.62, 3.67 (C02CH3), 4.45,4.51 (d, J  = 5.0 Hz, 1 H, H4), 7.86, 7.87 (s,
1 H, OCHO); !H NMR (250 MHz, CyDg, 90 *C) 8 0.88 (d, J  = 11.3 Hz, 1 H, HS^ y Q , 0.93 (s, 3 H, NCCH3),
1.05 (s, 3 H, NCCH3), 1.25 (s, 3 H, CHCC//3), 1.29 (s, 3 H, CHCC//3), 1.52 (dd, J  = 5.0, 11.3 Hz, 1 H, 
H5exo>’ 1 96 J  = 73  Hz, 1 H, H3), 2.60 (dd, /  = 6.8, 12.6 Hz, 1 H, H2), 2.98 (dd, J  = 7.9, 12.6 Hz, 1 H, 
H2), 3.48 (s, 3 H, C 02CH3), 4.43 (d, J  = 4.9 Hz, 1 H, H4), 7.61 (s, 1 H, OCHO); 13C NMR (50 MHz) 8 (all 
signals appear as rotamers) 23.1,23.5 (CH3), 23.6,24.0 (CH3), 25.0,25.1 (CHj), 30.4,30.5 (CH3), 46.5,47.4 
(C5), 51.7, 52.1 (C2), 52.4, 52.6 (C3), 53.7, 54.5 (C4), 60.6, 61.4 (C02CH3), 65.9, 66.6 (C6), 83.4, 83.5 
(CO), 153.7, 159.6, 160.0 (C(0)); MS (El, 70 cV) mlz (relative intensity) 270 (M+, 15), 225 (16), 168 (100), 
153 (47), 141 (72), 127 (81), 123 (41), 109 (32), 83 (38), 59 (45), 41 (89); HRMS calcd for C ^ H ^ N ^
270.1580, found 270.1581.
3-Chloro-l,8-diaza-7,7-dimethylbicyclo[3.2.1]oct-3-ene-8-carboxylic acid ethyl ester (60). A
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solution of 49 (201 mg, 0.79 mmol) in CH2CI2 (8 mL) was treated with TÍCI4 (1.32 mL of a 1.2 M solution, 
1.58 mmol) according to the general procedure F. After being stirred at rt for 18 h, the reaction was worked-up and 
purified by flash chromatography (ethyl acetate/hexane 1:1) to afford 60 (46 mg, 0.19 mmol, 24%) as a yellow 
oil, R e 0.69. K  v 1690; %  NMR (200 MHz) 8 1.18 (s, 3 H, CH3), 1.28 (t, 7 = 7.0 Hz, 3 H, CH2Ctf3), 1.39 
(s, 3 H, CH3), 1.95-2.10 (in, 2 H, 2 x H6), 3.49 (d, 7 = 18.1 Hz, 1 H, H2), 3.95 (d ,7=18.2 Hz, 1 H, H2), 4.25 
(q, 7 = 7.1 Hz, 2 H, C//2CH3), 4.50-4.75 (m, 1 H, H5), 6.15 (d, 7 =  5.5 Hz, H4); 13C NMR (50 MHz) 8 (some 
signals appear as rotamers) 14.6 (CH2CH3), 26.1, 26.3 (CH3), 32.1 (CH3), 49.7, 49.8 (C6), 54.4 (C5), 61.7 
(CH2CH3), 61.8, 61.9 (C2), 67.9 (C7), 128.8 (C4), 150.3 (C3), 153.0 (C(0)); MS (El, 70 eV) m/z (relative 
intensity) 244 (M+, 90), 208 (61), 187 (39), 152 (37), 143 (38), 121 (57), 115 (100), 80 (44), 65 (22), 58 (33), 
41 (33); HRMS calcd for Cn H17N202Cl 244.0979, found 244.0981.
►
1 .8 -D iaza -7 ,7 -d im e th y lb icy c Io [3 .2 .1 ]o c tan -3 -o n e -8 -ca rb o x y lic  acid  e th y l e s te r  (61). A 
solution of 49 (134 mg, 0.53 mmol) in HCOOH (5 mL) was stirred at 50 *C for 20 h. After addition of H20  (5 
mL), the reaction mixture was stirred at 60 #C for another 6 h and poured into aq satd NaHCO^ (100 mL). An 
additional amount of NaHCC^ was added until the water layer reached pH « 9. After extraction with CH2CI2 (3 x 
100 mL), the combined organic layers were dried (MgSC^), filtered and concentrated in vacuo. Flash 
chromatography (ethyl acetate/hexane 1:1) afforded 61 (56 mg, 0,25 mmol, 47%) as a light yellow oil, R j  0.28. 
IR v 1720,1690; *H NMR (200 MHz) 8 1.18 (s, 3 H, CH3), 1.61 (t, 7 = 6.9 Hz, 3 H, CH2Ctf3), 1.61 (s, 3 H, 
CH3), 1.69 (d, 7 = 12.8 Hz, 1 H, 2.24 (dd, 7 = 7.8, 12.8 Hz, 1 H, H6ex0), 2.42 (d, 7 = 16.6 Hz, 1 H, 
H4), 2.78 (dd, 7=3.2,16.3 Hz, 1 H, H4), 3.63 (s, 2 H, 2 x H2), 4.28 (q, 7 = 6.9 Hz, 2 H, Ctf2CH3), 4.75-5.00 
(m, 1 H, H5); 13C NMR (50 MHz) 8 14.8 (CH2CH3), 24.8 (CH3), 31.2 (CH3), 45.9 (C6), 48.5 (C4), 54.8 
(C5), 62.3 (CH2CH3), 62.9 (C2), 67.5 (C7), 154.0 (NC(0)), 208.2 (C(0)); MS (El, 70 eV) mlz (relative 
intensity) 226 (M+, 12), 198 (84), 157 (31), 143 (100), 71 (26); HRMS calcd forC u H18N202 226.1305, found 
226.1311.
3 ,4 -B enzo-l,8 -d iaza-7 ,7~ dim ethy lb icyclo [3 .2 .1 ]octane-8-carboxylic  acid  ethyl e s te r (62). 
According to the general procedure F, a solution of 50 (1.04 g, 3.4 mmol) in CH2CI2 (34 mL) was treated with 
TÍCI4 (5.7 mL of a 1.2 M solution in CH2CI2, 6.8 mmol). After being stirred at rt for 18 h, the reaction mixture 
was worked-up and the residue was chromatographed (ethyl acetate, then ethyl acetate/hexane 1:2) to afford 62 
(508 mg, 1,95 nimol, 62% (after correction)) as a colorless oil, Rf 0.28. IR V 1690; ^H NMR (200 MHz) 5 
(some signals appear as rotamers) 1.17-1.30 (m, 9 H, 3 x CH3), 1.89 (d, J  = 11.8 Hz, 1 H, H ó ^ ^ ,  2.23 (dd, J  
= 7.0, 11.9 Hz, 1 H, H6exo), 4.05-4.25 (m, 3 H, H2 and C//2CH3), 4.46 (d, J  =17.2 Hz, 1 H, H2), 5.02, 5.16 
(d, 7 = 6.0 Hz, 1 H, H5), 6.94-7.15 (m, 4 H, 4 x ArH); JH NMR (250 MHz, C6D6, 65 *C) 8 0.97 (s, 3 H, 
CH3), 1.06 (t, 7 = 7.1 Hz, 3 H, CH2Cff3), 1.19 (s, 3 H, CH3), 1.65 (d, 7 = 11.8 Hz, 1 H. H ó ^ ,  2.06 (dd,7 =
7.0, 11.8 Hz, 1 H, H6ex0), 3.88 (d, 7 = 17.6 Hz, 1 H, H2), 4.09 (q, 7 = 7.1 Hz, 2 H, C//2CH3), 4.48 (d, 7 =
17.6 Hz, 1 H, H2), 5.16 (d, 7 = 6.7 Hz, 1 H, H5), 6.60-7.00 (m, 4 H, 4 x ArH); 13C NMR (50 MHz) 8 (some 
signals appear as rotamers) 14.5 (CH2CH3), 25.4 (CH3), 31.9 (CH3), 50.9, 51.3 (C6), 52.7 (C2), 56.7, 57.2 
(C5), 61.2, 61.5 (CH2CH3), 66.0, 66.5 (C7), 124.1, 125.4, 126.2, 127.1 (ArH), 131.0, 140.0 (ArC), 154.0,
154.5 (C(0)); MS (El, 70 eV) m/z (relative intensity) 260 (M+, 81), 245 (11), 204 (62), 187 (37), 159 (370,131 
(100), 117 (72), 91 (36), 77 (17); HRMS calcd for C15H20N2O4 260.1525, found 260.1529.
1.8-D iaza-7,7-dim ethyl-3-m ethyIenebicyclo[3.2.11octane-8-carboxylic acid ethyl ester (63).
To a solution of 51 (101 mg, 0.32 mmol) in CH2C12 (4 mL) was added BF3-OEt2 (79 pL, 0.64 mmol) at 0 #C. 
The reaction mixture was stirred at 0 *C for 15 min and 2 h at rt, poured into aq satd NaCl (40 mL) and extracted
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with CH2CI2 (3 x 40 mL). The combined organic layers were dried (MgSO^, filtered and concentrated in vacuo. 
Purification of the residue by flash chromatography (ethyl acetate/hexane 1:1) afforded 63 (43 mg, 0.19 mmol, 
61%) as a colorless oil, R j  0.32. IR v 3070,1690; NMR (200 MHz) 8 (all signals appear as rotamers) 1.04,
1.09 (s, 3 H, CH3), 1.20-1.32 (m, 3 H, CH2C# 3), 1.33 (s, 3 H, CH3), 1.64, 1.66 (d, J  = 12.3 Hz, 1 H, 
H6endo>’ 1-75-2.15 (m, 2 H, H6exo and H4), 2.50-2.70 (m, 1 H, H4), 3.45-3.70 (m, 2 H, 2 x H2), 4.114.23 
(m, 2 H, C//2CH3), 4.47-4.65 (m, 2 H, H5), 4.88,4.93 (s, 2 H, =CH2); *H NMR (250 MHz, C?Dg, 90 *C) 8
1.02 (s, 3 H, CH3), 1.10 (t, ƒ = 7.1 Hz, 3 H, CH2C//3), 1.12 (s, 3 H, CH3), 1.42 (d, / =  14.3 Hz, 1 H,
H6endo>’ 171  (dd- J  = 7-7’ 12 1  Hz> 1 H’ H6ex(P’ 185 1 = 14-3 1 H- H4)- 2 58 <d*1 = 14' ! Hz- 1 H- 
H4), 3.31 (d, J  = 7.7,12.1 Hz, H2), 3.61 (d, J  = 15.6 Hz, 1 H, H2), 4.03-4.15 (m, 2 H, Ctf2CH3), 4.45-4.60
(m, 1 H, H5), 4.63-4.65 (m, 2 H, =CH2); ^3C NMR (50 MHz) 8 (some signals appear as rotamers) 14.8
(CH2CH3), 22.8 (CH3), 31.4, 31.5 (CH3), 39.4, 39.6 (C4), 43.7,44.3 (C6), 54.9, 55.6 (C5), 56.5,57.3 (C2),
61.2, 61.3 (CH2CH3), 66.5 (C7), 113.8, 114.0 (=CH2), 140.8,141.0 (C3), 154.5 (C(O)); MS (El, 70 eV) m lz
(relative intensity) 224 (M+, 93), 209 (24), 168 (38), 151 (100), 137 (42), 109 (32), 95 (25), 81 (17); HRMS
calcd for C 12^ 20^ 2^2 224.1525, found 224.1530.
l,8-D iaza«7,7-dim ethyl-3-m ethylenebicyclo[3.2.13octane-8“CarboxyHc acid ethyl ester (63). 
A solution of 51 (2.50 g, 7.97 mmol) in HCOOH (80 mL) was stirred for 18 h at rt. Concentration in vacuo and 
flash chromatography (ethyl acetate/hexane 1:1) afforded63 (1.52 g, 6.8 mmol, 85%) as a yellowish oil, Rjr 0.32.
1 .7-D iaza-5,5-dim ethyl-3-ethenylidenebicycIo[2.2 .1]heptane-7-carboxylic acid methyl ester 
(64). To a solution of 52 (109 mg, 0.37 mmol) in CH2CI2 (4 mL) was added BFjOEt^ (91 jiL, 0.74 mmol) at
0 °C. The reaction mixture was stirred at 0 *C for 15 min and for 18 h at rt. The resulting orange solution was 
poured into aq satd NaCl (50 mL) and extracted with CH2CI2 (3 x 50 mL). The combined organic layers were 
washed with H2O (50 mL), dried (MgSO^), filtered and concentrated in vacuo. The residue was chromatographed 
(ethyl acetate/hexane 1:1) to give 64 (48 mg, 0.23 mmol, 62%) as a colorless oil, Rj- 0.36. IR v 1980, 1960, 
1690, 890, 840; !H NMR (200 MHz) 8 1.23 (s, 3 H, CH3), 1.24 (s, 3 H, CH3), 1.51 (d, J  = 11.3 Hz, 1 H, 
H5endo), 1.94 (dd, 7 = 4.7,11.9 Hz, 1 H, H5ex0), 3.57 (dt, J  = 15.1,4.7 Hz, 1 H, H2), 3.74 (s, 3 H, C02CH3), 
3.81 (dt, J  = 15.1, 3.1 Hz, 1 H, H2), 4.83 (br s, 2 H, =CH2), 4.88 (d, J  = 4.7 Hz, 1 H, H4); 13C NMR (50 
MHz) 8 24.9 (CH3), 30.6 (CH3), 46.3 (C5), 53.0 (C02CH3), 54.3 (C2), 64.9 (C6), 65.0 (C4), 79.3 (=CH2),
100.8 (C=C=CH2), 156.0 (C(O)), 197.1 (C=C=CH2); MS (El, 70 eV) mlz (relative intensity) 208 (M+, 82), 193 
(14), 152 (100), 141 (74), 125 (30), 107 (16), 97 (20), 70 (8); HRMS calcd for Cn H16N202 208.1212, found 
208.1205.
1.7-D iaza«5,5-dim ethyl-3-ethenylidenebicyclo[2.2.1]heptane-7-carboxyIic acid m ethyl ester 
(64). A solution of 52 (96 mg, 0,45 mmol) in HCOOH (5 mL) was stirred at 50 *C for 18 h. Concentration in 
vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 64 (28 mg, 0.13 mmol, 42%) as a colorless 
oil, /?ƒ 0.36.
5 ,5 -D im eth y l-3 -hy d roxy -l-(2 -p rop eny l)-2 -py razo lid inecarb ox y lic  acid ethyl ester (65). A 
solution of 45 (174 mg, 0.74 mmol) in HCOOH (5 mL) was stirred for 18 h at 50 *C. Concentration in vacuo 
and flash chromatography (ethyl acetate/hexane 1:1) afforded 65 (129 mg, 0.56 mmol, 83%) as a colorless oil, 
R t 0.30. IR v 3410, 3080, 1720, 1675; !H NMR (200 MHz) 8 0.95 (s, 3 H, CH3), 1.19 (t, J  = 7.0 Hz, 3 H, 
C02CH2CW3), 1.26 (s, 3 H, CH3), 2.02 (dd, J  = 4.7, 13.5 Hz, 1 H, CHC/ffl), 2.22 (dd, J  = 6.0,13.5 Hz, 1 H, 
CHOW), 3.30-3.70 (m, 2 H, NCH2), 3.84 (br s, 1 H, OH), 4.15 (q ,/=  7.0 Hz, 2 H, C 02CW2CH3), 5.01-5.07
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(m, 2 H, =CH2), 5.49 (dd, / =  5.0, 6.0 Hz, 1 H, OCH), 5.85-6.10 (m, 1 H, =CH).
l-(2 -B u ten y I)-5 ,5 -d im e th y l-3 -h y d ro x y -2 -p y razo lid in eca rb o x y lic  acid  e th y l e s te r  (66). A 
solution of 47 (145 mg, 0.54 mmol) in HCOOH (5 mL) was stirred at 50 *C for 18 h. Concentration in vacuo 
and flash chromatography (ethyl acetate/hexane 2:1) afforded 66 (119 mg, 0.49 mmol, 91%) as a colorless oil, 
R f  0.33. IR v 3580, 3420, 1720, 1670; !H NMR (200 MHz) 5 (mixture) 0.98 (s, 3 H, CH3), 1.24 (t, J  =  7.0 
Hz, 3 H, C 02CH2C//3), 1.29 (s, 3 H, CH3), 1.50-1.65 (m, 3 H, CHCtf3), 2.07 (dd, J  = 4.7, 13.5 Hz, 1 H, 
CHCHH), 2.24 (dd, J  = 7.3, 13.4 Hz, 1 H, CHCHtf), 3.30-3.45 (m, 2 H, NCH2), 3.90 (br s, 1 H, OH), 4.05-
4.40 (m, 2 H, C 02C//2CH3), 5.45-5.65 (m, 3 H, CH=CH and OCH).
l-B enzyI-5,5-dim ethyI-3-hydroxy-2-pyrazolidinecarboxyIic acid ethyl ester (67). A solution of 
50 (564 mg, 1.84 mmol) in HCOOH (20 mL) was stirred at 50 *C for 18 h. Concentration in vacuo and flash 
chromatography (ethyl acetate/hexane 2:1) afforded 67 (409 mg, 1.47 mmol, 80%) as a colorless oil, R j  0.52. IR 
v 3400; *H NMR (200 MHz) 8 1.01 (s. 3 H, CH3), 1.19 (t, J  = 7.1 Hz, 3 H, CH2C «3), 1.36 (s, 3 H, CH3),
2.21 (dd, J  = 5.2, 13.4 Hz, 1 H, CHCflH), 2.32 (dd, J  = 7.1, 13.4 Hz, 1 H, CHCHtf), 3.89 (d, 7 =  11.7 Hz, 
NCtfH), 3.92 (q, J  = 7.0 Hz, 2 H, CH2CH3), 4.08 (d, J  = 11.7 Hz, 1 H, NCH/7), 4.10 (br s, 1 H, OH), 5.56 (dd, 
J = 5.3, 7.0 Hz, OCH), 7.15-7.45 (m, 5 H, ArH).
re/-(3S ,5S)-3-C hloro-l,8-diaza-7 ,7-dim ethyIbicycIo[3 .2 .1]octane (72). To a solution of 53 (65 
mg, 0.27 mmol) in MeCN (3 mL) was added MegSil (0.11 mL, 0.80 mmol) and the reaction mixture was stirred 
at 40 “C for 2 h. The resulting dark brown solution was poured into aq NaHS03 and extracted with CH2CI2 (3 x
20 mL). The combined organic layers were dried (MgSO^), filtered and concentratcd in vacuo. The residue was 
chromatographed (acetone) to yield 72 (37 mg, 0.21 mmol, 79%) as white crystals, mp 44.5-45 *C, /?ƒ 0.35. IR 
v 3300; *H NMR (200 MHz) 8 1.13 (s, 3 H, CH3ex0), 1,42 (s, 3 H, CH3endo), 1.67 (d, 1 H, /  = 12.9 Hz, 
H6endo). 1-89 (dd, 1 H, J = 12.9, 7.6 Hz, H6exo), 2.12 (m, 2 H, H4), 3.20 (dd, J  = 11.1, 14.0 Hz, 1 H, H2ax),
3.35 (dd, ƒ ■ 6.2, 14.0 Hz, 1 H, H2eq), 3.60 (m, 1 H, H5), 3.79 (br s, 1 H, NH), 4.20 (tt,y = 11 .1 , 6.3 Hz, 1 H, 
H3); 13C NMR (50 MHz) 8 22.9 (CH3), 31.9 (CH3), 42.2 (C4), 45.3 (C6), 50.9 (C3), 57.7 (C5), 58.1 (C2),
65.6 (C7); MS (El, 70 eV) m/z (relative intensity) 174 (M+, 52), 143 (5), 139 (100), 118 (24), 111 (76), 70 (75), 
67 (35), 56 (32), 41 (31); HRMS calcd for C8H15N2C1174.0924, found 174.0931.
re /-(3 S ,5S )-3 -C h lo ro -l,8 -d iaza-7 ,7 )8-trim ethy lb icyclo[3 .2 .1 ]octane (73). To a solution of 72 
(50 mg, 0.33 mmol) in MeCN (1 mL) were added 37% aq formaldehyde (130 |±L, 1.66 mmol) and N aB ^C N  (33 
mg, 0.53 mmol). After being stirred for 15 min at rt, a few drops of glacial acetic acid were added carefully until 
the pH was neutral. Stirring was continued for 45 min, while the pH was kept neutral by drop wise addition of 
glacial acetic acid. The solution was poured into 1 N KOH (10 mL) and extracted with CH2CI2 (3 x 20 mL). The 
combined organic layers were washed with H2O (10 mL), dried (K^COg), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1) to afford 73 (45 mg, 0.27 mmol, 82%) as a colorless oil, Rjr 0.40. IR 
v 1455,1260, 900,635; JH NMR (200 MHz) 8 1.28 (s, 3 H, CH3), 1.33 (s, 3 H, CH3), 1.56 (d,/ =  13.1 Hz, 1
H, H6cndo), 1.85-1.90 (m, 1 H, H6ex0), 2.10 (dd, J  = 12.6, 7.7 Hz, 1 H, H4), 2.23 (dd, J  = 13.1, 2.4 Hz, 1 H, 
H4), 2.68 (s, 3 H, NCH3), 3.00 (dd, J  = 6.4, 14.9 Hz, 1 H, H2), 3.25 (dd, J = 11.3, 14.9 Hz, 1 H, H2), 3.30-
3.40 (m, 1 H, H5), 4.28 (tt, J = 11.1, 6.8 Hz, 1 H, H3); 13C NMR (63 MHz) 8 22.8 (CH3), 29.5 (C6), 31.0 
(CH3), 32.7 (CH3), 42.9 (C4), 47.8 (C3), 52.4 (C2), 58.1 (C5), 73.9 (C7); MS (El, 70 eV) m/z (relative 
intensity) 188 (M+, 18), 153 (100), 97 (35), 43 (42); HRMS calcd for C9H17N2C1 188.1081, found 188.1077.
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3 ,4 -D ibenzo« l,8 -d iaza-7 ,7 -d im ethyIb icyclo [3 .2 .1 ]octane (74). A solution of 62 (187 mg, 0.72 
mmol) and KOH (160 mg, 2.88 mmol) in MeOH (7 mL) was heated at reflux temperature for 90 h. The resulting 
mixture was poured into aq said NH4CI (25 mL) and extracted with CH2CI2 (3 x 25 mL). The combined organic 
layers were dried (MgSO^), filtered and concentrated in vacuo. The residue was chromatographed (acetone) to yield 
74 (109 mg, 0.58 mmol, 81%) as a yellow oil, R f  0.13. IR v 3390,3060; !H NMR (250 MHz) 8 1.25 (s, 3 H, 
CH3), 1.27 (s, 3 H, CH3), 1.95-2.15 (m, 2 H, 2 x H6), 3.90 (br s, 1 H, NH), 4.07 (d, J  = 17.3 Hz, 1 H, H2), 
4.17 (d, J  = 6.0 Hz, 1 H, H5), 4.45 (d, J  = 17.3 Hz, 1 H, H2), 6.85-7.15 (m, 4 H, ArH); 13C NMR (50 MHz) 8
26.1 (CH3), 32.7 (CH3), 53.1, 53.3 (C2 and C6), 65.6 (C7), 124.4, 125.4,125.8, 126.9 (ArH), 132.1, 141.7 
(ArC); MS (El, 70 eV) mlz (relative intensity) 188 (M+, 64), 173 (23), 145 (8), 132 (66), 131 (100), 117 (36), 
104 (8), 91 (8), 77 (9), 32 (48), 31 (64); HRMS calcd for C12H16N2 188.1313, found 188.1320.
1 .8-D iaza-7 ,7-d im ethyl>3-m ethy!enebicycIo[3 .2 .1]octane (75). A solution of 63 (78 mg, 0.35 
mmol) and KOH (78 mg, 1,4 mmol) in MeOH (4 mL) was heated at reflux temperature for 90 h. The resulting 
solution was poured into aq satd NH4CI (25 mL) and extracted with CH2CI2 (3 x 20 mL). The combined organic 
layers were dried (MgS04), filtered and concentrated in vacuo. Purification of the residue by flash chromatography 
(acetone) afforded 75 (21.5 mg, 0.14 mmol, 40%) as a colorless oil, R j  0.10. IR v 3300, 3060, 895; *H NMR 
(200 MHz) 5 1.11 (s, 3 H, CH3), 1.38 (s, 3 H, CH3), 1.66 (d, J  = 12.0 Hz, 1 H, H6endo), 1.80 (ddd, J  = 0.7,
7.1, 12.4 Hz, 1 H, H6exo), 2.10 (d ,/=  13.9 Hz, 1 H, H4), 2.68 (d, 7= 13.3 Hz, 1 H, H4), 3.49 (d ,/=  15.4 Hz,
1 H, H2), 3.60-3.80 (m, 2 H, H2 and H5), 3.93 (br s, 1 H, NH), 4.75-4.85 (m, 2 H, = ( ^ 3); 13C NMR (63 
MHz) 8 23.1 (CH3), 32.0 (CH3), 41.0 (C4), 45.4 (C6), 57.4 (C5), 57.7 (C2), 66.4 (C7), 112.3 (=CH2), 142.7 
(C3); MS (El, 70 eV) mlz (relative intensity) 152 (M+, 33), 137 (100), 109 (13), 95 (26), 81 (25), 69 (40), 55 
(25), 41 (32); HRMS calcd forC9H16N2 152.1313, found 152.1310.
1 .8-D iaza-3-m ethyIene-7 ,7 ,8-trim ethylbicyclo[3 .2 .1]octane (76). To a suspension ofLiAltfy (17 
mg, 0.45 mmol) in THF (2 mL) was added dropwise a solution of 63 (51 mg, 0.23 mmol) in THF (2 mL) and 
the mixture was heated at reflux temperature for 3 h. After cooling to rt, H2O (53 mL) was added and the resulting 
suspension was washed with ether (50 mL). The organic layer was dried (MgS04), filtered and concentrated in 
vacuo to afford 76 (9.8 mg* 0.059 mmol, 13%) as a colorless oil, /?ƒ (ethyl acetate) 0.10. IR v 3060, 890; *H 
NMR (200 MHz) 5 1.27 (s, 3 H, CH3), 1.32 (s, 3 H, CH3), 1.62 (d, J  = 12.1 Hz, 1 H, H e g ^ ,  1.89 (d, J  =
14.9 Hz, 1 H, H4), 2.06 (dd, J  = 7.4, 12.1 Hz, 1 H, H6exo), 2.73 (s, 3 H, NCH3), 2.78 (d, J  = 14.9 Hz, 1 H, 
H4), 3.25 (d, J  « 16.2 Hz, 1 H, H2), 3.36-3.46 (m, 1 H, H5), 3.80 (dd, J  = 1.0, 16,2 Hz, 1 H, H2), 4.71-4.84 
(m, 2 H, =CH2); 13C NMR (50 MHz) 8 24.6 (CH3), 32.7 (C4), 33.0 (CH3), 35.9 (NCH3), 45.9 (C6), 49.1 
(C2), 59.8 (C5), 63.9 (C7), 111.3 (=CH2), 142.6 (C3); MS (El, 70 eV) mlz (relative intensity) 166 (M+, 57). 
151 (95), 125 (26), 111 (17), 95 (27), 83 (100), 82 (90), 55 (23), 43 (37); HRMS calcd for C1QH18N2 166.1470, 
found 166.1470.
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CHAPTER S
STUDIES TOWARDS THE SYNTHESIS OF AZATROPANE DERIVATIVESI
5.1 INTRODUCTION
During the last century, the tropane alkaloids have been prominent targets for organic 
synthesis.1 One of the most important representatives of this group of alkaloids is (/?)-(-)- 
cocaine 1 which is isolated from the leaves of Erythroxylon coca and has been a major subject of 
scientific investigations*2 It is one of the eight possible stereoisomers of 3-[(benzoyl)oxy]-8- 
methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid methyl ester with both substituents in the 
exo-position. The different isomers at the 2- and the 3-position are indicated with the prefixes 
pseudo and alio, respectively. For example, the isomer 2 with both substituents in the endo- 
position is referred to as allopseudococaine.
CO2M6
C 02Me
(fl)-cocaine (1) (R )-allopseudococaine (2)
It is well known that Sigmund Freud was one of the first investigators who studied the 
effects of cocaine and who in fact proposed its use in the treatment of alcohol and opiate abuse. 
Even though this error was soon recognized, cocaine has continued to be abused. In both 
animals and humans, cocaine is one of the most reinforcing drugs known, which is presumably 
related to its great abuse potential.
Cocaine has many physiological effects. It is a powerful vasoconstrictant and as such has 
some current use in medicine during nasal or throat surgery where control of bleeding is desired. 
Cocaine also has very potent effects on the sympathetic nervous system and it is well known to 
increase heart rate and blood pressure. From the point of view of drug abuse, the most relevant 
effects of the drug include its ability to produce euphoria and its reinforcing properties. The latter 
are readily demonstrated in animal models and the euphorigenic effects of cocaine are amply 
documented in humans.
*
Over the past ten years, there have been significant advances in understanding the 
mechanism of action of cocaine. The most important explanation is the so-called ’dopamine 
hypothesis’ which assumes that cocaine binds to the dopamine transporter in such a way that 




leading to a significant potentiation of dopaminergic transmission. This potentiation is 
responsible for the reinforcing properties of cocaine and probably for its euphorigenic effects as 
well. Because of the important role of the dopamine transporter in the action of cocaine, the 
transporter has been the subject of many studies to elucidate the characteristics of the cocaine 
binding site at the transporter. For this reason, many analogs of cocaine have been synthesized 
some of which are shown below.




It has been reported that the nitrogen atom can be moved from the 8- to the 6- (3) or the 
7-position (4) of the azabicyclic ring system without loss in binding potency.3 Remarkably, the 
(+)- and (~)-isomers of 4 showed similar binding potency. A representative of the class of aryl 
substituted tropane analogs is 5, which shows a high binding affinity at the receptor site.2*4
5.2  AZAANALOGS OF TROPANE ALKALOIDS
Regarding the ongoing search for new cocaine analogs, it is interesting that the method 
described in Chapter 4 provides a route which might lead to compounds that possess an 
azatropane skeleton, i.e. one of the bridgehead carbon atoms is replaced by a nitrogen atom. 
Starting from a dimethyl substituted pyrazolidinone, for example the azaanalog 7 of cocaine 6 
should be accessible.
C02Me
6 ^ O B z  /  ?  ^ - O B z
If the developed sequence is applied to unsubstituted 3-pyrazolidinone, an exact analog 
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Scheme 5.1 (continued)
V N' Sr°
A  C O o M efl
O
11 12
After transformation of the alkylation product 12 into the cyclization precursor 11, the 
cyclic compound 10 might be obtained. Cleavage of the dioxenone moiety and subsequent 
reduction and benzoylation of the (3-ketoester 9 might lead to the final product 8 .
In this sequence of reactions, the JJ-ketoester 13 is already introduced in the first step in 
its acetonide form 14. Cleavage of this acetonide to the P-ke toes ter is achieved thermally in most 
cases. It has been shown by Clemens et aL that thermolysis of the dioxenone 14 will lead to the 
acylketene 15 in a retro Diels-Alder reaction (eq 5.1).5 The very electrophilic acylketene 15 will 
react with any nucleophile present in the reaction mixture.6 If for instance methanol is added 















The successful use of 1 ,3-dioxen-4-ones for this purpose is illustrated by several recent 
applications of this moiety in intermolecular addition reactions.7 An interesting intramolecular 
variant is shown in eq 5.2, in which thermolysis of the dioxenones 17 and subsequent 
intramolecular nucleophilic attack of the alcohol at the acylketene 18 leads to the 8-membered (J- 
ketolactones 19 in very high yields (> 90%).**











5.3  CHOICE OF THE STARTING COMPOUND: UNSUBSTITUTED VERSUS
I l  I  I I  I
The application of the unsubstituted 3-pyrazolidinone (24) as the starting material would 
lead to unsubstituted azatropane systems. While all of the possible substituted pyrazolidinones 
can be synthesized by a condensation of the appropriate acrylic ester with hydrazine hydrate, this 
methodology does not work for the pyrazolidinone 24. A convenient synthesis for this 
pyrazolidinone is shown in eq 5.3. Hydrazine hydrate is reacted with acrylonitrile (20) to give 
the hydrazinonitrile 2 1 , which is cyclized under the influence of sulfuric acid, affording the 
stable sulfuric acid-salt of the aminopyrazoline 2 2 .9 Hydrolysis of the enamine and treatment 
with HC1 will give the stable HCl-salt 2 3 .10 The free pyrazolidinone 24 can be obtained after 










NH , *i (eq 5.3) 
NH
23 O 24
a) H2NNH2-H20  (1 equiv), 35 °C, 2 h (100%), b) H2S04 (3 equiv), EtOH, rt, 1 h (100%). c) H20, reflux,
6 h then NaOH, then HC1 (70%). d) NaOMe (1 equiv), MeOH (100%).
In order to study the sequence of reactions as described in Chapter 4 with the 
pyrazolidinone 24, both the benzyl and the methallyl substituent were chosen as model systems. 
The results of the different reactions are summarized in Table 5,1.
Table 5.1. Reactions with 3-pyrazolidinone.














30 (33%) 31 (6%)
It is remarkable that the alkylations occur in rather poor yields. The fact the the gem- 
dimethyl function is absent from the molecule should enhance the nucleophilicity of the N -l 
nitrogen atom as the steric hindrance is significantly decreased. Unfortunately, this decrease of
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steric bulk is probably one of the main reasons for some unwanted side reactions. For example, 
the alkylation method described in Chapter 4 (alkenyl halide (1 equiv), K2 CO3  (1.2 equiv), Lil 
(cat), 2-butanone) has to be carried out in a different solvent as the pyrazolidinone 24 will 
immediately condense with 2-butanone to give a mixture of the ylides 32 and 33 (eq 5.4) 9
(eq 5.4)
An indication of another side reaction which might be responsible for the low yield is 
given by work of Draheim and co-workers. Alkylation of the monosubstituted pyrazolidinone 
36 afforded the desired product 37 together with the ylide 38 (eq 5.6) . 1 2  A similar product can 
be’ formed in the reaction with 24, leading to the very polar ylide 35 (eq 5.5), which will remain 
in the water layer, thus giving rise to a low yield of the desired alkylation product 34. If there is 
a gem-dimethyl function present in the five-membered ring, dialkylation at the N-l nitrogen atom 
is impossible as a result of steric hindrance. In that case, if an excess of the alkylating agent is 
used, the second alkyl function will be introduced at the N-2 nitrogen atom (see Chapter 4).
-
34(18%) °  35
NH l)N aH  (1.1 equiv) H H
1 ------------------ -- .N— (  1 + .N —< 1 (eq5.6)
NH 2) eqiriv)1-6 “  V NH fB“  V N ■
36 0 37(19%) 0 38(10%)
The methoxycarbonylation reactions (Table 5.1) were carried out with LDA (1 equiv, -78 
°C, THF) and methyl cyanoformate (2 equiv, -78 flC). In the subsequent reduction step, another 
disadvantage of the unsubstituted 3-pyrazolidinone is encountered. If the reduction is canied out 
under ‘standard conditions* (excess of NaBH^, EtOH, -20 °C) only the ring-opened amide- 
alcohols 29 and 30 are obtained.
2 8  NaBH4
/ -)^L>'C02Me vk "COgMe ^OH 'COzMe





As shown in equation 5.7, during the reduction there is an equilibrium between the ring- 
closed lactol 39 and the ring-opened aldehyde 40. The latter intermediate can be further reduced 
with NaBH4 to give the alcohol 30. A similar result was obtained if the reductions were earned 
out at -78 °C, although in the case of the methallyl substituent a small amount of the desired 
ethoxypyrazolidine 31 was also found. Such a ring opening and overreduction were not 
observed if the pyrazolidinone ring was substituted with the gem-dimethyl function (see: Section
4.2).
The effect, that alkyl substitution favors the cyclic structure in cases of ring-chain 
tautomerism, is an example of the well-known ‘gem-dimethyl effect’ and was recognized for the 
first time by Ingold and Thorpe.13 A general explanation for this phenomenon was postulated by 
Allinger and Zalkow.14 They state that the effect is partly a result of a change in enthalpy and 
partly of a change in entropy. The effect of alkyl groups on the enthalpy of ring-closure is 
interpreted in terms of the change of gauche interactions in going from the reactant to the 
product, which is larger in the substituted cases. The loss of entropy upon cyclization is less in 
the substituted compound since the substituents restrict the rotation in the acyclic system, thereby 
lowering its entropy.
In the case of a similar type of pyrrolidinone (eq 5.8), identical changes in the 
equilibrium have been observed by Chiron and Graff.15 The hydroxylactams 41 exist entirely in 
the open form (42) when they are un- or monosubstituted (R = H, R’ = H or Me), whereas they 







The corresponding six-membered hydroxylactams show similar behavior. Other factors 
that influence the equilibrium are the temperature (the lower the temperature, the more the 
equilibrium will shift to the ring-closed form) and the substituent at the nitrogen atom (electron- 
withdrawing substituents will stabilize the anion, thus enhancing ring opening).
In order to circumvent the problems with the unsubstituted pyrazolidinone and to avoid 
the introduction of the ge/n-methyl function, an alternative pyrazolidinone was chosen as the 
starting material, containing one substituent at the 4-position which should be easily removable 
and make ring opening during the reduction less likely to happen. An advantage of such a 
starting material is also that it offers the possibility to start from an enantiopure pyrazolidinone 
(45, eq 5.9), leading eventually to enantiopure azatropane systems. This strategy bears analogy 
with the work that has been carried out with the (S)-malic acid derived succinimide 43. The 
stereocenter at the 4-position controls the stereochemistry at the 5-position in the N-acyliminium 
ion 44 with moderate to high diastereoselectivity.16 A similar induction might be expected in the
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case of the corresponding N-acylhydrazonium ion 46.
N +N
O ^ O R OR
43 44 45 46
Concerning the substituent X there are several options: X could be an oxygen atom 
protected with an alkyl or acyl group, or a protected nitrogen atom. The synthesis of such a 
synthon (X = OR) via a direct reaction of hydrazine with oxirane carboxylic acids (49 R* = H, 
eq 5.10) or oxirane carboxylates (49 R = alkyl)17 was not successful, although regioselective 
reactions with substituted oxirane carboxylic acids have been reported with other nucleophiles 
than hydrazine (e.g. thiophenol, diethylamine),18 Furthermore, substituted oxirane carboxylates 




r o ^ Y  ' n h *
°  48
> (eq 5.10)
A possible route to the alternative amino substituted pyrazolidinone has been developed 
at Eli Lilly & Company (eq 5» l l ).20 The readily available L-serine, protected with a Boc group 
and a methyl ester (50),21 was used as starting material and converted into the corresponding 
hydrazide by stirring it in the presence of hydrazine hydrate (eq 5.11). It was found that if the 
hydroxy function was converted into a good leaving group, i.e. a tosylate, the ring closure of the 
hydrazide gave rise to complete racemization 22
OH
f-B o cN H " ' 'C O jM e  ,  ^  ( e q 5 J 1 )
50 O 52
a) N2H4-H20  (1 equiv), MeOH, rt. b) EtSC(0)CF3 (1.5 equiv), EtOH, rt. c) PPh3 (1.1 equiv), DEAD (1.1 
equiv), THF, rt. d) 1 N NaOH, pH * 12,1  h.
Only if the cyclization was carried out under Mitsunobu-type conditions, the enantiopure 
pyrazolidinone 52 could be obtained. In order to perform such a ring closure, the hydrazide had 
to be activated with a trifluoroacetyl function, which was achieved by treating the hydrazide with
S -ethyl trifluorothioacetate. Ring closure took place upon treatment with equimolar amounts of
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triphenylphosphine and diethyl azodicarboxylate, after which the trifluoroacetyl function was 
removed by stirring in 1 N NaOH to give 52. In similar ring closure reactions, the Mitsunobu- 
type reaction was found to be the only reaction that gave satisfactory yields of five- or six- 
membered cyclic hydrazines.23,24
In order to investigate the application of this monofunctionalized pyrazolidinone, some 
model experiments were performed with the racemic CBz-protected 4-aminopyrazolidinone 54. 
This compound was obtained by a condensation of hydrazine hydrate with the protected 
dehydroalanine S3 .25
II R N N H yH .O  , , „
C B z N H ^ C 0 2Me ----------------- ► CBzNH—< (eq 5.12)
MeOH
53 0 54 (80%)
One of the possible routes for synthesizing this compound is shown in eq 5.13, in which 
benzyl carbamate 55 is reacted with pyruvic acid under azeotropic removal of water to give the 
dehydroalanine 5 6 .26 Estérification with diazomethane afforded the appropriate dehydroalanine 
methyl ester 5 3.
Me COjH I  W  J [
BnO NH2 ----------- CBzN H ^ C 0 2H -------------- C B zN H ^X 02Me (eq 5.13)
(I trichloroethene ether, 0 °C
O 55  Dean Stark 56
The results obtained with the pyrazolidinone 54 and the ge/n-dimethyl substituted 
pyrazolidinone are summarized in Table 5.2. The alkylations of 54 proceeded best (entries 1 and 
2), if they were carried out under the conditions described by White et al. (halide (1 equiv), 
Et^N (1 equiv), Lil (cat), DMF, rt) 27 The chlorinated dioxenone 58 used in this alkylation 
reaction was obtained by quenching the lithium enolate of the commercially available dioxenone 
57 with hexachloroethane (eq 5.14).28
O
O - -57
1) LDA, -78 °C
2) CI3CCCI3, -78 °C
(eq 5.14)
The relatively low yield (compared with the series described in Section 4.2) of the 
alkylation product 61 (entry 3) is explained by the thermal instability of the dioxenone moiety. 
This result was obtained after stirring in acetone at 40 “C for 40 h. Both higher and lower 
temperatures showed a decrease of the yield of 61.
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Ethoxycarbonylation of 59 and 60 (entries 1 and 2) was carried out by using diethyl 
dicarbonate (see: Section 4.2, method C). Although an excess of the dicarbonate was used, only 
the pyrazolidinone nitrogen atom reacted to give the hydrazines 62 and 63. This is indicated by 
the different positions at which the NH protons appear in the *H NMR spectra. The ring proton 
is found between 7 and 8 ppm, whereas the carbamate proton appears between 5 and 6 ppm. 
Compound 61 was deprotonated with NaH and treated with MeC^CCN to give the 
methoxycarbonylated product 64 in a reasonable yield.



























65 (58%) dtr 1:5
EtO C02Me






In the subsequent reduction step, ring opening and overreduction took place rapidly if the 
mono substituted pyrazolidinones were subjected to ‘standard conditions’ (NaBH^ (excess), -20 
°C). Small amounts of the desired product 67 could be obtained together with the ring-opened 
product 68 and starting material 60 if the reaction was performed at -78 °C. Reduction of 63 
with DIB AL-H or LiBH4 in THF did not give satisfactory results either. However, better results 
were obtained if the reduction was carried out in the presence of a stoechiometric amount of 
CeCl3*7H20  at -50 °C. This is explained by the high affinity of the cerous ion for oxygen, thus 
favoring the ring-closed product in the equilibrium with the open product.29 Unfortunately, 
formation of the open-chain products 66 an 68 could not be totally prevented. In accordance 
with the results presented in Chapter 4, reduction of 64 (entry 3) under ‘standard conditions’ 
(NaBH^ (4 equiv), -20 *C) led to 69 without a trace of the ring-opened product
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5.15). Acetic anhydride was expected to enhance the rate of the reaction via in situ formation of 






AC2O (3 equiv), 
CH2C12, 0 °C rt
-  A c NHm (eq 5.15)
EtQ CO2M©
71 (46%)
The formation of the acetyl protected carbamate 71 is probably a result of Lewis acid 
catalyzed debenzylation, followed by immediate reacylation with acetic anhydride. The fact that 
only the ethoxypyrazolidine 71 was found, suggests that the intermediate hydrazonium ion has 
not been formed, because otherwise the corresponding acetoxypyrazolidine should also have 
been found.
Reaction of 67 under these conditions led to decomposition of the dioxenone moiety. A 
completely different result was obtained by treatment of 67 with BF3*OEt2 and acetic anhydride 
(Scheme 5.2). Surprisingly, formation of the intermediate hydrazonium ion 72 did not lead to 
the desired cyclization product but to the bicyclic oxazolidinone 7 4, which was the only product 
that could be detected. This result can be explained by initial stabilization of the N- 
acylhydrazonium ion by the carbamate function giving the stabilized dioxycarbénium ion 73. 
During the course of the reaction or during work up, the benzyl group is removed and the 






Ac^ O (3 equiv), 




X< P QC02Me 11
O
72
J ^ o '  COzMe
74 (32%)
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In contrast with these results, the gem-dimethyl substituted precursor 69 led to the 
expected cyclization product 76. Although many conditions were tried, cyclization took only 
place after treatment with BF3*OEt2 (4 equiv). A smaller amount of BF3*OEt2 led to an 
incomplete conversion of the precursor 69 into the cyclization product 76. The use of TiCl4 and 
SnCl4 led to decomposition of the dioxenone moiety prior to cyclization.
HCOOH





BFrOEt2 (4 equiv) 
0 CH2C12, 0 °C it
(eq 5.16)
76 (94%)
Formic acid was the only protic acid that led to cyclization. However, at room 
temperature no reaction took place, whereas at high temperature (100 °C), the cyclization product 
immediately decarboxylated to give the azatropanone 75 (see compound 59, Chapter 4).
5.5 SYNTHESIS OF AZATROPANE DERIVATIVES
In order to convert the cyclization product 76 into azatropanes two major conversions 
were to be carried out. The methyl carbamate had to be converted into a methyl function and the 
dioxenone part had to be deprotected and reduced. It would be advantageous to perform a 
catalytic hydrogenation of the dioxenone at this stage, as it would immediately give the desired 
d.v-relationship between the two substituents. Various catalysts were tried at different pressures 
of H2 gas, but the double bond could not be reduced. This might be a result of the very hindered 
nature of this double bond. At the bottom-side, it is shielded by the ethylene bridge with the 
gem-dimethyl function and at the top-side the carbamate hinders the approach of a catalyst. If 7 6 
was treated with Na/NH331 the double bond remained unaffected (eq 5.17), but instead the N-N 








There are several methods to convert a methyl carbamate into the corresponding N- 
methyl compound. Direct conversion of 76 into the desired product 79 (eq 5.18) by a reduction
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with LJAIH4 led to decomposition of the dioxenone part. A suitable result was obtained if the 
carbamate 76 was first cleaved with (CHg^Sil to give the free hydrazine 78 (eq 5.18).32 
Conversion into the N-methyl compound with Mel or Me2SC>4 did not give satisfactory results. 
Therefore a reductive méthylation was carried out,33 using 37% aq formaldehyde in acetonitrile 
to give the intermediate iminium ion which was further reduced with NaBHgCN to the 
methylated compound 79.
b
a) M03S1I (1.2 equiv), MeCN, 1 h, 40 °C. b) (i) 37% aq H2CO (5 equiv), NaBH3CN (1.6 equiv), 
MeCN, rt (ii) AcOH.
(eq 5.18)
Efforts to reduce the double bond of the dioxenone at this stage by using a catalytic 
hydrogenation also failed. On the other hand, ring opening of the dioxenone proceeded smoothly 
and was proven to give the best result if the product 79 was heated in a sealed tube for 10 min at 
170 °C in xylenes in the presence of an excess of methanol (eq 5.19). The crude JJ-ketoester 80 
was obtained in a quantitative yield but could not be easily purified. Despite the clear NMR 
spectrum, flash chromatography gave a dramatic decrease of the yield. Therefore, crude 80 was 
treated with benzoyl chloride to afford the azatropane derivative 81 in a reasonable overall yield. 




P sealed tube, 10 min M©0 2G
80






The crude (3-ketoester 80 was also reduced in the presence of an excess of NaBtfy at 0 
°C to give the ecgonine analog 82 (eq 5.20). In accordance with the outcome of a similar 
reduction of 2-(carbomethoxy)tropanone at -30 *C carried out by Carroll et al.,34 only one 
isomer was obtained in which both substituents occupy the endo-position (allopseudo). They 
also reported that reduction at 0 °C gave a mixture of the pseudo- and the allopseudoisomer. The 
fact that reduction of 80 seems to be more selective probably is a result of the e/ufo-methyl 
substituent, which is shielding the bottom side of the molecule, thus preventing an endo-mack 
from occurring.
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NaBH4 (10 equiv),
------------------------------------------------------- ----
n O MeOH, 0-5 °C




The stereochemistry of 82 was proven by using *H NMR NOE-difference techniques. 
Irradiation of the proton adjacent to the hydroxy function (H3) showed an enhancement of the 
signals of all of the H2 and H4 protons, thus confirming its equatorial position. Irradiation of the 
hydroxyl proton showed a slight enhancement of the signal of the H2gq proton, but not of the 
H4 proton, indicating its axial position. The assigned stereochemistry was confirmed by 
comparison of the coupling constants of the H3 and H4 protons with allopseudococaine34 (H3; 
t, 3 ƒ = 4.9 Hz, whereas for allopseudococaine: dt, 3 ƒ = 1.1, 4.8 Hz; H4: br t, 3/  = 4 Hz, 
whereas for allopseudococaine: dd,3/  = 3.1, 4.8 Hz).
Attempts to convert this allopseudoecgonine derivative 82 into the benzoyl ester 
according to literature procedures were not successful.35 A possible explanation might be that 
the reactivity of the hydroxy function is strongly decreased as a result of the presence of the 
endo-methyl group.
5 .6  CONCLUSIONS
Several conclusions can be drawn from the results described in this Chapter. The 
unsubstituted 3-pyrazolidinone has been shown to be a troublesome starting compound. Its most 
important disadvantage is the instability of the corresponding hydroxypyrazolidine which easily 
gives ring-opening. A similar effect is observed in the monosubstituted systems, although a 
higher yield of the desired reduction product can be obtained. The use of a protected amino 
function to induce a stereoselective cyclization seems to be an improper choice as under various 
conditions cyclization to the desired products failed.
The gem-dimtthyl substituted 3-pyrazolidinone has been shown to be a suitable starting 
material for the synthesis of various azatropane derivatives. A major drawback of this compound 
is the presence of two methyl functions which makes the resulting compounds somewhat less 
attractive analogs of the corresponding tropane alkaloids.
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5.7 EXPERIMENTAL SECTION
General information. For experimental details, see: Section 2.11.
l-B enzyi-3-pyrazoIidinone (25). A mixture of 3-pyrazolidinone (24) (2.00 g, 23.3 mmol), benzyl chloride 
(2.1 g, 16.3 mmol), K2CO3 (4.8 g, 35 mmol) and a catalytic amount of Lil in THF (40 mL) was refluxed for 18 
h and concentrated in vacuo. The residue was taken up in H2O (100 mL) and extracted with CH2CI2 (3 x 100 
mL). The combined organic layers were dried (MgSO^), filtered, concentrated w vacuo and chromatographed (ethyl 
acetate) to afford 25 (872 mg, 4.95 mmol, 30%) as a colorless oil, Rjr 0.30. IR v 3420, 3400, 1660,1380, 690;
NMR (200 MHz) 8 2.50 (t, ƒ = 8.0 Hz, 2 H, C ity ,  3.33 ( t , /=  7.7 Hz, 2 H, NCH2), 3.84 (s, 2 H, CH2Ph),
7.32 (s, 5 H, ArH).
l-(2-M ethyl-2-propenyl)-3-pyrazo!id inone (26). A mixture of 3-pyrazolidinone (24) (500 mg, 5.81 
mmol), methallyl chloride (473 mg, 5.23 mmol), K2CO3 (960 mg, 7.00 mmol) and a catalytic amount of Lil in 
THF (10 mL) and MeOH (5 mL) was refluxed for 18 h and concentrated in vacuo. The residue was taken up in 
H2O (20 mL) and extracted with CH2CI2 (3 x 20 mL). The combined organic layers were dried (MgSC^), filtered, 
concentrated in vacuo and chromatographed (ethyl acetate) to afford 26 (123 mg, 0.88 mmol, 30%) as a colorless 
oil, R f  0.20. IR v 3410, 3400,1670,1440,1400, 900; JH NMR (200 MHz) 6 1.78 (s, 3 H, CHj), 2.54 (t, J  =
8.0 Hz, 2 H, CH2), 3.22 (s, 2 H, NCH2), 3.28 (t, J  = 7.7 Hz, 2 H, NCH2), 4.94 (br s, 2 H, =CH2), 7.54 (br s,
1 H, NH).
LB enzyl-3-pyrazolidinone-2-carboxylic acid m ethyl ester (27). A solution of 25 (500 mg* 2.84 
mmol) in THF (5 mL) was deprotonated with LDA (prepared from diisopropylamine (0.44 mL, 3.13 mmol) and 
K-butyllithium (2.0 mL of a 1.6 M solution in hexane, 3.2 mmol) in THF (10 mL) at 0 *C) at -78 *C and treated 
at that temperature with a solution of MeC^CCN (483 mg, 5.68 mmol) in THF (5 mL). The mixture was stirred 
at -78 *C for 1 h, allowed to warm to rt, poured into water (50 mL) and extracted with CH2CI2 (3 x 50 mL), The 
combined organic layers were dried (MgSC^), filtered, concentrated in vacuo and chromatographed (ethyl 
acetate/hexane 1:1) to give 27 (263 mg, 1.12 mmol, 40%) as a colorless oil, /?ƒ 0.30. IR v 1780,1735, 1430, 
1210, 690; *H NMR (200 MHz) S 2.56 (t, J = 7.5 Hz, 2 H, CH2), 3.32 (t, J  = 7.6 Hz, 2 H, NCH2), 3.90 ( s, 3
H, C02CH3), 4.04 (s, 2 H, CH2Ph), 7.36 (s, 5 H, ArH).
l-(2-M ethyI-2-propenyl)-3-pyrazolid inone-3-carboxylic acid m ethyl ester (28). A solution of 
26 (120 mg, 0.86 mmol) in THF (5 mL) was deprotonated with LDA (prepared from diisopropylamine (0.15 mL,
I.03 mmol) and n-butyllithium (0.65 mL of a 1.6 M solution in hexane, 1.04 mmol) in THF (4 mL) at 0 *C) at 
-78 °C and treated at that temperature with a solution of MeC^CCN (150 mg, 1.76 mmol) in THF (2 mL). The 
mixture was stirred at -78 °C for 1 h, allowed to warm to rt, poured into water (30 mL) and extracted with 
CH2CI2 (3 x 30 mL). The combined organic layers were dried (MgSC^), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1) to give 28 (44.5 mg, 0.22 mmol, 26%) as a colorless oil, /?ƒ 0.40. 
IR v 1780,1735,1430,1310,1290,900; !H NMR (200 MHz) 8 1.87 (s, 3 H, CH3), 2.73 (t, J  = 7.5 Hz, 2 H, 
CH2), 3.35 ( t , /=  7.5 Hz, 2 H, NCH2), 3.42 (s, 2 H, NCH-j), 3.89 (s, 3 H, CC^CH-j), 4.96 (br s, 2 H, =CH2).
l-B enzyM -(3-hydroxypropyl)-2-hydrazinecarboxylic acid methyl ester (29). A solution of 27 
(44 mg, 0.19 mmol) in EtOH (2 mL) was treated with NaBH4 (22 mg, 0.58 mmol) at -78 *C and every 10 min 
with one drop of a 2 M H2SC>4/EtC)H solution. After 1 h (the reaction was monitored with TLC), the mixture
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was acidified to pH « 3 at -78 °C, allowed to warm to rt, poured into aq satd NaHC03 (20 mL) and extracted with 
CH2CI2 (3 x 20 mL). The combined organic layers were dried (MgSO^, filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1) to give 29 (36.5 mg, 0.15 mmol, 80%) as a colorless oil, /?ƒ 0.20. 
IR v 3440, 3340,1720, 1490, 1450,1230, 690; *H NMR (200 MHz) 8 (1.75 (quintet, J  = 5.5 Hz, 2 H, O ty ,  
2.87 (br s, 2 H, NCHjO, 3.64 (s, 3 H, C02CH3), 3.74 (t. 7 =  5.3 Hz, 2 H, CHjOH), 3.93 (s, 2 H, CH2Ph), 
5.72 (br s, 1 H, NH); NMR (50 MHz) 8 28.9 (CH^, 52.1 (C02CH3), 55.3 (NCH2), 62.0 (CH2Ph), 127.5,
128.3, 129.2 (ArH), 135.7 (ArC), 157.0 (C(0)).
3 -E th o x y -l-(2 -m e th y I-2 -p ro p en y I)-p y razo Iid in e -2 -ca rb o x y lic  acid  m ethy l e s te r (31). A 
solution of 28 (43 mg, 0.21 mmol) in EtOH (2 mL) was treated with NaBH4 (32 mg, 0.84 mmol) at -78 *C and 
every 10 min with one drop of a 2 M ^ S O ^ tO H  solution. After 1 h (the reaction was monitored with TLC), 
the mixture was acidified to pH « 3 at -78 'C, allowed to warm to rt after 15 min, poured into aq satd NaHCOg 
(20 mL) and extracted with CH2CI2 (3 x 20 mL). The combined organic layers were dried (MgSC^), filtered, 
concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:1) to give 31 (3 mg, 0,013 mmol, 6%) as a 
colorless oil, Rjr 0.65 and l-(3 -hydroxypropy l)« l-(2 -m ethy l-2"propeny l)-2“hydrazinecarboxylic 
acid m ethyl ester (30) (14 mg, 0.069 mmol, 33%) as a colorless oil, Rjr 0.25. 31: IR v 1720,1690, 1445, 
1370, 1120, 1090, 900; JH NMR (200 MHz) 8 1.20 (t, J  = 7.0 Hz, 3 H, CH2Cff3), 1.88 (s, 3 H, CH3), 2.22-
2.26 (m, 2 H, CH2), 2.99-3.24 (m, 3 H. NCH2 and NCHH), 3.52-3.69 (m, 3 H, NCHtf and 0 / 2CH3), 3.75 (s,
3 H, C 02CH3), 4.87 (br s, 2 H, =CH2), 5.55 (t, J  = 5.1 Hz, 1 H, OCH). 30: IR v 3440, 3340, 1720, 1505, 
1450, 1235,900; JH NMR (200 MHz) 8 1.74 (quintet, J  = 5.5 Hz, 2 H, CH2), 1.82 (s, 3 H, CH3), 2.86 (t, J  =
5.5 Hz, 2 H, CH2), 3.24 (s, 2 H, NCH2), 3.69 (s, 3 H, C02CH3), 3.79 (t, J=  5.5 H z,2H , CH2), 4.88 (s, 2 H, 
=CH2), 5.53 (br s, 1 H, NH).
2 -P ropeny l-3 -py razo lid inone  (34). A solution of 3-pyrazolidinone (24) (2.16 g, 25.1 mmol), allyl 
bromide (1.74 mL, 20.1 mmol), EtgN (2.77 mL, 20.1 mmol) and a catalytic amount of Nal in DMF (25 mL) 
was stirred at rt for 18 h. Concentration in vacuo and purification of the residue by flash chromatography (ethyl 
acetate) afforded 34 (571 mg, 4.53 mmol, 18%) as a colorless oil, Rjr 0.10. IR v 3420, 3080,1670,1405, 990, 
925; l H NMR (200 MHz) 5 2.16 (t, J  = 7.6 Hz, 2 H, CH2), 2.93 (t, J  = 7.1 Hz, 2 H, NCT^), 2.98 (t, J  = 6.5 
Hz, 2 H, NCH2), 4.86 (d, J  * 9.8 Hz, 1 H, =CtfH), 4.91 (d, /  = 14.4 Hz, 1 H, =CHtf), 5,39-5.56 (m, 1 H, 
=CH), 8.22 (br s, 1 H, NH).
^ -[(B en zy lo x y icarb o n y lld eh y d ro a lan in e  m ethyl ester (53),25 To a solution of iV-[(benzyloxy)- 
carbonyl]dehydroalanine 562^ (12,11 g, 60.3 mmol) in ether (50 mL) was added at 0 *C diazomethane (prepared 
from Diazald® (26.8 g) and KOH (6.25 g) in ether (250 mL))36 until the yellow color persisted. The solution was 
concentrated in vacuo to afford 53 (12.9 g, 60.0 mmol, 100%) as a colorless oil. IR V 3405, 1730,1710, 1630,
1520,1440, 900,690; lH NMR 5 3.68 (s, 3 H, C 02CH3), 5.17 (s, 2 H, OCH2), 5.79 (s, 1 H, =C//H), 6.25 (s,
1 H, =CHƒ*), 7.38 (s, 5 H, ArH).
4-{[(Benzyloxy)carbonyI]am ino}-3-pyrazoIidinone (54).25 A mixture of 53 (12.0 g, 55.8 mmol) and 
hydrazine hydrate (3.0 mL, 61.8 mmol) in EtOH (150 mL) was heated at reflux temperature for 3 h. The solution 
was concentrated in vacuo and chromatographed (10% methanol/ethyl acetate) to afford 54 (10.5 g, 44.7 mmol, 
80%) as a white solid, mp 154-156 ‘C (lit.:25 mp 155-156*C), /?ƒ 0.15. IR v 1710,1680; lH NMR (250 MHz)
5 3.22 (br t, J  = 11.4 Hz, 1 H, NCtfH), 3.89-3.96 (m, 1 H, NCHtf), 4.33-4.43 (m, 1 H, NCH), 5.09 (s, 2 H, 
C//2Ph), 5.51 (br s, 1 H, NH), 7.24-7.33 (s, 6 H, ArH and NH).
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l-BenzyI-4-{[(benzyloxy)carbonyI]am ino}-3-pyrazoIidinone (59). A solution of 54 (545 mg, 2,32 
mmol) in DMF (3 mL) was treated with benzyl chloride (293 |iL, 2.55 mmol), Et3N (386 |iL, 2.78 mmol) and a 
catalytic amount of Lil. The mixture was stirred at rt for 18 h and concentrated in vacuo, The residue was taken up 
in ¥¡2O (50 mL) and extracted with CH2CI2 (3 x 50 mL). The combined organic layers were dried (MgSC^), 
filtered, concentrated in vacuo and chromatographed (ethyl acetate) to give 59 (257 mg, 0,79 mmol, 34%) as a 
colorless oil, R f  0.40. IR v 3410,1710,1500, 690; 1 H NMR (200 MHz) 8 3.05-3.20 (m, 1 H, NCWH), 3.80- 
3.95 (m, 3 H, CHjPh and NCHW), 4.48-4.60 (m, 1 H, NCH), 5.09 (s, 2 H, OCH2), 5.28-5.32 (m, 1 H, NH),
7.32 (s, 5 H, ArH), 7.60-7.70 (m, 1 H, NH).
4 -{ [(B en zy lo x y )ca rb o n y l]am in o } " l> [ (3 ,3 -d im e th y  I -5 -o x o -2 ,4 -d io x -6 -e n y l)m e th y l]-3 -  
pyrazolidinone (60). A solution of 54 (2.54 g, 10,8 mmol) in DMF (25 mL) was treated with dioxenone 
5828 (2.10 g, 11.9 mmol), Et3N (2.55 mL, 18.3 mmol) and a catalytic amount of Lil. The mixture was stirred at 
rt for 18 h and concentrated in vacuo. The residue was taken up in H2O (100 mL) and extracted with CH2CI2 (3 x 
100 mL). The combined organic layers were dried (MgSC>4), filtered, concentrated in vacuo and chromatographed 
(ethyl acetate) to give 60 (2.23 g, 5,95 mmol, 55%) as a white solid, which decomposed at 125 *C before 
melting, R f  0.40. IR v 3410,1710,1635,1360,900,690; %  NMR (200 MHz) 8 1.69 (s, 6 H, (C ^ ^ C ) ,  3.21 
(t, J  = 11.5 Hz, 1 H, NOffl), 3.52 (s, 2 H, NCH2), 3.73-3.82 (m, 1 H, NCH//), 4.50^.70 (m, 1 H, NCH), 5.10 
(s, 2 H, OCH2), 5.50 (s, 1 H, =CH), 5.66 (d, J  = 5.4 Hz, 1 H, NH), 7.33 (s, 5 H, ArH), 8.66 (br s, 1 H, NH).
5 ,5 -D im ethy l-l-[(3 ,3 -d im ethy l-5 -oxo-2 ,4 -d iox-6 -e iiy !)m ethy l]-3 -pyrazo lid inone (61). To a 
solution of 5,5-dimethyl-3-pyrazolidinone (3.55 g, 31.1 mmol) in acetone (130 mL) were added dioxenone 58 28 
(5.50 g, 31.2 mmol), K2CO3 (4,7 g, 34 mmol) and a catalytic amount of Lil. After being stirred at 45 *C for 48
h, the mixture was concentrated in vacuo, taken up in H2O (100 mL) and extracted with CH2CI2 (3 x 100 mL). 
The combined organic layers were dried (MgSC>4), filtered and concentrated in vacuo. The residue was purified by 
flash chromatography (ethyl acetate) to afford 61 (4.79 g, 18.9 mmol, 61%) as orange crystals, mp 112,5-113 *C 
(pentane/elher/CH2Cl2 10:10:1), R f  0.28 (ethyl acetate). IR v  3420,1720,1635, 1385, 1370, 1270, 1010; *H 
NMR (200 MHz) 8 1.30 (s, 6 H, (C H ^C C ), 1.71 (s, 6 H, (C ^ ^ C O ), 2.36 (s, 2 H, CH2), 3.40 (s, 2 H, 
NCH2), 5.52 (s, 1 H, =CH), 7.70 (br s, 1 H, NH); 13C NMR (50 MHz) 8 24.9 (4 x CH3), 42.7 (CH2), 54.1 
(NCH2), 63.0 (NC), 94.6 (=CH), 107.0 (OCO), 160.6, 167.3, 174.9 (2 x C(0) and =C); MS (El, 70 eV) m/z 
(relative intensity) 196 (M+-58,100), 127 (100), 83 (62), 43 (74).
l-B enzyI-4-{[(benzy loxy)carbonyl]am ino}-3-pyrazo lid inone-2-carboxylic  acid  ethy l este r 
(62). To a solution of 59 (250 mg, 0,77 mmol) in CH2CI2 (6 mL) were added diethyl dicaibonate (180 |iL,
1.54 mmol), (117 |iLt 0.85 mmol) and DMAP (103 mg, 0.84 mmol) and the mixture was stirred at rt for 
18 h. The resulting solution was concentrated in vacuo and purified by flash chromatography (ethyl acetate/hexane 
1:1) to afford 62 (173 mg, 0.44 mmol, 57%) as a colorless oil, R f  0 3 5 .  IR v 3420, 1785, 1710, 1490, 1160, 
900, 690; *H NMR (250 MHz) 8 1.37 (t, J  = 7.1 Hz, 3 H, CH2C//3), 3.17 (t, J  = 8.1 Hz, 1 H, NC//H), 3.68-
3.71 (m, 1 H, NCH//), 4.03 (d, J  = 12.6 Hz, 1 H, C//HPh), 4.07 (d, J  = 12.6 Hz, 1 H, CHflPh), 4.35 (q, 7=7.1 
Hz, 2 H, C//2CH3), 4.40-4.50 (m, 1 H, NCH), 5.07 (s, 2 H, OCH2), 5.15 (br d, 1 H, NH), 7.24-7.35 (m, 10 H, 
ArH).
4 -{ [(B enzy loxy  )c a rb o n y l]  am ino}-1 -[ (3 ,3 -d im e th y  1-5 -o x o -2 ,4 -d io x -6 -en y l)m e  th y  13-3-
pyrazolid inone-2-carboxylic  acid ethyl ester (63). To a solution of 60 (2.50 g, 6.67 mmol) in 
CH2CI2 (50 mL) were added diethyl dicarbonate (1.55 mL, 13.3 mmol), l ^ N  (1.85 mL, 13.3 mmol) and DMAP
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(814 mg, 6.67 mmol) and the mixture was stirred at rt for 18 h. The resulting solution was concentrated in vacuo 
and purified by flash chromatography (ethyl acetate/hexane 4:1) to afford 63 (1.57 g, 3.51 mmol, 53%) as a 
colorless oil, R f  0.35. IR v 3420, 1785, 1720, 1640, 1500, 1300, 900,690; %  NMR (200 MHz) 5 1.36 ( t,./ = 
7.2 Hz, 3 H, CH2C//3), 1.71 (s, 6 H, (CHj^C), 3.38 ( t , /=  12.2 Hz, 1 H, NC//H), 3.73 (s, 2 H, NCH2), 3.70-
3.80 (m, 1 H, NCH//), 3.35 (q, J  = 7.1 Hz, 2 H, C//2CH3), 4.65-4.80 (m, 1 H. NCH), 5.12 (s, 2 H, OCH2),
5.33 (br s, 1 H, NH), 5.59 (s, 1 H, =CH), 7.34 (s, 5 H, ArH); l3C NMR (63 MHz) 6 14.1 (CH2CH3), 24.4,
25.4 (2 x CH3), 50.8 (NCH), 55.7 (NCH2), 57.9 (NCH2), 63.9 (CH2CH3), 67.6 (CH2Ph), 95.9 (=CH), 107.3 
(OCO), 128.3, 128.5, 128.6 (ArH), 135.7 (ArC), 149.1,155.0,160.2,165.2, 170.0 (4 X C(0)and=Q.
5,5-D im ethyl-l-[(3,3-dim etJiyI-5-oxo-2,4-diox-6-enyI)m ethyIJ-3"pyrazoIidinone-2-carboxyIic 
acid m ethyl ester (64). To a suspension of NaH (29 mg, 1.2 mmol) in THF (2 mL) was added dropwise atrt 
a solution of 61 (303 mg, 1.2 mmol) in THF (4 mL). After being stirred for 15 min, the resulting clear solution 
was cooled to 0 *C and a solution of MeC^CCN (306 mg, 3,6 mmol) in THF (1 mL) was added. The mixture 
was stirred at 0 *C for 15 min and an additional 2 h at rt and poured into aq satd NaCl (20 mL) and extracted with 
CH2CI2 (3 x 40 mL). The combined organic layers were dried (MgSC^), filtered and concentrated in vacuo. The 
residue was chromatographed (ethyl acetate) to give 64 (255 mg, 0.82 mmol, 68%) as white crystals, mp 116-117 
'C (ethyl acetate/hexane), R f  0.52. IR v 1790, 1735, 1720, 1635, 1310, 1285, 1015; *H NMR (200 MHz) 8
1.28 (s, 6 H, (CH-j^CC), 1.69 (s, 6 H, (CH3)2CO), 2.79 (s, 2 H, CH2), 3.45 (s, 2 H, CH2), 3.86 (s, 3 H, 
C02CH3), 5.60 (s, 1 H, =CH); 13C NMR (50 MHz) 8 24.8 (2 x CH3), 25.3 (2 x CH3), 42.9 (CH2), 53.6 
(NCH2), 53.8 (C02CH3), 61.6 (NC), 95.2 (=CH), 106.7 (OCO), 150.4,160.4,167.5,171.7 (3 x C(0)and=C); 
MS (El, 70 eV) m h  (relative intensity) 312 (M+, 7), 254 (48), 185 (100), 103 (20), 83 (41), 69 (27), 43 (27); 
HRMS calcd for C14H20N2O6 312.1321, found 312.1306.
re /-(3 S ,4 S )-l-B en zy l-4 -{ [(b en zy lo x y )ca r bony l]am ino}-3 -ethoxypyrazo lid ine-2 -car boxy lie 
acid ethyl ester (65). To a solution of 65 (130 mg, 0.33 mmol) were added at -40 *C NaBH4 (12 mg, 0.33 
mmol) and C eC lg^^O  (123 mg, 0.33 mmol). The solution was stirred at -40 *C for 1 h, while every 10 min a 
drop of a 2 M H2S 04/EtC)H solution was added. The solution was cooled to -78 #C, carefully acidified to pH » 3 
with a 2 M H2SO4/E1OH solution and stirred at rt for 2 h. The mixture was poured into aq satd NaHCC^ (50 
mL) and extracted with CH2CI2 (3 x 50 mL). The combined organic layers were dried (MgSC^), filtered, 
concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to give 65 (82 mg, 0.19 mmol, 58%) as a 
colorless oil, 1:5 mixture of cisjtrans-isomers, 0.35 and l-b e n z y l- l-{ 2-{[(benzyloxy)carbonyl]« 
am ino}-3-hydroxypropyl}-2-hydrazinecarboxylic acid ethyl ester (66) (11 mg, 0.027 mmol, 8%) 
as a colorless oil, R f  0.15. trans-6Si IR v 3430,1710,1510,1375,1080,1070,900,690; !H NMR (200 MHz)
8 (some signals appear as retainers) 1.17-1.26 (m, 6 H, 2 x CH2C//3), 2.98 (d, J  = 10.8 Hz, 1 H, NC//H), 3.18-
3.22 (d, J  = 10.6 Hz, 1 H, NCH//), 3.50-3.60 (m, 2 H, OC//2CH3), 3.70 (d, J  = 11.8 Hz, CHHPh), 4.05-4.20 
(m, 2 H, C(0)C//2CH3), 4.29 (br s, 1 H, NCH), 4.38 (d ,/ =  11.8 Hz, 1 H, CHHPh), 5.05 (s, 2 H, OCH2), 5.13 
(br d, 1 H, NH), 5.30 (s, 1 H, NCHO); 13C NMR (63 MHz) 8 14.5, 14.9 (2 x CH2CH3), 56.7 (NCH), 57.1 
(NCH2), 62.1, 63.4 (2 x CH2CH3), 64.2 (NCH2), 67.0 (OCH2), 92.3 (NCO), 127.6, 128.0, 128.2, 128.3,
128.5, 129.6 (ArH), 136.2,136.6 (ArC), 155.6, 156.2 (C(0)). cis-65: 13C NMR (63 MHz) 8 14.4, 14.9 (2 x 
CH2CH3), 52.5 (NCH), 57.0, 62.0, 63.3, 64.1, 66.7 (CH2), 85.1 (NCO), 127.6, 128.0, 128.1, 128.2, 128.3,
128.4, 128.6,129.5 (ArH), 136.1,136.5 (ArC), 155.5,156.2 (C(0)). 66: IR v 3430, 3340,1705, 1490,1360, 
1160, 690; !H NMR (200 MHz) 8 1.17 (s, J  = 7.1 Hz, 3 H, CH2C//3), 2.60-2.90 (m, 2 H, NCH2), 3.60-3.90 
(m, 5 H, NC//2, C//2OH and NCH), 4.06 (q, J  = 7.1 Hz, 2 H, Ctf2CH3), 5.09 (s, 2 H, OC//2Ph), 5.60 (br s, 1
H, NH), 5.95 (br s, 1 H, NH), 7.30-7.40 (m, 10 H, ArH).
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r0i - ( 3S ,4S ) - l - [ ( 3,3-D im ethy I-5 -oxo-2,4-d io x -6-e n y l)m e th y l]-4-{ [(b en zy lo x y )ca rb o n y l]- 
amino}-3-ethoxypyrazoIid ine-2-carboxylic acid ethyl este r (67). To a solution of 63 (237 mg, 
0.53 mmol) were added at -50 *C NaBify (40 mg, 1.06 mmol) and CeCl3*7H20 (197 mg, 0.53 mmol). The 
solution was stiired at -50 *C for 1 h, while every 10 min a drop of a 2 M I^ S O ^ tO H  solution was added. The 
solution was cooled to -78 °C, carefully acidified to pH « 3 with a 2 M ^ S O ^ tO H  solution and stiired at rt for
2 h. The mixture was poured into aq satd NaHCOg (50 mL) and extracted with CH2CI2 (3 x 50 mL). The 
combined organic layers were dried (MgSC^), filtered, concentrated in vacuo and chromatographed (ethyl 
acetate/hexane 4:1) to give 67 (60 mg, 0.13 mmol, 24%) as a colorless oil, 1:4 mixture of cis/trans-isomers, Rj- 
0.45 and l-{2-{[(benzyIoxy)carbonyl]am ino}-3-hydroxypropyI}-l-[(3 ,3 -d im ethy l-5-oxo-2 ,4- 
diox-6-enyl)m ethyl]-2-hydrazinecarboxylic acid ethyl ester (68) (90 mg, 0.20 mmol, 38%) as a 
colorless oil,/?ƒ 0.20. trcms-67: IR v 3340,1720,1710,1635,1160,690; JHNMR (200 MHz) 8 1.15-1.25 (m,
6 H, 2 x CH2Ctf3), 1.69 (s, 6 H, (CH3)2C), 3.22 (AB system, 2 H, NCH2), 3.39 (d, 7 = 14.7 Hz, 1 H, 
C//HPh), 3.50-3.75 (m, 2 H, OGf/2CH3), 3.88 (d, J  = 14.7 Hz, 1 H, CHtfPh), 4.08-4.19 (m, 2 H, 
C(0)C//2CH3), 4.30-4.40 (m, 1 H, NCH), 5.08 (s, 2 H, OCH^, 5.23 (br d, J  = 7.0 Hz, 1 H, NH), 5.32 (s, 1 H, 
NCHO), 5.53 (s, 1 H, =CH), 7.33 (s, 5 H, ArH); 13C NMR (63 MHz) 8 14.4,14.8 (2 x CH2CH3), 24.8, 25.2 
((CHj^C), 57.4 (NCH), 58.4 (NCH2), 61.0 (NCH2), 62.4, 63.5 (2 x CH2CH3), 67.0 (OCH2), 92.5 (NCO),
95.4 (=CH), 106.9 (OCO), 128.2, 128.3,128.5 (ArH), 136.0 (ArC), 155.6, 156.0, 160.8 166.4 (3 x C(0) and 
=C). cis-67: 13C NMR (63 MHz) 8 14.4, 14.8 (2 x CH2CH3), 24.8, 25.2 ((C T ^ C ), 52.5 (NCH), 58.4 
(NCH2), 61.6 (NCH2), 62.4, 63.9 (2 x CH2CH3), 67.2 (OCH2), 85.3 (NCO), 95.4 (=CH), 106.9 (OCO),
128.2, 128.3,128.5 (ArH), 136.0 (ArC), 155.6, 156.0,160.8 166.4 (3 x C(0) and=C). 68: IR v 3430, 3350, 
1720,1635,1505,1270,1240, 900,690; JH NMR (250 MHz) 8 1.21 (t, 7 = 7.1 Hz, 3 H, CH2Ctf3), 1.64 (s, 6
H, (CH3)2C), 2.80-2.91 (m, 1 H, NC//H), 3.10-3.20 (m, 1 H, NCH//), 3.51-3.80 (m, 5 H, NC//2, C //2OH and 
NC//), 4.09 (q, 7 = 7.1 Hz, 2 H, C//2CH3), 5.09 (s, 2 H, OCH2), 5.60 (br s, 1 H, NH), 6.60 (br s, 1 H, NH),
7.33 (s, 5 H, ArH).
5,5-D im  e th y l l- [ (3 ,3 -d im e  thy  I-5 -o x o -2 ,4 -d io x -6 -e n y I)m e th y l]-3 -e th o x y p y ra z o lid in e -2 -  
carboxylic acid m ethyl ester (69). To a solution of 64 (59 mg, 0.19 mmol) inEtOH (2 mL) were added at 
-20 *C NaBH^ (29 mg, 0.76 mmol) and a few drops of a 2 M solution of H2SO4 in EtOH. The mixture was 
stirred at -20*C for 2 h, cooled to -78 *C and acidified to pH « 2 by adding dropwise the ^SO^/EtOH solution. 
After being stirred at rt for 30 min, the mixture was poured into aq satd NaHCC>3 (20 mL) and extracted with 
CH2CI2 (3 x 20 mL). The combined organic layers were dried (MgSO^), filtered, concentrated in vacuo and 
chromatographed (ethyl acctate/hexane 1:1) to afford 69 (44 mg, 0.13 mmol, 68%) as white crystals, mp 115-116 
•c (ethyl acetate/hexane 1:1), R* 0.38. IR v 1720, 1700, 1635, 1445, 1370, 1110, 1080, 1025, 900; !H NMR 
(200 MHz) 8 1.02 (s, 3 H, CH3), 1.17 (t,7  = 7.1 Hz, 3 H, CH2CZ/3), 1.41 (s, 3 H, CH3), 1.67 (s, 3 H, CH3),
1.69 (s, 3 H, CH3), 2.05 (dd,7 = 4.7, 13.4 Hz, 1 H, CHC//H),2.31 (dd, 7=7.2,13.6 Hz, 1 H, CHCH//), 3.50-
3.75 (m, 4 H, NCH2 and CH2CH3), 3.73 (s, 3 H, C 02CH3), 5.55-5.60 (m, 1 H, CHO), 5.60 (s, 1 H, =CH); 
13C NMR (50 MHz) 8 14.8 (CH2CH3), 23.0 (CH3), 24.4 (CH3), 25.1 (CH3), 28.1 (CH3), 45.2 (CH2), 52.9 
(C02CH3), 54.8 (NCH2), 64.1 (CH2CH3), 65.8 (NC), 90.9 (OCH), 95.3 (=CH), 106.7 (OCO), 154.0, 161.0,
168.0 (2  x C(O) and =C); MS (El, 70 eV) m/z (relative intensity) 342 (M+, 15), 284 (100), 239 (50), 216 (100), 
159 (100), 113 (60), 103 (37), 43 (27); HRMS calcd for CjgH^NjOg 342.1791, found 342.1801; Anal. Calcd. 
forC16H22N20 6: C, 56.12; H, 7.65. Found: C, 55.75; H, 7.68.
r£ i-(35 ,45)-l-B enzy l-4 -[(acety l)am ino]-3-e thoxypyrazo lid ine-2-carboxylic  acid ethyl ester
(71). To a solution of 70 (11 mg, 0.026 mmol) were added at -78 *C TiCl4 (156 jiL of a 1.0 M solution, 0.156
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mmol) and AC2O (10 jjL, 0.103 mmol). The mixture was stirred 10 min at -78 fC and 1 h at rt. The mixture was 
poured into aq satd NaHCC>3 (10 mL) and extracted with CH2CI2 (3 x 10 mL). The combined organic layers were 
dried (MgSC>4), filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:1) to afford 71 (4 mg, 
0.012 mmol, 46%) as a colorless oil, R f  0.30. JHNMR (200 MHz) 5 1.21 (t, J  = 7.0 Hz, 3 H, CH2C//3), 1.29 
(t, J  = 7.0 Hz, 3 H, CH2C//3), 1.92 (s, 3 H, C(0)CH3), 2.99 (d, J  = 10.8 Hz, 1 H, NCHH), 3.25 (dd, J  = 5.6,
10.8 Hz, 1 H, NCH//), 3.55-3.70 (m, 4 H, C//2Ph and OC//2CH3), 4.10-4.30 (m, 2 H, C//2CH3), 4.46 (t, /  =
5.5 Hz, 1 H, NCH), 5.27 (s, 1 H, NCHO), 5.87 (d, J  = 5.8 Hz, 1 H, NH), 7.30-7.38 (m, 5 H, ArH); 13C NMR 
(63 MHz) 8 14.5, 14.9 (2 x CH2CH3), 23.0 (C(0)CH3), 55.1 (NCH), 56.9, 62.1, 63.3, 64.3 (4 x  CH2), 91.9 
(NCO), 127.7,128.4,129.7 (ArH), 136.5 (ArC).
P yrazoline 74. To a solution of 67 (30 mg, 0.063 mmol) in CH2CI2 (1 mL) were added at 0 *C BF3*OEt2 
(40 jjL , 0.31 mmol) and acetic anhydride (18 |iL, 0,19 mmol). The mixture was stirred at 0 *C for 15 min and for
3 h at rt and poured into aq satd NaCl (10 mL) and extracted with CH2CI2 (3 x 20 mL). The combined organic 
layers were dried (MgSO^), filtered, concentrated in vacuo and purified by flash chromatography (ethyl acetate) to 
afford 74 (7 mg, 0.020 mmol, 32%) as a colorless oil, R f  0.20. IR v 3460, 1760, 1720, 1630, 1400, 1370, 
1020; JH NMR (200 MHz) 8 1.32 (t, J  = 7.1 Hz, 3 H, CH2Ctf3), 1.71 (s, 6 H, (C H ^C ), 3.26 (s, 2 H, 
NCH2), 3.75 (d, J  = 14.2 Hz, 1 H, NC//H), 3.84 (d, J  = 14.2 Hz, 1 H, NCH//), 4.15-4.30 (m, 2 H, C//2CH3), 
4.60-4.70 (m, 1 H, NCH), 5.72 (s, 1 H, =CH), 6.27 (br s, 1 H. NH), 6.53 (d, J  = 7.0 Hz, OCH); 13C NMR (50 
MHz) 8 14.4 (CH2CH3), 24.5 (CH3), 25.5 (CH3), 59.6 (NCH), 59.7 (NCH2), 60.7 (NCH2), 63.2 (CH2CH3),
89.4 (NCO), 95.2 (=CH), 107.1 (OCO), 152.0, 156.9,160.9, 166.6 (3 x C(0) and =C); MS (El, 70 cV) m lz  
(relative intensity) 242 ((M-99), 7), 225 (67), 172 (100), 156 (25), 137 (22), 73 (14).
l,8 -D iaza-7 ,7 -d im eth y lb icy cIo [3 .2 .1 ]o c tan » 3 « o n e-8 -carb o x y lic  acid  m ethyl es te r (75). A 
solution of 69 (77 mg, 0.23 mmol) was stirred in HCOOH (2 mL) at 100 *C for 5 h. Concentration in vacuo and 
purification by flash chromatography (ethyl acetate/hexane 1:1) afforded 75 (15 mg, 0.066 mmol, 29%) as a 
colorless oil, R f  0.28. IR v 1720, 1690; JH NMR (200 MHz) 8 1.18 (s, 3 H, CH3), 1.61 (s, 3 H, CH3), 1.69 
(d, J  = 12.8 Hz, 1 H, H6end0), 2.24 (dd, J  = 7.8, 12.8 Hz, 1 H, H6ex0), 2.42 (d, J  = 16.6 Hz, 1 H, H4), 2.78 (dd, 
J=  3.2, 16.3 Hz, 1 H, H4), 3.63 (s, 2 H, 2 x H2), 3.76 (s, 3 H, C02CH3), 4.75-5.00 (m, 1H, H5).
Cyclization p roduct 76. To a solution of 69 (1.57 g, 4.59 mmol) in CH2CI2 (50 mL) was added atO #C 
BFyOEt2 (2.26 mL, 18.4 mmol). The mixture was stirred at 0 ‘C for 10 min and for 18 h at rt. The mixture was 
poured into aq satd NaCl (100 mL) and extracted with CH2CI2 (3 x 100 mL). The combined organic layers were 
dried (MgSC>4), filtered and concentrated in vacuo. The residue was chromatographed (ethyl acetate/hexane 1:1) to 
give 76 (1.44 g, 4.86 mmol, 94%) as a colorless oil that solidified upon standing, mp 106-107 *C (ethyl 
acetate/hexane),/?ƒ 0.36. IR v 1720, 1645, 1420, 1370, 1290; ]H NMR 8 1.22 (s, 3 H, CH3), 1.34 (s, 3 H, 
CH3), 1.63 (s, 3 H, CH3), 1.66 (s, 3 H, CH3), 1.98 (d, J  = 11.5 Hz, 1 H, H ó ^ ,  2.12 (dd, ƒ = 6.0,12.0 Hz, 1
H, H6exo), 3.44 (d, J  = 18.9 Hz, 1 H, H2), 3.76 (s, 3 H, C02CH3), 3.90 (br d, J  = 19 Hz, 1 H, H2), 5.10 (br s,
1 H, H5); *3C NMR 8 (some signals appear as rotamers) 23.2,25.8,26.5, 32.1 (CH3), 49.7, 50.3, 51.2 (br, C2 
and C6), 51.7 (C5), 53.1 (C02CH3), 66.8, 67.6 (C7), 107.1,107.6 (OCO and C4), 155.0,158.3,161.7 (C3 and
2 x C(O)); MS (El, 70 eV) mlz (relative intensity) 296 (M+, 15), 238 (100), 210 (30), 155 (66), 109 (25), 80 
(12); HRMS calcd for C14H20N2O5 296.1372, found 296.1369; Anal. Caled for C ^ H jq N ^ :  C, 56.76; H, 
6.76. Found: C, 56.35; H, 6.76.
D iazepine 77. A solution of 76 (100 mg, 0.34 mmol) in THF (2 mL) was added to a solution of Na (31 mg,
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1.35 mmol) in NH3 (15 mL) at -78 *C. The mixture was stirred at -78 *C for 3 h, quenched by addition of NH4CI 
(182 mg, 3.4 mmol) and the ammonia was allowed to evaporate. The residue was dissolved in H2O (20 mL) and 
extracted with CH2CI2 (3 x 20 mL). The combined organic layers were dried (MgSO^), filtered, concentrated i n 
vacuo and chromatographed (ethyl acetate/hexane 4:1) to afford 76 (12 mg) and 77 (12 mg, 0.040 mmol, 16% 
(after correction)) as a white solid, mp 157-159 'C .R ,  0.20. IR v 3440,1720,1640,1500,1270; *HNMR (250 
MHz) 5 1.17 (s, 3 H, CH3), 1.21 (s, 3 H, CH3), 1.61 (s, 3 H, CH3), 1.65 (s, 3 H, CH3), 1.68 (d, J  = 14.9 Hz,
1 H, C//H), 1.77 (br s, 1 H, NH), 2.22 (dd, J = 7.8, 14.9 Hz, 1 H, CHfl), 3.44 (d, J  = 18.7 Hz, 1 H, NCtfH), 
3.61 (d, J = 18.7 Hz, 1 H, NCH//). 3.65 (s, 3 H, C 02CH3), 4.86 (br t, J  = 7.8 Hz, 1 H, NCH), 5.70 (br d, J  =
7.8 Hz, 1 H, NH); 13C NMR (63 MHz) 8 24.3, 25.5, 27.8, 31.7 (4 x CH3), 43.6,44.5 (NC and CH2), 45.0 
(NCH), 52.0 (C02CH3), 52.1 (NCH2), 105.3, 107.2 (OCO and C3), 155.9, 161.1, 168.8 (2 x C(0) and C4); 
MS (El, 70 eV) mlz (relative intensity) 298 (M+, 7), 223 (50), 183 (17), 165 (100), 150 (25), 71 (30), 58 (85).
Hydrazine 78. To a solution of 76 (700 mg, 2.36 mmol) in MeCN (3 mL) was added Me^Sil (403 pL, 2.83 
mmol) and the mixture was stirred at 40 *C for 2 h. It was poured into aq satd NaHSOg (50 mL) and extracted 
with CH2Cl2 (3 x 50 mL). The combined organic layers were dried (K2CO3), filtered, concentrated in vacuo and 
chromatopgraphed (acetone) to afford 78 (550 mg, 2.31 mmol, 98%) as a colorless oil that solidified upon 
standing, mp 150-160 ‘C (decomposes before melting), Rj? 0.30. IR v 3295, 1710, 1640, 1420, 1295, 1110, 
1030, 890; ¡H NMR (200 MHz) 8 1.21 (s, 3 H, CH3), 1.34 (s, 3 H, CH3), 1.64 (s, 6 H, 2 x CH3), 1.91 (dd ,/ 
= 5.8, 12.2 Hz, 1 H, H6ex0), 2.06 (d, J  = 12.2 Hz, 1 H, H ó , ^ ,  3.41 (d, J  « 18.8 Hz, 1 H, H2), 3.81 (d, J  =
18.7 Hz, 1 H, H2), 4.16 (d. J  = 5.7 Hz, 1 H, H5), 4.20 (br s, 1 H, NH); 13C NMR (50 MHz) 8 23.3, 26.2,
26.5, 32.6 (CH3), 51.5, 51.6 (C2 and C6), (53.2 (C5), 66.2 (C l), 106.5 (OCO), 107.9 (C4), 159.0,162.6 (C3 
and C(0)); MS (El, 70 eV) mlz (relative intensity) 238 (M+, 7), 180 (67), 152 (20), 97 (45), 70 (17), 43 (18). 
HRMS calcd for C12HlgN20 3 238.1317, found 238.1313; Anal. Caled, for C12H18N20 3: C, 60.49; H, 7.61; 
N, 11.76. Found: C, 60.36; H, 7.72; H, 11.69.
N-M ethyl hydrazine 79. To a solution of 78 (600 mg, 2.52 mmol) in MeCN (6 mL) were added 37% aq 
formaldehyde (1.01 mL, 12.3 mmol) and N aB^CN  (253 mg, 4.03 mmol). After being stirred for 15 min at rt, 
glacial acetic acid was added carefully until the pH was neutral. Stirring was continued for 45 min, while the pH 
was kept neutral by dropwise addition of glacial acetic acid. The solution was poured into 1 N KOH (40 mL) and 
extracted with CH2CI2 (3 x 50 mL). The combined organic layers were washed with H2O (30 mL), dried 
(K2CO3), Filtered, concentrated in vacuo and chromatographed (ethyl acetate) to afford 79 (570 mg, 2.26 mmol, 
90%) as a white solid, mp 64.5-66.5 #C (ethyl acetate), R f  0.20. IR v 1715, 1640, 1415, 1400, 1380, 1370, 
1290,1265,1100; !H NMR (200 MHz) 8 1.28 (s, 3 H, CH3), 1.38 (s, 3 H, CH3), 1.69 (s, 6 H, 2 x CH3), 1.94 
(d ,/=  11.9 Hz, 1 H, H6endo), 2.33 (dd, J  = 6.1, 12.2 Hz, 1 H, H6exo), 2.66 (s, 3 H, NCH3), 3.31 ( d , /=  19.3 
Hz, 1 H, H2), 3.75 (d, J  = 19.2 Hz, 1 H, H2), 3.91 (d, J  = 6.0 Hz, 1 H, H5); 13C NMR (50 MHz) 8 23.7, 26.2,
27.4, 33.6 (4 x CH3), 38.8 (NCH3), 56.7 (C5), 65.0 (C7), 105.4, 106.4 (OCO and C4), 159.4, 161.9 (C3 and 
C(O)); MS (El, 70 eV) mlz (relative intensity) 252 (M+, 30), 194 (100), 166 (27), 111 (86), 83 (26), 43 (17); 
HRMS calcd for C13H20N2O3 252.1474, found 252.1479.
3 -B en zo y Io x y -7 ,7 ,8 -trim eth y l-l,8 -d iazab icy c lo [3 .2 .1 ]o c t-3 -en e-4 -carb o x y lic  acid  m ethyl 
ester (81). A solution of 79 (13 mg, 0.052 mmol) and MeOH (18 pL, 0.5 mmol) in xylenes (0.5 mL) was 
heated at 170 *C for 10 min in a sealed tube. The mixture was concentrated in vacuo to afford 3 -oxo-7,7,8- 
trim ethyl-1,8-diazabicyclo[3.2.l]octane-4-carboxylic acid methyl ester (80) (10 mg) as a light 
yellow oil. ’h  NMR (200 MHz) 8 1.27 (s, 3 H, CH3), 1.35 (s, 3 H, CH3), 1.86 (d, /  = 11.7 Hz. 1 H, H ö ^ ,^ ,
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2.27 (dd, J  * 6.2, 11.9 Hz, 1 H, H6ex0), 2.64 (s, 3 H, NCH3), 2.82 (d, / =  3.8 Hz, 1 H, H4), 3.34 (d, J  »  19.2 
Hz, 1 H, H2), 3.76 (s, 3 H, C 02CH3), 3.82 (d, J  = 19.2 Hz, 1 H, H2), 3.83 (dd, ƒ = 6.1, 3.8 Hz, 1 H, H5). The 
crude residue was dissolved in CH2CI2 (1 mL) and treated with benzoyl chloride (6.5 pL, 0.056 mmol) and Et3N 
(8 jiL, 0.057 mmol) at 0 *C. The mixture was stirred at 0 #C for 10 min and 5 h at rt and concentrated in vacuo. 
Flash chromatography (ethyl acetate/hexane 4:1) afforded 81 (12 mg, 0.036 mmol, 70%) as a colorless oil, Rj- 
0.35. 1HNM R(200M Hz)6 1.39 (s, 3 H, CH3), 1.45 (s, 3 H, CH3),2.01 (d, /  = 11.8 Hz, 1 H, H6), 2.30 (dd, 
J=  6.5, 11.8 Hz, 1 H, H6), 2.74 (s, 3 H, NCH3), 3.45 (d, /  = 19.7 Hz, 1 H, H2), 3.59 (s. 3 H, C 02CH3), 3.82 
(d, J = 19.9 Hz, 1 H, H2), 4.04 (d, J  = 6.5 Hz, 1 H, H5), 7.40-7.60 (m, 3 H, ArH), 8.06-8.11 (m, 2 H, ArH); 
13C NMR (63 MHz) 8 26.6, 33.1 (2 x CH3), 36.5 (NCH3), 45.6 (C6), 51.2 (C2), 51.7 (C02CH3), 59.7 (C5),
65.3 (C7), 120.0 (C4), 128.6, 129.8, 133.7 (ArH), 128.9 (ArC), 152.0 (C3), 164.0,164.2 (C(O)); MS (El, 70 
cV) m/z (relative intensity) 330 (M+, 20), 169 (20), 105 (100), 77 (21); HRMS calcd for C18H22N20 4
330.1580, found 330.1579.
(3-Hydroxy-7,7,8-trimethyl-l ,8-diazabicyclo[3.2.1]octane-4-carboxylic acid methyl ester 
(82). A solution of 79 (13 mg, 0.052 mmol) and MeOH (18 jjL, 0.5 mmol) in xylenes (0.5 mL) was heated at 
170 °C for 10 min in a sealed tube and concentrated in vacuo to afford 80 (10 mg) as a light yellow oil. The crude
residue was dissolved in MeOH (1 mL) and treated at 0 #C with NaBH4 (12 mg, 0.32 mmol). After being stirred
1 '
at 0 °C for 3 h, the solution was poured into H20  (5 mL) and extracted with CH2CI2 ( 3 x 5  mL). The combined 
organic layers were dried (MgSC^), filtered, concentrated in vacuo and chromatographed (acetone) to afford 82 (9 
mg, 0.038 mmol, 73%) as a colorless oil, R t  0.30. IR v 3600, 1705, 1430, 1290, 1060, 900; JH NMR (200 
MHz) 8 1.35 (s, 3 H, CH3exo), 1.51 (s, 3 H, CH3endo), 1.98 (dd, J  = 7.8, 12.5 Hz, 1 H, H6exo), 2.26 (d, J  =
12.5 Hz, 1 H, H6endo), 2.66 (s, 3 H, NCH3), 3.05 (t, J  = 4 Hz, 1 H, H4), 3.12 (d, J = 16.2 Hz, H2), 3.43 (dd, J 
= 5.3, 16.3 Hz, 1 H, H2), 3.47 (dd, J  = 7.6, 2.6 Hz, 1 H, H5), 3.73 (s, 3 H, C 02CH3), 3.79 (br s, 1 H, OH),
4.09 (t, J  = 4.9 Hz, 1 H, H3); 13C NMR (63 MHz) 8 24.4, 33.1, 34.9 (3 x CH3), 40.2 (C4), 42.8 (C6), 45.2 
(C2), 51.9 (C02CH3), 58.5 (C5), 62.6 (C3), 63.2 (C7), 174.3 (C(0)); MS (El, 70 eV) m/z (relative intensity) 
227 (M+-l, 18), 171 (M+-57, 36), 122 (25), 105 (100), 77 (37).
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CHAPTER 6
SYNTHESIS OF BICYCLIC PYRAZOLIDINONES 
VIA EXOCYCLIC N -ACYLHYDRAZONIUM IONS1
6 .1 INTRODUCTION
Functionalized bicyclic pyrazolidines have found widespread use in physical2 and 
biological applications.3 Common syntheses of these compound classes include condensations 
of pyrazolidines and hexahydropyridazines with a,co-dihalides,4 a,co-diacylhalides5 or a,co­
diesters,5 a , (3-unsaturated aldehydes,6 a , p-unsaturated esters7 or a , p-unsaturated acylhalides.8 
Some more recently developed sequences will be detailed in the sequel.
One interesting class of compounds consists of the so-called bimanes,9 which can be 
divided in symmetrical (syn-2) and asymmetrical (anti-2) compounds (eq 6.1). In contrast with 
the tram- isomers, the syn-isomers exhibit a strong fluorescence in solution, thus rendering them 
very useful in biochemical investigations.10
K2CO3 or
■ ■ ■  \
/-Pr2NEt
CH3 + h3C (eq 6.1)
1 syn-2 anti-2
The synthesis of bimanes has been described extensively9 and starts from a suitable 
pyrazolinone. For example, if 1 is treated with a base, a mixture of symmetrical and 
asymmetrical bimanes 2 is obtained in a ratio that is strongly dependent of the base that is used 
The desired syn-bimane can be obtained in large excess if K2CO3 is used.
Comparable saturated pyrazolopyrazoles (e.g. 5) axe obtained via the so-called ‘criss­
cross’ cycloaddition reaction of aldazines (condensation products of hydrazine with two identical 










Me02C COgM© (eq 6.2)
3 4 5
An example is shown in eq 6.2, in which reaction of benzaldazine (3) with one equiv of methyl 
acrylate affords the dipolar species 4, which will give a cycloaddition reaction with a second
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molecule of methyl acrylate to give the diadduct 5 . This reaction proceeds with high 
regioselectivity to the ‘iratts’-products.
As an application of the 1,3-dipolar cycloaddition reaction, the stable ylide 6 , obtained 
by a condensation of the corresponding pyrazolidinone with formaldehyde, was reacted with 
several symmetric and asymmetric acetylenes to afford the [3.3.0] pyrazolidinones 7 as shown
in eq 6.3.12
R02C - - = - - R ’
O 6 O 7 C02R
R = allyl, r-Bu, Me
R’ -  H, C02Me, Ph, CH2OH
The antibacterial acitivity of some of these compounds has already been described in
Section 1.3.3. Via a different route various other functionalized [3.3.0] pyrazolidinones could be 
obtained (Scheme 6, l ).13
Schem e 6.1
X
NH PO3R2 / ' '•N '''VY ' X Of-BocNH—< .1... ---------------► /-BocNH»-f 1 I uNH
0
c i - ^ v 0
NH P03R2 ,-pr2NEt (1 equiv)




o 0 ^ C 0 2ally! O C02allyl
10 11
The pyrazolidinone 8 was reacted with the phosphonate to give the 1,4-addition product 
9. Treatment of 9 in a one-pot procedure with allyloxalyl chloride and 2 equiv of i-P^NEt 
afforded the bicyclic hydrazine 11 via an intramolecular Wadsworth-Homer-Emmons reaction. 
The intermediacy of the initial product 10 was proven by treatment of 9 with allyloxalyl chloride 
and only one equiv of i-P^NEt.
Upon use of a comparable methodology, the corresponding [4.3.0] pyrazolidinones 
(e.g. 14, Scheme 6.2) could also be synthesized.14 The alkylated pyrazolidinone 12 afforded 
after treatment with NaH and the sulfoxide the bicyclic system 13. Elimination of the sulfoxide 
with DBU led to the desired bicyclic [4.3.0] pyrazolidinone 14.
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A novel method for the preparation of both simple and methoxycarbonylated bicyclic 
[3.3.0] and [4.3.0] pyrazolidinones is presented in this Chapter. A short outline of the method is 
shown in a retrosynthetic way in eq 6.4.
/" N  Nuc „ / " N  Ni
’  y . 4  X \ .N H
°  17 R
Nuc (eq 6.4)
In contrast with the method described in Chapter 4, exocyclic N-acylhydrazonium ions 
16 are the intermediates that are expected to react intramolecularly to give the fused hydrazines 
15. Via this method not only the bicyclic hydrazines (15, R = H) should be accessible, but also 
the corresponding bicylic a-hydrazino acid derivates (15, R -  CO2CH3) that are obtained if the 
precursors 17 contain a one carbon moiety with both a methoxycarbonyl substituent and a good 
leaving group. The starting compounds for this sequence are the alkylated pyrazolidinones 18 
that have been described in Section 4.2.
6 .2 SYNTHESIS OF BICYCLIC HYDRAZINES
The precursors 19-22 (Table 6.1) were obtained in a similar way as described in Section
2.4 for the acyclic hydrazines. Upon use of identical conditions (NaH (1.1 equiv), DMF then 
chloromethyl methyl ether (1.5 equiv), 0 °C -» rt), moderate to good yields of the desired 
products were obtained* Use of other bases or solvents did not lead to more satisfactory results. 
A side reaction that is probably responsible for the somewhat disappointing yields is reaction at 
oxygen, which was also encountered in the reactions with methyl chloroformate (see: Section
4.3). The resulting products however, could not be traced after the reaction.
The precursors were subjected to the Lewis acids TiCl^ (2 equiv, -78 *C —> rt) for the 
non-activated nucleophiles 19 and 20 (entries 1 and 3), and BF3*OEt2 (2 equiv, 0 °C —» rt) for 





Table 6.1. Cyclizations to bicyclic hydrazines.
























24 X = Cl (76%)








a) 50 °C, 17 h. b) 25 °C, 17 h. c) 25 °C, 5 h.
The results of these reactions are summarized in Table 6.1. Most of the Lewis acid- 
promoted cyclizations occurred in good yields to give the expected products. In the case of the 
prenyl precursor 20 (entry 3) treatment with TiCl4 did not only give the expected product 24 but 
also a small amount of the elimination product 25. Surprisingly, this is the thermodynamically 
less favored product. The formic acid cyclizations gave, without exception, excellent yields of 
the desired products. In contrast with other type of N-acylhydrazonium ion cyclizations (see
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Sections 2.6 and 4.3), the formic acid cyclizations provided better yields than the Lewis acid 
cyclizations. The transition state of the cyclization is visualized in eq 6.5 for the allylsilane 21. 
The six-membered ring is likely to adopt a chair-like conformation 29 , which will react 






In situ generation of the N-acylhydrazonium ion, starting from the pyrazolidinone 3 0 (eq 
6.6) led to the phthalazine derivative 23. 1,3,5-Trioxane in HCOOH15 was used to form the 
hydrazonium intermediate, which cyclized under rather harsh conditions (80 °C, 18 h) in a 
reasonable yield.
1,3,5-trioxane (1.5 equiv)
— ........ ' .............
HCOOH, 80 °C, 18 h
(eq 6,6)
2 3 (66%)
In addition to the precursors shown in Table 6.1, also the allyl- and methally 1-substituted 
pyrazolidinones were treated with Lewis and protic acids, but cyclization products were only 
obtained in very small quantities (< 5%), independent of the acid that was used. Conversion of 
the methoxy group into a chloride did not give better results either. A possible explanation for 
this problem will be detailed in Section 6.3.
6.3 S YNTHESIS OF BICYCLIC a-HYDRAZINO ACID DERIVATIVES
In analogy with the synthesis of cyclization precursors starting from alcohols16 or the 
corresponding pyrrolidinones,17 the a-methoxycarbonylated precursors 33 might be accessible 
via an addition reaction with methyl glyoxylate. The reaction is shown in eq 6.7.
N' R HCOC02CH3*H20  or
31
HC0C02CH3 (2 equiv), 
PhHorPhCH3,rt 0
Ac20  (5 equiv),
Y ° H DMAP (cat), 





Condensation of the pyrazolidinone 31 with methyl glyoxylate hydrate18 or anhydrous 
methyl glyoxylate19 yielded the corresponding stable hydroxy compounds 32 upon stirring at 
room temperature. The hydroxy compounds 32 were converted without any further purification 
into the acetates 33 by treatment with an excess of acetic anhydride (DMAP (cat), pyridine, 18 
h). As shown in Table 6.2, all reactions occurred in reasonable to good overall yields.
These results sharply contrast with the outcome of the attempts to add glyoxylate to the 
acyclic hydrazides under similar circumstances (Section 2.7). This is probably due to the less 
electronegative amine nitrogen atom in the present case, leaving the amide nitrogen atom 
sufficiently nucleophilic to react with methyl glyoxylate.
Table 6 ,2 . Cyclizations to bicyclic a-hydrazino acid derivatives.
cyclization 




























39 X = Cl (36%) 4 0 (20%)




4 2 (69%) 
42(21%)
C02Me
4 3 (68%) 
4 3 (54%)
a) 50 °C, 18 h. b) 25 °C, 40 h. c) 25 °C, 5 h.
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The cyclization reactions were carried out under the same conditions as described in 
Section 6.2 and the results are summarized in Table 6.2. Generally, it can be concluded that the 
Lewis acid cyclizations give better yields than the formic acid cyclizations. In the case of the 
prenyl precursor 35 (entries 3 and 4), mixtures of the cis~ and products were obtained. 
This can be rationalized by looking at the possible conformations leading to the transition states 
(Scheme 6.3). Cyclization can either take place via the boat-like conformation 44 or the chair- 
like conformation 45. In both cases, the iminium double bond has the (Z)-geometry to avoid 
pseudo-allylic 1,3-strain.1 Cyclization in a 5-exo fashion via the chair-like conformation 
45 will then lead to the #mv~product 46 which is trapped by a nucleophile. On the other hand,
5-£Jtocyclization can also proceed via the boat-like conformation 44, giving the intermediate co­
product 47. The positive charge can be stabilized by the formation of the dioxycarbenium ion 
48, eventually leading to the lactone 40. Such a mechanism explains the formation of an excess 








The ira/w-relationship of both substituents was secured by an X-ray crystallographic 
analysis of 39 as depicted in Fig 6.1. As a result of the strain in the fused system, the amide 
nitrogen atom is slightly deformed from planarity.
Fig 6 .1 .  Chem3D view of the bicyclic pyrazolidinone 39.
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The /ra/tf-relationship in the corresponding formate 41 was deduced by comparison of 
the coupling constants of the a-methine protons of 39 and 41 (39: 4.60, d, V  = 5.2 Hz; 41: 
4.61, d, 3/  = 4.9 Hz; whereas for 40: 5.01, d, 3/  = 9.1 Hz).
Both six-membered rings 38 and 42 were obtained in reasonable yields under Lewis 
acidic conditions (entries 1 and 5). These results form a remarkable contrast with cyclizations 
carried out under identical circumstances with the precursors 49-51 (Chart 6.1, yields are 
shown in parentheses). Treatment with TiCl4 (2 equiv, -78 "C —> rt) afforded the cyclization 
products 52-54 in reproducibly low yields. Several Lewis and protic acids were tried but did 
not give better results. The suggestion that the gem-dimethyl function might be responsible for 
the low yields could be excluded as cyclization of the unsubstituted precursor 51 also proceeded 
in very low yield. The stereochemistry of the products 52 and 54 was concluded from the 
coupling constants of the (axial) protons adjacent to the chlorine atoms, showing two axial-axial 
and two axial-equatorial couplings (e.g. 54, 4.04 ppm, tt, J^m  =11.6 Hz, 3/ ^  = 4.5 Hz). The 




49 R = H, R' -  Me (71%) 52 (6%) 
5 0 R = R' = Me (86%)
51 R = R' = H (60%)
53 (8%) 54 (6%)
A difference with the six-membered rings mentioned in Table 6.2 is that in the latter cases 
the initially formed positive charge is neither well-stabilized, nor quickly neutralized via facile 
formation of an olefin or an aromatic system. Possibly, the low yields are due to a highly 
strained transition state, caused by the presence of the pyrazolidinone moiety. This explanation is 
in accordance with high yields of comparable cyclization reactions, in which the pyrazolidinone 
part is absent from the molecule (see: Section 7.4).
The cyclizations of both silanes 36 and 37 with formic acid (entries 6 and 8) afforded the 
desired products 42 and 43 in relatively poor yields. When the reactions were carried out at 
higher temperatures, protodesilylation became a major side reaction.
A better yield of the bicyclic aliene 43 was obtained by using BF3*OEt2- Upon treatment 
of 43 with a strong base (DBU (1 equiv), -78 *C rt), isomerization led to the unstable 
conjugated product 55, which resembles biologically active bicyclic pyrazolidinones (eq 6.8).^  
Reaction at low temperature afforded a mixture of starting material and product, whereas only at 
room temperature a complete conversion into the conjugated system 55 could be effected.
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Application of other bases (LDA, KOr-Bu, NaH) did not lead to product 55 but to intractable 
material.
Synthesis of bicyclic pyrazolidinones
DBU (1 equiv)
- ........




6 .4 SYNTHESIS OF 5,7-BICYCLIC PYRAZOLIDINONES
Cyclization of a pyrazolidinone with a 4-butenyl substituent would lead to fused 5,7- 
bicyclic pyrazolidinones. Because cyclization of unsubstituted butenyl precursors did not give 
the desired products, the phenyl substituted precursor 58 was subjected to the cyclization 
conditions. A route that leads to this precursor is provided by work of Dorn,21 who studied 
Grignard additions to ylides such as 57.
1 )  « ^ M g c i  ( 1  e q u i v )
NH PhCHO (1 equiv), "  THF,0°C-»rt
(eq 6.9)
pTSA (cat), Y  2) 6 M HC1
toluene, reflux
57 (89%) 58 (45%)
The ylide 57 was obtained by acid-catalyzed condensation of 3-pyrazolidinone 56 with 
benzaldehyde (eq 6.9). Subsequent reaction with allylmagnesium chloride gave the addition 
product 58 after acidic work-up.
SnC  ^(2 equiv),
■ ■■
CH2CI2, ~78 °C —m
CO2M6
59 (45%) 60 (18%)
(eq 6.10)
The glyoxylate addition occurred in moderate yield, probably as a result of the sterically 
crowded environment of the nitrogen atom. The best cyclization result was obtained with SnCl^ 
which afforded the bicyclic product 60 as a single isomer in a yield of 18% (eq 6.10). The 
relative configuration of 60 was not established. Cyclizations of similar precursors with a 
methoxy substituted phenyl group or a more highly substituted double bond did not provide any 




6 .5 ESTIMATION OF THE INVERSION BARRIERS OF 5,6-BICYCLIC HYDRAZINES
The *H and NMR spectra of the 5,6-bicyclic pyrazolidinones 23 and 27 taken at 
room temperature showed some very broad signals as a result of slow inversion of one of the 
nitrogen atoms. This inversion process is visualized in eq 6.11, showing the equilibrium 
between 27 and its ‘enantiomer’ 27 ’, This nitrogen inversion is attended with a chair-chair 




The inversion process can be followed by *H and NMR. At low temperature, slow 
exchange is taking place so that all hydrogen atoms in the *H NMR spectra are observed as 
sharp signals (Fig 6.2 and 6.3). At higher temperatures, fast exchange occurs, leading to signals 
of an ‘average’ structure. For example, the protons of the methylene groups of 27 (Fig 6.3) 
show separate signals at low temperature, whereas at higher temperatures they become 
equivalent. The temperature at which the conversion of two separate signals into one single 
signal is observed, is called the coalescence temperature (Tc). By determining the Tc of a signal, 
a quantitative estimation of AG$ of the inversion process can be made, according to the 
following equations. The rate constant k  is given by the Eyring equation:22
r>
Approximately, the rate constant k  at the coalescence temperature (kc ) is defined as:23
kc=  Av (eq 6.13)
in which Av is the frequency difference of the signals at slow exchange* Combination of 6.12 
and 6.13 will give the following equation for AG$:
AG* = RTAn - ~ c-  ~------ (eq 6.14)
c k -Na - h Av
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Fig 6 .3 . Selected parts of the AH NMR (250 MHz) spectra of pyrazolidinone 27 at various
temperatures in CyDg.
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If the appropriate values fori? (8.31 J’K '^m or1), NA (6.02-1023 mol"*) and h 
(6.63-10"34 J*s) are used, 4G^(kJ/mol) can be calculated according to:
AG* = 19.140-3>Tc(9.97 + log Tc - log Av ) (eq 6.15)
Of both compounds 23 and 27, *H NMR spectra were recorded at various temperatures 
in CyDg (250 MHz) in order to determine the coalescence temperature of some signals. The data 
of 23 and 27 for three signals are shown in Table 6.3.
Table 6.3. Coalescence data of 23 and 27.
23 8 (ppm) Av (Hz) Tc ( K) AG^kJ/mol) 27 8 (ppm) Av (Hz) Tc (K) AG*(kJ/mol)
1.23 119 273 53.9 1.16 88 273 54.5
3.65 52 263 53.6 2.28 69 276 55.7
4.77 291 283 53.8 3.06 127 278 54.8
Although estimating the height of the inversion barriers via the coalescence temperature is 
not a very precise method, the average value of the three signals might give a reasonable value 
for the A G$. A more reliable outcome might have been obtained if the coalescence measurements 
were performed at different frequencies.
Assuming that the error in Tq is ± 2 K (which is a lower value), the error in AG$ will be 
± 0.4 kJ/mol. The average value for 23 is then 53.8 ± 0.4 kJ/mol and for 27 55.0 ± 0.4 kJ/mol 
(12.9 ± 0.1 and 13.1 ± 0.1 kcal/mol respectively). This means that 27 has a slightly higher 
inversion barrier than 23.
6.6 CONCLUSIONS
*
In this Chapter, an efficient method for the synthesis of bicyclic hydrazines and a- 
hydrazino esters via exocyclic N-acylhydrazonium intermediates is detailed. Introduction of the 
appropriate nucleophilic side chains gave rise to both 5,5- and 5,6-bicyclic pyrazolidinones. The 
5,6-bicyclic systems were formed in low yields if the initially formed cation was not properly 
stabilized by a substituent and subsequently converted into a double bond by a fast elimination 
process. The synthesis of one 5,7-bicyclic pyrazolidinone was achieved via this method, albeit 
in a rather low yield.
In accordance with cyclizations mentioned in Chapters 2 and 4, the Lewis acids TiCl  ^
and BF3*OEt2 afforded the best results. Remarkably, in the case of the unsubstituted exocyclic 
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6.7 EXPERIMENTAL SECTION
General information: for experimental details, see: Section 2,11.
General procedure A for the reactions with chloromethyl methyl ether. Sodium hydride (purchased 
as a 55% dispersion in oil) was washed prior to use with pentane, removing the pentane by syringe after the 
sodium hydride had settled. The dry solid was then mixed with DMF and the hydrazide, dissolved in DMF was 
added drop wise to the suspension at rt. After being stirred for 15 min at rt, the resulting clear solution was cooled 
to 0 °C and a solution of chloromethyl methyl ether in DMF was added. After being stirred for 15 min at 0 *C and
3 h at rt, the mixture was poured into aq satd NaCl, extracted with 1,1,1 -trichloroethane (6 x), dried (MgSO^), 
filtered and concentrated in vacuo. The residue was subjected to flash chromatography to afford the pure hydrazides.
l-B en zy l-5 ,5 ~ d im eth y l-2 -(m eth o x y m eth y l)-3 -p y ra zo lid in o n e  (19). According to the general 
procedure A, 1-benzyl-5,5-dimethyl-3-pyrazolidinone (500 mg, 2,45 mmol) was depmtonated with NaH (65 mg,
2.70 mmol) and alkylated with chloromethyl methyl ether (220 nL* 2,97 mmol), while all compounds were 
dissolved in DMF (5 mL), Work-up and flash chromatography (ethyl acetate/hexane 1:2) afforded 19 (523 mg,
2.11 mmol, 86%) as a colorless oil, Rf  0.35. IR v 3085, 3060, 3030,1690, 1450,1370, 1070, 690; XHNMR 
(200 MHz) 8 1.26 (s, 6 H, (CH3)2C), 2.47 (s, 2 H, C(0 )CH2), 3.29 (s, 3 H, OCH3), 4.01 (s, 2 H, CH2Ph),
4.35 (s, 2 H, NCH2), 7.20-7.40 (m. 5 H, ArH).
5.5-D im ethyl-2-(m ethoxym ethyl)-l-(3-m ethyl-2-butenyl)-3-pyrazoIidinone (20). According to 
the general procedure A, 5,5-dimethyl-l-(3-methyl-2-butenyl)-3-pyrazolidinone (385 mg, 2,12 mmol) was 
deprotonated with NaH (56 mg, 2.33 mmol) and chloromethyl methyl ether (240 jxL, 3.16 mmol), all compounds 
dissolved in DMF (5 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) afforded 20 (166 mg, 
0.73 mmol, 35%) as a colorless oil, R* 0.30. IR v 1685, 1450, 1405, 1370, 1305, 1245, 1090, 1070, 910; *H 
NMR (200 MHz) 8 1.26 (s, 6 H, (C f^ C ) , 1.62 (s, 3 H, CH3), 1.71 (s, 3 H, CH3), 2.40 (s, 2 H, CCOJCHj), 
3.39 (s, 3 H, C 02CH3), 3.52 (d, J  = 6.8 Hz, 2 H, NCH2), 4.76 (s, 2 H, OCH2), 5.29 (tt, J  = 1.4,6.8 Hz, 1 H, 
=CH).
5 .5 - D im e t h y l - 2 - ( m e t h o x y m e t h y l ) - l - { 2 - [ ( t r im e t h y ls i ly l ) m e t h y l ] - 2 - p r o p e n y I } “3- 
pyrazolidinone (21). According to the general procedure A, 5,5-dimethyl-l-{2-[(trimethylsilyl)methyl]-2- 
propenyl} -3-pyrazolidinone (931 mg, 3.88 mmol) was treated with NaH (105 mg, 4.37 mmol) and chloromethyl 
methyl ether (480 |JL, 6,25 mmol), all compounds dissolved in DMF (5 mL). Work-up and flash chromatography 
(ethyl acetate/hexane 1.2:1) afforded 21 (585 mg, 2.06 mmol, 53%) as a yellowish oil, Rj- 0.35. IR v 3075,
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1690, 1370, 1245,1070, 850; JH NMR (250 MHz) 6 0.02 (s, 9 H, (CH3)3Si), 1.25 (s, 6 H, (C H ^C ), 1.68 (s, 
2 H, CH2Si), 2.39 (s, 2 H, C(0)CH2), 3.28 (s, 2 H, NCH2), 3.37 (s, 3 H, OCHj), 4.64 (br s, 1 H, =CWH),
4.70 (s, 2 H, OCH2), 4.85 (d,J=  1.5 Hz, 1 H, =CHH).
5 ,5 -D im eth y l-2 -(m eth oxym eth y l)-l-[4 -(tr im eth y lsn yI)-2 -b u tyn y l]-3 -p yrazoIid in on e (22). 
Following the general procedure A, 5,5-dimethyl-l-[4-(trimethylsilyl)-2-butynylj-3-pyrazolidinone (200 mg, 0.84 
mmol) was treated with NaH (22 mg, 0.92 mmol) and chloromethyl methyl ether (107 jiL, 1,27 mmol), all 
compounds dissolved in DMF (2 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:2) afforded 22 
(127 mg, 0.45 mmol, 54%) as a colorless oil, R f  0.30. IR v 2200, 1685, 1400, 1370, 1250, 1075, 850; JH 
NMR (200 MHz) S 0.05 (s, 9 H, (CH3)3Si), 1.29 (s, 6 H, (CH3)2C), 1.43 (t, /  = 2.4 Hz, 2 H, CH2Si), 2.57 (br 
s, 2 H, C(0)CH2), 3.71 (br s, NCH^, 4.80 (s, 2 H, OCH^.
M ethyl glyoxylate hydrate. ^  To a solution of dimethyl L-tartrate (9.85 g, 55.3 mmol) in ether (100 mL)
was added at 5 'C periodic acid (12.9 g, 56.4 mmol) in portions during 1 h. The white mixture was stirred until 
the ether layer turned colorless and a white solid precipitated. The white solid was filtered off and the ether layer 
was dried (CaC^), filtered, concentrated in vacuo and distilled to give methyl glyoxylate hydrate (7.25 g, 68.4 
mmol, 62%) as a colorless oil, bp 70-80 °C (14 mm).
M ethyl g lyoxylate. ^  A mixture of the methyl hemiacetal of methyl glyoxylate (1 equiv) and P2O5 (1 equiv) 
was distilled to give anhydrous methyl glyoxylate (50-90%) as a colorless oil, bp 40-43 #C (20 mm).
General procedure B for the reactions with methyl glyoxylate or methyl glyoxylate hydrate.
To a solution of the alkylated pyrazolidinone in benzene or toluene was added at rt an excess of freshly distilled 
methyl glyoxylate (hydrate). After complete reaction (according to TLC), the solution was concentrated in vacuo, 
taken up in pyridine and treated with an excess of acetic anhydride and a catalytic amount of DMAP. After being 
stirred at rt for 18 h, the dark brown solution was concentrated in vacuo and purified by flash chromatography to 
afford the pure product.
a-A cetoxy-l-benzyl-5 ,5-d im ethyl-3-pyrazolid inoneacetic acid methyl ester (34). According to 
the general procedure B, a solution of 1-benzyl-5,5-dimethyl-3-pyrazolidinone (374 mg, 1.83 mmol) in benzene 
(20 mL) was treated with methyl glyoxylate hydrate (409 mg, 3.86 mmol) and acetylated with Ac^O (0.86 mL,
9.15 mmol) in pyridine (20 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) afforded 34 (433 
mg, 1.30 mmol, 71%) as a colorless oil, R f  0.45. IR v 1750,1705,1370,1230,1040, 955,690; *HNMR (200 
MHz) 5 1.15 (s, 3 H, CH3), 1.20 (s, 3 H, CH3), 2.07 (s, 3 H, C(0)CH3), 2.21 (d, J  = 16.4 Hz, 1 H, 
C(0)C//H), 2.69 (d, J  = 16.5 Hz, 1 H, C(O)CHW), 3.82 (s, 3 H, C02CH3), 4.14 (d, J  = 14.4 Hz, 1 H, NCWH),
4.24 (d, J  = 14.5 Hz, 1 H, NCIW), 6.45 (s, 1 H, NCH), 7.23-7.38 (m, 5 H, ArH); 13C NMR (50 MHz) 8 20.5 
(CH3), 24.7 (CH3), 27.6 (CH3), 41.1 (C(0)CH2), 52.7 (C02CH3), 58.0 (CH2Ph), 63.0 (NC), 76.4 (NCH),
127.2,128.2,128.4 (ArH), 138.2 (AiC), 164.9,169.4,173.5 (3 x C(0)).
a-A cetoxy-5,5-dim ethyl*‘l-(3 -m eth yl-2 -b u ten yl]-3 -p yrazo lid in on eacetic  acid methyl ester  
(35 ). Following the general procedure B, a solution of 5,5-dimethyl-l-(3-methyl-2-butenyl)-3-pyrazolidinone 
(5.00 g, 28.0 mmol) in toluene (100 mL) was treated with methyl glyoxylate (5.86 g, 66 mmol) and acetylated 
with Ac20  (10.5 mL, 110 mmol) in pyridine (75 mL), Work-up and flash chromatography (ethyl acetate/hexane 
1:2) afforded 35 (8.47 g, 27 mmol, 97%) as a colorless oil, R f  0.30. IR v 1750,1705,1435,1370,1230,1040,
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960; XH NMR (200 MHz) 8 1.15 (s, 3 H, CH3), 1.35 (s, 3 H, CH3), 1.62 (s, 3 H, CH3), 1.69 (s, 3 H, CH3),
2.11 (s, 3 H, C(0)CH3), 2.15 (d, J  = 16.4 Hz, 1 H, C(0)CWH), 2.60 (d, J  = 16.4 Hz, 1 H, C(0)CHH), 3.40-3.65 
(m, 2 H, NCH2), 3.76 (s, 3 H, C02CH3), 5.28 (l, J  = 7.4 Hz, 1 H, =CH), 6.56 (s, 1 H, NCH).
a-A cetoxy-5 ,5-d im ethyM -{2-[(trim ethyIsiIyI)m ethyl]-2-propeiiy l}-3-pyrazoH dinoiieacetic
acid  m eth y l e s te r  (3 6 ) . Following the general procedure B, a solution of 5,5-dimethyl-1-{2- 
[(trimethylsilyl)methyl]-2-propenyl}-3-pyrazolidinone (453 mg, 1,89 mmol) in benzene (20 mL) was treated with 
methyl glyoxylate hydrate (717 mg, 6.76 mmol) and acetylated with Ac^O (0.89 mL, 9.45 mmol) in pyridine (8 
mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1) afforded 36 (443 mg, 1.25 mmol, 66%) as a 
colorless oil./Jr 0.45. IR v 3070,1750,1705,1435,1370,1245,1225, 1040, 855; ^ N M R  (250 MHz) 8 0.02 
(s, 9 H, (CH3)3Si), 1.21 (s, 3 H, CH3), 1.27 (s, 3 H, CH3), 1.48 (d. J  = 13.5 Hz, 1 H, O/HSi), 1.67 (d, J  =
13.5 Hz, 1 H, CH//Si), 2.10 (s, 3 H, C(0)CH3), 2.17 (d ,/=  16.4 Hz, 1 H, C(0)C«H), 2.62 (d ,/  = 16.4 Hz, 1
H, C(O)CHW), 3.43 (s, 2 H, NCH2), 3.76 (s, 3 H, C 02CH3), 4.66 (br s, 1 H, =C//H), 4.89 (d ,/=  1.5 Hz, 1 H, 
=CHH), 6.44 (s, 1 H, NCH); 13C NMR (50 MHz) 8 -0.4 ((CH3)3Si), 20.5 (CH3), 23.8 (CH2Si), 24.1 (CH3),
27.2 (CH3), 41.1 (C(0)CH2), 52.6 (C02CH3), 60.2 (NCH2), 62.5 (NC), 76.3 (NCH), 110.7 (=CH2), 143.2 
(=C), 164.7, 169.4,173.4 (3 x C(O)).
a-Acetoxy-5,5-dim  ethyl-l-[4-(triinethyIsiIyl)-2-butynyI}-3«pyrazolidinoneacetic acid methyl
ester (37). According to the general procedure B, a solution of 5,5-dimethyl-l-[4-(irimethylsilyl)-2-butynyl]-3- 
pyrazolidinone (400 mg, 1,68 mmol) in benzene (5 mL) was treated with methyl glyoxylate hydrate (356 mg, 
3.36 mmol) and acetylated with AC2O (0.80 mL* 7.26 mmol) in pyridine (7 mL). Work-up and flash 
chromatography (ethyl acetate/hexane 1:2) afforded 37 (556 mg, 1.51 mmol, 90%) as a colorless oil, /?ƒ 0.30. IR 
v 2200, 1755, 1710, 1370, 1250, 1040, 850; XH NMR (200 MHz) 8 0.05 (s, 9 H, (C H ^Si), 1.13 (s, 3 H, 
CH3), 1.39 (s, 3 H, CH3), 1.42 (t, J  = 2.4 Hz, 2 H, CH2Si), 2.12 (s, 3 H, C(0)CH3), 2.15 (br s, 1 H, 
C(0 )C//H), 3.0 (br s, 1 H, C(0)CH//), 3.50 (dt, J  = 18.6, 2.3 Hz, 1 H, NC//H), 3.75 (s, 3 H, C 02CH3), 3.84 
(d,7= 18.6 Hz, 1 H, NCH//), 6.77 (s, 1 H, NCH).
General procedure C for the cyclization reactions with T iC l^  To a 0.1 M solution of the hydrazide 
in CH2CI2 was added T1CI4 (2 equiv, as a solution of TiC^ in CH^C^) at -78 *C by a syringe. The mixture was 
stirred at -78 *C for 15 min and for 5-18 h at rt. The reaction mixture was poured into cold aq satd NaHCC^ and 
the resulting suspension was filtered over Celite and extracted with CH2CI2 (3 x). The combined organic layers 
were dried (MgSC^), filtered and concentrated in vacuo. Purification of the residue by flash chromatography 
afforded the pure cyclization produces).
2 ,3 -D ih yd ro -3 ,3 -d im eth y l-ltf-p yrazo lo [l,2 -£ ]p h th a laz in -l-on e  (23). According to the general 
procedure C, a solution of 19 (322 mg, 1.30 mmol) in CH2CI2 (8 mL) was treated with TiCl4 (2.16 mL of a 1.2 
M solution, 2.60 mmol). Work-up and flash chromatography (ethyl acetate) afforded 23 (275 mg, 1.27 mmol, 
98%) as white crystals, mp 78-79 'C (ether/hexane 10:1), *ƒ  0.30. IR V 3060, 1670, 1430, 1410, 1250, 1120. 
890; ’h  NMR (200 MHz) 8 1.39 (br s, 6 H, (CH,)2C), 2.47 (br s, 2 H, C(0)CH2), 3.92 (br s, 2 H, NCH2),
4.75 (br s, 2 H, NCH2), 7.07-7.26 (m, 4 H, ArH); %  NMR (250 MHz, -40 *C, C?Dg, see Fig 6.2) 8 0.98 (s, 3
H, CH3), 1.33 (s, 3 H, CH3), 2.17 (d, /  = 16.3 Hz, 1 H, C(0 )C//H), 2.44 (d, J  = 16.3 Hz, 1 H, C(O)CHH),
3.41 (d, J = 13.2 Hz, 1 H, NCHH), 3.55 (d, J = 13.2 Hz, 1 H, NCHtf), 4.31 (d, J  = 16.5 Hz, 1 H, NCHH), 5.44 
(d, J  = 16.6 Hz, 1 H, NCH//), 6.80-7.22 (m, 4 H, ArH); 'h  NMR (250 MHz, 60 ‘C, C7Dg) 8 1.23 (s, 6 H, 
(CH3)2C), 2.27 (s, 2 H, C(0)CH2), 3.65 (s, 2 H, NCH2), 4.77 (s, 2 H, NCH2), 6.90-7.20 (m, 4 H, ArH); 13C
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NMR (50 MHz) 8 41.8 (C(0)CH2), 42.9 (NCH2), 51.2 (NCH2), 59.2 (NC), 125.8,126.6,127.2,127.5 (ArH),
130.9, 132.2 (AiC), 170.6 (C(0)); 13C NMR (63 MHz, -30 'C) 8 22.2 (CH3), 28.3 (CH3), 40.8 (C(0)CH2),
42.1 (NCH2), 50.8 (NCH2), 58.8 (NC), 125.3, 126.1, 126.8, 127.1 (ArH), 130.0, 131.4 (ArC), 170.3 (C(0)); 
MS (El, 70 eV) mlz (relative intensity) 216 (M+, 62), 201 (100), 118 (13), 104 (45); HRMS calcd for
c 13h 16N2 °  216.1263, found 216.1274; Anal. Calcd. for C13H16N20: C, 72.19; H, 7.46; N, 12.95. Found: C, 
72.10; H, 7.49; N, 12.86.
2,3-Dihydro>3,3-dimethyl-lAr-pyrazolo[l,2-ft]phthalazin>l>one (23) Absolution of 19 (268 mg,
1.08 mmol) in HCOOH (10 mL) was stirred at 50 *C for 17 h. Concentration in vacuo and purification by flash 
chromatography (ethyl acetate) afforded 23 (122 mg, 0.56 mmol, 52%) as a white solid, üy*0.30.
6 -(l-C h lo ro -l-m eth y le th y l)te tra h y d ro -3 ,3 -d im eth y U l//,5 tf-p y ra zo lo [l,2 -fl]p y ra zo l-l-o n e  
(24). According to the general procedure C, a solution of 20 (69 mg, 0.31 mmol) in CH2CI2 (3 mL) was 
treated with TÍCI4 (0.50 mL of a 1.2 M solution, 0,61 mmol). Work-up and flash chromatography (ethyl acetate) 
afforded 6-(l-m ethylethenyl)tetrahydro-3,3-d im ethyM /J,5//-pyrazolo[l>2-fi]pyrazoI-l-one (25) 
(10 mg, 0.052 mmol, 17%) as a colorless oil, /?ƒ 0.40 and 24 (49 mg, 0.21 mmol, 76%) as white crystals, mp 
91-92.5 -C (ether), R ,  0.30. 25: IR v 1680,1450,1360; *H NMR (200 MHz) 5 1.29 (s, 3 H, CH3), 1.30 (s, 3 
H, CH3), 1.72 (s, 3 H, CH3), 2.38 (d, J  = 16.7 Hz, 1 H, C(O)CHH), 2.52 (d, J  = 17.4 Hz, 1 H, C(0)CHH),
2.61 (t, J  = 8.0 Hz, 1 H, NCHH), 2.75-2.90 (m, 1 H, CH), 2.97 (t, J  = 7.4 Hz, 1 H, NCHH), 3.25-3.55 (m, 2 
H, NCH2), 4.80 (br s, 2 H, =CH2); 13C NMR (63 MHz) 8 20.4, 24.4,27.3 (3 x CH3), 44.4,45.4 (C(0)CH2 
and NCH2), 47.7 (CH), 51.5 (NCH2), 57.4 (NC), 111.9 (= 0 ^ ), 142.7 (=C), 175.0 (C(0)); MS (El, 70 eV) 
mlz (relative intensity) 194 (M+, 40), 179 (65), 11 (40), 83 (30), 67 (40), 56 (40); HRMS calcd for Cn HlgN20  
194.1419, found 194.1402. 24: IR v 1660, 1450,1360; JH NMR (200 MHz) 8 1.32 (s, 6 H, (CH3¿C), 1.54 
(s, 3 H, CH3), 1.55 (s, 3 H, CH3), 2.38 (d, J  = 16.6 Hz, 1 H, C(0)CHH), 2.51 (d, J  = 17.2 Hz, 1 H, 
C(0)CHH), 2.61 (t, J  = 8.0 Hz, 1 H, NCHH), 2.75-2.90 (m, 1 H, CH), 2.97 ( t , /=  7.4 Hz, 1 H, NCHH), 3.37 
(br dd, J  = 9.2, 11.1 Hz, 1 H, NC//H), 3.66 (dd, J=  6.3,11.3 Hz, 1 H, NCHH); 13C NMR (50 MHz) 8 24.1,
27.9, 31.1 (4 x CH3), 43.5, 43.8 (NCH2 and C(0)CH2), 49.6 (NCHj), 57.3 (NC), 69.7 (CC1), 175.0 (C(0)); 
MS (E l,70 eV) mlz (relativeintensity) 230(M+, 50), 215 (100), 179 (30), 147 (30), 127 (40), 111 (45),83 (40), 
69 (60); HRMS calcd for Cn H19N2OCl 230.1185, found 230.1181; Anal. Calcd. for Cn H19N2OCl: C, 57.26;
H, 8.30; N, 12.14. Found: C, 57.18; H, 8.38; N, 12.03.
6 -[l-(F orm yloxy)-l-m eth y leth y l]tetrah yd ro-3 ,3 -d im eth y l-lH ,5J /-p yrazo lo [l,2 -fl]p yrazo l-l-  
one (26). A solution of 20 (82 mg, 0.36 mmol) in HCOOH (4 mL) was stirred at rt for 17 h. Concentration 
in vacuo and flash chromatography (ethyl acetate) afforded 26 (83 mg, 0.35 mmol, 96%) as white crystals, mp 
65-67 'C (ether), Rf  0.15. IR v 1680,1660,1360; *H NMR (200 MHz) 8 1.26 (s, 6 H, (CH3)2C), 1.46 (s, 3 H, 
CH3), 1.47 (s, 3 H, CH3), 2.32 (d, J  = 17.1 Hz, 1 H, C(0)CHH), 2.45 (d, J  = 17.1 Hz, 1 H, C(0)CHH), 2.41-
2.49 (m, 1 H, NCHH), 2.69-2.87 (m, 2 H, NCHH and CH), 3.23-3.33 (m, 1 H, NCHH), 3.48-3.57 (m, 1 H, 
NCHH), 7.89 (s, 1 H, CHO); XH NMR (250 MHz, C7Dg, 80 -C) 8 1.24 (s, 3 H, CH3), 1.30 (s, 3 H, CH3),
I.46 (s, 3 H, CH3), 1.47 (s, 3 H, CH3), 2.26 (d, J  = 16.8 Hz, 1 H, C(0)CHH), 2.36 (d, J  = 17.0 Hz, 1 H, 
C(O)CHH), 2.51 (t, J  = 8.1 Hz, 1 H, NCHH), 2.67 (t, J  = 8.1 Hz, 1 H, NCHH). 2.76-2.88 (m, 1 H. CH), 3.42 
(dd, J = 9 .2,11.4 , 1  H, NCHH), 3.55 (dd, J  = 6.4,11.4,1 H, NCHH), 7.80 (s, 1 H, CHO); 13C NMR (63 MHz) 
8 24.3, 24.4, 26.1, 27.8 (4 x  CH3), 42.5 (C(0)CH2), 43.4 (NCH2), 48.3 (NCH2), 51.6 (CH), 57.1 (NC), 82.0 
(CO), 160.0,175.3 (C(0)); MS (El, 70 eV) mlz (relative intensity) 240 (M+, 60), 225 (60), 179 (40), 137 (30), 
111 (100), 83 (25), 69 (50); HRMS calcd for C ^ H ^ N -^  240.1469, found 240.1488.
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H exahydro-3,3-dim ethyl-6-m ethyIene-li/-pyrazoIo[l,2-tf]pyridazin-l-one (27). To a solution of
21 (312 mg, 1.10 mmol) in CH2CI2 (6 mL) was added at 0 *C BF3*OEt2 (270 jiL, 2.20 mmol) and the mixture 
was stirred at 0 'C for 15 min and for 3 h at rt. The solution was poured into aq satd NaCl (100 mL) and extracted 
with CH2CI2 (3 x 100 mL). The combined organic layers were dried (MgSO .^), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate) to give 27 (138 mg, 0.77 mmol, 71%) as a colorless oil, R f  0.30. IR v 1670, 
1415,1260,1115, 905; !H NMR (200 MHz) 5 1.28 (s, 6 H, (C H ^C ), 2.21 (t, J  = 5.8 Hz, 2 H, NCH2CH2),
2.42 (s, 2 H, C(0)CH2), 3.10-4.10 (br s, 2 H, NCff2CH2), 3.20 (s, 2 H, NCH2C=), 4.96 (s, 1 H. =CWH), 4.98 
(s, 1 H, =OW); JH NMR (250 MHz, -40 ‘C, C7Dg, see Fig 6.3) 8 0.98 (s, 3 H, CH3), 1.25 (s, 3 H, CH3),
1,93 (dd ,/=  3.3,13.4 Hz, 1 H, NCH2CHH), 2.07 (dt,7 = 5.8,12.4 Hz, 1 H,NCH2CHfl), 2.18 (d, J  = 16.5 Hz,
1 H, C(O)CtfH), 2,45 (d, J  = 16.5 Hz, 1 H, C(O)CHW), 2.73 (d, J  = 10.5 Hz, 1 H, NOfflC=), 2.92 (dt, J  = 3.9,
12.5 Hz, 1 H, NC//HCH2), 3.15 (d ,/=  10.6 Hz, 1 H, NCHtfC=), 4.46 (dd, J  = 5.5,12.5 Hz, 1 H, NCHtfCH2),
4.92 (s, 1 H, =CtfH), 4.98 (s, 1 H, =CHH); !H NMR (250 MHz, 60 'C, C?D8) 8 1.16 (s, 6 H, (C H ^C ), 2.07 
(t, J  = 6.0 Hz, 2 H, NCH20 / 2), 2.28 (s, 2 H, C(0)CH2), 3.06 (s, 2 H, NCH2C=), 3.61 (br s, 2 H, NC//2CH2),
4.90 (s, 1 H, =C//H), 4.93 (s, 1 H, =CH/Z); 13C NMR (50 MHz) 8 31.7 (NCH2CH,), 40.9 (NCH2CH2), 42.5 
(C(0)CH2), 55.7 (NCH2C=), 58.3 (NC), 112.4 (=CH2), 140.7 (=C), 170.6 (C(0)); 13C NMR (63 MHz, -30 *C) 
5 22.3 (CH3), 28.4 (CH3), 31.7 (NCH2CH2), 40.8 (NCH^Hj), 41.9 (C(0)CH2), 56.0 (NCH2C=), 58.5 (NC),
113.4 (=CH2), 139.9 (=C), 170.8 (C(O)); 13C NMR (63 MHz, 70 *C, C6D6) 8 25.1 ((CH3)2C), 32.2 
(NCH2CH2), 41.6 (NCH2CH2), 43.2 (C(0)CH2), 55.8 (NCH2C=), 58.2 (NC), 111.2 (=CH2), 142.7 (=C),
170.5 (C(O)); MS (El, 70 eV) m/z (relative intensity) 180 (M+, 24), 165 (96), 137 (15), 83 (24), 67 (63), 53
(58), 41 (100); HRMS calcd for C10H16N2O 180.1262, found 180.1267.
Hexahydro-3,3«dim ethyl-6-m ethyIene-l/f-pyrazolo[l»2-a]pyridazin-l'One (27). A solution of 21 
(300 mg, 1.06 mmol) in HCOOH (8 mL) was stirred at rt for 5 h. Concentration in vacuo and flash 
chromatography (ethyl acetate/hexane 1:1) afforded 27 (174 mg, 0.97 mmol, 91%) as a colorless oil, R j  0.10.
6-Ethenylidenetetrahydro-3,3-dim ethyM /?,5ff-pyrazolo[l,2-a]pyrazoI-l-one (28). To a solution 
of 22 (90 mg, 0.31 mmol) in CH2Cl2 (3 mL) was added atO fC BF3*OEt2 (79 pL, 0.63 mmol) and the mixture 
was stirred at 0 *C for 15 min and for 3 h at rt The solution was poured into aq satd NaCl (50 mL) and extracted 
with CH2CI2 (3 x 50 mL). The combined organic layers were dried (MgSO^), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1) to give 28 (49 mg, 0.28 mmol, 88%) as a colorless oil, Rjr 0.25. IR 
v 1960, 1680; ! H NMR (200 MHz) 8 1.31 (s, 6 H, (CH3)2C), 2.41 (s, 2 H, C(0)CH2), 3.38 (br s, 2 H, 
NCH2), 4.07 (br s, 2 H, NCH2), 4.89 (quintet, J  = 4.0 Hz, 2 H, =CH2); 13C NMR (50 MHz) 8 26.0 (br, 2 x 
CH3), 42.9 (C(O)CHo), 44.5, 51.3 (2 x NCH2), 57.2 (NC), 80.0 (=CH2), 98.4 (C=C=CH2), 176.8 (C(O)),
199.4 (C=C=CH2); 13C NMR (63 MHz, C7Dg, 90 'C) 8 27.3 (br, 2 x  CH3), 43.8 (C(0)CH2), 46.3, 52.7 (2 x 
NCH2), 58.1 (NC), 80.1 (=CH2), 101.1 (C=C=CH2), 178.0 (C(O)), 200.7 (C=C=CH2); MS (El, 70 eV) m lz  
(relative intensity) 178 (M+, 100), 163 (85), 135 (22), 95 (35), 83 (50), 66 (27), 39 (23); HRMS calcd for 
C10H14N2 °  178.1106, found 178.1102.
6-EthenyIidenetetrahydro-3,3-dim ethyl-lff,5tf-pyrazoIo[l,2-a]pyrazoM -one (28). A solution of
22 (88 mg, 0.31 mmol) in HCOOH (3 mL) was stirred at rt for 5 h. Concentration in vacuo and flash 
chromatography (ethyl acetate/hexane 1:1) afforded 28 (50 mg, 0.28 mmol, 94%) as a colorless oil, R j 0.25.
2 ,3 ,5 ,1 0 -T etra h y d ro -l,l-d m eth y N 3 “O xo-l//-pyrazoIo[l,2 -£jphthalazine-5-carboxylic  acid  
methyl ester (38). Following the general procedure C, a solution of 34 (112 mg, 0.336 mmol) in CH2CI2 (3
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mL) was treated with TÍCI4 (1,23 mL of a 1.2 M solution, 0.67 mmol). Work-up and flash chromatography 
(ethyl acetate) afforded 38 (63 mg, 0.23 mmol, 68%) as white crystals, mp 123-124 *C (ether/ethanol), Rjr 0.60. 
IR v 3030, 1745, 1680,1430,1260, 1220, 1000; XH NMR (250 MHz) 8 1.42 (s, 6 H, (CHfoC), 2.31 (d, J  =
16.4 Hz, 1 H, C(O)CZffl), 2.66 (d ,/ =  16.5 Hz, 1 H, C(0)CHH), 3.75 (s, 3 H. C02CH3). 3.92 (s, 2 H, NCH2),
5.76 (s, 1 H, NCH), 7.07-7.09 (m, 1 H, ArH), 7.21-7.26 (m, 2 H, ArH), 7.53-7.56 (m, 1 H, ArH); 13C NMR 
(50 MHz) 8 22.6 (CH3), 28.0 (CH3), 41.5 (C(0)CH2), 50.9 (NCH2), 52.6 (C02CH3), 54.1 (NCH), 59.5 (NC),
127.1, 127.3, 127.6,128.0 (ArH), 128.0,132.7 (ArC), 169.1, 170.4 (2 x  C(0)); MS (El, 70 eV) m/z (relative 
intensity) 274 (M+, 25), 259 (7), 215 (35), 199 (7), 173 (47), 131 (13), 116 (9), 40 (24), 32 (86); HRMS calcd 
for Cl 5H18N20 3 274.1317, found 274.1340.
2 ,3 ,5 ,10 -T etrah yd ro-l,l-d im eth y l-3 -oxo-l/7 -p yrazo lo [l,2~6]p h th a lazin e-5 -carb oxy lic  acid 
m ethyl ester (38). A solution of 34 (48 mg, 0.14 mmol) in HCOOH (2 mL) was stirred at 50 *C for 17 h. 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 38 (13 mg, 0.047 mmol, 
33%) as a white solid, Rjr 0.25,
r e /- ( lS ,2 lS )-2 -(l-C h loro-l-m eth y leth yI)tetrah yd ro-5 ,5 -d im eth y l-7 -oxo-ltf,5 //-p yrazo lo [l,2 -  
ajpyrazole-l-carboxylic acid methyl ester (39). According to the general procedure C, a solution of 35 
(220 mg, 0.705 mmol) in CH2CI2 (7 mL) was treated with TiCl  ^ (1.2 mL of a 1.2 M solution, 1.57 mmol). 
Work-up and flash chromatography (ethyl acetate/hexane 1:1) afforded 39 (73 mg, 0.25 mmol, 36%) as an 
inseparable mixture with 40 (34 mg, 0.14 mmol, 20%) as a colorless oil, Rjr 0.35. A small amount of 39 could 
be obtained in pure form after another purification by flash chromatography, which solidified upon standing, mp 
91-93 'C (ethyl acetate/hexane 1:5). 39: IR v 1750,1710; *HNMR (200 MHz) 8 1.32 (s, 3 H, CH3), 1.35 (s, 3 
H, CH3), 1.52 (s, 3 H, CH3), 1.61 (s, 3 H, CH3), 2.31 (d, / =  17.3 Hz, 1 H, C(0)C//H), 2.54 (d, J  = 17. 3 Hz,
1 H, C(0)CH/7), 2.64 (dd, J = 9.4, 8.0 Hz, 1 H, NCflH), 3.03-3.11 (t, /  = 8.0 Hz, 1 H, NCH// and ddd, J  = 9.5,
5.3, 7.8 Hz, 1 H, CH), 3.73 (s, 3 H, C02CH3), 4.60 (d. J  = 5.2 Hz, 1 H, NCH); 13C NMR (50 MHz) 8 23.5,
29.1, 31.5, 32.0 (4 x CH3), 41.7 (C(0)CH2), 51.0 (NCHj), 52.8 (C02CH3), 56.9 (NC), 57.5 (CH), 57.8 
(NCH), 69.9 (CC1), 171.0, 176.8 (2 x C(0)); MS (El. 70 eV) mlz (relative intensity) 288 (M+, 25), 273 (40), 
238 (20), 187 (20), 99 (100), 43 (40); HRMS calcd for C ^ j ^ C ^ C l  288.1240, found 288.1205. 40: *H 
NMR (200 MHz) 8 1.31 (s, 3 H, CH3), 1.35 (s, 3 H, CH3), 1.44 (s, 3 H, CH3), 1.49 (s, 3 H, CH3), 2.33 (d ,/  
= 17.7 Hz, 1 H, CHH), 2.49 (d, J = 17.2 Hz, 1 H, CHH), 2.45-2.52 (m, 1 H, NCWH), 2.91 (t, /  = 8.3, I H, 
CH), 3.09 (d, J = 9.8 Hz, 1 H, NCHH), 4.99 (d, 7= 9 .1  Hz, 1 H, NCH).
Crystallographic data of 39.
Monoclinic, P2X!c, a = 10.129(2), b = 16.521(1), c = 10.270(1) A, a  = 90', P = 119.237(8)\ y  = 90’, V = 
1499.7(4) A3, Z = 4, Dx = 1.28 gem'3, X(CuKa) = 1.5418 A, |i(CuKa) = 23.3 cm'1, F(000) = 616, rt. Final R
= 0.084 for 2402 observed reflections.








Table 6.4. Bond distances of the atoms (A), with standard deviations in parentheses.
CI-C9 1,836(5) C5-C9 1.542(8) C2-H22 1.09(6) C8-H83 1.05(3)
C1-C2 1.511(6) C6-C12 1.511(9) C4-H41 1.04(3) C10-H101 1.04(6)
Cl-Nl 1.371(6) C6-N1 1.426(6) C4-H42 1.07(4) C10-H102 0.99(3)
Cl-Ol 1.218(5) C9-C10 1.52(1) C5-H5 1.03(3) C10-H103 1.08(3)
C2-C3 1.527(7) C9-C11 1.581(6) C6-H6 1.08(4) C ll-H lll 0.97(3)
C3-C7 1.510(7) C12-02 1.21(1) C7-H71 1.04(3) C11-H112 0.97(6)
C3-C8 1.540(9) C12-03 1.297(8) C7-H72 1.06(4) C11-H113 1.01(6)
C3-N2 1.509(5) C13-03 1.59(1) C7-H73 1.06(5) C13-H131 1.11(7)
C4-C5 1.526(5) N1-N2 1.452(5) C8-H81 1.08(4) C13-H132 1.21(3)
C4-N2 1.484(7) C2-H21 1.06(5) C8-H82 1.05(3) C13-H133 1.10(4)
C5-C6 1.576(8)
Table 6.5. Bond angles of the atoms (*), with standard deviations in parentheses.
C2-C1-N1 107.2(4) C6-N1-N2 107.5(3) H71-C7-H72 125(3)
C2-C1-01 128.3(4) C3-N2-C4 116.8(4) H71-C7-H73 114(4)
Nl-Cl-Ol 124.4(4) C3-N2-N1 102.5(3) H72-C7-H73 101(4)
C1-C2-C3 104.3(4) C4-N2-N1 100.4(3) C3-C8-H81 106(3)
C2-C3-C7 115.7(5) C12-03-C13 104.0(7) C3-C8-H82 106(3)
C2-C3-C8 110.3(5) C2-C1-H22 44(2) C3-C8-H83 107(3)
C2-C3-N2 103.8(3) N1-C1-H22 111(4) H81-C8-H82 99(3)
C7-C3-C8 110.2(4) 01-C1-H22 110(3) H81-C8-H83 116(4)
C7-C3-N2 110.6(4) C1-C2-H21 111(3) H82-C8-H83 122(4)
C8-C3-N2 105.6(4) C1-C2-H22 63(5) C9-C10-H101 110(4)
C5-C4-N2 102.9(4) C3-C2-H21 117(2) C9-C10-H102 109(3)
C4-C5-C6 102.5(4) C3-C2-H22 115(5) C9-C10-H103 110(3)
C4-C5-C9 113.8(4) H21-C2-H22 127(6) H101-C10-H102 122(5)
C6-C5-C9 116.8(4) C5-C4-H41 111(2) H101-C10-H103 100(4)
C5-C6-C12 113.2(4) C5-C4-H42 108(2) H102-C10-H103 106(3)
C5-C6-N1 104.0(3) N2-C4-H41 107(3) C9-C11-H111 89(3)
C12-C6-N1 110.2(6) N2-C4-H42 101(3) C9-C11-H112 84(2)
C1-C9-C5 109.0(3) H41-C4-H42 125(3) C9-C11-H113 101(2)
C1-C9-C10 106.8(4) C4-C5-H5 111(2) H111-C11-H112 93(5)
C1-C9-C11 106.2(3) C6-C5-H5 105(3) H111-C11-H113 125(5)
C5-C9-C10 109.3(4) C9-C5-H5 108(3) H112-C11-H113 142(4)
C5-C9-C11 110.7(5) C5-C6-H6 95(3) 03-C13-H131 119(3)
C10-C9-C11 114.5(4) C12-C6-H6 115(3) 03-C13-H132 101(3)
C6-C12-02 123.8(5) N1-C6-H6 118(2) 03-C13-H133 89(3)
C6-C12-03 111.9(7) C3-C7-H71 103(3) H131-C13-H132 64(4)
02-C12-03 124.3(6) C3-C7-H72 106(3) H131-C13-H133 79(4)
C1-N1-C6 123.1(4) C3-C7-H73 105(2) H132-C13-H133 143(4)
C1-N1-N2 112.1(3) t
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re I- ( 1 5 ,2 5  ) - 2 - [ l - ( F o r  my lo x y ) - l - m e t h y le t h y  I] te trahydr o -5 ,5 -d im e  thy l - 7 « o x o - l i / ,5 / i -  
p yrazo lo [l,2 -a ]p yrazo le-l-carb oxyIic  acid methyl ester (41). A solution of 35 (200 mg, 0.64 
mmol) in HCOOH (6 mL) was stirred at rt for 40 h. Concentration in vacuo and purification by flash 
chromatography (ethyl acetate/hexane 1:1) afforded an inseparable mixture of 41 (101 mg, 0.34 mmol, 53%) and 
40 (29 mg, 0.12 mmol, 18%) as a colorless oil, Rjr 0.10. After recrystallization, 41 could be obtained in pure 
form as white crystals, mp 108-109 *C (ether). 41: IR v 1715,1460,1435, 1390, 1370,1260,1180,1140; *H 
NMR (200 MHz) 8 1.33 (s, 3 H, CH3), 1.37 (s, 3 H, CH3), 1.53 (s, 3 H, CH3), 1.60 (s, 3 H, CH3), 2.34 (d, J 
= 17.4 Hz, 1 H, C(O)CtfH), 2.55 (d, J  « 17.4 Hz, 1 H, C(0)CHfl), 2.49-2.54 (m, 1 H, NC//H), 2.98 (m, 2 H, 
NCHH and CH), 3.74 (s, 3 H, C 02CH3), 4.59 (d, J  = 4.9 Hz, 1 H, NCH), 7.91 (s, 1 H, CHO); 13C NMR (50 
MHz) 8 23.5, 24.4, 25.0, 29.0 (4 x CH3), 41.7 (CH2), 49.4 (NCH^), 52.7 (C02CH3), 56.4, 56.3 (2 x CH),
56.8 (NC), 81.6 (CO), 159.7, 170.9, 177.0 (3 x C(0)); MS (El, 70 eV) mlz (relative intensity) 298 (M+, 100), 
283 (83), 237 (34), 197 (37), 151 (17), 83 (20), 31 (40); HRMS calcd for C14H22N20 5 298.1529, found 
298.1519; Anal. Calcd. for C14H22N20 5: C, 56.36; H, 7.43; N, 9.39. Found: C, 56.22; H, 7.31; N, 9.26.
H exahydro-l,l-d im ethyl-7-m ethylene-3-oxo-ltf-pyrazolo[l,2«fl}pyridazine-5-carboxylic acid 
methyl ester (42). To a solution of 36 (98 mg, 0.28 mmol) in CH2CI2 (3 mL) was added at 0 *C BF3*OEt2 
(68 |iL, 0.55 mmol) and the mixture was stirred at 0 *C for 15 min and for 3 h at rt. The solution was poured into 
aq satd NaCl (50 mL) and extracted with CH2CI2 (3 x 50 mL). The combined organic layers were dried (MgSO^, 
filtered* concentrated in vacuo and chromatographed (ethyl acetate) to afford 42 (45 mg, 0.19 mmol, 69%) as 
white crystals, mp 65-66 "C (hexane), R r 0.30. IR v 3080,1740,1670,1435,1410,1270,1230,1050,910; JH 
NMR (250 MHz) 8 1.16 (s, 3 H, CH3), 1.27 (s, 3 H, CH3), 2.29 (d, J  = 16.5 Hz, 1 H, C(O)CHH), 2.32 (d, J  =
13.3 Hz, 1 H, CHC/7H), 2.54 (d, J=  16.6 Hz, 1 H, C(0)CHH), 2.85 (d, J  = 14.0 Hz, 1 H.CHCHH), 3.06 (d, J  =
10.8 Hz, 1 H, NC//H), 3.31 (d, J  = 10.7 Hz, 1 H, NCH//), 3.69 (s, 3 H, C 02CH3), 4.94-5.00 (m, 3 H, =CH2 
and NCH); 13C NMR (63 MHz) 8 22.2 (CH3), 27.8 (CH3), 32.6 (CHCH2), 42.7 (C(0)CH2), 52.1 (O ^C H ^,
52.3 (NCH), 55.1 (NCH2), 58.8 (NC), 114.2 (=CH2), 138.2 (=C), 169.5, 171.1 (2 x C(0)); MS (El, 70 eV) 
mlz (relative intensity) 238 (M+, 40), 223 (44), 179 (24), 163 (34), 137 (71), 41 (22); HRMS calcd for
C12H18N2°3  238.1317, found 238.1307; Anal. Calcd. for C12H18N20 3: C, 60.49; H, 7.61; N, 11.76. Found: 
C, 60.55; H, 7.68; N, 11.68.
H exah ydro-l,l-d im ethyI-7-m eth ylen e-3-oxo-l//-pyrazoIo[l)2-fl]pyridaziiie-5-carboxylic acid 
m ethyl ester (42). A solution of 36 (120 mg, 0.33 mmol) in HCOOH (3 mL) was stirred at rt for 5 h. 
Concentration in vacuo and flash chromatography (ethyl acetate) afforded 42 (16 mg, 0.067 mmol, 21%) as a 
white solid, /?ƒ 0.30.
2 -E th en ylid en etetrah yd rp -5 ,5 -d im eth y l-7 -oxo-l/f,5 //-p yrazo lo [l,2 -a ]p yrazo le-l-carb oxy lic  
acid m ethyl ester (43). To a solution of 37 (195 mg, 0.54 mmol) in CH2CI2 (5 mL) was added at 0 *C 
BF^-OEt2 (136 piL, 1.09 mmol) and the mixture was stirred at 0 *C for 15 min and for 3 h at rt. The solution 
was poured into aq satd NaCl (50 mL) and extracted with CH2CI2 (3 x 50 mL). The combined organic layers were 
dried (MgSO^, filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:1) to give 43 (85 mg,
0.36 mmol, 68%) as a colorless oil, R t  0.30. IR v 1960, 1730,1700,1430,1370, 1300, 1240, 990, 860; JH 
NMR (200 MHz) 8 1.32 (s, 3 H, CH3), 1.43 (s, 3 H, CH3), 2.45 (d, J  = 17.2 Hz, 1 H, C(0)C//H), 2.54 (d, J  =
17.2 Hz, 1 H, C(0)CHtf), 3.34 (dt, J  = 11.2, 4.0 Hz, 1 H, NCZ/H), 3.59 (dt, J=  11.2, 2.1 Hz, 1 H, NCH//),
3.76 (s, 3 H, C 02CH3) 5.02-5.08 (m, 3 H, =CH2 and NCH); 13C NMR (50 MHz) 8 23.2, 28.0 (2 x CH3),
43.4 (CH2), 50.6 (NCH2), 52.7 (C02CH3), 56.7 (NCH), 58.2 (NC), 81.6 (=CH2), 99.3 (C=C=CH2), 168.3,
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171.2 (2 x C(0)), 200.8 (C=C=CH2); MS (El, 70 eV) mlz (relative intensity) 236 (M+, 45), 221 (25), 204 (50), 
186 (55), 146 (100), 135 (50), 59 (35); HRMS calcd for C12H16N203 236.1161, found 236.1172.
2-E thei*ylideuetetrahydro-5,5-dim ethyl-7-oxo-lH ,5H “p yrazo l0 [l,2 -a ]p yrazo le-l-carb oxy lic  
acid methyl ester (43). A solution of 37 (220 mg, 0.60 mmol) in HCOOH (6 mL) was stirred at rt for 5 h. 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 43 (77 mg, 0.33 mmol, 
54%) as a colorless oil, Rjr 0.30.
a-Acetoxy-5,5-dimethyl- l-(2-propenyl)-3-pyrazoHdi!io i ieacetic  acid methyl ester (49).
According to the general procedure B, a solution of 5,5-dimethyl-l-(2-propenyl)-3-pyrazoIidinone (1.00 g, 6.49 
mmol) in benzene (25 mL) was treated with methyl glyoxylate hydrate (1.38 g, 13.0 mmol) and acetylated with 
Ac^O (3.07 mL, 32.5 mmol) in pyridine (20 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:2) 
afforded 49 (1.31 g, 4.61 mmol, 71%) as a colorless oil, /?ƒ 0.50. IR v 3080, 1760, 1750, 1435, 1370, 1230, 
1140; JH NMR (200 MHz) 8 1.17 (s, 3 H, CH3), 1.32 (s. 3 H, CH3), 2.13 (s, 3 H, C(0)CH3), 2.14 (d, J  = 16.4 
Hz, 1 H, C(0)CHH), 2.58 (d, J  = 16.4 Hz, 1 H, C(0)CHH), 3.51 (dd, ƒ = 6.6,15.2 Hz, I H, NCHH), 3.65 (dd, 
J  = 7.0,15.2 Hz, NCHH), 3.77 (s, 3 H, C 02CH3), 5.18-5.32 (m, 2 H, =CH2), 5.84-6.05 (m, 1 H, =CH), 6.60 
(s, 1 H, NCH),
a-Acetoxy-5,5-dimethyl-l-(2-methyN2-propenyI)-3-pyrazolidinoneacetic acid methyl ester
(50). Following the general procedure B, a solution of 5,5-dimethyl-l-(2-methyl-2-propenyl)-3-pyrazolidinone 
(655 mg, 3.90 mmol) in benzene (25 mL) was treated with methyl glyoxylate hydrate (826 mg, 7.80 mmol) and 
acetylated with Ac20  (1.85 mL, 19.5 mmol) in pyridine (20 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 1:2) afforded 50 (1.00 g, 3.36 mmol, 86%) as a colorless oil, /?ƒ 0.50. IR v 3070, 1750, 1705, 
1435, 1370, 1225, 1040, 900; %  NMR (200 MHz) 8 1.20 (s, 3 H, CH3), 1.27 (s, 3 H, CH3), 1.75 (s, 3 H, 
CH3), 2.13 (s, 3 H, C(0)CH3), 2.17 (d, J  = 16.4 Hz, 1 H, C(O)CWH), 2.66 (d, / =  16.4 Hz, 1 H, C(0)CHH),
3.55 (s, 2 H, NCH2), 3.78 (s, 3 H, C02CH3), 4.85 (s, 1 H, =CHH), 4.95 (s, 1 H, =CHff), 6.51 (s, 1 H, NCH).
a-Acetoxy-l-(2-propenyl)-3-pyrazoIidinoneacetic acid methyl ester (51). According to the general 
procedure B, a solution of l-(2-propenyl)-3-pyrazolidinone (300 mg, 2.38 mmol) was treated with methyl 
glyoxylate (419 mg, 4.76 mmol) in toluene (10 mL) and acetylated with Ac20  (1.12 mL, 11.9 mmol) in pyridine 
(10 mL). Work-up and flash chromatography (ehtyl acetate/hexane 1:1) afforded 51 (363 mg, 1.42 mmol, 60%) as 
a colorless oil, fly 0.35. IR v 3080, 1750,1710, 1365,1225, 1050,900; rH NMR (200 MHz) 8 2.15 (s, 3 H, 
C(0)CH3), 2.20-2.40 (m, 1 H, C(0)CHH), 2.65-2.85 (m, 1 H, C(0)CHW), 3.15-3.60 (m, 4 H, 2 x  NCH^, 
3.79 (s, 3 H, C 02CH3), 5.20-5.31 (m, 2 H, =CH2), 5.77-5.97 (m, 1 H, =CH), 6.73 (s, 1 H, NCH).
re/*‘(5 5 ,7 /? )-H e x a h y d ro -l,l-d im e th y l-7 -c h Io r o -3 -o x o -ljH r-p y r a z o lo [l,2 -a ]p y r id a z in e -5 -  
carboxylic acid methyl ester (52). Following the general procedure C, a solution of 49 (200 mg, 0.70 
mmol) in CH2C12 (7 mL) was treated with T1CI4 (0.70 mL of a 2.0 M solution, 1.40 mmol). Work-up and flash 
chromatography (ethyl acetate/hexane 1:1) afforded 52 (10 mg, 0.038 mmol, 6%) as a colorless oil, /?ƒ 0,30. IR v 
1735, 1680, 1220; XH NMR (200 MHz) 8 1.27 (s, 6 H, (C ^ ^ C ), 1.74 (dt, J  = 6.2, 12.4 Hz, 1 H, 
NCHCHH^), 2.32 (d, J  = 16.6 Hz, 1 H, C(O)CtfH), 2.48 (t, J  = 10.0 Hz, 1 H, NCHW^), 2.52 (d, J  = 16.6 Hz,
1 H, C(O)CHW), 2.78 (d d ,/= 4.5,13.1 Hz, 1 H, NCHCHff^, 3.21 (dd, J  = 4.1,10.0 Hz, 1 H, N C H / y ,  3.76 
(s, 3 H, C 02CH3), 4.06 (dddd, J = 10,12,4.1,4.5 Hz, 1 H, CHC1), 4.98 (d, J  = 5.9 Hz, 1 H, NCH); 13C NMR 
(63 MHz) 8 22.3, 27.7 (2 x CH3), 34.4 (NCHCH2), 43.0 (C(0)CH2), 51.5, 51.9 (NCH and CHC1), 52.7
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(C02CH3), 56.2 (NCH2), 59.0 (NC), 169.2, 171.0 (2 x C(O)); MS (El, 70 eV) m/z (relative intensity) 260 
(M+, 64), 245 (78), 201 (49), 159 (100), 43 (63); HRMS calcd for Cn H17N20 3Cl 260.0928, found 260.0921.
r£ /-(5 5 ,7 fl)-H ex a h y d ro -l,l,7 -tr im e th y l-7 -c h lo r o -3 -o x o -l//-p y r a z o Io [l,2 -ff]p y r id a z in e -5 -  
carboxylic acid methyl ester (53). According to the general procedure C, a solution of 50 (125 mg, 0.42 
mmol) in CH2C12 (6 mL) was treated with TiC^ (0.70 mL of a 1.2 M solution, 0.84 mmol). Work-up and flash 
chromatography (ethyl acetate/hexane 1:1) afforded 53 (9 mg, 0.033 mmol, 8%) as a colorless oil, R f  0.40. IR v 
1735, 1680; NMR (200 MHz) 8 1.27 (s, 3 H, CH3), 1.32 (s, 3 H, CH3), 1.62 (s, 3 H, CH3), 2.14 (dd, 7 = 
13.7, 7.1 Hz, 1 H, NCHCHtfax), 2.39 (d, J  = 16.5 Hz, 1 H, C(O)CtfH), 2.49 (d, J  « 16.5 Hz, 1 H, C(0)CHH),
2.65 (dt, J  = 13.5, m 1.8 Hz, NCHCH//^, 2.77 (d, J  = 10.4 Hz, 1 H, NCH//^), 2.90 (dd, ƒ » 10.4,1.4 Hz, 1 
H, NCH tf^, 3.75 (s, 3 H, C 02CH3), 4.82 (dd, J  = 2.4,7.1 Hz, 1 H, NCH); l *C NMR (63 MHz) 8 22.5, 26.9,
27.8 (3 x CH3), 29.7 (NCHCH2), 39.9 (NCH2), 43.6 (C(0)CH2), 51.8 (NCH), 52.6 (C02CH3), 60.5 (NC),
65.0 (CC1).
r e /- (5 5 ,7 /? )-H e x a h y d r o -7 -c h lo r o -3 -o x o -l//“p yrazo Io [l,2 -a J p y n d a zin e-5 -ca rb o x y lic  acid
m ethyl ester (54). Following the general procedure C, a solution of 51 (140 mg, 0.54 mmol) in CH2C12 (5 
mL) was treated with TiCl  ^ (0.91 mL of a 1.2 M solution, 1.09 mmol). Work-up and flash chromatography 
(ethyl acetate/hexane 4:1) afforded 54 (8 mg, 0.034 mmol, 6%) as a colorless oil, Rjr 0.25. IR v 1735,1690; *H 
NMR (200 MHz) 8 1.84 (dt, J  = 6.0, 12.2 Hz, 1 H, NCHCHtf^), 2.48 (t, 1 H, J  = 10.4 Hz, 1 H, NCH//^), 
2.53-2.65 (m, 1 H, C(0)C//H), 2.75-2.89 (m, 2 H, C(0)CHtf and NCHCHtf^, 3.35 (dd, J  = 10.4, 4.0, 1 H, 
NCH/Zgq), 3.58 (dt, ƒ = 9.8, 6.3,1 H, NCtfH), 3.77 (s, 3 H, CO^CH^, 3.71-3.86 (m, 1 H, NCHtf), 4.04 (tt, J 
= 11.6,4.5 Hz, 1 H, CHC1), 4.90 (d, J  = 5.9 Hz, 1 H, NCH); 13C NMR (50 MHz) 5 30.3 (CHj), 34.1 (CH2),
50.0 (CH), 50.1 (CH2), 52.6 (C02CH3), 52.9 (CH), 63.2 (NCH2), 169.0,171.4 (2 x C(0)); MS (El, 70 eV) 
m h  (relative intensity) 232 (M+, 45), 173 (66), 130 (100); HRMS calcd for CgH.iNoOiCl 232.0615, found 
232.0600.
2,3-D ihydro-2-ethenyl-5,5-d im ethyl-7 -o x o - l /f ,5tf-p y ra zo lo [l,2-a]pyra2:ole-l-carboxylic acid 
m ethyl ester (55). To a solution of 43 (80 mg, 0.34 mmol) in THF (2 mL) was added at -78 #C DBU (50 
\iL , 0.34 mmol) and the mixture was allowed to warm to rt in 2 h. Concentration in vacuo and flash 
chromatography (ethyl acetate/hexane 1:1) afforded 55 (16 mg, 0.068 mmol, 20%) as a yellow oil, R j  0.40. IR v 
1745, 1700, 900; JH NMR (200 MHz) 8 1.26 (s, 6 H, 2 x CH3), 2.63 (s, 2 H, CH^, 3.89 (s, 3 H, C02CH3),
4.04 (s, 2 H, NCH2), 5.16 (d, J  = 17.7 Hz, 1 H, =CHH), 5.38 (d, J  = 10.9 Hz, 1 H, =CHH), 6.98 (dd, / =  10.9,
17.6 Hz, 1 H, =CH); 13C NMR (50 MHz) 8 22.5 (CH3), 49.0, 49.5 (NCH2 and CH2), 52.4 (C02CH3), 62.7 
(NCH2), 119.4 (=CH2), 127.6 (=CH), 130.8 (C=CC(0)), 159.5 (C(0)), 165.5 (C=CC(0)), 171.0 (C(0)).
0
5 ,5 -D im eth y l-l-(l-p h en y l-3 -b u ten y I)-3 -p y ra zo lid in o n e  (58). To a solution of 5,5-dim ethyl-3- 
pyrazolidinone (56, 1.65 g, 14.5 mmol) in toluene (20 mL) were added benzaldehyde (1.54 g, 14.5 mmol) and a 
catalytic amount of pTSA. The resulting solution was refluxed under azeotropic removal of H20  for 18 h. 
Filtration and recrystallization (CH2Cl2/ether 1:5) afforded the ylide 57 (2.59, 12.9 mmol, 89%) as white 
crystals, mp 143-144 ’C. IR v 3060,1655,1580; !H NMR 8 1.71 (s, 6 H, (CHj^C), 2.72 (s, 2 H, C ^ C H j),
7.08 (s, 1 H, CH), 7.43-7.47 (m, 3 H, ArH), 8.32-8.37 (m, 2 H, ArH). To a solution of 57 (1.50 g, 7.43 mmol) 
in THF (15 mL) was added dropwise at 0 *C allylmagnesium chloride (3.7 mL of a 2.0 M solution in THF, 7.4 
mmol) and the mixture was allowed to warm to rt. After being stirred at ambient temperature for 2 h, the mixture 
was refluxed for another hour and concentrated in vacuo. The residue was taken up in CH2C12 (10 mL) and 0.95
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mL of 8 N aq HC1 was added dropwise. After addition of CH2CI2 (50 mL), the organic layer was dried (MgSC^), 
filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:1) to afford 58 (821 mg, 3.36 mmol, 
45%) as a white solid, mp 108-110 'C ,R t0.35. IR v 3410,1680,910,690; !HNMR (250 MHz) 8 1.18 (s, 3
H, CH3), 1.29 (s, 3 H, CH3), 1.78 (d, J  = 16.1 Hz, 1 H, C(0)CA/H), 2.05 (d, J  = 16.1 Hz, 1 H, C(0)CW/), 
2.58-3.99 (m, 2 H, CHCH2), 3.96 (dd, J  = 6.0, 8.6 Hz, 1 H, NCH), 4.87-5.00 (m, 2 H, =CH2), 5.47-5.59 (m, 1
H, =CH), 7.18-7.36 (m, 5 H, ArH), 9.03 (br s, 1 H, NH); 13C NMR (63 MHz) 8 25.0, 27.9 (2 X CH3), 40.0 
(CHCH2), 43.6 (C(0)CH2), 63.5 (NC), 65.6 (NCH), 116.7 (=CH2), 127.4, 128.2, 128.7 (ArH), 134.9 (=CH),
140.6 (AiC), 176.0 (C(0));
a -A ceto x y -5 ,5 -d im eth y l-l-(l-p h en y l“3-b u ten yl)-3 -p yraso lid in on eacetic  acid m ethyl ester
(59). According to the general procedure B, a solution of 58 (939 mg, 3.84 mmol) in benzene (20 mL) was 
treated with methyl glyoxylate hydrate (814 mg, 7.7 mmol) and acetylated with Ac20  (1.81 mL, 19.1 mmol) in 
pyridine (15 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:3.5) afforded 59 (650 mg, 1.74 
mmol, 45%) as a colorless oil, 1:1 mixture of diastereomers,/^ 0.30. IR v 1765,1750,1715, 1370,1220, 690; 
*H NMR (200 MHz) 8 (two diastereomers) 1.17,1.23 (s, 3 H, CH3), 1.27,1.32 (s, 3 H, CH3), 1.63,1.78 (br s,
2 H, C(0)CH2), 2.17, 2.19 (s, 3 H, C(0)CH3), 2.74-2.79 (m, 2 H, CH2), 3.81, 3.89 (s, 3 H, C 02CH3), 4.07-
4.15 (m, 1 H, CH), 4.93-5.06 (m, 2 H, =CH2), 5.50-5.70 (m, 1 H, =CH), 6.18,6.59 (s, 1 H, NCH), 7.24-7.54 
(m, 5 H, ArH).
7 -Ch lor ohexahydro- 1,1-dim ethyI-3»oxo-9-p h e n y l- li i ,  5 //-p y ra zo Io [l, 2 -a ][l,2 ]d ia zep  ine-5- 
carboxylic acid methyl ester (60), According to the general procedure C, a solution of 59 (100 mg, 0.27 
mmol) in CH2CI2 (3 mL) was treated with SnCl4 (0.27 mL of a 2.0 M solution, 0.54 mmol). Work-up and flash 
chromatography (ethyl acetate/ hexane 1:1.3) afforded 60 (18 mg, 0,051 mmol, 18%) as white crystals, single 
isomer, mp 153-154 ‘C (ether), R j  0.40. IR v 1740, 1680, 1390, 690; XH NMR (250 MHz) 8 0.92 (s, 3 H, 
CH3), 1.46 (s, 3 H, CH3), 2.10 (d, J  = 16.3 Hz, 1 H, C(O)CHH), 2.15-2.45 (m, 3 H, CH2 and CHH), 2.83 (d, 
J = 16.3 Hz, 1 H, C(0)CHH), 2.89-3.01 (m, 1 H, CHfl), 3.78 (s, 3 H, C 02CH3), 4.07-4.19 (m, 1 H, CHC1),
4.50 (dd, J  = 2.3, 5.1 Hz, 1 H, NCtfPh), 4.81 (dd, J  = 10.8, 3.1 Hz, 1 H, NCHC(0)), 7.25-7.38 (m, 5 H, ArH); 
13C NMR (63 MHz) 8 24.2, 29.0 (2 x CH3), 37.7,42.2 (2 X CH2), 43.6 (C(0)CH2), 52.4 (C02CH3), 53.4,
53.6 (2 x CH), 63.2 (CH), 63.4 (NC), 126.5, 127.4, 128.8 (ArH), 142.4 (ArC), 170.3, 172.0 (C(0)); Anal. 
Caled, for C18H23N20 3C1: C, 61.62; H, 6.61; N, 7.98. Found: C, 61.68; H, 6.56; N, 7.94.
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SYNTHESIS OF CYCLIC oc-HYDRAZINO ACID DERIVATIVES
7.1  INTRODUCTION
About three decades ago, several monamycin antibiotics were isolated from cultures of 
Streptomyces jamaicensis. 1 All of these monamycins are cyclic hexadepsipeptides, containing 
unusual amino acids, i.e. hexahydropyridazine-3-carboxylic acids, abbreviated as piperazic 
acids.2 Most abundant in the monamycin antibiotics are the piperazic acids 1 and 2 (Chart 7.1).
More recently, various classes of oligopeptides and cyclic hexadepsipeptides that contain 
similar types of piperazic acids were isolated. Examples of such oligopeptides are the 
antrimycins 3 3 and the cirratiomycins 4.4
COoH
3 antrimycins, Rj = Me, Et, n-Pr, z-Bu
R2 = Me, Et
4 cirratiomycins, R* -  Me, z-Bu, R2 = Ht
Examples of cyclic peptides that possess piperazic acid moieties are the azinothricin 
antitumor antibiotics,5 the antibiotic L-156,6026 and its derivative L-365,2097 and the
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As a result of the diverse biological activities of these compounds, there is a strongly 
increasing interest in the synthesis of these piperazic acid residues. The unsaturated piperazic 
acid 5 was synthesized9,10 by using methodology that was developed for the synthesis of 
acyclic a-hydrazino acids*11 The presence of the chiral auxiliary in the protected aldehyde 8 led 
to a highly diastereoselective conjugate addition of its enolate with di-te/t-butyl azodicarboxylate 
(eq 7.1), affording the hydrazine 9. Removal of the auxiliary and concomitant esterification with 












a) LDA, -78 °C, then DBAD. b) MeOMgl, CH2Cl2-MeOH. c) CF3CO2H, CH2C12.
Recently, a more refined use of this methodology was reported,12 in which the 
intermediate 1,4-adduct was converted in a one-pot procedure into the cyclic compound 11 (eq 
7 ,2). This reaction only occurred after the addition of 26 equiv of the HMPA substitute DMPU. 
Subsequent cleavage of the auxiliary and the carbamates led to the desired piperazic acid 12.
u  I I  ’ C F : j C O z  +
vRn ^  Br
ün v COoH
10 11 Boc 12
h H2N
HISL J (eq 7.2)
a) (i) LDA, -78 °C, then DBAD. (ii) DMPU. b) (i) LiOH, THF-H20  (2:1), 0 °C (ii) CF3C 02H, CH2Cl2.
The hydroxy-substituted piperazic acid 7, which was found in luzopeptin A, could be 
obtained starting from the functionalized ally lie alcohol 13 (eq 7.3).13 Asymmetric epoxidation, 
followed by oxidation and esterification afforded 14. A diastereoselective addition of hydrazine 
to the potassium salt of 14 led to the unstable product 15, which was immediately treated with 
trifluoroacetic acid to afford the desired piperazic acid 7.
u 11 ^  O. * OH OMe ç p.. a,b,c MeOoCX ï d,e ____  1 1 f  Nu n urvi ^ s .
-  K0 2C'V A v ^ OMe J w , ,  (ecl7*3)^ 1 -- - HN X "OH
MeO" "OMe MeO' "OMe NHNH2
13 14 15
a) TBHP, Ti(Oi-Pr)4, L-(+)-diethyl tartrate, b) Ru04. c) CH2N2. d) K2C 03, MeOH, H20 . e) i^NNH^ 
H20 .f)C F 3C 02H,H20.
The piperazic acid 1 occurring in monamycin was synthesized via a completely different 
route as shown in Scheme 7.1.14 A Diels-Alder reaction of the phthalazinedione 16 with the 
diene afforded the adduct 17 which could either be reduced to the piperazic acid 6 , or oxidized to 
the acetate 18. Selective catalytic hydrogenation yielded the ds-hydroxy piperazic acid 14 in
4
large excess, which, after hydrolysis, was resolved into its enantiomers with quinine. Cleavage 
of the phthalazine moiety with hydrazine afforded the desired piperazic acid 1 .
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Scheme 7.1.
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a) CH2N2, then Hg(OAc)2, NaOAc, AcOH. b) H2, Rh/Al20 3. c) 6 N HC1, reflux, d) Resolution with 
quinine, e) N2H4, H^O.
In this Chapter a novel approach for the synthesis of cyclic hydrazino acids is detailed, 
which is based on the intermediacy of N-acylhydrazonium ions that are substituted with a 
carboxyl function. A sequence that might lead to the chlorine substituted a-hydrazino acid 2 is 
given in retrosynthetic form in Scheme 7.2. The free hydrazine 2 might be obtained by 



















It is known from comparable N-acyliminium ion cyclizations15 that the cationic 
intermediate 21 is likely to adopt a chair-like conformation, in which the N-acyliminium part has 
a (Z)-geometry. The preference for this geometry can be visualized by looking at the two 






H " X 0 2Me
A
r o 2c . + . n v
u




The (£)-isomer B is less likely to be formed as a result of pseudo-ally lie 1,3-strain16 
between the two carbonyl functions, which is absent in the (Z)-isomer A. Attack of a 
nucleophile (e.g. chloride) to the intermediate rc-complex occurs in such a way that an overall 
rrans-addition with respect to the double bond takes place, leading to the desired trans- 
relationship between both substituents.
The cyclization precursor 22 could be derived from the suitably protected hydrazine 23 
by subsequent alkylation with allyl bromide and methyl glyoxylate. Moreover, introduction of 
various nucleophilic side chains might lead to the synthesis of numerous functionalized cyclic <x- 
hydrazino acids of different ring sizes.
7 .2  CHOICE OF THE PROTECTIVE GROUPS
A proper choice of the protective group R’ at the amine nitrogen atom (Nl) can be made 
by considering the results of Sections 2.6 and 6.2. In the former case, the presence of an 
electron-withdrawing acyl substituent at Nl is considered responsible for the fact that addition of 
the amide type nitrogen atom (N2) to methyl glyoxylate does not take place. In the latter case, 
however, N l bears an alkyl substituent, thus enhancing the reactivity of N2 towards methyl 
glyoxylate. For these reasons, the easily removable benzyl function was chosen as a protective 
group for N 1.
With respect to the protective group at N2, there are several possibilities. Among them 
are the feri-butoxycarbonyl, the ethoxycarbonyl and allyloxycarbonyl (Alloc) function. In view 
with its known acid-lability, the terf-butoxy carbonyl group is not suitable. The ethoxy carbonyl 
group is a possible choice, but as deprotection conditions are more severe compared with those 
for the Alloc function (see Chapter 3), the latter one is preferred as protective group for N2.
Conversion of (commercially available) ethyl carbazate (24) to the mono benzyl product 
25 proved to be impossible under ‘standard* alkylation conditions (eq 7.4). Independent of the 
amount of benzyl chloride that was used, the ¿//benzyl product 26 was formed in a higher yield 
than the monobenzyl product 25. Apparently, the nucleophilicity of N l is increased by the 
introduction of a benzyl substituent, so that, despite the increased steric hindrance, the initial 
product 25 will react faster than the starting material.
NH BnCl (1.05 equiv), ^ .B n  Bn- N-Bn
I 2 --------------------------^  , + , (eq 7 4)
Et02C Et3N (1.05 equiv), Et02C ' H Et02C 'NH
EtOH, reflux
2 4  25 (12% ) 2 6  (50%)
Therefore, in the case of allyl carbazate (27) an alternative route was developed for the 
synthesis of the wo nobenzyl hydrazine 29. In contrast with ethyl carbazate (24), allyl carbazate 
(27) is not commercially available and was synthesized by monoacylation of hydrazine hydrate
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with allyl chloroformate (eq 7.5). The highest yield was obtained with a large excess of 
hydrazine hydrate at -20 °C. Reaction did not take place at lower temperatures, whereas at higher 
temperatures the ¿ftacylated hydrazine was also obtained The allyl carbazate (27) could be easily 
purified by distillation.
Ph Ph
NH2 a NH2 b N c HN . „  „
NH2'H20 .NH _NH xnh q ' ^z 2 Alloc Alloc Alloc
27 (77%) 28 (94%) 29 (99%)
a) allyl chloroformatc (0.25 equiv), K2C03 (0.6 equiv), EtOH, -20 °C —> rt. b) PhCHO (1.05 equiv), 
toluene, rt. c) (i) NaBHi CN (1.0 equiv),pTSA (1.0 equiv), THF, rt (ii) 1N NaOH, rt, 1 h.
In order to obtain 29, allyl carbazate (27) was condensed with benzaldehyde to give the 
hydrazone 28 , which was easily reduced with NaBHgCN to give 29 as its hydrazine- 
cyanoborane complex.17 Hydrolysis of the complex with NaOH afforded the monobenzyl 
hydrazine 29, which was virtually pure according to *H NMR data.
7 .3  SYNTHESIS OF THE PRECURSORS
The protected precursors 25 and 29 were alkylated under the ’standard’ conditions 
mentioned in Chapter 4 (alkenyl halide (1.1 equiv), K2CO3 (1.2 equiv), Lil (cat), butanone, 
acetone or ethanol, reflux). The results of these alkylations are summarized in Table 7.1. In 
general, reasonable to good yields were obtained for the activated alkenyl halides. The less 
activated butenyl bromide gave rise to a lower yield (entry 9).
The precursor 39 (entry 14) was alkylated with the corresponding iodide, that was 
prepared from the alcohol18 via the mesylate.19 Under refluxing conditions, the propargylsilane 
was desilylated to give the allene 36 (entry 10) in a rather low yield. At room temperature 
however, the desired propargylsilane 39 was formed in a fair yield (entry 14).
Chart 7,2 
Me3S i- = — ^ OH
74








The (£)-vinylsilane 40 (entry 15) was obtained upon alkylation of 29 with the bromide 
7 6 (Chart 7.2). This bromide was prepared by a stereoselective reduction of 3-(trimethylsilyl)~
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2-propynoI (74) with Red-Al20 and subsequent bromination with PBrç.21 The vinylsilanes 41 
(entry 17) were obtained as a 1*9:1 mixture of (Z)- and (£)-isomers after alkylation with the 
(£)/(Z)-mixture of the bromides 78. Partial hydrogenation of 3-(trimethylsilyl)-2-propynol (74) 
to 77 ,22 followed by bromination with PBr 2^1 afforded a 2.5:1 (Z)/(£)-mixture of 78, though 
this sequence was reported to proceed stereospecifically.22 The dioxenone 42 (entry 18) was 
obtained upon treatment of 29 with chloride 7 9 .23 Introduction of the dioxenone residue proved 
to be a difficult reaction. Slight variation of the temperature and reaction time led to dramatic 
changes in the yield of the reaction.
Introduction of the glyoxylate moiety was performed by stirring the alkylated product in 
the presence of anhydrous methyl glyoxylate.24 The ease of condensation with the glyoxylate 
proved to be strongly dependent on the steric bulk of the alkyl group. For example, the allyl 
precursors 30 and 31 (Table 7.2, entries 1 and 2) reacted within 2 h to give the desired 
products, while for the benzyl and dioxenone precursors 37 and 42 (entries 11 and 18) longer 
reaction times were required (up to 40 h). Because polymerization of unreacted methyl 
glyoxylate was a major side reaction, freshly distilled methyl glyoxylate had to be added after 18 
h if the reaction was not completed. In some cases, large amounts (ca. 20 equiv) of methyl 
glyoxylate were used, so that purification by flash chromatography of the intennediate hydroxy 
compound was necessary. Acétylation with acetic anhydride and a catalytic amount of DMAP in 
pyridine led to the cyclization precursors 43-55 in good yields as summarized in Table 7.1.
7.4 CYCLIZATION REACTIONS
The cyclization reactions were carried out under ‘standard’ conditions with the Lewis 
acids TiCl4 (2 equiv, -78 °C -> rt), SnCl4 (2 equiv, -78 °C -> rt), Et2AlCl (2-4 equiv, -78 aC 
rt), and BFjOEt2 (2-6 equiv, 0 aC rt) and the protic acid HCOOH. In contrast with the 
cyclizations reported in Chapters 2 ,4  and 6, use of SnCl4 afforded better results than TiCl^ The 
Lewis acid Et2AlCl was also successfully applied in some cyclization reactions. The results are 
shown in Table 7.2.
Cyclization of the allyl precursors 43 and 44 (entries 1 and 2) led to the unexpected 
formation of the five-membered rings 56 and 57 with the /raw-stereoisomers as the main 
products. These products cannot arise from a normal 5-exo type cyclization, because the 
chloromethyl substituent would then be at the 4-position. A possible explanation for the 
formation of 43 and 44 is detailed in Scheme 7.3. Presumably, cyclization initially gives rise to 
the formation of the secondary carbocation 80 , which is then trapped by the relatively 
nucleophilic amine nitrogen atom to give the aziridinium intermediate 81. Attack of chloride 
gives ring opening of the aziridinium moiety, thus leading to the frmy-azaproline derivative 57.
In similar jV-acyliminium cyclizations,15 the minium ion is formed at -78 8C and 
stabilized as a dioxycarbenium ion by the carbamate function (compare 82). Quenching with 
saturated aqueous NaHC03 at -78 °C then gives the corresponding hydroxy compound.
150
Synthesis o f cyclic a-hydrazino acid derivatives
Table 7.1. Synthesis of cyclic a-hydrazino acids.














1 30  R = Et (93%) 43 R = Et (83%) TiCl4
2 31  R = Allyl (89%) 44  R = Allyl(91%) SnCl4
C02Me
56  R = Et (70%) c/tr 1:5
57  R = Allyl (75%) c/tr 1:5














SnCl4 58  (38%) trans 59 X = Cl (32%) trans 
Et2AlCl 58 (27%) c/tr 1:1.8 59  X = Cl (59%) c/tr 1:8.8 
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8 34 (73%) E/Z 3.3 :1 47 (82%)a SnCl 63 (56%) 5:1 mixture of isomers
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SnCU 64 (65%) 1:1 mixture of isomers
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18 42 (53%) 5 5 (66%)
Me0 2ô
CF3S0 3SiMe3 73  (48%)
a) The (£)/(Z) ratio could not be determined from the1H NMR spectrum, b) Yield in one step from allyl carbazate (2 7).
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Such a sequence might block the rearrangement and directly give the precursor 83 for the 
piperazic acid 1. However, when the cyclization reaction of 4 4 was quenched with saturated 
aqueous NaHCC>3 at -78 or at -30 *C, only starting material was recovered. Apparently, 
formation of the N-acylhydrazonium ion is more difficult than of its iminium analog. Reaction 
only took place at -20 °C, but quenching after stirring for 30 min at this temperature afforded a 
mixture of starting material and the rearranged products 57. This means that as soon as the 
intermediate cationic six-membered ring 80 is formed, stabilization via the aziridinium 














Formation of the tram-five-membered ring was confirmed by reduction of the tram- 
cyclization product 57 with n-BugSnH which led to 91 (Chart 7.3) clearly showing the 
characteristic doublet of the methyl substituent in the ^H NMR spectrum. The structure was 
proven by an X-ray crystallographic analysis of the deprotected product 121 (see: Section 7.5). 
The formation of the c1 s-flve-membered ring product 57 was concluded by comparison of the 
« C  NMR data of the cis- and fra/ts-isomers of 57.
Recently, the intermediacy of an aziridinium intermediate in ring contractions has been 
reported in the synthesis of derivatives of azasteroids.25 The chloride 84 (eq 7.6) rearranges via  
the cationic intermediate 85 to the ring-contracted product 86 .
84
(eq 7,6)
A comparable mechanism in the case of the methallyl substituent 45 (entries 3 to 5) leads 
to mixtures of five- and six-membered rings. The more stable tertiary carbocation 87 (Scheme
7.4) is less prone to be stabilized by the nitrogen atom and thus gives a considerable amount of 
the six-membered ring 59. As attack of chloride will occur from the less hindered equatorial
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side, the product will have the ira/u-configuration. This stereochemistry was assigned by using 
NOE difference NMR techniques on 59. Irradiation of the methyl function showed an 
enhancement of the signal of one of the H6 protons and of the broad signal of both H4 protons.
*
The fact that the signal of only one of the H6 protons was enhanced leads to the conclusion that 
the methyl group is in the axial position. Consistent with the proposed conformation of the 








The formation of the five-membered rings 58 was proven by reduction with n-B^SnH  
to 92 (Chart 7.3). The relative configuration of trans-5 8 was secured by NOE difference 
NMR techniques. Irradiation of the methylene group adjacent to the chlorine atom showed an 
enhancement of the a-methine proton, whereas irradiation of the methyl function did not. 
Remarkably, the reaction proceeded less stereo selectively when Et2AlCl was used as a Lewis 
acid so that mixtures of cis- and trans-products were obtained. When formic acid was used for 
the cyclization (entry 5), only the trans six-membered ring 60 could be found. The tertiary 
carbocation 87 probably gives a faster reaction with formate as a result of the large excess of the 
nucleophile so that ring contraction does not take place.
Cyclization of the prenyl precursor 46 (entries 6 and 7) afforded the expected five-
membered rings 61 and 62 with a frms'-relationship between both substituents. Surprisingly, 
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The /raw-relationship between the substituents can be explained by assuming that the 
chair-like conformation 47-C of the precursor (eq 7.7) will lead to a more favorable transition 
state than the sterically hindered boat-like conformation 47-B . The preference for the formation 
of a five-membered ring is remarkable, because generally six-membered rings are obtained. For 
example, the comparable N-acyliminium ion precursors 90 led to exclusive formation of six- 
membered rings.15b Reduction of the cyclization product 63 with n-I^SnH  to 93 confirmed 
the formation of the five-membered ring, clearly showing the signals of the ethyl substituent in 
the NMR spectrum. These signals would be absent in the case of a six-membered ring. The 
iratts-orientation was confirmed by NOE difference NMR techniques. Irradiation of the 























Eq 7.8 shows a mechanism that accounts for the formation of 65. Initially, cyclization 
takes place to afford the vinylic cation 94. This intermediate rearranges via a 1,2-H shift to the 
more stable tertiary allylic cation 95, which is trapped by the nucleophile to afford 65.
The seven-membered ring 64 (entry 9) was obtained upon cyclization of the butenyl 
precursor 48. Although in none of the reactions mentioned in Table 7.1, cyclization of the 
benzyl function was observed as a side reaction, cyclization of the dibenzyl precursor 50 (entry 
11) took place smoothly to give 6 6 in excellent yield. This is remarkable and might be partly 
explained by the difference in nucleophilicity with other substituents, but also by the strong 
preference for the formation of five-membered rings. Another reason that the side reaction did 
not occur might be that the molecule is likely to adopt a conformation in which the relatively large 
benzyl function is moved away from the glyoxylate moiety and thus will be less available for
155
Chapter 7
cyclization. If cyclization takes place, ring contraction is hindered as a result of the fast formation 
of the aromatic system.
An additional way of blocking the ring contraction was observed upon cyclization of the 
allylsilane 51 (entry 12). Treatment with Et2AlCl initially led to the silicon stabilized carbocation 
96 (eq 7.9) which gave a fast elimination to the exocyclic double bond. An indication that 
formation of six-membered rings in such systems is a relatively slow process, is seen in entry 
13. Treatment of the allylsilane precursor 51 with protic acid afforded 68 as a single product, 
which is explained by protodesilylation of 51 to the methallyl precursor 45 (eq 7.9) followed by 
cyclization to the expected six-membered ring 68 (treatment of 51 with HCOOH gave the 









-  45 *-68  (eq 7.9)
51
In an analogous way, the propargylsilane 52 (entry 14) was treated with BF3*OEt2 to 
give the allene 69 in a rather poor yield. Probably, the use of SnC^ or Et2AlCl would have 
given a better result.
A striking difference was observed between cyclization of the (E)- and (Z)-vinylsilanes 
53 and 54, respectively (entries 15 to 17). The chair-like transition state conformations of both 
starting materials are visualized in Scheme 7.5. The (E)-vinylsilane 53 will react via  
conformation 97 to the cyclic cationic intermediate 98 in which the trimethylsilyl group occupies 
the equatorial position.
Scheme 7.5 C02Me .. C02Me
B n-N ^/ an -N  *
AIIOC
W  £ - « M *  -  / /
Alloc' 97 Allocai 00 , siMe.






Bn_ ? + C02Me CT CO,Me
---------  Bn-N:|~ 7 \ J  Bn'N.f
'3 ... .N
/  J L  /
Alloc
71 COaMe 99 72
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Because the (3-C-Si bond is not oriented coplanar with respect to the vacant p-orbital, 
stabilization of the positive charge by the silicon atom and subsequent elimination is not likely to 
take place, thus leading to a ring contraction via the aziridinium intermediate 99. Attack of a 
nucleophile (which is the acetate in the BF3*OEt2 cyclization) affords the final products 70 and 
71. The stereochemistry of both products was confirmed by subjecting 71 to NOE difference 
NMR techniques, showing an enhancement of only the a-methine proton upon irradiation of 
the proton adjacent to the silicon atom.
Cyclization of the (Z)-precursor 54 will occur via conformation 100 and cation 101 in 
which the trimethylsilyl group is axially oriented. In this orientation, maximal o - n  
hyperconjugative stabilization of the developing positive charge is possible, followed by fast 
elimination to the unsaturated six-membered ring 72, thereby excluding the formation of the 
aziridinium intermediate. Considering these mechanistic details, starting from the precursor 54, 
that was obtained as a 1:1.2 mixture of (E)- and (Z)-isomers, the corrected yields for 71 and 72 
(entry 17) are 70% and 90%, respectively. Comparing the yield of the five-membered ring 
product 71, with the yield of 71 from the pure (£)-precursor 53 (entry 16), it is evident that the 
(Z)-isomer leads to exclusive formation of the six-membered ring 72. These observations are in 
full accord with results published by Overman and co-workers,26 who reported the (Z)- 
vinylsilane to be at least 7000 times more reactive than its (£>analog in iminium ion cyclizations.
Cyclization of the dioxenone precursor 55 (entry 18) proved to be a difficult reaction. 
Various Lewis acids were attempted but did not give satisfactory results. Strong Lewis acids led 
to decomposition of the dioxenone part, whereas BF3*OEt2 afforded only starting material. 
Reaction with HCOOH at higher temperatures led to opening of the dioxenone residue prior to 
cyclization, while at room temperature only starting material was recovered. A reasonable result 
was obtained upon treatment of 55 with CF3S03SiMe3 (4 equiv, CH2CI2, -78 “C rt, 18 h) 
affording the bicyclic product 73 in a satisfactory yield.
aiioc"N' Y ' y °
. MeOoC O
102 103
Formation of the six-membered ring is most likely the result of the mesomeric 
stabilization of the positive charge in the cationic intermediate 102 by the adjacent oxygen atom 
(103), thus precluding aziridinium stabilization by the nitrogen atom. Abstraction of the acidic 




In line with deprotections of similar protected pipecolic acid derivatives,15 56 was first 
debenzylated by catalytic hydrogenation (H2, Pd/C, MeOH) to the hydrazine 104, and then 
treated with 2 N HC1 to hydrolyze the carbamate and methyl ester. This sequence is preferred, 
because the hydrazine is less prone to oxidation as long as the electron-withdrawing carbamate 
function is present in the molecule. Treatment with 2 N HC1 unfortunately did not lead to the 
HCl-salt 105.
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7. S DEPROTECTION OF THE C YCLIZATION PRODUCTS
CHoCl CHoCI CHoCI
H2, Pd/C (5%) ? 2NHC1
HC1 (cat), MeOH Eto 2c  
C02Me C02Mg C02H
56 104 (79%) 105
After stirring for two hours at 100 °C, the carbamate function was still present in the molecule 
according to NMR data. Longer reaction times or higher temperatures (sealed tube) only led 
to decomposition of the starting material.
Therefore, the Alloc group was introduced, which can be converted into the easily 
removable rerf-butoxycarbonyl group by the transprotection reaction described in Chapter 3. The 
intended sequence for the deprotection reaction is then as depicted in eq 7*11, First, a 
transprotection reaction is carried out (the nitrogen still has to be protected) to compounds 107, 
followed by a debenzylation to the hydrazines 108. Hydrolysis under acidic conditions should 
finally lead to the HCl-salts 109.
b (eq 7.11)
COoMe COzMe C02Me C02H
106 107 108 109
a) Pd(PPh3)4 (0.02 equiv), B0C2O (1.5 equiv), rt-Bu3$nH (1.1 equiv), CH2CI2. b) H2, Pd/C (5%), 
H+ (caL). MeOH. c) 2 N HC1, 60 °C, 2 h.
The results of several transprotections are summarized in Table 7.2. The desired products 
were not obtained in all cases. The transprotection of the five-membered rings to the desired 
products usually proceeded in reasonable yields (see entries 1, 2 and 5), but in some cases 
oxidation products were obtained in excess (entries 3 and 4). In the latter cases, deprotection of 
the Alloc group took place, but reprotection with B0C2O did not occur. This was indicated by the 
initial isolation of the corresponding NH compounds that were readily oxidized upon standing in 
air to the products 113 and 114.
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110R  = H (77%)
111 R « SiMCj (64%)
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121 R = H (90%) 




































Apparently, the reaction with B0C2O is veiy sensitive to steric hindrance caused by the benzyl 
substituent and the methyl ester. This is reflected in the outcome of entries 3 and 4, in which the 
presence of one additional methyl group (61) hinders the reaction with B0C2O, thus leading to 
the oxidation product 114.
With the six-membered rings, transprotection proved to be almost impossible. Both 59 
and 6 7 (entries 6 and 7) were converted into the corresponding deprotected hydrazines, which 
were oxidized to 116 and 117. Only the benzyl derived cyclization product 66 (entry 8) 




A possible explanation for this observation is detailed in eq 7.12. Pd(0)-catalyzed 
cleavage of the Alloc group in the presence of /2-BU3S11H will first lead to the tin carbamate 124. 
If this tin carbamate is cleaved by an electrophile before reaction with B0C2O occurs, immediate 
ring inversion to the thermodynamically more stable six-membered ring 126 will take place. 
This inversion is also observed after cleavage of the carbamate group of pipecolic acid 
derivatives15 and is caused by the relief of pseudo-ally lie 1,3-strain. Once the ring inversion has 
taken place, addition of a tert-butoxycarbonyl group is no longer possible for steric reasons. 
Even attempts to introduce smaller electrophiles like an acetyl function failed.
The seven-membered ring 64 (entry 9) afforded the transprotected product 120 in a 
reasonable yield. Probably, the methyl ester causes less steric strain in a larger, more flexible 
ring.
Analogous to the ethoxy derivative 56, debenzylation of 110, 111, and 120 provided a 
good yield of the corresponding hydrazines (entries 1, 2 and 9). The formation of the five- 
membered ring 121 and the fra/w-relationship of the substituents was secured by an X-ray 
crystallographic analysis of the product 121 as depicted in Fig 7.1. The amide nitrogen atom is 
almost completely planar, whereas the amine nitrogen atom is pyramidal.






M0O2G ► 117 (eq 7.12)
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The replacement of the ethoxycarbonyl function by a te/t-butoxycarbonyl function allows 













7 .6 SYNTHESIS OF PROTECTED 5-HYDROXY PIPERAZIC ACID
As cyclization of the allyl precursors 43 and 44 led to five- instead of six-membered 
rings, a different method had to be chosen for the synthesis of the piperazic acids 1 and 2, A 
possibility is to use the (Z)-vinylsilane 54, which affords an unsaturated six-membered ring that 
might be further functionalized to the desired piperazic acid. An alternative is to start from the 
ketone 128 (eq 7.14) which might be obtained either from the allylsilane-derived cyclization 
product 6 7 upon ozonoly sis of the double bond or from the dioxenone cyclization product 7 3.
Because several experiments to cleave the methylene function of 67 with ozone (without 














It was already established in Chapter 5, that the dioxenone residue can be cleaved at 170 
°C and that the intermediate acylketene can be trapped by a nucleophile. Thus, treatment of the 
product 73 with water under such circumstances led to the (3-ketoacid 129 (eq 7.15), which 
















130 (95%) cltr 6.3:1
a) H2O (10 equiv), xylenes, 170 °C, sealed tube, 10 min. b) NaBR* (1.1 equiv), -10 °C, MeOH.
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This ketoester 128 could be reduced to afford the corresponding alcohols 130. 
Reduction with NaBH4 (-10 °C, MeOH) led to a mixture of cis- and /rany-isomers of 130 in a 
ratio of approximately 6:1. Attack of the hydride is more likely to take place from the less 
hindered equatorial side, as the axial side is shielded by the ester function.
Alloc
C02Me C02Me
trans-130 cis-130 131 (57%) 132 (33%)
a) NaOMe (cat), MeOH, rt. b) //TSA (cat), toluene, reflux, c) Boc20  (2 equiv), Pd(PPh3)4 (0.02 equiv), 
/z-B^SnH (1.1 equiv), CH2CI2» rt.
(eq 7.16)
An attempt to convert cis-130 into the lactone 131 with sodium methoxide led to 
complete formation of trans-130 (eq 7.16). Apparently, under these circumstances 
deprotonation adjacent to the ester function gave isomerization to the thermodynamically more 
stable tfmy-product before lactonization could take place. On the other hand, under acidic 
conditions, isomerization could not occur so that the lactone 131 was obtained.
The formation of the lactone has three advantages: (i) the cw-relationship between the 
ester and the hydroxy function is fixed; (ii) the hydroxy group is adequately protected for the 
transprotection reaction; (iii) inversion of the six-membered ring is inhibited so that the tin 
carbamate should readily react with B0C2O. In accordance with these theories, transprotection of 
the lactone 131 led (in moderate yield) to the fully protected hydroxypiperazic acid 132.
7 .7  NMR DATA
The structures assigned to the compounds described in this Chapter, are primarily based 
on *H, 13C and NMR NOE difference data. In several cases, crucial information was 
obtained upon reduction of some cyclization products with n-B^SnH or by an X-ray analysis 
of the deprotected product 121. As already described in Section 2.9, the NMR spectra of the 
tetrasubstituted hydrazines 43-55 show rotamers and broad signals as a result of hindered 
rotation around the N-N and the amide bond. The latter effect is also observed in and 1 ^ C 
NMR spectra of some of the cyclization products. Generally, the NMR spectra of five- 
membered rings show sharp signals, while the signals of six-membered rings are considerably 
broadened.
Two representative examples are shown in Fig 7.2 and 7.3. The former shows the 
NMR spectrum of the six-membered ring 72, obtained upon cyclization of the (Z)-vinylsilane 
precursor 54. The H6 protons show a broad AB-system, the oc-methine proton (H3) shows a 
broad singlet at 5.10 ppm and no distinction can be made between the olefinic protons.
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Fig 7 .2 .
*H NMR spectrum 
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In some other cases, spectra were taken at a higher temperature but this did not lead to a 
significant improvement of the spectra.
A completely different spectrum was obtained from the (£)-vinylsilane-derived 
cyclization product 72 as depicted in Fig 7,3. All protons display sharp signals. The a-methine 
proton (H3) at 5.01 ppm shows a doublet (3/  = 9.0 Hz) and the H4 proton a triplet (2.00 ppm, 
37 = 9.1 Hz) as a result of identical cis-and frms-coupling constants. The methylene protons 
adjacent to the chlorine and the benzylic protons show sharp AB-systems. Furthermore, the 
protons of the Alloc group can be easily recognized.
7*8 CONCLUSIONS
It is evident that a large variety of cyclic a-hydrazino acid derivatives can be efficiently 
synthesized via the method described in this Chapter. Several conclusions can be drawn from the 
outcome of the cyclization reactions.
There is a strong preference for the formation of five-membered rings which is illustrated 
by the crotyl and allene precursor that both produced the corresponding five- instead of six- 
membered rings.
Furthermore, if a six-membered ring is formed during the cyclization, stabilization of the 
cationic intermediate by the amine nitrogen atom may take place, leading to a five-membered ring 
via an aziridinium intermediate. This ring contraction can be inhibited by stabilization of the 
developing positive charge by a hetero- or JJ-silicon atom followed by a fast elimination process.
A remarkable difference is observed in reactivity between the benzyl group and the 
introduced nucleophiles; Cyclization of the benzyl group takes place only if no other nucleophile
I
is present in the molecule. In contrast with cyclizations of other types of hydrazonium ions, 
SnCl4 and in some cases Et2AlCl afforded the best results.
The transprotection reactions did not give satisfactory results. The lack of reactivity of 
the activated carbonyl compounds is probably due to the steric hindrance caused by the a- 
methoxycarbonyl function.
Although it appeared to be difficult to obtain a suitable precursor for the naturally 
occurring piperazic acids, application of the dioxenone moiety eventually leads to protected 5- 
hydroxypiperazic acid.
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7 . 6  EXPERIMENTAL SECTION
General inform ation. For experimental details, see: Section 2.11.
l-B en zy l-2-hydrazinecarboxyIic acid ethy! ester (25). A solution of ethyl carbazate (2.00 g, 19.2 
mmol), benzyl chloride (2.55 g, 20.2 mmol) and Et3N (2.80 mL, 20.2 mmol) in EtOH was refluxed for 18 h. 
After concentration in vacuo, the residue was taken up in water (100 mL) and extracted with CH2CI2 (3 x 100 
mL). The combined organic layers were dried (MgSO^, filtered, concentrated in vacuo and chromatographed (ethyl 
acetate/hexane 1:1) to afford l,l-d ib en z y l-2-hydrazinecarboxylic acid ethyl ester (26) (2.73 g, 9.60 
mmol, 50%) as a colorless oil, R j 0.60 and 25 (445 mg, 0.23 mmol, 12%) as a colorless oil, R j 0.35. 25: IR v 
3440, 3340,1710,690; *H NMR (200 MHz) 8 1.26 (t, 7= 7 .1  Hz, 3 H, CH2C//3), 4.00 (s, 2 H, NCH2), 4.16 
(q, /  = 7.1 Hz, 3 H, CW2CH3 and NH), 6.26 (br s, 1 H, NH), 7.30-7.33 (m, 5 H, ArH). 26: IR v 3430, 3340, 
1715, 690; *H NMR (200 MHz) 8 1.16 (t, J  = 7.1 Hz, 3 H, CH2Ctf3), 4.04 (q, J  = 7.1 Hz, 2 H, Cff2CH3), 
3.90-4.15 (br s, 4 H, 2 x  NCH2), 5.77 (br s, 1 H, NH), 7.30-7.40 (m, 10 H, ArH).
H ydrazinecarboxylic acid allyl ester (27). To a solution of hydrazine hydrate (128 mL, 2.64 mmol) in 
EtOH (1.3 L) was added dropwise in 1.5 h allyl chloroformate (70.0 mL, 0.66 mmol) while the temperature inside 
the flask was kept around -20 ’C. The mixture was allowed to warm to rt, stirred at ambient temperature for 1 h 
and after the addition of K2CO3 (91.2 g, 0.66 mol) it was stirred for an additional hour. After filtration and 
concentration in vacuo, the residue was distilled to afford 27 (59.2 g, 0.51 mol, 77%) as a colorless oil, bp 82 *C 
(0.3 mm), R f  0.35 (ethyl acetate/hexane 1:1). IR v 3460, 3350, 1710, 1625, 995, 935; lH NMR (200 MHz) 5
3.66 (br s, 2 H, 4.56 (d, J  = 5.6 Hz, 2 H, OCH2), 5.15-5.31 (m, 2 H, =CH2), 5.77-5.97 (m, 1 H, =CH),
6.61 (br s, 1 H, NH).
l-B enzyl-2-hydrazinecarboxylic acid allyl ester (29). To a solution of allyl carbazate (27), (10.0 g,
86.2 mmol) in toluene (170 mL) was added benzaldehyde (9.1 mL, 90.5 mmol) and the mixture was stirred at rt 
for 18 h. Filtration and necrystallization (ethyl acetate/hexane/methanol 5:10:1) afforded the hydrazone 28 (16.5 g,
80.9 mmol, 94%) as while crystals, mp 147-148 *C. IR v 3400, 3340, 1730, 690; !H NMR (250 MHz) 8 4.64 
(d, J  = 5.4 Hz, 2 H, OCH2), 5.24-5.41 (m, 2 H, =CH2), 5.90-6.06 (m, 1 H, =CH), 7.24 (s, 1 H. ArH), 7.34 (m, 
2 H, ArH), 7.68 (m, 2 H, ArH), 7.86 (s, 1 H, NH), 8.01 (s, 1 H, N=CH). To a solution of pTSA (23.6 g, 124 
mmol) in THF (125 mL) was added dropwise in 2.5 h a solution of the hydrazone 28 (25.3 g, 124 mmol) and 
NaB^CN (9.18 g, 124 mmol) in THF (300 mL) and the mixture was stirred for one additional h at rt. The 
resulting mixture was diluted with ethyl acetate (600 mL) and extracted subsequently with aq satd NaCl (600 mL), 
aq satd NaHC03 (600 mL) and aq satd NaCl (600 mL). The organic layer was dried (MgSO^), filtered, 
concentrated in vacuo, taken up in 1 N NaOH (250 mL), stirred at ambient temperature for 1.5 h, neutralized with
2 M HC1 and extracted with CH2CI2 (3 x 100 mL). The combined organic layers were dried (MgSO^), filtered and 
concentrated in vacuo to afford 29 (25.3 g, 123 mmol, 99%) as a colorless oil, /?ƒ 0-45 (ethyl acetate/hexane 4:1). 
IR v 3440, 3340, 1710, 990, 930, 690; JH NMR (200 MHz) 8 4.00 (s, 2 H, CH2Ph). 4.25 (br s, 1 H, NH),
4.61 (d, J  = 5.5 Hz, 2 H, OCH2), 5.20-5.35 (m, 2 H, =CH2), 5.82-6.01 (m, 1 H, =CH), 6.44 (br s, 1 H, NH), 
7.26-7.36 (m, 5 H, ArH).
General procedure A for the alkylation reactions. To a solution of 25 or 29 in 2-butanone, EtOH or 
acetone were added the alkylating agent (1.1-2 equiv), K2CO3 (1.1-2 equiv) and a catalytic amount of Lil. After 
heating at reflux temperature for 18 h, the mature was concentrated in vacuo, taken up in H20  and extracted with
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CH2CI2 (3 x). The combined organic layers were dried (MgSO^), filtered, concentrated in vacuo and 
chromatographed to afford the pure alkylated hydrazine.
l-B enzyl-l-(2-propenyl)-2-hydrazinecarboxyU c acid ethyl ester (30). According to the general 
procedure A, 25 (1.20 g, 6.19 mmol) was alkylated by using allyl bromide (1.50 g, 12.4 mmol) and K2CO3 
(1.71 g, 12.4 mmol) in EtOH (100 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:1.8) afforded
30 (1.34 g, 5.73 mmol, 93%) as a colorless oil, R f  0.40. IR v 3435, 3320, 1730, 1700, 920; NMR (200 
MHz) 8 1.18 (t, J=  7.0 Hz, 3 H, CH2C% ), 3.40-3.50 (m, 2 H, NCH2), 3.97 (br s, 2 H, C//2Ph), 4.24 (q, J  = 
7.0, 2 H, C//2CH3), 5.17-5.26 (m, 2 H, =CH2), 5.66 (br s, 1 H, NH), 5.83-6.00 (m, 1 H, =CH), 7.29-7.33 (m, 
5 H, ArH).
l-B en zy l-l-(2 -p rop en y l)-2 -h yd razin ecarb oxy lic  acid a lly l ester (31). Following the general 
procedure A, 29 (3.00 g, 14.6 mmol) was alkylated by using allyl bromide (3.52 g, 29.1 mmol) and K2CO3 
(2.00 g, 14.6 mmol) in EtOH (100 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded
31 (3.20 g, 13.0 mmol, 89%) as a white solid, mp 34-36.5 *C, Rf  0.30. IR v 3430, 3330,1720,690; *H NMR 
(200 MHz) 5 3.45 (br s, 2 H, NCH2), 3.99 (br s, 2 H, CH2Ph), 4.52 (d, J  = 5.4 Hz, 2 H, OCH2), 5.15-5.28 (m,
4 H, 2 x =CH2), 5.76-6.03 (m, 3 H, 2 x =CH and NH), 7.30-7.35 (m, 5 H, ArH).
l-Benzyl-l-(2-m ethyl-2-propenyl)-2-hydrazinecarboxyIic acid allyl ester (32). According to the 
general procedure A, 29 (10.0 g, 48.5 mmol) was alkylated by using 3-chloro-2-methyl-2-propene (5.28 mL,
53.4 mmol) and K2CO3 (7.38 g, 53.4 mmol) in EtOH (250 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 1:4) afforded32 (9.81 g, 37.7 mmol, 78%) as a light yellow oil, R j 0.30. IR v 3440, 3340,1720, 
695; %  NMR (200 MHz) 5 1.83 (s, 3 H, CHj), 3.41 (br s, 2 H, NCH2), 4.02 (br s, 2 H, Cff2Ph), 4.53 (d, J  =
5.2 Hz, 2 H, OCH2), 4.90 (d, J  = 6.6 Hz, 2 H, C ^ H j), 5.16-5.28 (m, 2 H, CH=C//2), 5.75-5.95 (m, 2 H, 
=CH and NH), 7.26-7.38 (m, 5 H, ArH).
l-B enzyl-l-(3-m ethyl-2-butenyl)«2-hydrazinecarboxylic acid allyl ester (33). According to the 
general procedure A, 29 (7.04 g, 34.2 mmol) was alkylated by using 4-bromo-2-methyl~2-butene (5.60 g, 37.6 
mmol) and K2CO3 (5.20 g, 37.6 mmol) in EtOH (300 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 33 (2.89 g, 10.5 mmol, 66% (after correction)) as a light yellow oil, /?ƒ 0.40. IR v 
3440, 3340, 1725, 690; 'h  NMR (200 MHz) 8 1.63 (s, 3 H, CHj), 1.74 (s, 3 H, CH3), 3.45 (br s, 2 H, 
NCH2), 3.97 (br s, 2 H, Ctf2Ph), 4.52 (d, J  = 5.3 Hz, 2 H, OCH2), 5.14-5.36 (m, 3 H, =CH2 and NCHjCtf),
5.75-5.95 (m, 2 H, =CH and NH), 7.23-7.34 (tn, 5 H, ArH).
l-B e n z y M -(2-b u ten y l)-2-hydrazinecarboxylic acid a lly l ester (34). According to the general 
procedure A, 29 (10.0 g, 48.5 mmol) was alkylated by using 4-bromo-2-butene ((E)/(Z) 3.3:1) (5.28 mL, 53.4 
mmol) and K2CO3 (7.38 g, 53.4 mmol) in EtOH (250 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 34 (9.18 g, 35.3 mmol, 73%) as a light yellow oil, (E)/(Z) 3.3:1, R f  0.35. IR v 
3440, 3340, 1720, 690; *H NMR (200 MHz) 8 1.64 (d, J  = 6.4 Hz, 3 H, CH3(Z)), 1.70 (d, ƒ  = 5.0 Hz, 3 H, 
CH3(E)), 3.38 (br s, 2 H, NCH2), 3.95 (br s, 2 H, Ctf2Ph), 4.52 (d, J  = 5.3 Hz, 2 H, OCH-j), 5.14-5.26 (m, 2
H, =CH2), 5.45-5.92 (m, 4 H, =CH, NH and CH=CH), 7.26-7.32 (m, 5 H, ArH).
l-B en zy l-l-(3 -b u ten y l)-2 -h yd razin ecarb oxy lic  acid a lly l ester (35). According to the general 
procedure A, 29 (2.91 g, 14.1 mmol) was alkylated by using 4-bromo-l-butene (2.10 g, 15.5 mmol) and K2CO3 
(2.15 g, 15.5 mmol) in EtOH (150 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded
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35 (384 mg, 1.50 mmol, 39% (after correction)) as white crystals, mp 50-51 #C, /?ƒ 0.45. IR v 3440, 3340, 
1740, 690; ]H NMR (200 MHz) 8 2.26-2.34 (m, 2 H, NCH2C//2), 2.70-2.95 (br s, 2 H, NCH2), 3.80-4.15 (m,
2 H, Ctf2Ph), 4.55 (d, J  = 5.4 Hz, 2 H, OCH^, 4.98-5.21 (m, 4 H, 2 x  5.55-5.95 (m, 3 H. 2 x  =CH
and NH), 7.26-7.35 (m, 5 H, ArH).
l-BenzyI-l-(ethenyIidenem ethy!)-2-hydrazinecarboxylic acid allyl ester (36). According to the 
general procedure A, 29 (2.32 g, 11.3 mmol) was alkylated by using 4-iodo-l-(trimethylsilyl)-2-butyne1^  (4.09 
g, 12.4 mmol) and K^CO  ^ (1.71 g, 12.4 mmol) in EtOH (100 mL). Work-up and flash chromatography (ethyl 
acetate/hexane 1:5) afforded 36 (670 mg, 2.60 mmol, 23%) as an orange oil, R j  0.40. IR v 3440, 3340, 1950, 
1725, 690; ’h  NMR (200 MHz) S 3.64 (br s, 2 H, NCH^, 4.00 (br s, 2 H, C//2Ph), 4.54 (d, J  = 5.5 Hz, 2 H, 
OCH2), 4.76 (dt, J  = 6.5, 2.3 Hz, 2 H, C=CH2), 5.16-5.28 (m, 3 H, CH=Cff2 and Cff=C=€H2), 5.77-5.96 (m,
2 H, =CH and NH), 7.27-7.36 (m, 5 H, ArH).
l,l-D ibenzyl-2-hydrazinecarboxylic  acid ally! ester (37). According to the general procedure A, 27 
(15.0 g, 130 mmol) was alkylated by using benzyl chloride (29.7 mL, 260 mmol) and K2CO3 (36 g, 260 mmol) 
in EtOH (300 mL). Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded 37 (31.9 g, 110 mmol, 
83%) as a white solid, mp 52-54 "C, R ,  0.45. IR v 3440, 3340,1725,690; JH NMR (200 MHz) 8 3.96 (br s, 4 
H, 2 x C//2Ph), 4.49 (d, J  = 5.5 Hz, 2 H, OCH2), 5.12-5.19 (m, 2 H, =CH2), 5.73-5.92 (m, 2 H, =CH and 
NH), 7.24-7.32 (m, 10 H, ArH); Anal. Caled, for C18H20N2O2: C, 72.95; H, 6.80; N, 9.45. Found: C, 72.90; 
H, 6.75; N, 9.54.
l-B enzyl-l-{2-[(trim ethylsilyI)m ethyl]"2-propenyl}-2-hydrazinecarboxyH c acid allyl ester
(38). According to the general procedure A, 29 (3.42 g, 16.6 mmol) was alkylated by using 2-(chloromethyl)-3- 
(trimethylsilyl)-l-propene (2.97 g, 18.3 mmol) and K2CO3 (2.52 g, 18.3 mmol) in 2-butanone (175 mL). Work­
up and flash chromatography (ethyl acetate/hexane 1:4) afforded 38 (3.20 g, 9.60 mmol, 58%) as a colorless oil, 
R f  0.55. IR V 3440, 3340, 1720, 1240, 850, 690; *H NMR (200 MHz) 5 -0.04 (s, 9 H, (C T ^ Si), 1.69 (s, 2
H, CH2Si), 3.35 (br s, 2 H, NCH^, 4.03 (br s, 2 H, 4.53 (d, J  * 5.2 Hz, 2 H, OCH2), 4.68 (s, 1 H, 
C=CflH), 4.85 (s, 1 H, C=CHtf), 5.16-5.28 (m, 2 H, CH=CH2\  5.75-5.90 (m, 2 H, =CH and NH), 7.24-7.35 
(m, 5 H, ArH).
l-B en zy l-l-[4 -(tr im e th y ls ily I )-2 -b u te r iy I]-2 -h y d r a z in e c a rb o x y lic  acid  a lly l ester  (39). 
According to the general procedure A, 29 (1,40 g, 6.80 mmol) was alkylated by using 4-iodo-1 -(trimethylsilyl)-2- 
butyne1  ^ (1.88 g, 7.50 mmol) and K2C03 (1.03 g, 7.50 mmol) in acetone (50 mL) by stirring at rt for 18 h. 
Work-up and flash chromatography (ethyl acetate/hexane 1:6) afforded 39 (1.82 g, 5.50 mmol, 81%) as a colorless 
oil, R f  0.35. IR v 3440, 3340, 2190, 1730, 1240, 850, 690; XH NMR (200 MHz) 8 0.16 (s, 9 H, (C ^ ^ S i),
I.56 (t, J  = 2.4 Hz, 2 H, CH2Si), 3.60 (t, J  = 2.3 Hz, 2 H, NCH^, 3.90 (s, 2 H, CH2Ph), 4.54 (dt, J  = 5.5,1.3 
Hz, 2 H, OCH2), 5.15-5.29 (m, 2 H, = 0 1 ^ , 5.77 (m, 2 H, =CH and NH), 7.26-7.41 (m, 5 H, ArH).
l-B enzyl-l-[(¿?)-3-(trim ethylsilyI)-2-propenyl)-2-hydrazinecarboxyl¡c acid allyl ester (40).
According to the general procedure A, 29 (6.23 g, 30.2 mmol) was alkylated by using (E)-3-bromo-l“ 
(trimethylsilyl)-1 -propene 76 (4.09 g, 21.2 mmol) and K2CX>3 (4.18 g, 30.2 mmol) in 2-butanone (250 mL). 
Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded 40 (5.93 g, 18.6 mmol, 88%) as a colorless 
oil, /?ƒ 0.50. IR V 3440, 3340,1740, 1245, 835,690; JH NMR (200 MHz) 8 0.06 (s, 9 H, (C H ^Si), 3.48 (br 
s, 2 H, NCH2), 3.98 (br s, 2 H, Ctf2Ph), 4.52 (d, J  = 5.0 Hz, 2 H, OCH2), 5.15-5.27 (m, 2 H, =CH2), 5.70-
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5.93 (m, 2 H, C//=CH2, NH and CHSi), 6.12 (dt, J = 18.6, 5.8 Hz, 1 H, CH2Ctf), 7.27-7.35 (m, 5 H, ArH).
l-B enzyl-l-[(Z )*3-(trim ethylsily l)-2-propenyl)-2-hydrazinecarboxylic  acid ally 1 ester (41). 
According to the general procedure A, 29 (3.71 g, 18.0 mmol) was alkylated by using 3-bromo-1 -(trimethylsilyl)-
1-propene 78 (2.31 g, 12.0 mmol, (£)/(Z) 1:2.5) and K2CC>3 (2.65 g, 19.2 mmol) in 2-butanone (130 mL). 
Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded 41 (1.97 g, 6,19 mmol, 52%) as a colorless 
oil, (£)/(Z) 1:1.9, R f  0.50. IR v 3440, 3340, 1740, 1245, 835, 690; *H NMR (250 MHz) 5 0.07 (s, 9 H, 
(CH3)3Si), 3.55 (br s, 2 H, NCH2), 4.00 (br s, 2 H, CH2Ph), 4.52 (d, J  = 4.8 Hz, 2 H, OCH2), 5.18-5.28 (m, 2
H, =CH2), 5.75-5.88 (m, 2 H, C//=CH2, NH and CHSi), 6.41 (dt, J  = 14.3, 7.2 Hz, 1 H, CH2CH), 7.27-7.35 
(m, 5 H, ArH).
l-B enzyI-l-[(3 ,3»d im ethyl-5-oxo-2 ,4-d iox-6-enyl)m ethyl]-2-hydrazinecarboxylic  acid ally 1 
ester (42). According to the general procedure A, 29 (4.95 g, 24.0 mmol) was alkylated by using 6- 
(chloromelhyl)-2,2-dimethyl-l,3-dioxen-4-one ( 7 9 ( 4,44 g, 25.2 mmol) and K2CC>3 (3.48 8* 25.2 mmol) in 
acetone (250 mL) at 45 °C for 36 h. Work-up and flash chromatography (ethyl acetate/hexane 1:2) afforded 42 
(4.36 g, 12.6 mmol, 55%) as a light yellow oil, R f  0.40. IR v 3440, 3350,1725, 1635, 690; XH NMR (200 
MHz) S 1.66 (s, 6 H, (CH3)2C), 3.66 (br s, 2 H, NCH2), 4.09 (br s, 2 H, C//2Ph), 4.52 (d, J  = 4.1 Hz, 2 H, 
OCH2), 5.17-5.27 (m, 2 H, =CH2), 5.55 (s, 1 H, C=CH), 5.75-5.95 (m, 1 H, CH2=Cfl), 6.30 (br s, 1 H, NH), 
7.31 (br s, 5 H, ArH); 13C NMR (50 MHz) 8 25.0 ((CH3)2C), 56.6 (CH2Ph), 63.5 (NCH2), 94.8 (C=CH),
106.8 (OCO), 118.1 (CH=CH2), 127.9, 128.6,129.2 (ArH), 132.2 (CH2=CH), 135.0 (AiC), 160.9, 167.0 (=C 
and C(0)).
é
General procedure B for the reactions with m ethyl glyoxylate. To a solution of the alkylated 
hydrazine in toluene was added at rt an excess of freshly distilled methyl glyoxylate.^ After complete reaction 
(according to TLC), the solution was concentrated in vacuo, The residue was taken up in pyridine and treated with 
an excess of acetic anhydride and a catalytic amount of DMAP. After being stirred at rt for 18 h, the dark brown 
solution was concentrated in vacuo and purified by flash chromatography to afford the pure product
a-A cetoxy-“l-benzyl-2-(ethoxycarbonyl)-l-(2-propenyl)-2-hydrazineacetic acid m ethyl ester
(43). Following the general procedure B, a solution of 30 (1.34 g, 5.73 mmol) in toluene (40 mL) was reacted 
with methyl glyoxylate (2.00 g, 11,5 mmol) for 4 h and acetylated with Ac^O (2.71 mL, 28.7 mmol) in pyridine 
(30 mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 43 (1.73 g, 4.76 
mmol, 83%) as a colorless oil, R f  0.30. IR v 1760, 1740, 1715, 1230, 690; !H NMR (200 MHz) 8 (some 
signals appear as rotamers) L26 (br s, 3 H, CH2C//3), 1.98, 2.00 (s, 3 H, C(0 )CH3), 3.58 (br s, 2 H, NCH2), 
3.67, 3.73 (s, 3 H, C 02CH3), 4.25 (br s, 4 H, CH2Ph and C//2CH3), 4.98-5,14 (m, 2 H, ^CH2), 5.24-5.99 (m,
1 H, =CH), 6.54, 6.56 (s, 1 H, NCH), 7,22-7.33 (m, 5 H, ArH).
a-A cetoxy-l-(anyloxycarbonyl)-2-benzyl-2-(2-propenyl)hydrazineacetic  acid m ethyl ester
(44). Following the general procedure B, a solution of 31 (3.20 g, 13.0 mmol) in toluene (100 mL) was reacted 
with methyl glyoxylate (2.29 g, 26.0 mmol) for 4 h and acetylated with Ac20  (6.15 mL, 65.0 mmol) in pyridine 
(100 mL). Concentration in vacuo and flash chromatography (ethyl acetates/hexane 1:5) afforded 44 (4.45 g, 11.8 
mmol, 91%) as a colorless oil, /?ƒ 0.45. IR v 1760, 1740, 1710, 1360, 690; *H NMR (200 MHz) 5 (some 
signals appear as rotamers) 1.97, 2.00 (s, 3 H, C(0 )CH3), 3.50-3.81 (m, 2 H, NCH^, 3.66, 3.73 (s, 3 H, 
C02CH3), 4.17-4.25 (m, 2 H, C//2Ph), 4.68 (br s, 2 H, OCH2), 4.98-5.34 (m, 4 H, 2 x  =CH2), 5.54-6.03 (m,
2 H, 2 x =CH), 6.55, 6.57 (s, 1 H, NCH), 7.21-7.33 (m, 5 H, ArH).
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a -A c e to x y - l- (a lly lo x y c a r b o n y l)-2-b en zy l-2-(2-m eth y l-2-p rop en y i)h yd razin eacetic  acid  
m ethyl ester (45). Following the general procedure B, a solution of 32 (4.00 g, 15.4 mmol) in toluene (150 
mL) was reacted with methyl glyoxylate (9.5 g, 0.11 mol) for 18 h and acetylated with Ai^O (7.3 mL, 0.08 mol) 
in pyridine (150 mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:5) afforded 45 
(5.88 g, 15.1 mmol, 98%) as a colorless oil, R f  0.30. IR v 1760,1740,1720, 690; lHNMR (250 MHz) 5 1.80 
(s, 3 H, CH3), 1.91 (s, 3 H, C(0)CH3), 3.41-3.74 (m, 2 H, NCH2), 3.64 (s, 3 H, C02CH3), 3.95-4.25 (m, 2
H, Ctf2Ph), 4.60 (br s, 2 H, OCH2), 4.80-4.90 (m, 2 H, C=CH2), 5.10-5.45 (m, 2 H, CH=C//2), 5.75-6.05 (m, 
1 H, =CH), 6.44 (br s, 1 H, NCH), 7.20-7.33 (m, 5 H, ArH).
a-Acetoxy-l-(aIlyloxycarbonyl)-2-benzyl-2-(3-m etbyl-2-butenyI)taydraziiieacetic acid methyl 
ester (46). According to the general procedure B, a solution of 33 (800 mg, 2.90 mmol) in toluene (30 mL) 
was reacted with methyl glyoxylate (2.6 g, 29 mmol) for 18 h and acetylated with AC2O (2.76 mL, 29 mmol) in 
pyridine (50 mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 46 (670 
mg, 1.70 mmol, 57%) as a colorless oil, R f  0.40. IR v 1760, 1735, 1715, 690; *H NMR (250 MHz) 6 1.53-
I.73 (m, 6 H, (CH3)2C), 1,98 (s, 3 H, C(0 )CH3), 3.40-3.75 (m, 5 H, NCH2 and CO2CH3), 4.10-4.25 (m, 2 H, 
Ctf2Ph), 4.60-4.80 (m, 2 H, OCH2), 5.15-5.45 (m, 3 H, =CH2 and C=CW), 5.75-6.05 (m, 1 H, CH2=Ctf), 6.51 
(s, 1 H, NCH), 7.19-7.34 (m, 5 H, ArH).
a-A cetoxy-l-(aIIyIoxycarbonyI)-2-b en zyl-2-(2-b iite iiy l)hyd raziiieacetic  acid m ethyl ester
(47). Following the general procedure B, a solution of 34 (3.00 g, 11.5 mmol) in toluene (120 mL) was reacted 
with methyl glyoxylate (7.1 g, 80 mmol) for 4 h and acetylated with Ac20  (7.5 mL, 80 mmol) in pyridine (125 
mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 47 (3.70 g, 9.5 mmol, 
82%) as a colorless oil, R f  0.30. IR v 1760,1710, 690; !H NMR (300 MHz) 8 (mixture of isomers) 1.58,1.64 
(m, 3 H, CH3), 2.01,2.05 (s, 3 H, C(0 )CH3), 3.50-3.73 (m, 2 H, NCH2), 3.66, 3.74 (s, 3 H, C0 2CH3), 4.10-
4.25 (m, 2 H, Ctf2Ph), 4.60-4.75 (m, 2 H, OCH2), 5.23-5.35 (m, 2 H, =CH2), 5.48-5.57 (m, 2 H, CH=CH),
5.80-6.10 (m, 1 H, CH2=Ctf)> 6.54 (s, 1 H, NCH), 7.22-7.33 (m, 5 H, ArH).
a -A cetoxy-l-(aIlyIoxycarb on yl)-2 -b en zy l-2 -(3 -b u ten yl)h yd razin eacetic  acid m ethyl ester
(48). Following the general procedure B, a solution of 35 (384 mg, 1.48 mmol) in toluene (15 mL) was reacted 
with methyl glyoxylate (650 mg, 7.4 mmol) for 5 h and acetylated with Ac20  (0.70 mL, 7.38 mmol) in pyridine 
(15 mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 48 (279 mg, 0.72 
mmol, 48%) as a colorless oil, /?ƒ 0.45. IR V 1765, 1740, 1715, 690; %  NMR (200 MHz) 5 (some signals 
appear as rotamers) 2.03, 2.06 (s, 3 H, C(0)CH3), 2.25-2.35 (m, 2 H, NCH2Ctf2), 2.75-3.35 (m, 2 H, NCH2), 
3.70, 3.73 (s, 3 H, C 02CH3), 4.10-4.30 (m, 2 H, C//2Ph), 4.68 (br s, 2 H, OCH2), 4.88-5.03 (m, 2 H, =CH2),
5.20-5.45 (m, 2 H, =CH2), 5.50-6.00 (m, 2 H, 2 x =CH), 6.54 (s, 1 H, NCH), 7.22-7.40 (m, 5 H, ArH).
a-A cetoxy-l-(allyloxycarbonyl)-2-benzyl-2-(ethenyIidenem ethyl)hydrazineacetic acid methyl 
ester (49). Following the general procedure B, a solution of 36 (530 mg, 2.10 mmol) in toluene (25 mL) was 
reacted with methyl glyoxylate (720 mg, 8.2 mmol) for 4 h and acetylated with AC2O (0.97 mL, 10.3 mmol) in 
pyridine (25 mL). Concentration in vacuo and flash chromatography (ethyl acetale/hexane 1:6) afforded 49 (660 
mg, 1.70 mmol, 83%) as a yellow oil, Rjr 0.40. *H NMR 8 (some signals appear as rotamers) 2.01 (s, 3 H, 
C(0)CH3), 3.48-3.91 (m, 2 H, NCH2), 3.68, 3.74 (s, 3 H, C 02CH3), 4.05-4.40 (m, 2 H, C//2Ph), 4.55^.95 
(m, 4 H, OCH2 and C=CH2), 5.10-5.50 (m, 3 H, CH=Ctf2 0 = 0 /) , 5.75-6.10 (m, 1 H, C H ^ /Q , 6.57,
6.60 (s, 1 H, NCH), 7.26-7.34 (m, 5 H, ArH).
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a-A cetoxy-l-(aIlyloxycarbonyI)-2,2-dibenzylhydrazineacetic acid methyl ester (50). According 
to the general procedure B, a solution of 37 (10.0 g, 33.8 mmol) in toluene (200 mL) was reacted with methyl 
glyoxylate (5.95 g, 68 mmol) for 40 h and acetylated with Ac^O (16.0 mL, 169 mmol) in pyridine (200 mL). 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 50 (14.3 g, 33.6 mmol, 
99%) as a colorless oil. R t  0.30. IR v 1760, 1735, 1715, 1220, 690; NMR (200 MHz) 8 1.77 (br s, 3 H, 
C(0)CH3), 3.57 (s, 3 H, C 02CH3), 4.10-4.41 (m, 4 H, 2 x CW2Ph), 4.69 (br s, 2 H, OCH2), 5.15-5.40 (m, 2
H, =0% ), 5.60-6.10 (m, 1 H, =CH), 6.42 (s, 1 H, NCH), 7.21-7.37 (m, 10 H, ArH).
a-A cetoxy-l-(alIyloxycarbonyl)-2-benzyl-2-{2-(trim ethylsilyl)m ethyl]-2"propenyI}hydrazine- 
acetic acid m ethyl ester (51). Following the general procedure B, a solution of 38 (1.00 g, 3.01 mmol) in 
toluene (30 mL) was reacted with methyl glyoxylate (2.65 g, 30.1 mmol) for 18 h (2 x) and acetylated with A^O  
(1.42 mL, 15.1 mmol) in pyridine (30 mL). Concentration in vacuo and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 51 (1.10 g, 2.38 mmol, 79%) as a colorless oil, /?ƒ 0.50. IR v 1760, 1735, 1715, 
1240, 850, 690; 1 H NMR (200 MHz) 8 (some signals appear as rotamers) -0.10, -0.09 (s, 9 H, (CH3)3Si),
I.43, 1.63 (s, 2 H, CH2Si), 1.91 (s, 3 H, C(0)CH3), 3,25-3.70 (m, 2 H, NCH2), 3.66 (s, 3 H, C 02CH3), 3.85-
4.35 (m, 2 H, Ctf2Ph), 4.50-4.75 (m, 3 H, OCH2 and G=CtfH), 4.88 (s, 1 H, C=CHtf), 5.15-5.50 (m, 2 H, 
CH=CH2)t 5.75-6.10 (m, 1 H, =CH), 6.42 (s, 1 H, NCH), 7,22-7.34 (m, 5 H, ArH),
a -A cetoxy-l-(aIlyIoxycarb on y l)-2 -b en zy l-2 -[4 -(tr im eth y lsily l)-2 -b u tyn y l]h yd razin eacetic  
acid methyl ester (52). According to the general procedure B, a solution of 39 (150 mg, 0.45 mmol) in 
toluene (5 mL) was reacted with methyl glyoxylate (9.5 g, 0.11 mol) for 4 h at 80 #C and acetylated with Ac^O 
(220 \±L, 2.27 mmol) in pyridine (5 mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 
1:6) afforded 52 (170 mg, 0.37 mmol, 82%) as a light yellow oil, R j  0.35. IR v 2210,1765,1735,1715,1245, 
845, 690; *H NMR 8 (some signals appear as rotamers) 0.08, 0.09 (s, 9 H, (CH3)3Si), 1.40-1.55 (m, 2 H, 
CH2Si), 1.75-2,00 (m, 3 H, C(0)CH3), 3.55-3.95 (m, 5 H, NCH2 and C02CH3), 4.24 (br s, 2 H, C//2Ph),
4.66 (m, 2 H, OCH2), 5.15-5.36 (m, 2 H, =CH2), 5.82-5.96 (m, 1 H, =CH), 6.50 (s, 1 H, NCH), 7.26-7.37 (m,
5 H, ArH).
a -A cetoxy-l-(a lly ioxycarb on y l)-2 -b en zy l-2 -[(E )-3 -(tr im eth y lsily l)-2 -p rop en y l)h yd razin e-  
acetic acid methyl ester (53)* Following the general procedure B, a solution of 40 (5.93 g, 18.6 mmol) in 
toluene (200 mL) was reacted with methyl glyoxylate (13.1 g, 150 mmol) for 42 h and acetylated with Ac^O 
(17.6 mL, 0.19 mol) in pyridine (200 mL). Concentration in vacuo and flash chromatography (ethyl 
acetate/hexane 1:3) afforded 53 (6.20 g, 13.8 mmol, 74%) as a light yellow oil, R f  0.50. IR v 1765,1700,1240, 
840, 690; *H NMR (200 MHz) 8 (some signals appear as rotamers) -0.06, 0.00 (s, 9 H, (CH3)3Si), 2.00, 2.05 
(s, 3 H, C(0)CH3), 3.68 (br s, 2 H, NCH2), 3.75 (s, 3 H, C 02CH3), 4.05-4.25 (m, 2 H, C//2Ph), 4.55-4.80 
(m, 2 H, OCH2), 5.15-5.50 (m, 2 H, =CH2), 5.68-5.77 (m, 2 H, CH=CH), 5.80-6.15 (m, 1 H, CH2=C/Z), 6.50,
6.60 (s, 1 H, NCH), 7.24-7.32 (m, 5 H, ArH).
♦
a-A cetoxy-l-(a lly loxycarb on y l)-2 -b en zy!-2 -[(Z )-3 -(tr im eth y lsily l)-2 -p rop en y l)h yd razin e-
acetic acid m ethyl ester (54). Following the general procedure B, a solution of 41 (1.95 g, 6.13 mmol) in 
toluene (60 mL) was reacted with methyl glyoxylate (2.70 g, 30.7 mmol) for 42 h and acetylated with Ac20  (5.8 
mL, 61 mmol) in pyridine (60 mL). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) 
afforded 54 (2.17 g, 4.84 mmol, 79%) as a light yellow oil, (£)/(Z) 1:1.2, R f  0.50. IR v 1760, 1740, 1720, 
1240, 835, 690; %  NMR (250 MHz) 8 0.05 (s, 9 H, (CH3)3Si), 1.94 (s, 3 H, C(0)CH3), 3.64 (br s, 2 H,
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NCH2), 3.70 (s, 3 H, C 02CH3), 4.05-4.22 (m, 2 H, C//2Ph), 4.65-4.75 (m, 2 H, OCH2), 5.15-5.35 (m, 2 H, 
=CH2), 5.40-6.00 (m, 2 H, CHSi and =CH), 6.42 (dt, J  = 14.3, 7.2 Hz, 1 H, CH2C//)» 6.63 (s, 1 H, NCH), 
7.22-7.32 (m, 5 H, ArH).
a -A c e  t o x y - 1 - ( a l ly  lo x y  c a r  b o n y  l ) - 2 - b e n z y l - 2 - [ ( 3 ,3 -d im e  th y  l - 5 - o x o - 2 , 4 - d i o x - 6 - 
enyl)m ethyl]hydrazineacetic acid methyl ester (55). According to the general procedure B, a solution 
of 42 (2.22 g, 6.40 mmol) in toluene (100 mL) was reacted with methyl glyoxylate (13.1 g, 150 mmol) for 18 h 
(2 x) and acetylated with Ac20  (3.03 mL, 32 mmol) in pyridine (80 mL). Concentration in vacuo and flash 
chromatography (ethyl acetate/hexane 1:2) afforded 55 (2.01 g, 4.20 mmol, 66%) as a light yellow oil, R j  0.30. 
IR v 1760» 1700, 1635, 690; 1 H NMR (200 MHz) 8 (some signals appear as rotamers) 1.55 (s, 3 H, CH3),
1.59, 1.60 (s, 3 H, CH3), 1.98 (s, 3 H, C(0)CH3), 3.55-3.90 (m, 2 H, NCH2), 3.71, 3.74 (s, 3 H, C 02CH3),
4.04-4.35 (m, 2 H, CH2Ph), 4.60-4.85 (m, 2 H, OCH2), 5.20-5.40 (m, 3 H, =CH2 and C=CH), 5.75-6.05 (m, 1 
H, CH2=Ctf), 6.58, 6.60 (s, 1 H, CH), 7.26-7.31 (m, 5 H, ArH); MS (El, 70 eV) mtz (relative intensity) 476 
(M+, 1), 349 (57), 335 (6), 275 (11), 188 (36), 91 (100); HRMS calcd for C ^ H ^ N ^  476.1795, found 
476.1749.
General procedure C for the cyclization reactions with Lewis acids. To a 0.1 M solution of the 
hydrazide in CH2C12 was added TÍCI4, SnCl4 (2 equiv of a solution in CH2C12) or Et2AlCl (2 equiv of a 1.0 M 
solution in toluene) at -78 *C by a syringe. The mixture was stirred at -78 #C for 15 min and for 5-18 h at rt. The 
reaction mixture was poured into cold aq satd NaHC03 and the resulting suspension was filtered over Celite and 
extracted with CH2C12 (3 x). The combined organic layers were dried (MgSC^), filtered and concentrated in  
vacuo. Purification of the residue by flash chromatography afforded the pure cyclization product(s).
r« /-(3S ,55)-l-B enzyI-2-(ethoxycarbonyl)-5-(ch lorom ethyI)-3-pyrazoH dinecarboxylic  acid  
m ethyl ester (trans-56 ). Following the general procedure C, a solution of 43 (1.23 g, 3.38 mmol) in 
CH2C12 (33 mL) was cyclized by using TÍCI4 (5.63 mL of a 1.2 M solution, 6.76 mmol). Work-up and flash 
chromatography (ethyl acetate/hexane 1:2) afforded 56 (777 mg, 2.37 mmol, 70%) as a colorless oil, c/tr\:5*Rf 
0.25. irons-56: IR V 1740, 1680, 1375, 690; *H NMR 8 1.22 (t, J  = 7.1 Hz, 3 H, CH2C//3), 2.46-2.66 (m, 2 
H, 2 x H4), 3.11 (dd, J  = 8.8,10.6 Hz, 1 H, C//HC1), 3.31-3.44 (m, 2 H, CHHCl and H5), 3.72 (d, J  = 13.7 Hz, 
1 H, CtfHPh), 3.82 (s, 3 H, C 02CH3), 4.13 (q, J  = 7.1 Hz, 2 H, CH2CH3), 4.22 (d, J  = 14.1 Hz, 1 H, 
CHMPh), 4.65 (t, J = 8.8 Hz, 1 H, H3), 7.27-7.47 (m, 5 H, ArH); 13C NMR (63 MHz) 8 14.5 (CH2CH3), 31.9 
(C4), 45.0 (CH2C1), 52.6 (C0 2CH3), 59.3 (C3), 62.0 (CH2Ph), 62.1 (Ctf2CH3), 64.2 (C5), 127.7, 128.6,
129.5 (ArHD, 137.1 (ArC), 172.8 (C(O)).
re/-(3S ,5S)-2-(A lly loxycarbonyl)-l-benzyl-5-(ch lorom ethyl)-3-pyrazoH dinecarboxylic acid  
methyl ester (tra n s-S l) . According to the general procedure C, a solution of 44 (500 mg, 1.33 mmol) in 
CH2C12 (13 mL) was cyclized by using S11CI4 (1.33 mL of a 2.0 M solution, 2.66 mmol). Work-up and flash 
chromatography (ethyl acetate/hexane 1:4) afforded 57 (352 mg, 1.00 mmol, 75%) as a colorless oil, dtr 1:5, /?ƒ 
0.25. trans-ST: IR v 1740, 1680, 1375, 690; !HNMR 8 2.46-2.72 (m, 2 H, 2 x  H4), 3.11 (dd, J  = 8.8, 10.6 
Hz, 1 H, CHHC1), 3.31-3.44 (m, 2 H, CHtfCl and H5), 3.80 (d, J  = 12.6 Hz, 1 H, CHHPh), 3.81 (s, 3 H, 
C 02CH3), 4.24 (d, J  = 12.6 Hz, 1 H, CHHPh), 4.50-4.60 (m, 2 H, OCH2), 4.67 (t, J  = 8.8 Hz, 1 H, H3), 5.17-
5.35 (m, 2 H, =CH2), 5.79-5.97 (m, 1 H, =CH), 7.27-7.47 (m, 5 H, ArH); 13C NMR (50 MHz) 8 31.9 (C4),
45.0 (CH2C1), 52.6 (C02CH3), 59.4 (C3), 62.1 (CH2Ph), 64.1 (C5), 66.4 (OCH2), 117.5 (=CH2), 127.7,





(CH2C1), 52.4 (C0 2CH3), 58.6 (C3), 60.6 (CH2Ph), 64.0 (C5), 66.4 (OCH^, 117,7 («CH^, 127.8, 128.4,
129.4 (ArH), 132.4 (=CH), 136.2 (ArQ, 171.6 (C(0)).
C yclization of 45 with S11CI4 . Following the general procedure, a solution of 45 (1.59 g, 4.07 mmol) in 
CH2C12 (40 mL) was cyclized by using SnCl  ^ (6.78 mL of a 1.2 M solution, 8.13 mmol). Work-up and flash 
chromatography (ethyl acetate/hexane 1:5) afforded r tf/-(3 S ,5 S )-2 « (a lly Io x y ca rb o n y l)-l-b en zy l-5 -  
chloro-5-m ethylhexahydro-3-pyridazinecarboxyIic acid methyl ester (trans-59 ) (479 mg, 1.32 
mmol, 32%) as a colorless oil, Rjr 0.40 and j,* /- (3 S ,5 S ) -2 - (a lly lo x y c a r b o n y I ) - l-b e n z y I -5 -  
(chlorom ethyl)-5-m ethyl-3-pyrazolidinecarboxyHc acid methyl ester (trans-SS) (559 mg, 1.50 
mmol, 38%) as a colorless oil, R f  0.20. trans-59: IR v 1735,1700,690; l H NMR (200 MHz) 8 1.51 (s, 3 H, 
CH3), 2.35 (br s, 2 H, 2 x  H4), 2.86 (d, J  = 13.5 Hz. 1 a  H6), 3.20 ( d , /=  13.5 Hz, 1 H, H6), 3.76 (s, 3 H, 
C02CH3), 4.30 (d, /  = 14.0 Hz, 1 H, CflHPh), 4.41 (d, J  -  14.0 Hz, 1 H, CHHPh), 4.63-4.65 (m, 2 H, OCHn,),
4.704.90 (m, 1 H, H3), 5.22-5.36 (m, 2 H, =CH2), 5.68-6.05 (m, 1 H, =CH), 7.26-7.40 (m, 5 H, ArH); 13C 
NMR (50 MHz) 5 30.6 (CH3), 40.0 (C4), 52.3 (C02CH3), 52.5 (C3), 60.2 (CH2Ph), 66.8 (OCH^, 118.3 
(=CH2), 127.8, 128.2, 129.2 (ArH), 132.2 (=CH), 137.7 (AiC); MS (El, 70 eV) mlz (relative intensity) 366 
(M+, 6), 331 (14), 281 (8), 231 (5), 160 (41), 91 (100); HRMS calcd for C18H23N20 4C1 366.1346, found 
366.1318. trans-SS: IR v 1745, 1685, 690; *H NMR (200 MHz) 8 1.43 (s, 3 H, CHj), 2.19 (dd, J  = 13.2 Hz,
10.6 Hz, 1 H, H4), 2.88 (dd, J=  13.2,8.9 Hz, 1 H, H4), 3.18 (d ,/=  11.3 Hz, 1 H, CHHCI), 3.37 (d, J  = 11.3,1 
H, CH//C1), 3.82 (s, 3 H, C 02CH3), 4.00 (d, J  = 13.2 Hz, 1 H, CHHPh), 4.11 (d ,/=  13.2 Hz, 1 H, NCHHPh), 
4.41-4.55 (m, 3 H, H3 and OCH2), 5.10-5.23 (m, 2 H, =CH2), 5.55-5.80 (m, 1 H, =CH), 7.22-7.53 (m, 5 H, 
ArH); 13C NMR (63 MHz) 8 19.7 (CH3), 37.1 (C4),49.2 (CH2Cl), 52.5 (C02CH3), 58.1 (CH2Ph), 59.6 (C3),
66.4 (C9), 69.3 (C5), 118.2 (=CH2), 127.0,128.0, 129.4 (ArH), 132.3 (=CH), 138.0 (ArC), 172.6 (C(0)); MS 
(El, 70 eV) mlz (relative intensity) 366 (M+, 45), 331 (31), 317 (14), 281 (18), 231 (31), 91 (100); HRMS calcd 
forClgH23N20 4Cl 366.1346, found 366.1381.
C yclization o f 45 with E t2AlCL Following the general procedure C, a solution of 45 (982 mg, 2.52 
mmol) in CH2C12 (25 mL) was treated with Et2AlCl (7.55 mL of a 1.0 M solution in toluene, 7.55 mmol). 
Work-up and flash chromatography (ethyl acetate/hexane 1:5) afforded trans-59 (488 mg, 1.33 mmol, 53%) as a 
colorless oil, trans-SS (178 mg, 0.49 mmol, 19%) as an inseparable mixture with cis-59 (59 mg, 0.16 mmol, 
6%) and cis-58 (76 mg, 0.21 mmol, 8%) as a colorless oil, R f  0.20. cis-S9: *H NMR (300 MHz) 8 1.30 (s, 3 
H, CH3), 2.06 (dd, J  = 14 5, 7.2 Hz, 1 H, H4)f 2.86-2.88 (m, 2 H, H4 and H6), 3.02 (d, J  = 14.7 Hz, 1 H, H6),
3.82 (s, 3 H, C0 2CH3), 4.01 (d, ƒ=13.0 Hz, 1 H, CtfHPh), 4.10 (d, J  = 13.0 Hz, 1 H, CH/TPh), 4.15-4.90 (m,
3 H, OCH2 and H3), 4.95-5.40 (m, 2 H, =CH2), 5.92-6.03 (m, 1 H, =CH), 7.20-7.52 (m, 5 H, ArH); 13C NMR 
(50 MHz) 8 30.8 (CH3), 40.0 (C4), 52.3 (C02CH3), 57.9 (CH2Ph), 59.6 (C6), 59.7 (C3), 63.0 (C5), 67.0 
(OCH2), 117.6 (=CH2), 127.2, 128.2, 129.6 (ArH), 132.5 (=CH), 138.1 (AiC), 172.6 (C(0)). cis-SZ: IR v 
1745,1685,690; !H NMR (200 MHz) 8 1.27 (s, 3 H, CH3), 2.37-2.43 (m, 2 H, 2 x  H4), 3.51 (d, J  = 11.2 Hz, 
1 H, C//HC1), 3.76 (d, J  = 11.2 Hz, 1 H, CH//CI), 3.79 (s, 3 H, C 02CH3), 3.96 (s, 2 H, C//2Ph), 4.25-4.45 
(m, 2 H, OCH2), 4.50-4.70 (m, 1 H, H3), 5.09-5.21 (m, 2 H, =CH2), 5.55-5.80 (m, 1 H, =CH), 7.24-7.49 (m,
5 H, ArH); %  NMR (250 MHz, 50 *C) 8 1.25 (s, 3 H, CH3), 2.30-2.44 (m, 2 H, 2 x  H4), 3.47 (d, J  = 11.3 Hz, 
1 H, CtfHCl), 3.73 (d, J  = 11.3 Hz, 1 H, CHHC1), 3.78 (s, 3 H, C 02CH3), 3.97 (s, 2 H, C//2Ph), 4.25-4.45 
(m, 2 H, OCH2), 4.57 (dd, / =  9.1, 7.7 Hz, 1 H, H3), 5.08-5.20 (m, 2 H, =CH2), 5.60-5.80 (m, 1 H, =CH),
7.18-7.47 (m, 5 H, ArH); 13C NMR (50 MHz) 8 22.3 (CH3), 38.4 (C4), 48.8 (CH2C1), 52.5 (C02CH3), 56.9 
(CH2Ph), 59.5 (C3), 66.3 (OCH2), 68.4 (C5), 117.4 (=CH2), 127.2, 128.0, 129.6 (ArH), 132.4 (=CH), 137.3 
(ArC), 173.1 (C(0)); MS (El, 70 eV) mlz (relative intensity) 366 (M+, 68), 331 (10), 317 (20), 307 (6), 281
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(35), 255 (9), 231 (59), 91 (100); HRMS calcd for C jg l^ ^ C ^ C l 366.1346, found 366.1387.
re I - (3 5  , 5S ) - 2 - ( A l I y l o x y c a r  b o n y l ) - l - b e n z y I - 5 - i o r m y l o x y - 5 - m e t h y l h e x a h y d r o - 3 -
pyridazinecarboxylic acid methyl ester (60). A solution of 45 (565 mg, 1.45 mmol) in HCOOH (15 
mL) was stirred for 18 h at rt. Concentration in vacuo and purification by flash chromatography (ethyl 
acetate/hexane 1:4) afforded60 (369 mg, 0.98 mmol, 68%) as a colorless oil, R r 0.30. IR v 1740,1700,690; 
NMR (200 MHz) 6 1.51 (s, 3 H, CH3), 2.20-2.40 (m, 1 H, H4), 2.40-2.60 (m, 1 H, H4), 2.87 (d, J = 13.7 Hz, 
1 H, H6), 3.38 (d, J  = 13.7 Hz, 1 H, H6), 3.74 (s, 3 H, C 02CH3), 4.20 (d ,/=  13.7 Hz, 1 H. CW2Ph), 4.27 (d, 
J  = 13.7 Hz, 1 H, CH2Ph), 4.64 (d, J  = 5.5 Hz, 2 H, OCH2 and br s, 1 H, H3), 5.22-5.36 (m, 2 H, =CH2),
5.80-6.05 (m, 1 H, =CH), 7.22-7.33 (m, 5 H, ArH), 7.91 (s, 1 H, CHO); 13C NMR (50 MHz) 8 24.4 (CH3),
34.9 (C4), 52.2 (C02CH3), 54.5 (C3), 56.7 (CH2Ph), 61.0 (C6), 66.6 (OCH2), 79.4 (C5), 118.1 (=0% ),
127.3, 128.1, 128.9 (ArH), 132.2 (=CH), 137.6 (ArC), 157.0,159.7,172.0 (3 x C(0)); MS (El, 70 eV) mlz 
(relative intensity) 376 (M+ , 43), 331 (14), 317 (7), 259 (13), 245 (26), 91 (100); HRMS calcd for 
C19H24N2°6C1 376.1634, found 376.1609.
r*/-(3S,4S)-2-(AUyloxycarbonyI)-l-benzyl-4-(l-chIoromethylethyl)-3-pyrazoIidraecarboxyIic 
acid methyl ester (61). Following the general procedure C, a solution of 46 (140 mg, 0.35 mmol) in 
CH2CI2 (4 mL) was treated with SnCl^ (0.58 mL of a 1.2 M solution, 0.70 mmol). Work-up and flash 
chromatography (ethyl acetate/hexane 1:4) afforded 61 (76 mg, 0.20 mmol, 58%) as a colorless oil, R f 0.25. IR v 
1735,1690, 690;1 H NMR (200 MHz) 8 1.54 (s, 3 H, CH3), 1.66 (s, 3 H, CH3), 3.13-3.28 (m, 3 H, H4 and 2 
x H5), 3.81 (d, J  = 12.5 Hz, 1 H, CHHPh), 3.82 (s, 3 H, C02CH3), 4.17 (d, J  = 12.5 Hz, 1 H, CHHPh), 4.56 
(d, J  = 5.3 Hz, 2 H, OCH2), 4.70 (d, J  = 6.2 Hz, 1 H, H3), 5.15-5.31 (m, 2 H, =CH2), 5.70-5.95 (m, 1 H, 
=CH), 7.26-7.44 (m, 5 H, ArH); 13C NMR (50 MHz) 8 31.5,31.9 (2 x CH3), 52.7 (C02CH3), 54.9 (C5), 55.8 
(C4), 61.9 (CH2Ph), 62.6 (C3), 66.5 (OCH2), 69.4 (CC1), 117.6 (=CH2), 127.5, 128.2, 129.4 (ArH), 132.3 
(=CH), 137.2 (ArC), 173.4 (C(0)); MS (El, 70 eV) mlz (relative intensity) 380 (M+, 67), 344 (36), 295 (44), 
245 (51), 91 (100); HRMS calcd for Ci9H25N20 4Cl 380.1503, found 380.1548.
re/-(3S ,4S )-2-(a lly loxycarb on yl)-l-b en zy l»4-[l-(form yloxy)-l-m eth yleth y l)-3 -p yrazo lid in e-
carboxylic acid methy! ester (62). A solution of 46 (173 mg, 0.43 mmol) in HCOOH (5 mL) was stirred 
at rt for 18 h. Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 62 (110 mg, 
0.28 mmol, 66%) as a colorless oil, R f 0.25. IR v 1735,1715,1690,690; *H NMR (200 MHz) 8 1.53 (s, 3 H, 
CH3), 1.61 (s, 3 H, CH3), 3.06 (d, J  = 8.7 Hz, 2 H, 2 x H5), 3.26-3.39 (m, 1 H, H4), 3.81 (s, 3 H, C02CH3),
3.82 (d, J  = 12.3 Hz, 1 H, CHHPh), 4.20 (d, J  = 12.3 Hz, 1 H, CHHPh), 4.56 (d, J  = 5.5 Hz, 2 H, OCH2), 4.62 
(d, J = 1A  Hz, 1 H, H3), 5.16-5.32 (m, 2 H, =CH2), 5.75-5.95 (m, 1 H, =CH), 7.27-7.43 (m, 5 H, ArH), 7.93 
(s, 1 H, OCHO); 13C NMR (50 MHz) 8 24.2, 25.0 (2 x CH3), 52.6 (C02CH3), 53.3 (C5), 53.7 (C4), 61.3 
(C3), 61.7 (CH2Ph), 66.5 (OCH2), 81.6 (CO), 117.7 (=CH2), 127.4,128.2,129.4 (ArH), 132.3 (=CH), 137.1 
(ArC), 159.8, 173.2 (2 x  C(0)); MS (El, 70 eV) m/z (relative intensity) 390 (M+, 34), 345 (6), 227 (20), 91 
(100); HRMS calcd for C20H26N2O6 390.1791, found 390.1749.
re/-(3iS,4S)-2-(Allyloxycarbonyl)-l-benzyl-4-(l-chloroethyl)-3-pyrazolidinecarboxyHc acid 
methyl ester (63). According to the general procedure C, a solution of 47 (513 mg, 1.32 mmol) in CH2CI2 
(15 mL) was treated with SnCl4 (2.19 mL of a 1.2 M solution, 2.63 mmol). Work-up and flash chromatography 
(ethyl acetate/hexane 1:4) afforded 63 (267 mg, 0.73 mmol, 56%) as a colorless oil, 5:1 mixture of isomers, R f  
0.30. IR v 1740, 1690, 690; JH NMR (250 MHz) 8 (mixture) 1.57 (d ,/ =  6.4 Hz, 3 H, CH3), 3.05-3.17 (m, 3
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H, H4 and 2 x H5), 3.72-3.82 (m, 1 H, C//HPh), 3.80 (s, 3 H, C 02CH3), 4.16 (d, / =  12.4 Hz, 1 H, CHtfPh), 
4.24-4.28 (m, 1 H, H3), 4.46-4.53 (m, 3 H, CHC1 and OCH2), 5.13-5.27 (m, 2 H, =CH2), 5.72-5.90 (m, 1 H, 
=CH), 7.24-7.43 (m, 5 H, ArH);1H NMR (250 MHz, 50 *C) 6 1.56 (d, J  = 6.7 Hz, 3 H, CH3), 3.05-3.18 (m, 3 
H, H4 and H5), 3.76 (d, J  = 12.3 Hz, 1 H, C/fflPh), 3.81 (s, 3 H, C 02CH3), 4.19 (d, J  = 12.5 Hz, 1 H, 
CHflPh), 4.25-4.27 (m, 1 H, H3), 4.48-4.50 (m, 1 H, CHC1), 4.55 (d, J  = 5.5 Hz, 2 H, OCH2), 5.14-5.29 (m, 2 
H, =CH2), 5.72-5.95 (m, 1 H, =CH), 7.22-7.43 (m, 5 H, ArH); 13C NMR (63 MHz) 8 (mixture) 23.5, 24.1 
(CH3), 51.5, 51.8 (C4), 52.5, 52.7 (C02CH3), 54.6, 55.3 (C5), 57.5, 56.8 (CHC1), 61.7, 62.0 (CH2Ph), 63.2,
63.0 (C3), 66.6, 66.7 (OCH2), 117.7, 118.3 (=CH2), 127.5, 127.7, 128.3, 128.4, 129.5, 129.8 (ArH), 132.2,
132.3 (=CH), 137.1, 137.2 (ArC), 154.2, 154.3, 172.4, 172.5 (2 x C(0)); MS (El, 70 eV) m/z (relative 
intensity) 366 (M+, 38), 330 (6), 281 (21), 231 (24), 91 (100); HRMS calcd for ClgH23N20 4Cl 366.1346, 
found 366.1369.
2 -(A Ily lo x y ca rb o n y I)-l-b en zy l-5 -ch lo ro -l/M ,2 -d ia zep in e-3 -ca rb o x y lic  acid m ethyl ester  
(64). Following the general procedure C, a solution of 48 (279 mg, 0.72 mmol) in CH2CI2 (7 mL) was treated 
with SnCl4 (1.19 mL of a 1.2 M solution, 1.43 mmol). Work-up and flash chromatography (ethyl acetate/hexane 
1:4) afforded 64 (170 mg, 0.46 mmol, 65%) as a colorless oil, 1:1 mixture of isomers, Rj- 0.25. IR v 1745, 
1685, 690; 'h  NMR (200 MHz) 8 1.50-1.75 (m, 2 H, 2 x H6), 2.23 (dd, J  = 12.7,9.0 Hz, 1 H, H4), 2.61 (ddd, 
J  = 13.0,9.2, 7.2 Hz, 1 H, H4), 3.15-3.50 (m, 3 H, 2 x H7 and H5), 3.73 (d, J  = 12.4 Hz, 1 H, CflHPh), 3.81 
(s, 3 H, C02CH3), 4.17 (d,/ =  12.4 Hz, 1 H, CHWPh), 4.48-4.67 (m, 3 H, OCH2 and H3), 5.18-5.33 (m, 2 H, 
= 01^ , 5.77-5.94 (m, 1 H, =CH), 7.26-7.44 (m, 5 H, ArH); 13C NMR (50 MHz) 8 (mixture) 30.4, 34.3, 35.9,
36.0 (C4 and C6), 41.9 (C7), 52.6 (C02CH3), 59.6 (C3), 59.2, 61.2 (C5), 61.6 (CH2Ph), 66.3 (OCH2), 117.5 
(=CH2), 127.3, 128.1, 129.5 (ArH), 132.2 (=CH), 137.0 (AiC), 172.7 (C(0)); MS (El, 70 eV) m/z (relative 
intensity) 366 (M+, 52), 325 (9), 303 (6), 275 (23), 91 (100).
2-(A lIy loxycarbonyl)-l-benzyM “[(chloroinethyl)inethyleiie]-3-pyrazolidiiiecarboxyU c acid 
methyl ester (65)* According to the general procedure C, a solution of 49 (660 mg, L70 mmol) in CH2CI2 
(17 mL) was treated with TiCl  ^ (2.84 mL of a 1.2 M solution, 3.40 mmol). Work-up and flash chromatography 
(ethyl acetate/hexane 1:6) afforded 65 (280 mg, 0.77 mmol, 45%) as a yellowish oil, 1.2:1 mixture of (E)/(Z) 
isomers, R f  0.40. IR v 1740,1700,690; *H NMR (200 MHz) 8 (one isomer) 2.61-2.75 (m, 1 H, CtfHCl), 3.31 
(dd,J  = 6.4,3.1 Hz, 1 H, CH//C1), 3.55-4.00 (m, 2 H, 2 x  H5), 3.71 (s, 3 H, C 02CH3), 4.35 (d, J  = 13.4 Hz, 1 
H, C//HPh), 4.47 (d, J  = 13.4 Hz, 1 H, CHtfPh), 4.65 (m, 2 H, OCH2), 4.90 (dd, J  = 12.2, 5.4 Hz, 1 H, 
C=CH), 5.21-5.45 (m, 2 H, =CH2), 5.56-5.60 (br s, 1 H, H3), 5.83-6.10 (m, 1 H, CH2=CW), 7.26-7.41 (m, 5 
H, ArH); (other isomer) 2.61-2.75 (m, 1 H, CHHCl), 3.25 (dd. J  = 6.5, 3.1 Hz, I H, CH//C1), 3.55-4.00 (m, 2 
H, 2 x H5), 3.71 (s. 3 H, C 02CH3), 4.11 (d ,/=  13.4 Hz, 1 H, C//HPh), 4.46 (d, J  = 13.4 Hz, 1 H, CHHPh),
4.77 (d, J  = 5.7 Hz, 2 H, OCH2), 5.05 (dd, J  = 12.6, 5.4 Hz, 1 H, C=CH), 5.21-5.45 (m, 2 H, =CH2), 5.56-5.60 
(br s, 1 H, H3), 5.83-6.10 (m, 1 H, CH2=Ctf), 7.26-7.41 (m, 5 H, ArH); 13C NMR (50 MHz) 8 (mixture of 
isomers) 36.5, 36.6 (CH2C1), 51.2, 51.8 (C5), 52.4, 52.5 (C02CH3), 59.9, 60.9 (CH2Ph), 60.8, 61.1 (C3),
66.1,66.9 (OCH2), 117.3,118.5 (=CH2), 124.9,125.7 (C=CH), 127.0,127.3 (C4), 127.5, 128.4, 128.9 (ArH),
132.3, 132.4 (CH2=CH), 138.2, 138.3 (AiC), 154.5, 171.3, 171.4 (2 x C(0)); MS (El, 70 eV), m/z (relative 
intensity) 364 (M+, 6), 329 (25), 305 (11), 273 (42), 193 (21), 91 (100); HRMS calcd for C18H21N20 4C1 
364,1190, found 364.1159.
2-(A U yloxycarbonyl)-3-benzyl-l,2,3,4-tetrahydro-l-phthalazinecarboxyIic acid methyl ester
(66). According to the general procedure C, a solution of 50 (2.00 g, 4.69 mmol) in CH2CI2 (45 mL) was
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treated with S11CI4 (7.82 mL of a 1.2 M solution, 9.38 mmol). Work-up and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 66 (1.55 mg, 4.23 mmol, 91%) as a colorless oil, /?ƒ 0.30. IR v 1740, 1685,1400* 
690; *H NMR 5 3.65-3.75 (m, 2 H, NCH2), 3.78 (br s, 3 H, C 02CH3), 3.95-4.20 (m, X H, C/fflPh), 4.45-
4.70 (m, 3 H, OCH2 and CHHPh), 5.15-5.40 (m, 2 H, =CH2), 5.63 (br s, 1 H, NCH), 5.80-6.05 (m, 1 H, 
=CH), 7.00-7.50 (m, 9 H, ArH); 13C NMR (50 MHz) 8 51.5 (NCH), 52.6 (C02CH3), 57.7 (NCH2), 59.3 
(CH2Ph), 66.7 (OCH2), 117.9 (=CH2), 118.6, 127,1, 127.5, 128.3, 128.8, 129.3 (ArH), 132.5 (=CH), 134.0, 
135.1, 137.0 (ArC), 171.0 (C(O)); MS (El, 70 eV) m/z (relative intensity) 366 (M+, 32), 307 (15), 226 (32), 
105 (100), 91 (100); HRMS calcd for C21H22N20 4 366.1580, found 366.1579.
2-(A lly loxycarbonyl)-1 -benzyl-5-m ethyIenehexahydro-3-pyridazinecarboxylie acid methyl 
ester (67). According to the general procedure C, a solution of 51 (1.10 g, 2.38 mmol) in CH2CI2 (25 mL) 
was treated with Et2AlCl (5.95 mL of a 1.0 M solution, 5.95 mmol). Work-up and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 67 (517 mg, 1.57 mmol, 83% (after correction)) as a colorless oil, R j  0.35. IR v 
1735, 1680, 690; !H NMR (200 MHz) 8 2.59-2.70 (m, 1 H, H4), 3.01 (d, J  = 14.1 Hz, 1 H, H4), 3.20 (m, 1 H, 
H6), 3.40 (d, J  = 14.3 Hz, 1 H, H6), 3.75 (s, 3 H, C 02CH3), 3.86 (d, J = 12.5 Hz, 1 H, CtfHPh), 4.05 (d, J =
12.5 Hz, 1 H, CHHPh), 4.62-4.80 (m, 2 H, OCH2), 4.88 (s, 1 H, C=CWH), 5.05 (m, 1 H, H3), 5.15 (s, 1 H, 
C=CHtf), 5.24-5.43 (m, 2 H, CH=C//2), 5.96-6.04 (m, 1 H, =CH), 7.23-7.40 (m, 5 H, ArH); XH NMR (250 
MHz, 50 "C) 8 2.64 (dd, J  = 14.2, 7.4 Hz, 1 H, H4), 2.96 (dd, J  = 14.2, 3.3 Hz, 1 H, H4), 3.21 (d, J  = 14.5 Hz, 
1 H, H6), 3.42 (d, J  = 14.5 Hz, 1 H, H6), 3.73 (s, 3 H, C 02CH3), 3.91 (d, J  = 12.5 Hz, 1 H, CHHPh), 4.08 (d, 
J  = 12.5 Hz, 1 H, NCHtfPh), 4.65-4.80 (m, 2 H, OCH2), 4.84 (s, 1 H, C=CWH), 4.97 (br s, 1 H, H3), 5.10 (s, 
1 H, C=CHH), 5.22-5.40 (m, 2 H, CH=CW2), 5.91-6.07 (m, 1 H, =CH), 7.20-7.39 (m, 5 H, ArH); 13C NMR 
(50 MHz) 8 32.0 (C4), 52.2 (C02CH3), 53.9 (C6), 55.5 (C3), 57.9 (CH2Ph), 66.6 (OCH2), 91.5 (C5), 113.7 
(C=CH2), 117.6 (CH=CH2), 127.2,128.1,129.0 (ArH), 132.5 (=CH), 137.4 (AiC), 172.0 (C(0)); MS (El, 70 
eV) m/z (relative intensity) 330 (M+, 46), 271 (24), 245 (44), 195 (20), 185 (24), 159 (69), 142 (29), 135 (42), 
91 (100); HRMS calcd for ClgH22N20 4 330.1580, found 330.1548.
r e / - ( 3 5 ,55 )-2 -(a lly  loxy c a r b o n y l)- l-b e n z y I-5 -m e th y l-5 -(tr  if  Iuoroacetoxy  )hexahydr 0-3- 
pyridazinecarboxylic acid methyl ester (68). A solution of 51 (232 mg, 0.50 mmol) in CH2Cl2 (5 
mL) was treated with CF3CO2H (155 |iL, 2.00 mmol) at 0 *C. After being stirred at rt for 18 h, the mixture was 
poured into aq satd NaHCOj (25 mL) and extracted with CH2CI2 (3 x 15 mL). The combined organic layers were 
dried (MgSC>4), filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to afford 68 (155 
mg, 0.35 mmol, 70%) as a light yellow oil, R* 0.35. IR v 1775,1735,1710,690; XH NMR (200 MHz) 8 1.54 
(s, 3 H, CH3), 2.30-2.55 (m, 2 H, 2 x  H4), 2.89 (d, J  = 13.7 Hz, 1 H, H6), 3.39 (d, J  = 13.7 Hz, 1 H, H6), 3.76 
(s, 3 H, C02CH3), 4.27 (s, 2 H, CW2Ph), 4.65 (d, J  = 5.5 Hz, 2 H, OCH2), 4.75-4.95 (m, 1 H, H3), 5.24-5.37 
(m, 2 H, =CH2), 5.80-6.05 (m, 1 H, =CH), 7.26-7.34 (m, 5 H, ArH); MS (El, 70 eV) m/z (relative intensity) 
444 (M+ , 8), 348 (13), 277 (8), 263 (7), 245 (10), 160 (42), 121 (29), 91 (100); HRMS calcd for 
C20H23N2 °6 F3 444.1508, found 444.1543.
2-(A lly loxycarbonyl)-l-benzyI-4-ethenylidene-3-pyrazolid inecarboxyIic  acid methyl ester 
(69). To a solution of 52 (250 mg, 0.53 mmol) in CH2CI2 (25 mL) was added at 0 *C BF3*OEt2 (0.40 mL,
3.15 mmol) and the mixture was stirred at 0 *C for 15 min. After being stirred at rt for 4 h, the mixture was 
poured into aq satd NaCl (100 mL) and extracted with CH2Cl2 (3 x 50 mL). The combined organic layers were 
dried (MgSC^), filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:5) to afford 69 (51 
mg, 0.16 mmol, 30% (after correction)) as a light yellow oil, /?ƒ 0.20. IR v 1950, 1745, 1685, 690; *H NMR
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(200 MHz) 8 3.65 (m, 2 H, 2 x  H5), 3.81 (s, 3 H, C 02CH3), 3.83 (d, J  = 12.4 Hz, 1 H, CflHPh), 4.10 (d, J  =
12.4 Hz, 1 H, CH/yPh), 4.59 (d, J  = 5.5 Hz, 2 H, OCH2), 4.65-4.75 (m, 1 H, H3). 5.08-5.11 (m, 2 H, C=CH2),
5.18-5.34 (no, 2 H, CH=Ctf2), 5.77-5.97 (m, 1 H, =CH), 7.28-7.46 (m, 5 H, ArH); 13C NMR (50 MHz) 8 52.6 
(C02CH3), 55.5 (C5), 61.3 (C3), 61.8 (CH2Ph), 66.6 (OCH2), 81.1 (C=CH2), 99.0 (C4), 117.9 (OfcsCHj),
127.6,128.3,129.7 (ArH), 132.3 (=CH), 136.8 (ArC), 169.6 (C(0)), 200.3 (C=C=CH2); MS (El, 70 eV) m lz  
(relative intensity) 328 (M+, 53), 243 (18), 193 (11), 124 (6), 91 (100); HRMS calcd for C18H20N2O4 
328.1423, found 328.1401.
r i/-(3 ft , 4 £ ,  55 ) -5-(Acetoxy m ethyl)-2-(ally  loxy car bonyl)- l~benzyl~4-(tr im ethy ls i ly l) -3-  
pyrazolidinecarboxylic acid methyl ester (70)* To a solution of 53 (105 mg, 0.23 mmol) in CH2CI2 
(3 mL) was added at 0 *C BF3-OEt2 (177 |iL, 1.41 mmol) and the mixture was stirred at 0 *C for 15 min. After 
being stirred at rt for 4 h, the mixture was poured into aq satd NaCl (25 mL) and extracted with CH2CI2 (3 x 25 
mL). The combined organic layers were dried (Mg804), filtered, concentrated in vacuo and chromatographed (ethyl 
acetate/hexane 1:4) to afford 70 (24 mg, 0.06 mmol, 23%) as a light yellow oil, R f  0.30. IR v 1735, 1690, 
1250, 840; JH NMR (250 MHz) 8 0.11 (s, 9 H, (C H ^Si), 1.66 (t, J  = 9.0 Hz, 1 H, H4), 1.82 (s, 3 H, 
C(0)CH3), 3.35-3.45 (m, 1 H, H5), 3.65-3.85 (m, 2 H, CHCtf2), 3.75 (s, 3 H, C 02CH3), 3.92 (d ,/ =  12.9 Hz,
1 H, CHHPh), 4.23 (d, J  = 12.9 Hz, 1 H, CHHPh), 4.45-4.65 (m, 2 H, OCH2), 4.98 (d, J  = 9.5 Hz, 1 H, H3), 
5.16-5.33 (m, 2 H, C H ^ , 5.75-5.95 (m, 1 H, =CH), 7.23-7.42 (m, 5 H, ArH); 13C NMR (50 MHz) 8 1.0 
((CH3)3Si), 20.7 (C(0)CH3), 35.2 (C4), 52.2 (C02CH3), 62.2 (C3), 63.1 (CH2Ph), 66.5 (OCH2 and CHCHj),
66.6 (C5), 117.4 (=CH2), 127.3, 128.1, 129.6 (ArH), 132.6 (=CH), 137.8 (ArC), 155.8, 170.6, 173.4 3 x  
(C(0)); MS (El, 70 eV) mlz (relative intensity) 448 (M+, 32), 389 (6), 375 (16), 363 (9), 243 (46), 91 (100); 
HRMS calcd for C22H32N20 6Si 448.2030, found 448.2065.
re /-(3 /f , 4 5 ,5 5  )-2 -(  A lly loxycar  bony l) - l-b e n z y l-5 - (c h  lor o m e th y l)-4 -(tr  im e th y !s ily l)-3 -  
pyrazolidinecarboxylic acid methyl ester (71). According to the general procedure C, a solution of 53 
(925 mg, 2.06 mmol) in CH2Cl2 (25 mL) was treated with S11CI4 (3.44 mL of a 1.2 M solution, 4.13 mmol). 
Work-up and flash chromatography (ethyl acetate/hexane 1:4) afforded 71 (591 mg, 1.39 mmol, 68%) as a 
colorless oil, R f  0.45. IR v 1735,1685,1250, 940, 690; 'h  NMR (200 MHz) 8 0.12 (s, 9 H, (CH3)3Si), 2.00 
(t, 7 = 9.1 Hz, 1 H, H4), 3.07 (dd, ƒ  = 11.5, 4.3 Hz, 1 H, CHHCl), 3.25 (dd, J  = 11.5, 3.4 Hz, 1 H, CHtfCl), 
3.47-3.56 (m, 1 H, H5), 3.78 (s, 3 H, C02CH3), 3.99 (d ,/=  12.8 Hz, 1 H, C//HPh), 4.36 (d, J  = 12.7 Hz, 1 H, 
CH/ZPh), 4.56 (ddt, J  = 13.6, 5.3,1.4 Hz, 1 H, OC//H),4.67 (ddt, J  = 13.6, 5.3,1.4 Hz, 1 H, OCH/7), 5.01 (d, 
J  = 9.0 Hz, 1 H, H3), 5.18-5.40 (m, 2 H, =CH2), 5.91-5.98 (m, 1 H, =CH), 7.26-7.51 (ArH); 13C NMR (63 
MHz) 8 1.5 (CH3)3Si), 35.3 (C4), 47.7 (CH2C1), 52.1 (C02CH3), 62.4 (C3). 63.4 (CH2Ph), 66.5 (OCH^,
68.8 (C5), 117.4 (=CH2), 127.5,128.2,129.4 (ArH), 132.6 (=CH), 137.8 (AiC), 156.0,172.3 (2 x C(0)); MS 
(El, 70 eV) mlz (relative intensity) 424 (M*\ 57), 409 (10), 339 (13), 289 (10), 243 (20), 185 (23), 91 (100); 
HRMS calcd for C20H29N2O4ClSi 424.1585, found 424.1569.
2-(AUyloxycarbonyl)-l~benzyl-l,2,3,6-tetrahydro-3~pyridazinecarboxylic acid methyl ester
(72). According to the general procedure C, a solution of 54 (500 mg, 1.12 mmol) in CH2CI2 (12 mL) was 
treated with SnCl4 (1.86 mL of a 1.2 M solution, 2.23 mmol). Work-up and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 71 (152 mg, 0.36 mmol, 32%) as a colorless oil, R j  0.45 and 72 (176 mg, 0.56 
mmol, 50%) as a colorless oil, R j  0.25. 72: IR v 1740,1680,1400, 985, 690; *H NMR (250 MHz) 8 3.09 (dd, 
ƒ = 17.6,4.2 Hz, 1 H, H6), 3.46 (br d, / =  19.3 Hz, 1 H, H6), 3.78 (s, 3 H, C02CH3), 3.82 (d, / =  12.5 Hz, 1 
H, CtfHPh), 4.22 (d, /  = 12.5 Hz, 1 H, CHtfPh), 4.604.80 (m, 2 H, OCH9), 5.10 (br s, 1 H, H3), 5.23-5.45
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(m, 2 H, =CH2), 5.65-6.15 (m, 3 H, CH2=CH, H4 and H5), 7.22-7.39 (m, 5 H, ArH); 13C NMR (63 MHz) 8
46.9 (C6), 52.4 (C02CH3), 52.5 (C3), 59.3 (CH2Ph), 66.6 (OCH2), 117.6 (=CH2), 121.0, 124.6 (C4 and C5),
127.3, 127.5, 128.0 (ArH), 132.7 (CH2=CH), 138.0 (ArC), 155.0, 170.2 (2 x C(0)); MS (El, 70 eV) mlz 
(relative intensity) 316 (M+ , 10), 257 (10), 231 (13), 171 (14), 91 (100), 41 (43); HRMS calcd for 
c 17h20n 2°4 316.1423, found 316.1401.
6-(Allyloxycarbonyl)-7-benzyI-2,2-dimethyM<oxo-5,6,7,8-tetrahydro-4tf-l ,3-dioxino[4,5-  
rf]pyridazine-5-carboxylic acid methyl ester (73). To a solution of 55 (229 mg, 0.48 mmol) in 
CH2CI2 (5 mL) was added at -78 #C CF3S 0 3SiMe3 (348 |iL, 1,92 mmol) and the mixture was stirred at -78 'C 
for 15 min. After being stirred at rt for 18 h, the mixture was poured into aq satd NaCl (50 mL) and extracted with 
CH2CI2 (3 x 25 mL). The combined organic layers were dried (MgSO^, filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:2.5) to afford 73 (96 mg, 0.23 mmol, 48%) as a light yellow oil, /?ƒ 
0.30. IR v 1735, 1725,1715, 1650, 690; %  NMR (200 MHz) 8 1.68 (s, 3 H, CH3), 1.79 (s, 3 H, CH3), 3.07-
3.16 (m, 1 H, H6), 3.60-3.75 (m, 1 H, H6), 3.72 (s, 3 H, C 02CH3), 4.15 (s, 2 H, O i2Ph), 4.67-4.69 (m, 2 H, 
OCH2), 5.23-5.38 (m, 2 H, =CH2), 5.59 (s, 1 H, H3), 5.88-5.99 (m, 1 H, =CH), 7.26-7.30 (m, 5 H, ArH); %  
NMR (250 MHz, 50 *C) 8 1.67 (s, 3 H, CH3), 1.78 (s, 3 H, CH3), 3.10-3.30 (m, 1 H, H6), 3.60-3.75 (m, 1 H, 
H6), 3.72 (s, 3 H, C 02CH3), 4.15 (s, 2 H, C«2Ph), 4.67 (d, J  = 5.7 Hz, 2 H, OCH2), 5.22-5.37 (m, 2 H, 
=CH2), 5.52 (s, 1 H, H3), 5.86-5.99 (m, 1 H, =CH), 7.26-7.30 (m, 5 H, ArH); 13C NMR (63 MHz) 8 24.4,
25.9 (2 x CH3), 47.5 (C6), 52.8 (C02CH3), 59.7 (CH2Ph), 64.5 (C3), 67.1 (OCH2), 100.0 (C4a), 107.4 
(OCO), 118.4 (=CH2), 127.8, 128.5, 128.9 (ArH), 132.0 (=CH), 135.5 (AiC), 155.0,158.0,162.5,169.8 (3 x  
C(O) and C8a); MS (El, 70 eV) mlz (relative intensity) 416 (M+, 4), 358 (18), 299 (10), 262 (5), 105 (26), 91 
(35), 32 (100); HRMS calcd for C ^H ^N jO y 416.1584, found 416.1573.
re/-(3S ,5/?)-2-(Allyloxycarbonyl)-l-benzyl-5-methyl-3-pyrazolidinecarboxylic acid methyl 
ester (91). To a refluxing solution of n-Bu^SnH (160 mL, 0.60 mmol) in benzene (2 mL) was added dropwise 
in 1 h a solution of 57 (55 mg, 0.15 mmol) and AIBN (5 mg, 0.030 mmol) in benzene (2 mL). After refluxing 
for 18 h, the solution was concentrated in vacuo and chromatographed (hexane, then ethyl acetate/hexane 1:4) to 
afford 91 (31 mg, 0.097 mmol, 65%) as a colorless oil, R* 0.25. IR v 1740, 680, 1400, 690; *H NMR (200 
MHz) 8 0.98 (d, J  = 7.1 Hz, 3 H, CH3), 2.18 (dd, J  = 12.5, 8.7 Hz, 1 H, H4), 2.45-2.60 (m, 1 H, H4), 3.37 
(quintet, J  = 6.6. Hz, 1 H, H5), 3.74 (d, J  = 12.8 Hz, 1 H, C//HPh), 3.80 (s, 3 H, C 02CH3), 4.17 (d, J  = 12.8 
Hz, 1 H, CHWPh), 4.57 (d, J  = 5.5 Hz, 2 H, OCH2), 4.59 (t, J  = 8.9 Hz, 1 H, H3), 5.14-5.32 (m, 2 H, =CH2),
5.76-5.95 (m, 1 H, =CH), 7.23-7.47 (m, 5 H, ArH); 13C NMR (50 MHz) 8 19.9 (CH3), 35.4 (C4), 52.5 
(C02CH3), 58.6, 59.5 (2 x NCH), 61.5 (CH2Ph), 66.3 (OCH2), 117.2 (=CH2), 127.3, 128.2, 129.4 (ArH),
132.7 (=CH), 137.8 (ArC), 173.2 (C(0)).
' 2-(A!ly loxycarbonyl)- l-benzyl-5 ,5-dimethyl-3»pyrazolid inecarboxylic  acid methyl ester 
(92). To a refluxing solution of n-Bu3SnH (217 |iL, 0.82 mmol) in benzene (2 mL) was added dropwise in 1 h a 
solution of 58 (75 mg, 0.20 mmol) and AIBN (3.4 mg, 0.02 mmol) in benzene (2 mL). After refluxing for 18 h, 
the solution was concentrated in vacuo and chromatographed (hexane, then ethyl acetate/hexane 1:4) to afford 92 
(35 mg, 0.11 mmol, 51%) as a colorless oil, R j  0.15. IR v 1740,1680, 690; ^ N M R  (200 MHz) 5 1.25 (s. 6
H, (CH3)2C)i 2.30 (d, J  = 9.2 Hz, 2 H, 2 x H4), 3.80 (s, 3 H, C 02CH3), 3.85 (d, J  = 12.4 Hz, 1 H, CHHPh), 
3.99 (d, J  = 12.4 Hz, 1 H, CHtfPh), 4.10-4.45 (m, 2 H, OCH2), 4.60 (t, J = 9.3 Hz, 1 H, H3), 5.05-5.17 (m, 2
H, =CH2), 5.55 (m, 1 H, C H ), 7.17-7.54 (m, 5 H, ArH).
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re/-(35 ,45 )-2 -(A llyIoxycarb on yI)-l-b en zy l-4 -eth y l-3 -p yrazo lid in ecarb oxyIic  acid m ethyl 
ester (93). To a refluxing solution of n-BujSnH (324 pL, 1.22 mmol) in benzene (2 mL) was added dropwise 
in 1 h a solution of 63 (112 mg, 0.31 mmol) and AIBN (5.0 mg, 0.030 mmol) in benzene (2 mL). After 
refluxing for 18 h, the solution was concentrated in vacuo, taken up in THF (10 mL) and stirred with KF (93 mg,
1.22 mmol) and TBAF (122 mL of a 1.0 M solution in THF, 0.12 mmol) for 17 h. The organic layer was dried 
(MgSC>4), filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:4) to afford 93 (39 mg, 
0.12 mmol, 38%) as a colorless oil, R f  0.25. IRv 1740,1685,690; *H NMR (200 MHz) 8 0.94 (t ,/ =  7.5 Hz,
3 H, CH2C//3), 1.40-1.55 (m, 1 H, CflHCHj), 1.70-1.90 (m, 1 H, CHHCH3), 2.65-2.73 (m, 2 H, 2 x  H5), 
3.15-3.18 (m, 1 H, H4), 3.82 (s, 3 H, C 02CH3), 3.75-3.85 (m, 1 H, CtfHPh), 4.05-4.25 (m, 2 H, CHWPh and 
H3), 4.53 (d, J  = 5.4 Hz, 2 H, OCH2), 5.14-5.30 (m, 2 H, =CH2), 5.76-5.90 (m, 1 H, =CH), 7.23-7.46 (m, 5 H, 
ArH); 13C NMR (50 MHz) 8 12.2 (CH2CH3), 24.7 (CH2CH3), 45.5 (C4), 52.5 (C02CH3), 57.8 (C5), 61.7 
(CH2Ph), 65.8 (C3), 66.5 (OCH2), 117.7 (=CH2), 127.4,128.3,129.6 (ArH), 132.5 (=CH), 137.4 (AiC), 173.1 
(C(0)).
re/-(35,55)-2-(Ethoxycarbonyl)-5-(chlorom ethyl)-3-pyrazoIidinecarboxylic acid methyl ester 
(104). A mixture of 56 (100 mg, 0.29 mmol), Pd/C (20 mg of 10% Pd on C, 0.02 mmol) and a few drops of a
1 M HCl/MeOH solution in MeOH (5 mL) was stirred under a ^-atmosphere for 2 h. After filtration over 
Celite, the solution was concentrated in vacuo, taken up in aq satd NaHCOg (10 mL) and extracted with CH2CI2 
(3 x 10 mL). The combined organic layers were dried (MgSC^), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1) to afford 104 (57 mg, 0.23 mmol, 79%) as a colorless oil, R j  0.39. 
IR v 1740, 1700, 1120, 1375, 1340; JH NMR (300 MHz) 8 1.25 (t, J  = 7.1 Hz, 3 H, CH2C//3), 2.25 (ddd, J  =
13.2, 7.1, 5.1 Hz, 1 H, H4), 2.54 (ddd, J  = 13.2, 9.2, 4.4 Hz, 1 H, H4), 3.39 (dd, J  = 11.4, 7.4 Hz, 1 H, 
CflHCl), 3.57 (dd, J  = 11.4,4.9 Hz, 1 H, CHHC1), 3.73 (s, 3 H, C 02CH3), 3.66-3.77 (m. 1 H, H5), 4.13-4.25 
(m, 2 H, CH2CH3), 4.30-4.60 (br s, 1 H, NH), 4.66 (dd, J  = 5.0,9.2 Hz, 1 H, H3); 13C NMR (75 MHz) 8 14.6 
(CH2CH3), 35.5 (C4), 44.9 (CH2C1), 52.5 (C02CH3), 59.1 (C3 and C5), 62.2 (CH2CH3), 172.3 (C(0)); 13C 
NMR (50 MHz, CgDg) 8 15.4 (CH2CH3), 36.3 (C4), 46.0 (CH2C1), 52.5 (C02CH3), 60.1,60.2 (C3 and C5),
62.5 (CH2CH3), 173.1 (C(0)); MS (El, 70 eV) m/z (relative intensity) 250 (M+, 60), 201 (55), 177 (60), 119 
(100), 69 (62), 29 (59); HRMS calcd for C9H15N20 4C1250.0720, found 250.0709.
General procedure D for the transprotection reactions. To a solution of the Alloc compound and 
B0C2O (2 equiv) in CH2CI2 was added PdOPPh^ (0.02 equiv), immediately followed by the whole amount of n- 
BugSnH (1.1 equiv) and the mixture was stirred at rt for 2 h. Concentration in vacuo and flash chromatography 
(first with hexane, then with the suitable eluent) afforded the pure produces).
re/-(3S,55)-l-Benzyl-2-(ferf-butoxycarbonyl)-5-(chlorom ethyl)-3-pyrazoIidinecarboxylic acid 
methyl ester (110). Following the general procedure D, a solution of 57 (760 mg, 2.16 mmol) in CH2O 2 
(25 mL) was treated with B0C2O (990 |iL, 4.31 mmol), Pd(PPh3)4 (50 mg, 0.043 mmol) and n-B^SnH (629 
jiL, 2.37 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 110 (612 
mg, 1.66 mmol, 77%) as a light yellow oil, Re 0.35. IR v 1740,1680,1360,690; !H NMR (200 MHz) 8 1.43 
(s, 9 H, (CH3)3), 2.47-2.69 (m, 2 H, 2 x  H4), 3.11 (dd, ƒ  = 8.1, 10.6 Hz, 1 H, CflHCl), 3.30-3.44 (m, 2 H, 
CHHC1 and H5), 3.77 (d, J  = 12.6 Hz, 1 H, CtfHPh), 3.81 (s, 3 H, C 02CH3), 4.23 (d, J  = 12.6 Hz, 1 H, 
CHWPh), 4.59 (t, J  = 8.8 Hz, 1 H, H3), 7.27-7.47 (m, 5 H, ArH).
rel-(3R , 4 5 ,5 5  )- l-B e n z y  l-2 -(fer /-b u to x y ca rb o n y l)-5 -(ch Io ro m eth y l)-4 -(tr im eth y ls ily l)-3 -  
pyrazolidinecarboxylic acid methyl ester (111). Following the general procedure D, a solution of 71
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(434 mg, 1.02 mmol) in CH2CI2 (15 mL) was treated with Bcx^O (0.52 mL, 2.25 mmol), PdOPPhj^ (35 mg, 
0.031 mmol) and /t-Bi^SnH (0.30 mL, 1.13 mmol). Concentration in vacuo and flash chromatography (ethyl 
acetate/hexane 1:4) afforded 111 (288 mg, 0.65 mmol, 64%) as a light yellow oil, Ry 0.60. IR v 1760, 1690, 
1250,840.690; XH NMR (200 MHz) S 0.11 (s, 9 H, (CHj^Si), 1.45 (s. 9 H, (CH j^C), 1.97 (t, 7 = 9.0 Hz, 1
H,H4), 3.06 (dd, J  = 11.4,4.3 Hz, 1 H, C//HC1), 3.24 (dd, J  = 11.4,3.4 Hz, 1 H, CHtfCl), 3.43-3.50 (m, 1 H, 
H5), 3.77 (s, 3 H, C 02CH3), 3.96 (d, J  = 12.7 Hz, 1 H, CtfHPh), 4.32 (d, J  = 12.7 Hz, 1 H, CHHPh), 4.99 (d, 
J  = 9.0 Hz, 1 H, H3), 7.26-7.51 (m, 5 H, ArH); 13C NMR (50 MHz) 8 1.7 ((C H ^Si), 28.3 ((CH3)3C), 35.1 
(C4), 47.9 (CH2C1), 52.0 (C02CH3), 62.0 (C3), 63.2 (CH2Ph), 68.7 (C5), 80.8 ((CH3)3C), 127.4, 128.2,
129.4 (ArH), 138.1 (ArC), 155.7,172.8 (2 x C(0)); MS (El, 70 eV) mlz (relative intensity) 440 (M+, 26), 340 
(90), 325 (12), 185 (13), 159 (5), 133 (8), 91 (100); HRMS calcd for C21H33N20 4ClSi 440.1898, found 
440.1905.
Deprotection of 58. Following the general procedure D, a solution of trans-SS (320 mg, 0.87 mmol) in 
CH2CI2 (10 mL) was treated with B0C2O (0.42 mL, 1.92 mmol), PdfPPhj)^ (30 mg, 0.026 mmol) and n- 
B^SnH  (0.25 mL, 0.96 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) 
afforded r e / - ( 3 5 ,5S ) - l - b e n z y  l -2 - ( /£r f -bu  toxy car bony I ) -5 - (ch lorom e thy I)-5-methy 1-3- 
pyrazolidinecarboxylic acid methyl ester (112) (40 mg, 0.10 mmol, 12%) as a light yellow oil, Ry 
0.35 and l -benzyl-5-(chloromethyl)-3-methyl-2-pyrazoline-3-carboxylic  acid methyl ester 
(113) (155 mg, 0.55 mmol, 63%) as a colorless oil, R f0 .2 5 .112: IR v 1740,1680,690; *H NMR (200 MHz) 
8 1.29 (s, 9 H, (CH3)3C), 1.52 (s, 3 H, CH3), 2.17 (dd, J  = 13.0, 9.7 Hz, 1 H, H4), 2.80 (dd, J  = 13.0, 8.7 Hz,
1 H, H4), 3.16 (d, J  = 11.4 Hz, 1 H, CHHC1), 3.33 (d, J  = 11.4 Hz, 1 H, CHHC1), 3.80 (s, 3 H, C 02CH3), 3.97 
(d, J  = 13.0 Hz, 1 H, CtfHPh), 4.07 (d, J  = 13.0 Hz, 1 H, CHHPh), 4.45 (m, 1 H, H3), 7.22-7.55 (m, 5 H, 
ArH). 113: !H NMR (200 MHz) 8 1.32 (s, 3 H, CH3), 3.22-3.90 (m. 4 H. CH2C1 and 2 x H4), 3.73 (s, 3 H, 
C02CH3), 4.48 (d, / =  14.0 Hz, 1 H, C//HPh), 4.62 (d ,/=  14.0 Hz, 1 H, CHHPh).
l-Benzyl-2-(fer/-butoxycarbonyl)-4-(l-chloro-l-methyIethyl)-2-pyrazoline-3-carboxylic acid 
methyl ester (114). According to the general procedure D, a solution of 61 (100 mg, 0.26 mmol) in CH2CI2 
(3 mL) was treated with B0C2O (133 |iL, 0.58 mmol), Pd(PPh3)4 (9 mg, 7.9-10"^ mmol) and w-BugSnH (77 nL, 
0.29 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 114 (50 mg, 
0.17 mmol, 65%) as a colorless oil, R* 0.40. IR v 1700, 690, 645; !H NMR (200 MHz) 8 1.51 (s, 3 H, CH3),
I.61 (s, 3 H, CH3), 3.20-3.50 (m, 1 H, H4), 3.60-3.78 (m, 2 H, 2 x H5). 3.82, 3.84 (s, 3 H, C 02CH3), 4.33,
4.42 ( d, J  = 14.4 Hz, 1 H. C/fflPh), 4.66,4.75 (d, J  = 14.4 Hz, 1 H, CHHPh), 7.27-7.41 (m, 5 H, ArH).
9
re/«(35,45)-l-Benzy!-2-Oer/-butoxycarbonyl)-4-(l-chloroethyI)-3-pyrazolidinecarboxylic acid 
methyl ester (115). According to the general prócedure D, a solution of 63 (90 mg, 0.25 mmol) in CH2CI2 
(3 mL) was treated with B0C2O (124 pL, 0.54 mmol), P d fP P h^  (8.5 mg, 7.4* 10"  ^mmol) and /i-B^SnH (72 
|_lL, 0.27 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 115 (49 
mg, 0.13 mmol, 54%) as a light yellow oil, R e 0.35. IR v 1745,1700, 1680, 690; %  NMR (200 MHz) 8 1.39 
(s, 9 H, (CH3)3C), 1.56 (d, J  = 6.7 Hz, 3 H, CH3), 3.03-3.10 (m, 3 H, H4 and 2 x H5), 3.69-3.85 (m, 2 H, 
CH2Ph), 3.82 (s, 3 H, C 02CH3), 4.15-4.30 (m, 2 H, H3 and CHC1), 7.26-7.46 (m, 5 H, ArH); 13C NMR (50 
MHz) 8 24.1 (CH3), 28.2 ((CH3)3C), 51.5 (C4), 52.6 (C02CH3), 54.5 (C5), 57.5 (CHC1), 61.8 (CHjPh), 63.2 
(C3), 81.0 ((CH3)3C), 127.4, 128.3, 129.6 (ArH), 137.5 (ArC), 172.9 (C(0)); MS (El, 70 eV) mlz (relative 




l-B en zy I-5 -ch io ro -5 -m e th y l-l,4 ,5 ,6 -te trah y d ro -3 -p y rid az in eca rb o x y Iic  acid  m ethyl e s te r 
(116). Following the general procedure D, a solution of 59 (160 mg, 0.44 mmol) in C H jC ^ (5 mL) was 
treated with Boo^O (221 (¿L, 0.96 mmol), Pd(PPh3)4 (15 mg, 0.013 mmol) and /»-BugSnH (127 ^iL, 0.48 
mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 116 (78 mg, 0.28 
mmol, 64%) as a light yellow oil, R* 0.25. IR v 1690, 1560, 690, 645; JH NMR (300 MHz) 6 1.55 (s, 3 H, 
CH3), 2.59 (dd, J  -  18.4, 2.8 Hz, 1 H, H4), 2.90 (d, J  = 18.2 Hz, 1 H, H4), 2.95 (br d, J  = 15 Hz, 1 H, H6), 
3.14 (dd, J  = 12.8,3.0 Hz, 1 H, H6), 3.84 (s, 3 H, C 02CH3), 4.65 (d, /  = 14.7 Hz, 1 H, CtfHPh), 4.73 (d, /  =
14.7 Hz, 1 H, CHflPh), 7.27-7.44 (m, 5 H, ArH).
l-B en zy l-3 -m eth y len e-I,4 ,5 ,6 -te trah y d ro -3 -p y rid az in ecarb o x y !ic  acid  m ethyl e s te r (117).
According to the general procedure D, a solution of 67 (100 mg, 0.30 mmol) in CH2CI2 (3 mL) was treated with 
B0C2O (153 pL, 0.67 mmol), Pd(PPh3)4 (11 mg, 9 .M 0 '^  mmol) and /»-Bu3SnH (88 jjlL, 0.33 mmol). 
Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 117 (58 mg, 0.24 mmol, 
78%) as a colorless oil, R t  0.25. !H NMR (200 MHz) 8 3.14 (s, 2 H, 2 x H4), 3.43 (s, 2 H, 2 x H6), 3.84 (s, 3 
H, C02CH3), 4.61 (s, 2 H, CH2Ph), 4.93 (s, 1 H, C=CWH), 5.03 (s, 1 H, C=CHH), 7.24-7.35 (m, 5 H, ArH).
D eprotection  of 66. Following the general procedure, a solution of 66 (200 mg, 0.55 mmol) in CH2CI2 (3 
mL) was treated with B0C2O (139 \ib , 0.61 mmol), Pd(PPh3)4 (13 mg, 0.011 mmol) and /i-B^SnH (160 jiL, 
0.61 mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 3-benzyl-2- 
(/ert-bu toxycarbonyl)-l,2 ,3 ,4 -te trahydr0"l-ph thalazinecarboxylic  acid m ethyl ester (118) (118 
mg, 0.31 mmol, 56%) as a colorless oil, Ry 0.35 and 3-benzyl-3 ,4-d ihydro-l-ph thalazinecarboxylic  
acid m ethyl ester (119) (35 mg, 0.12 mmol, 22%) as a colorless oil, /?ƒ 0.32.118: IR v 1735, 1670,1130, 
690; *H NMR (200 MHz) 8 (some signals appear as rotamers) 1.52,1.53 (s, 9 H, ( C /^ C ) ,  3.30-4.50 (br m, 7
H, C02CH3, C//2Ph and NCH^, 5.40, 5.60 (br s, 1 H, NCH), 7.00-7.50 (m, 9 H, ArH); 13C NMR (63 MHz)
8 28.4 ((CH3)3C), 52.4 (C02CH3), 52.8 (NCH), 55.6 (NCH-j), 59.1 (CH2Ph), 81.3 ((CH3)3Q , 126.1, 127.4,
127.9, 128.3,129.4,131.7 (ArH), 132.0, 136.1,138.0 (ArC), 171.5 (C(0)). 119: IR v 1700, 1435,1135,690; 
]H NMR (200 MHz) 8 3.94 (s, 3 H, C 02CH3), 4.08 (s, 2 H, NCH2), 4.69 (s, 2 H, Cff2Ph), 6.89-6.94 (m, 1
H, ArH), 7.23-7.40 (m, 7 H, ArH), 8.08-8.13 (m, 1 H, ArH).
l-B enzyl-2-(/er/-butoxycarbonyl)-5-chlorohexahydro-l/T -diazepine-3-carboxylic acid m ethyl 
ester (120). According to the general procedure D, a solution of 64 (76 mg, 0.21 mmol) in CH2CI2 (3 mL) 
was treated with B0C2O (105 |lL, 0.46 mmol), Pd(PPh3)4 (7.2 mg, 6.2-10'^ mmol) and n-B^SnH (60 pL, 0.23 
mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:4) afforded 120 (51 mg, 0.13 
mmol, 64%) as a colorless oil, /?ƒ 0.50. IR v 1740,1680,690; lH NMR (200 MHz) 8 1.38 (s, 9 H, (CH3)3C),
I.45-1.65 (m, 2 H, 2 x H6), 2.19 (dd, J  = 12.8, 8.9 Hz, 1 H, H4), 2.59 (ddd, J  = 13.0, 9.3, 7.0 Hz, 1 H, H4),
3.20-3.55 (m, 3 H, H5 and 2 X H7), 3.68 (d, J = 12.3 Hz, 1 H, CtfHPh), 3.80 (s, 3 H, C 02CH3), 4.13 (d, J  =
13.0 Hz, 1 H, CHtfPh), 4.50 (t, J  = 8.8 Hz, 1 H, H3), 7.22-7.44 (m, 5 H, ArH); 13C NMR (50 MHz) 8 (two 
diastereomers) 28.2 ((C H ^C ), 30.5, 34.4, 36.0, 35.9 (C4 and C6), 41.9 (C7), 52.4 (C02CH3), 59.5 (C3), 60.2 
(C5), 61.4 (CH2Ph), 80.6 ((CH3)3C), 127.3, 128.1, 129.8 (ArH), 137.6 (ArC), 173.4 (C(O)); MS (El, 70 eV) 
miz (relative intensity) 382 (M+, 3), 327 (20), 281 (58), 163 (10), 91 (100).
4
re /-(3 /? ,5S )-2-(/tfr/-B utoxyearbonyl)-5“C hlorom ethyl-3-pyrazolid inecarboxylic acid m ethyl
ester (121). A mixture of 110 (120 mg, 0.33 mmol), Pd/C (30 mg of 10% Pd on C, 0.03 mmol) and a few 
drops of a 1 M HCl/MeOH solution in MeOH (10 mL) was stirred under a ^-atmosphere for 1 h. After filtration
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over Cclite, the solution was concentrated in vacuo, taken up in aq satd NaHCC>3 (20 mL) and extracted with 
CH2Cl2 (3 x 20 mL). The combined organic layers were dried (MgSO^), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1) to afford 121 (81 mg, 0,29 mmol, 90%) white solid, mp 45-47 *C, 
R f  0.15. IR v 1740,1705,1365,1130; !H NMR (200 MHz) 8 1.45 (s, 9 H, (C H ^C ), 2.23 (ddd, J  = 13.2, 7.1, 
5.1 Hz, 1 H, H4), 2.54 (ddd, J  = 13.2,9.2,4.4 Hz, 1 H, H4), 3.43 (dd, ƒ = 11.2,7.3 Hz, 1 H, CHHC1), 3.60 (dd, 
J  = 11.2,4.8 Hz, 1 H, CHtfCl), 3.75 (s, 3 H, C 02CH3), 3.66-3.77 (m, 1 H, H5), 4.59 (dd, J  = 4.9,9.1 Hz, 1
H, H3); 13C NMR (50 MHz) 8 28.3 ((C H ^C ), 35.7 (C4), 44.9 (CH2C1), 52.4 (C02CH3), 59.0, 59.2 (C3 and 
C5), 81.1 ((CHo}oC); MS (El, 70 cV) mlz (relative intensity) 178 (NfMOO, 90), 119 (100), 95 (45), 91 (100), 
69 (60).
Crystallographic data.
Tetragonal, P-Alxc, a = 17.4709(7), b = 17.4709(7), c = 9.695 A, a = p = y  = 90 \ V = 2959.3(2) A3, Z ■ 8, Dx 
= 1.25 gem’3, X(CuKa) = 1.5418 A, |i(CuKa) = 23.98 cm"1, F(000) = 1184, rt. Final R = 0.076 for 1164 
observed reflections.
The numbering of the atoms in Tables 7.3 and 7.4 is as shown in the following structure:
PH2ci
N2 1 r
Table 7.3. Bond distances of the atoms (A), with standard deviations in parentheses.
C1-C4 1.777(8) C7-N1 1.337(8) C2-H21 1.07(6) C9-H92 1.10(4)
C1-C2 1.553(9) C7-03 1.193(8) C2-H22 1.11(3) C9-H93 1.07(7)
C1-C4 1.51(1) C7-04 1.366(7) C3-H3 1.06(4) C10-H101 1.09(5)
C1-N2 1.467(8) C8-C9 1.49(1) C4-H41 1.07(4) C10-H102 1.08(4)
C2-C3 1.548(9) C8-C10 1.52(1) C4-H42 1.08(6) C10-H103 1.08(4)
C3-C5 1.496(9) C8-C11 1.51(1) C6-H61 1.08(7) C ll-H lll 1.10(3)
C3-N1 1.441(8) C8-04 1.489(8) C6-H62 1.10(4) C11-H112 1.09(4)
C5-01 1.21(1) N1-N2 1.420(6) C6-H63 1.09(6) C l1-HI13 1.07(5)
C5-02 1.306(9) Cl-HI 1.05(4) C9-H91 1.08(5) N2-H2 1.06(5)
C6-02 1.47(1)
Table 7.4. Bond angles of the atoms Q , with standard deviations in parentheses.
C2-C1-C4 113.6(5) C1-N2-N1 103.4(4) H6I-C6-H63 90(5)
C2-C1-N2 104.4(5) C5-02-C6 114.5(6) H62-C6-H63 145(5)
C4-C1-N2 107.2(5) C7-04-C8 121.1(5) C8-C9-H91 100(3)
C1-C2-C3 103.0(5) C2-C1-H1 106(2) C8-C9-H92 99(4)
C2-C3-C5 108.9(5) C4-C1-H1 111(3) C8-C9-H93 98(4)
C2-C3-N1 103.1(5) N2-C1-H1 115(2) H91-C9-H92 128(5)
C5-C3-N1 115.8(6) C1-C2-H21 97(4) H91-C9-H93 115(6)
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CI-C4-C1 112.2(5) C1-C2-H22 107(3) H92-C9-H93 110(5)
C3-C5-01 121.5(7) C3-C2-H21 107(4) C8-C10-H101 99(3)
C3-C5-02 114.4(6) C3-C2-H22 113(3) C8-C10-H102 103(3)
01-C5-02 124.1(7) H21-C2-H22 126(5) C8-C10-H103 105(3)
N1-C7-03 126.4(6) C2-C3-H3 122(3) H101-C10-H102 115(4)
N1-C7-04 107.7(5) C5-C3-H3 106(2) H101-C10-H103 123(4)
03-C7-04 125.8(6) N1-C3-H3 101(3) H102-C10-H103 109(4)
C9-C8-C10 110.0(6) C1-C4-H41 94(3) C8-C11-H111 102(4)
C9-C8-C11 112.0(6) C1-C4-H42 118(4) C8-C11-H112 105(2)
C9-C8-04 109.0(5) C1-C4-H41 116(3) C8-C11-H113 115(3)
C10-C8-C11 113.0(6) C1-C4-H42 101(4) H111-C11-H112 110(5)
C10-C8-04 102.3(5) H41-C4-H42 118(5) H111-C11-H113 129(6)
C11-C8-04 110.1(5) 02-C6-H61- 95(4) H112-C11-H113 94(4)
C3-N1-C7 126.5(5) 02-C6-H62 97(3) C1-N2-H2 107(4)
C3-N1-N2 114.3(4) 02-C6-H63 100(4) N1-N2-H2 108(4)
C7-N1-N2 118.9(5) H61-C6-H62 118(5)
r e / - ( 3 / ? ,4 S ,5 iS ) - 2 - ( / e r f - B u to x y c a r b o n y I ) - 5 - c h lo r o m e th y l - 4 * ( t r im e th y l s i ly l ) - 3 -  
pyrazolidinecarboxylic acid methyl ester (122). A mixture of 111 (275 mg, 0.63 mmol), Pd/C (67 mg 
of 10% Pd on C, 0.06 mmol) and a few drops of a 3 M HCl/MeOH solution in MeOH (7 mL) was stirred under a 
^-atmosphere for 45 min. After filtration over Celite, the solution was concentrated in vacuo, taken up in aq satd 
NaHCC>3 (10 mL) and extracted with CH2CI2 (3 x 10 mL). The combined organic layers were dried (MgSO^J, 
filtered, concentrated in vacuo and chromatographed (ethyl acetate/hexane 1:2) to afford 122 (178 mg, 0.51 mmol, 
81%) as a colorless oil, 0.50. IR v 1735, 1700,1250,840; *H NMR (200 MHz) 8 0.10 (s, 9 H, (CH3)3Si),
1.45 (s, 9 H, (CH3)3C), 1.84 (t, 7 = 9 .0  Hz, 1 H, H4), 3.57-3.84 (m, 6 H, C 02CH3, H5 and CH2C1), 4.65 (d, 
J  = 8.8 Hz, 1 H, H3); 13C NMR (50 MHz) 8 1.7 ((CH3)3Si), 28.2 ((CH3)3C), 36.1 (C4), 45.2 (CH2C1), 51.8 
(C02CH3), 60.6 (C3), 63.0 (C5), 81.1 ((CH3)3C), 153.2, 172.0 (2 x C(0)); MS (El, 70 eV) m il (relative 
intensity) 350 (M+, 8), 279 (9), 250 (100), 191 (47), 185 (19), 133 (18); HRMS calcd for C14H27N20 4ClSi 
350.1429, found 350.1468.
2 -(/e rf-B u to x y carb o n y l)-5 -ch lo ro h ex ah y d ro -l//-d iazep in e-3 -carb o x y lic  acid  m ethyl e s te r
(123). A mixture of 120 (40 mg, 0.10 mmol), Pd/C (11 mg of 10% Pd on C% 0.01 mmol) and one drop of a 3 
M HCl/MeOH solution in MeOH (5 mL) was stirred under a ^-atmosphere for 1 h. After filtration over Celite, 
the solution was concentrated in vacuo, taken up in aq satd NaHCOg (10 mL) and extracted with CH2CI2 (3 x 10 
mL). The combined organic layers were dried (MgSO^, filtered, concentrated in vacuo and chromatographed (ethyl 
acetate/hexane 1:2) to afford 123 (20 mg, 0,065 mmol, 65%) as a colorless oil, Ry 0.25, IR v 3450,1720,1685; 
*H NMR (200 MHz) 8 1.45 (s, 9 H, (CH3)3), 1.69-1.84 (m, 2 H, 2 x H6), 2.19-2.27 (m, 2 H, 2 x H4), 3.53- 
3.78 (m, 3 H, H5 and 2 x H7), 3.75 (s, 3 H, C02CH3), 4.50-4.63 (m, 1 H, H3); l3C NMR (50 MHz) 8 28.0 
((CH3)3C), 30.5, 35.6, 35.8, 38.2, 38.3 (C4 and C6), 42.0 (C7), 52.1 (C02CH3), 56.0, 56.5 (C5), 58.8 (C3),
80.9 ((CH3)3C), 172.7 (C(O)); MS (El, 70 eV) mh  (relative intensity) 292 (M+, 6), 236 (8), 192 (20), 175 (13), 
167 (23), 153 (27), 131 (100).
r£/-(3/?,5i$)-5-chlorom ethyl-3-pyrazolidinecarboxylic acid hydrogen chloride (127). A solution 
of 121 (30 mg, 0.11 mmol) in 2 M HC1 was heated at 60 *C for 2 h and concentrated in vacuo to afford 127 (18
182
Synthesis o f cyclic a-hydrazino acid derivatives
mg, 0.090 mmol, 82%) as a viscous yellow oil. NMR (200 MHz, D2O) 5 2.46 (dt, /  = 13.8, 8.4 Hz, 1 H, 
H4), 2.67 (ddd, /  = 4.5,7.8,13.9 Hz, 1 H, H4), 3.74 (dd, /  = 7.5,12.4 Hz, 1 H, C//HC1), 3.90 (dd ,/=  3.8,12.3 
Hz, 1 H, CH//C1), 4.08-4.20 (m, 1 H, H5), 4.49 (dd, J  = 4.4, 8.9 Hz, 1 H, H3); 13C NMR (50 MHz, D20) 8
34.9 (C4), 44.8 (CH2C1), 62.4, 62.6 (C3 and C5), 174.5 (C(0)).
2 -(A Ily loxycarbo n y l)-l-b en zy l-5 -o x o h ex ah y d ro -3 -p y rid az in ecarb o x y lic  acid  m ethyl este r 
(128). A solution of 73 (75 mg, 0.18 mmol) and H20  (16 \iLt 0.90 mmol) in xylenes (3 mL) was heated in a 
sealed tube for 10 min at 170 *C. Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:2) 
afforded 128 (44 mg, 0.13 mmol, 74%) as a colorless oil, R t  0.35. IR v 1730,1710,1690,690; *H NMR (200 
MHz) 8 2.75-3.10 (m, 2 H, 2 x H4), 3.35-3.65 (m, 2 H, 2 X H6), 3.74 (s, 3 H, C 02CH3), 4.15-4.40 (m, 2 H, 
Ctf2Ph), 4.69 (d, J  = 5.6 Hz, 2 H, OCH2), 5.01 (t, J  = 6.8 Hz, 1H, H3), 5.25-5.40 (m, 2 H, =CH2), 5.86-6.03 
(m, 1 H, =CH), 7.18-7.34 (m, 5 H, ArH); 13C NMR (63 MHz) 8 38.8 (C4), 53.0 (C02CH3), 56.9 (C3), 59.9 
(CH2Ph), 61.4 (C6), 76.3 (OCH2), 118.8 (=CH2), 128.1, 128.7, 129.2 (ArH), 132.3 (=CH), 136.8 (=CH), 
171.3, 204.4 (2 x C(0)); MS (El, 70 eV) m/z (relative intensity) 332 (M+, 11), 302 (12), 273 (7), 169 (6), 150 
(22), 105 (30), 91 (100); HRMS calcd forC17H20N2O5 332.1372, found 332.1364.
R eduction  of 128. To a solution of 128 (44 mg, 0.13 mmol) in MeOH (2 mL) was added at -10 #C NaEtffy 
(5.5 mg, 0.151 mmol) and the mixture was stirred at -10 *C for an additional h. The mixture was poured into aq 
satd NaHCO^ (10 mL) and extracted with CH2CI2 (3 x 10 mL). The combined organic layers were dried
(MgSC>4), filtered, concentrated in vacuo and chromatographed to yield rW -(3S,5S )-2-(ally loxy car bony l)- 
l-benzyl-5-hydroxyhexahydro-3-pyridazinecarboxylic acid m ethyl ester (cfc-130) (36 mg, 0.108 
mmol, 82%) and trans-130 (6 mg, 0.018 mmol, 13%) as a colorless oil, Ry 0.35. cw-130: IR v 3450, 1730, 
1680, 690; JH NMR (200 MHz) 8 1.95-2.07 (m, 1 H, H4), 2.37-2.44 (m, 1 H, H4), 2.81-3.05 (m, 2 H, 2 x 
H6), 3.73 (s, 3 H, C02CH3), 3.89 (m, 1 H, H5), 4.17 (d, J  = 11.9 Hz, 1 H, CHHPh), 4.55 (d, J  = 12.8 Hz, 1 H, 
CHtfPh), 4.70 (m, 2 H, OCH2), 4.96 (s, 1 H, H3), 5.25-5.41 (m, 2 H, =CH2), 5.92-6.06 (m, 1 H, =CH), 7.21- 
7.39 (m, 5 H, ArH); 13C NMR (63 MHz) 8 31.5 (C4), 52.7 (C02CH3), 53.0 (C6), 59.5 (CH2Ph), 63.7 (C3), 
66.5 (OCH2), 118.0 (=CH2), 127.3, 128.3, 129.2 (ArH), 132.4 (=CH), 138.0 (AiC), 156.0, 173.0 (C(0)); MS 
(El, 70 eV) m h  (relative intensity) 334 (M+, 92), 276 (30), 250 (72), 211 (28), 207 (21), 162 (32), 106 (93), 91 
(100); HRMS calcd for C17H22N20 5 334.1529, found 334.1551. trans-130: IR v 3450, 1730,1680, 690; !H 
NMR (200 MHz) 8 1.50-1.80 (m, 2 H, H4), 2.90 (m, 1 H, H6), 2.97 (dd, J  = 12.8,4.5 Hz, 1 H, H6), 3.77 (s, 3 
H, C 02CH3), 4.00-4.30 (m, 3 H, NCH2 and H5), 4.70 (m, 2 H, OCH2), 5.09 (m, 1 H, H3), 5.24-5.41 (m, 2 H, 
=CH2), 5.90-6.06 (m, 1 H, =CH), 7.21-7.31 (m, 5 H, ArH); 13C NMR (50 MHz) 8 33.5 (C4), 52.4 (C02CH3),
53.9 (C6), 59.3 (NCH2), 63.7 (C3), 66.9 (OCH2), 118.2 (=CH2), 127.4, 128.3, 128.7 (ArH), 132.4 (=CH),
138.0 (AiC), 157.2,172.0 (C(0)); MS (El, 70 eV) m/z (relative intensity) 334 (M+, 15), 278 (10), 244 (9), 222 
(100), 183 (160,155 (18), 118 (17), 91 (26).
rc/-(lS ,S S)-3-B enzyl-6-oxa-2 ,3-d iazabicyclo[3 .2 .1]octan-7-one-2-carboxyIic acid allyl ester 
(131). A solution of cw-130 (194 mg, 0.58 mmol) and pTSA  (6.6 mg, 0.03 mmol) in toluene (8 mL) was 
refluxed under azeotropic removal of MeOH for 2 h. The solution was poured into H2O (10 mL) and extracted 
with CH2CI2 (3 x 1 0  mL). The combined organic layers were dried (MgS04), filtered, concentrated in vacuo and 
chromatographed (ethyl acetate/hexane 1:1.5) to afford 131 (100 mg, 0.33 mmol, 57%) as a colorless oil, R j
0.30. IR v 1790,1700, 690; XH NMR (200 MHz) 8 2.10 (d, J  = 12.2 Hz, 1 H, H4), 2.38-2.47 (m, 1 H, H4), 
3.03 (dd ,J=  14.0, 2.3 Hz, 1 H, H8), 3.17 (d ,7 =  13.8 Hz, 1 H, H8), 4.26 (d, J=  13.1 Hz, 1 H, CtfHPh), 4.38 
(d, J  = 13.1 Hz, 1 H, CHHPh), 4.64 (d, J  = 5.6,2 H, OCH^, 4.74 (m, 1 H. H5), 4.93 (t, J  = 4.5 Hz, 1 H, HI),
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5.23-5.37 (m, 2 H, =CH2), 5.83-6.00 (m, 1 H, =CH), 7.22-7.43 (m, 5 H, ArH); 13C NMR (50 MHz) 8 36.5 
(C8), 46.7 (C5), 50.9 (C4), 54.2 (Cl), 61.9 (CH2Ph), 67.0 (OCH2), 118.5 (=CH2), 127.6,128.3,129.1 (ArH),
132.1 (=CH), 137.2 (AiC), 155.2,172.7 (C(0)); MS (El, 70 eV) mlz (relative intensity) 302 (M+, 30), 218 (24), 
173 (4), 139 (5), 120 (7), 91 (100); HRMS calcd for C16H18N20 4 302.1267, found 302.1294.
re l-( lS  ,55)-3-B enzyl-6-oxa-2 ,3-d iazabicyclo[3 .2 .1]octan-7-one-2-carboxylic acid  te r t-bu ty l 
ester (132). According to the general procedure D, a solution of 131 (20 mg, 0.066 mmol) in CH2CI2 (1 mL) 
was treated with B0C2O (33 t^L, 0.015 mmol), PdiPPhg^ (2 mg, 2-10*^ mmol) and w-BugSnH (19 |iL, 0.073 
mmol). Concentration in vacuo and flash chromatography (ethyl acetate/hexane 1:1) afforded 132 (7 mg, 0.022 
mmol, 33%) as a light yellow oil, R* 0.55. IR v 1785, 1700, 690; JH NMR (200 MHz) 8 1.49 (s, 9 H, 
(CH3)3C), 2.06 (d, J -  12.2 Hz, 1 H, H8), 2.30-2.45 (m, 1 H, H8), 2.90-3.05 (m, 1 H, H4), 3.15 (d, J  = 13.4 
Hz, 1 H, H4), 4.25 (d, J  = 13.1 Hz, 1 H, O/HPh), 4.38 (d, J  = 13.1 Hz, 1 H, CHHPh), 4.66-4.68 (m, 1 H, H5), 
4.89 (t, J = 4.2 Hz, 1 H, HI), 7.26-7.42 (m, 5 H, ArH); 13C NMR (50 MHz) 8 28.3 ((CH3)3C), 36.6 (C8),
50.8 (C4), 61.6 (CH2Ph), 82.0 ((CH3)3C), 127.5, 128.3, 129.0 (ArH), 137.6 (ArC); MS (El, 70 eV) m lz  
(relative intensity) 318 (M+, 1), 218 (87), 167 (19), 149 (12), 127 (15), 91 (100); HRMS calcd for 
C 17H22N2°4 318.1580, found 318.1593.
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SYNTHESIS OF CYCLIC HYDRAZINES AND a-HYDRAZINO ACID
DERIVATIVES VIA N-ACYLHYDRAZONIUM IONS
This thesis describes the reactivity and application of the different types of N~ 
acylhydrazonium ions A-E as intermediates in the synthesis of cyclic hydrazine derivatives. An 
important difference from the corresponding well-known N-acyliminium ions is the presence of 






A B C R" = H E
D R" = C02Me
In Chapter 1 a literature survey is presented on the properties and recent applications of 
organic hydrazine derivatives in various fields of chemistry* Furthermore, some general 
information is provided about the reactivity of different types of iminium ions*
In Chapter 2 cyclization reactions via the N,N’ -diacylhydrazonium ions A are described, 
leading to protected monofunctionalized cyclic hydrazines. A typical example is shown in eq 1, 
















Remarkably, these cyclizations provide higher yields of seven-membered rings than of 
six-membered rings. This is probably due to a more strained transition state in the latter case as a 
result of the vicinal carbamate functions. Compared with cyclization reactions of the 
corresponding N-acyliminium ions, more strongly acidic conditions (TiCl^) are required to form 
the reactive intermediates. This is in accord with the expected more difficult formation of the 
hydrazonium ions as a result of the destabilizing effect of the nitrogen substituent.
Chapter 3 reports a search for a convenient method to deprotect cyclic hydrazines which 
are protected with an allyloxycarbonyl (Alloc) function. Palladium(0)-catalyzed cleavage of the 
Alloc group in the presence of the hydride donor n-Bu3SnH initially furnishes a ditin carbamate, 
which can either be cleaved with an acid to give the (protonated) free hydrazine or be reacted 
with an activated carbonyl compound to form a new amide bond. An example of the latter
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possibility is shown in eq 1, in which the cyclic ketone 2 is ‘ transprotected ’ to give the 
monoprotected product 3 *
Chapter 4 deals with the synthesis of various bridged bicyclic hydrazines such as 5 and 
7 (eqs 2 and 3). These compounds are obtained upon cyclization of the corresponding 
precursors 4 and 6 via the endocyclic N-acylhydrazonium ions B. The strong Lewis acid TiCl4 
also provides the best results in these types of cyclization reactions, except in the case of silicon 
nucleophiles. This methodology provides an effective route for the synthesis of different [3.2.1] 











A comparable strategy is utilized for the synthesis of some azatropane derivatives as 
described in Chapter 5. In order to introduce the desired functionalities, a protected p-ketoester 
is used as a nucleophile in the cyclization reaction. Cyclization of 8 leads to a high yield of the 
desired cyclization product 9 (eq 4), which is converted into different azatropane derivatives 









In Chapter 6 the synthesis of bicyclic hydrazines via the exocyclic N-acylhydrazonium 
ions C and D are described. Examples of both cases are shown in eq 5, in which the bicyclic 
hydrazine 13 and the bicyclic a-hydrazino ester 14 are formed. Cyclization reactions to form
5,5- and 5,6-bicyclic pyrazolidinones occur in good yields, if the initially formed cationic 






1 1 R = H, X = OMe 
12 R = COzMe, X = OAc
13 R = H
14 R -  CQ^ Me
(eq 5)
Cyclization reactions via the N-acylhydrazonium intermediates E are described in 
Chapter 7. A remarkable example is shown in eq 6, in which cyclization of the allyl precursor 
15 only affords the five-membered rings 18, whereas a six-membered ring is expected. The 
formation of the five-membered rings is explained by assuming the intermediacy of the 
aziridinium ion 17, which is formed by stabilization of the carbocation 16 via the amine nitrogen 
atom. Nucleophilic ring opening then gives the pyrazoiidines 18*
. * COpMe















In general, it is found that such a ring contraction takes place if the initially formed cationic 
intermediate is not properly stabilized by a substituent. A preference for the formation of five- 
membered rings is also observed in some other cyclization reactions, giving only the 5-exo 
product, while the 6-endo product is expected.
In contrast with the cyclization reactions discussed in the previous Chapters, in these 
cases higher yields are obtained if the milder Lewis acids SnCl4 and Et2AlCl are used. Various 
protected five- and six-membered a-hydrazino esters can be synthesized via this method. The 
formation of six-membered rings opens a route to precursors of naturally occurring piperazic 
acids (hexahydro-3-pyridazinecarboxylic acids). The cyclization product 19 (eq 7) can be 
converted into the ketoester 20 , which upon reduction and transprotection affords the fully 
protected 5-hydroxypiperazic acid 2 1 ,
Alloc
Me02C
B f l  (10 equiv)







SYNTHESE VAN CYCLISCHE HYDRAZINEN EN a-HYDRAZINOZUUR
DERIVATEN VIA N-ACYLHYDRAZONIUMIONEN
In dit proefschrift worden de reakdviteit en toepassingen van de verschillende N-acyl- 
hydrazoniumionen A-E beschreven als inteimediairen in de synthese van cyclische hydrazine- 
derivaten. Een belangrijk verschil met de overeenkomstige N-acyliminiumionen is de aanwezig­
heid van een elektronenzuigend stikstofatoom dat het iminiumion extra destabiliseert.





R02C ^ ^ C° zMe
A B C R" = H E
D R" = C02Me
Hoofdstuk 1 omvat een literatuuronderzoek naar eigenschappen en recente toepassingen 
van organische hydrazinederivaten in uiteenlopende richtingen. Tevens wordt ingegaan op een 
aantal eigenschappen van verschillende soorten iminiumionen.
In Hoofdstuk 2 worden cyclisatiereakties via de N,N’ -diacylhydrazonium intermediaiien 
A beschreven, die leiden tot beschermde, monogesubstitueerde, cyclische hydrazinen. Een 
illustratief voorbeeld is weergegeven in vgl 1, waar cyclisatie van de butynylprecursor 1 leidt tot 
het cyclische keton 2 .
^  Pd(PPh3)4
A l l o c ^ ^ ^  HCOOH W0° ' A  o  «-Bu3SnH,
Alloc"Nv^ 'OR' Alloc" ^ — ' Bo&jO,
i  2 ch2q 2
(vgl. 1)
3
Opvallend aan deze cyclisatiereakties is de relatief gemakkelijke vorming van zevenringen 
vergeleken met zesringen. Dit wordt waarschijnlijk veroorzaakt door een meer gespannen 
overgangstoestand in het geval van de zesringen als gevolg van spanning tussen de twee 
carbamaatgroepen. Verder blijkt dat, vergeleken met cyclisaties van overeenkomstige N- 
acyliminiumionen, sterkere Lewiszuren (zoals TiC^) een beter resultaat geven. Dit komt overeen 
met de te verwachten moeilijkere vorming van de reaktieve intermediairen door de aanwezigheid 
van de destabiliserende stikstofsubstituent.
Hoofdstuk 3 omvat onderzoek naar het ontwikkelen van een geschikte methode om 
hydrazinen, die met een allyloxycarbonyl (Alloc) groep zijn beschermd te ontschertnen. Een 
Pd(0)~gekatalyseerde splitsing van de allylcarbamaten in aanwezigheid van de hydridedonor n-
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Samenvatting
B113S11H geeft een ditincarbamaat, dat vervolgens of onder invloed van zuur het (geprotoneerde) 
vrije hydrazine geeft, of met een geactiveerde carbonylverbinding kan reageren onder vorming 
van een amidebinding. Een voorbeeld van de laatste reaktie is weergegeven in vgl. 1, waarbij 
‘ transprotectie’ van het keton 2 leidt tot het monobeschermde produkt 3.
In Hoofdstuk 4 wordt de synthese behandeld van verschillende gebrugde hydrazinen 
zoals 5 en 7 (vgl. 2 en 3). De synthese van deze verbindingen verloopt door cyclisatie van de 
overeekomstige precursors 4 en 6 via de endocyclische N-acylhydrazoniumionen B. Ook in dit 
type cyclisatiereakties blijkt het sterke Lewiszuur TiCl4 de beste resultaten te geven, behalve in 
het geval van siliciumnucleofielen. Het gebruik van mierezuur leidt niet in alle gevallen tot 














Dezelfde methode wordt tevens in Hoofdstuk 5 toegepast in de synthese van een aantal 
azatropaanderivaten. Voor het invoeren van verschillende functionaliteiten wordt gebruik 
gemaakt van een beschermde p-ketoester als nucleofxele zij keten. Cyclisatie van de precursor 8 
leidt in hoge opbrengst tot het gewenste cyclisatieprodukt 9, dat uiteindelijk onder meer kan 
worden omgezet in het azatropaanderivaat 10. Pogingen om precursors te cycliseren waar de 
geminale methylsubstituenten ontbreken, verliepen zonder succes.







In Hoofdstuk 6 wordt de synthese beschreven van bicyclische hydrazinen via de 
exocyclische N-acylhydrazoniumionen C en D. Voorbeelden van beide zijn de cyclisaties tot 13 
en 14 (vgl. 5), waarbij in het laatste geval een bicyclisch oc-hydrazinozuur wordt gevormd.
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H, X = OMe 




13 R = H
1 4 R = C 0 2 M e
Cyclisaties tot 5,5- en 5,6-bicyclische pyrazolidines verlopen in goede opbrengsten, indien het 
initieel gevormde carbokation in voldoende mate door subsütuenten wordt gestabiliseerd
Cyclisatiereakties via de N-acylhydrazoniumionen E staan centraal in Hoofdstuk 7. Een 
kenmerkend voorbeeld is weergegeven in vgl. 6, waarbij na cyclisatie van de allylprecursor 15 
slechts vijfring gevonden wordt. Deze vijfringvorming wordt verklaard door aanname van het 
aziridinium intermediair 17, dat ontstaat door stabilisatie via het amine-stikstofatoom van het 














In het algemeen wordt gevonden dat, indien het primair gevormde kation niet door een 
substituent wordt gestabiliseerd, een dergelijke ringcontractie optreedt Verder blijkt ook in een 
aantal andere cyclisatiereakties een opmerkelijke voorkeur voor 5-exo- boven 6-endo-cyclisatie 
op te treden.
In tegenstelling tot de in eerdere hoofdstukken besproken cyclisatiereakties, blijken in 
deze gevallen mildere Lewiszuren zoals SnCl^ en Et2AlCl de hoogste opbrengsten te geven. 
Diverse beschermde vijf- en zesring a-hydrazinozuren kunnen via deze methode worden 
gesynthetiseerd. De vorming van zesringen opent een route naar precursors van natuurlijke 
piperazinezuren (hexahydro-3-pyridazinecarbonzuren). Het cyclisatieprodukt 19 (vgl. 7) kan 
worden omgezet in de ketoester 20, die vervolgens na reduktie en transprotectie het volledig 
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